<SEC-DOCUMENT>0001683168-25-004372.txt : 20250610
<SEC-HEADER>0001683168-25-004372.hdr.sgml : 20250610
<ACCEPTANCE-DATETIME>20250610145804
ACCESSION NUMBER:		0001683168-25-004372
CONFORMED SUBMISSION TYPE:	S-1
PUBLIC DOCUMENT COUNT:		22
FILED AS OF DATE:		20250610
DATE AS OF CHANGE:		20250610

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Forward Industries, Inc.
		CENTRAL INDEX KEY:			0000038264
		STANDARD INDUSTRIAL CLASSIFICATION:	PLASTICS PRODUCTS, NEC [3089]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		EIN:				131950672
		STATE OF INCORPORATION:			NY
		FISCAL YEAR END:			0930

	FILING VALUES:
		FORM TYPE:		S-1
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-287906
		FILM NUMBER:		251036831

	BUSINESS ADDRESS:	
		STREET 1:		700 VETERANS MEMORIAL HWY, SUITE 100
		CITY:			HAUPPAUGE
		STATE:			NY
		ZIP:			11788
		BUSINESS PHONE:		631-547-3055

	MAIL ADDRESS:	
		STREET 1:		700 VETERANS MEMORIAL HWY, SUITE 100
		CITY:			HAUPPAUGE
		STATE:			NY
		ZIP:			11788

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	FORWARD INDUSTRIES INC
		DATE OF NAME CHANGE:	19950105

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PROGRESS HEAT SEALING CO INC
		DATE OF NAME CHANGE:	19721111
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-1
<SEQUENCE>1
<FILENAME>forward_s1.htm
<DESCRIPTION>FORM S-1
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:us-roles="http://fasb.org/us-roles/2025" xmlns:country="http://xbrl.sec.gov/country/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:FORD="http://forwardindus.com/20250528">
<head>
     <title>Forward Industries, Inc. S-1</title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02E_US%2DGAAP%2D2025 -->
<!-- Field: Set; Name: xdx; ID: xdx_03A_FORD_forwardindus.com_20250528 -->
<!-- Field: Set; Name: xdx; ID: xdx_04D_20250528_20250528 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_056_edei%2D%2DEntityCentralIndexKey_0000038264 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2025-05-28" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2025-05-28" id="Fact000004" name="dei:EntityCentralIndexKey">0000038264</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="ford-20250528.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2025-05-28">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000038264</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-05-28</xbrli:startDate>
        <xbrli:endDate>2025-05-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-size: 7pt"><a href="#s1_001">Table of Contents</a></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>As filed with the Securities and Exchange Commission
on June 10, 2025</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><b>Registration No. 333</b>-[<span style="font-family: Symbol">&#183;</span>]</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>UNITED STATES SECURITIES AND EXCHANGE COMMISSION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Washington, D.C. 20549</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FORM <span id="xdx_900_edei--DocumentType_c20250528__20250528_zZFwTTueLdO4"><ix:nonNumeric contextRef="AsOf2025-05-28" id="Fact000009" name="dei:DocumentType">S-1</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>REGISTRATION STATEMENT UNDER THE SECURITIES
ACT OF 1933</b></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1pt solid; width: 100%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><img src="image_001.jpg" alt="" style="height: 95px; width: 174px"/></b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="xdx_904_edei--EntityRegistrantName_c20250528__20250528_zeuqQSMg2lZ6" style="font-size: 12pt"><b><ix:nonNumeric contextRef="AsOf2025-05-28" id="Fact000010" name="dei:EntityRegistrantName">Forward
    Industries, Inc.</ix:nonNumeric></b></span></p></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center; font-size: 10pt">(Exact Name of Registrant As Specified In Its Charter)</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1pt solid; width: 32%; text-align: center"><b><span id="xdx_902_edei--EntityIncorporationStateCountryCode_c20250528__20250528_zv9OoYj0wM7e"><ix:nonNumeric contextRef="AsOf2025-05-28" format="ixt-sec:stateprovnameen" id="Fact000011" name="dei:EntityIncorporationStateCountryCode">New York</ix:nonNumeric></span></b></td>
    <td style="padding-bottom: 1pt; width: 2%; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 32%; text-align: center"><b>8711</b></td>
    <td style="padding-bottom: 1pt; width: 2%; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 32%; text-align: center"><b><span id="xdx_90D_edei--EntityTaxIdentificationNumber_c20250528__20250528_zEmTBZu7oPHf"><ix:nonNumeric contextRef="AsOf2025-05-28" id="Fact000012" name="dei:EntityTaxIdentificationNumber">13-1950672</ix:nonNumeric></span></b></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center">(State Or Other Jurisdiction Of Incorporation Or Organization)</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">(Primary Standard Industrial<br/>
Classification Code Number)</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">(I.R.S. Employer<br/>
Identification Number)</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 100%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_902_edei--EntityAddressAddressLine1_c20250528__20250528_zzqtO2Ka6jg"><ix:nonNumeric contextRef="AsOf2025-05-28" id="Fact000013" name="dei:EntityAddressAddressLine1">700 Veterans Memorial Highway</ix:nonNumeric></span></b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_903_edei--EntityAddressAddressLine2_c20250528__20250528_ztSLyvW4GrW7"><ix:nonNumeric contextRef="AsOf2025-05-28" id="Fact000014" name="dei:EntityAddressAddressLine2">Suite 100</ix:nonNumeric></span></b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_90A_edei--EntityAddressCityOrTown_c20250528__20250528_zTh8z9YFbi05"><ix:nonNumeric contextRef="AsOf2025-05-28" id="Fact000015" name="dei:EntityAddressCityOrTown">Hauppauge</ix:nonNumeric></span>, <span id="xdx_909_edei--EntityAddressStateOrProvince_c20250528__20250528_z8QBpOxoj126"><ix:nonNumeric contextRef="AsOf2025-05-28" format="ixt-sec:stateprovnameen" id="Fact000016" name="dei:EntityAddressStateOrProvince">New
    York</ix:nonNumeric></span> <span id="xdx_900_edei--EntityAddressPostalZipCode_c20250528__20250528_z9HCeiqIEcZ7"><ix:nonNumeric contextRef="AsOf2025-05-28" id="Fact000017" name="dei:EntityAddressPostalZipCode">11788</ix:nonNumeric></span></b></p></td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1pt solid; text-align: center; font-size: 10pt"><b><span id="xdx_900_edei--CityAreaCode_c20250528__20250528_ztb3SP5jPQak"><ix:nonNumeric contextRef="AsOf2025-05-28" id="Fact000018" name="dei:CityAreaCode">(631)</ix:nonNumeric></span>&#160;<span id="xdx_903_edei--LocalPhoneNumber_c20250528__20250528_zhnH1IKZs2h7"><ix:nonNumeric contextRef="AsOf2025-05-28" id="Fact000019" name="dei:LocalPhoneNumber">547-3055</ix:nonNumeric></span></b></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center; font-size: 10pt">(Address, Including Zip Code, And Telephone Number, Including Area Code, Of Registrant&#8217;s Principal Executive Offices)</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center; font-size: 10pt">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center; font-size: 10pt"><b>Kathleen Weisberg</b></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center; font-size: 10pt"><b>Chief Financial Officer</b></td></tr>
  <tr style="vertical-align: top">
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>700 Veterans Memorial Highway</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Suite 100</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Hauppauge, New York 11788</b></p></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center; font-size: 10pt"><b>(631)&#160;547-3055 </b></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center; font-size: 10pt">(Name, Address, Including Zip Code, And Telephone Number, Including Area Code, Of Agent for Service)</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">COPIES TO:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><b>Brian S. Bernstein,
Esq.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><b>Brian A. Pearlman,
Esq.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><b>Nason Yeager Gerson
Harris &amp; Fumero P.A.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><b>3001 PGA Blvd., Suite
305</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><b>Palm Beach Gardens,
Florida 33410</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><b>(561) 686-3307</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="border-top: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">APPROXIMATE DATE
OF COMMENCEMENT OF PROPOSED SALE TO THE PUBLIC:</p>

<p style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">As soon as practicable
after this Registration Statement becomes effective.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If any of the securities being registered on this
Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, check the following
box: <span style="font-family: Times New Roman, Times, Serif">&#9746;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If this Form is used to register additional securities
for an offering pursuant to Rule 462(b) under the Securities Act, check the following box and list the Securities Act registration statement
number of the earlier effective registration statement for the same offering. <span style="font-family: Times New Roman, Times, Serif">&#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If this Form is a post-effective amendment filed
pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of
the earlier effective registration statement for the same offering. <span style="font-family: Times New Roman, Times, Serif">&#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If this Form is a post-effective amendment filed
pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of
the earlier effective registration statement for the same offering. <span style="font-family: Times New Roman, Times, Serif">&#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant
is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company.
See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221;
and "emerging growth company" in Rule 12b-2 of the Exchange Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="vertical-align: top; width: 29%; text-align: justify">Large accelerated filer </td>
    <td style="width: 2%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#9744;</span></td>
    <td style="width: 37%; text-align: justify">&#160;</td>
    <td style="vertical-align: top; width: 24%; text-align: justify">Accelerated filer </td>
    <td style="width: 8%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#9744;</span></td></tr>
  <tr>
    <td style="vertical-align: top; text-align: justify"><span id="xdx_904_edei--EntityFilerCategory_c20250528__20250528_zbhVpwr2JXs2"><ix:nonNumeric contextRef="AsOf2025-05-28" format="ixt-sec:entityfilercategoryen" id="Fact000020" name="dei:EntityFilerCategory">Non-accelerated filer</ix:nonNumeric></span> </td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#9746;</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: justify">Smaller reporting company</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90E_edei--EntitySmallBusiness_c20250528__20250528_zLz2xUbz9eR"><ix:nonNumeric contextRef="AsOf2025-05-28" format="ixt:booleantrue" id="Fact000021" name="dei:EntitySmallBusiness">&#9746;</ix:nonNumeric></span></span></td></tr>
  <tr>
    <td style="vertical-align: top; text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: justify">Emerging growth company</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_909_edei--EntityEmergingGrowthCompany_c20250528__20250528_zFmjhQDSs8D5"><ix:nonNumeric contextRef="AsOf2025-05-28" format="ixt:booleanfalse" id="Fact000022" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. <span style="font-family: Times New Roman, Times, Serif">&#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>The registrant hereby amends this registration
statement on such date or date(s) as may be necessary to delay its effective date until the registrant shall file a further amendment
which specifically states that this registration statement shall thereafter become effective in accordance with Section 8(a) of the Securities
Act of 1933, or until the registration statement shall become effective on such date as the Commission acting pursuant to said Section
8(a) may determine.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo; Options: Hidden -->&#160;<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The information in this prospectus is not complete
and may be changed. These securities may not be sold until the registration statement filed with the Securities and Exchange Commission
of which this prospectus is a part becomes effective. This prospectus is not an offer to sell these securities and it is not soliciting
an offer to buy these securities in any state where the offer or sale is not permitted.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Subject to Completion, dated June 10, 2025</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PROSPECTUS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Forward Industries, Inc.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>273,000 Shares of Common Stock </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">This prospectus relates to the
potential resale from time to time by C/M Capital Master Fund, LP (the &#8220;Selling Stockholder&#8221;) of up to 273,000 shares of common
stock, par value $0.01 per share. The shares of common stock to which this prospectus relates consist of shares that have been or may
be issued by us to the Selling Stockholder pursuant to a Securities Purchase Agreement, dated as of May 16, 2025, by and between us and
the Selling Stockholder (the &#8220;Purchase Agreement&#8221;), establishing an equity line of credit. Such shares of our common stock
include (i) up to 245,571 shares of common stock, or the Purchase Shares, that we may elect, in our sole discretion, subject to the restrictions
and satisfaction of the conditions in the Purchase Agreement, to issue and sell to the Selling Stockholder, from time to time from and
after the Commencement Date (as defined below) under the Purchase Agreement, and subject to applicable stock exchange rules and (ii) up
to 27,429 shares of common stock, or the Commitment Shares, that have or may be issued to the Selling Stockholder in connection with related
issuances and sales of Purchase Shares as consideration for the Selling Stockholder&#8217;s execution and delivery of the Purchase Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The actual number of shares of
our common stock issuable will vary depending on the then-current market price of shares of our common stock sold to the Selling Stockholder
under the Purchase Agreement, but will not exceed the number set forth in the preceding paragraphs unless we file an additional registration
statement under the Securities Act of 1933 (&#8220;Securities Act&#8221;), with the Securities and Exchange Commission (&#8220;SEC&#8221;),
and we obtain the approval of the issuance of shares of common stock by our stockholders in accordance with the applicable stock exchange
rules.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Under the applicable rules of
The Nasdaq Stock Market LLC (&#8220;Nasdaq&#8221;), in no event may we issue to the Selling Stockholder shares of our common stock representing
more than 19.99% of the total number of shares of common stock outstanding as of the date of the Purchase Agreement, unless (i) we obtain
the approval of the issuance of such shares by our stockholders in accordance with the applicable stock exchange rules or (ii) the average
price paid for all shares of common stock issued under the Purchase Agreement (including both Purchase Shares and Commitment Shares) is
equal to or greater than $7.10, which is a price equal to the lower of (A) the Nasdaq Official Closing Price immediately preceding the
execution of the Purchase Agreement and (B) the average Nasdaq Official Closing Price of our common stock for the five trading days immediately
preceding the execution of the Purchase Agreement, as calculated in accordance with the rules of Nasdaq, such that the sales of such common
stock to the Selling Stockholder would not count toward such limit because they are &#8220;at market&#8221; under applicable stock exchange
rules. See &#8220;<i>The Committed Equity Financing</i>&#8221; for a description of the Purchase Agreement and &#8220;<i>Selling Stockholder</i>&#8221;
for additional information regarding the Selling Stockholder.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are not selling any securities
under this prospectus and will not receive any of the proceeds from the sale of the shares of our common stock by the Selling Stockholder.
Additionally, we will not receive any proceeds from the issuance or sale of any Commitment Shares. However, we may receive up to $35 million
in aggregate gross proceeds from the sale of the shares of common stock to the Selling Stockholder under the Purchase Agreement, from
time to time in our discretion, subject to the restrictions and satisfaction of the conditions in the Purchase Agreement, after the date
the registration statement that includes this prospectus is declared effective and after satisfaction of other conditions in the Purchase
Agreement. The actual proceeds from the Selling Stockholder may be less than this amount depending on the number of shares of our common
stock sold and the price at which the shares of our common stock are sold.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Selling Stockholder may
offer, sell or distribute all or a portion of the shares of our common stock acquired under the Purchase Agreement and hereby registered
publicly or through private transactions at prevailing market prices or at negotiated prices. We will bear all costs, expenses and fees
in connection with the registration of the shares of our common stock, including with regard to compliance with state securities or &#8220;blue
sky&#8221; laws. The Selling Stockholder will bear all commissions and discounts, if any, attributable to its sale of shares of our common
stock. See &#8220;<a href="#s1_012"><i>Plan of Distribution</i></a>&#8221; for more information about how the Selling Stockholder may sell or otherwise
dispose of the shares of common stock being registered pursuant to this prospectus. The Selling Stockholder is an underwriter under the
Securities Act with respect to the resale of shares held by it.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">You should read this prospectus
and any prospectus supplement or amendment, together with additional information described under the headings &#8220;<a href="#s1_017">Where You Can Find More Information</a>&#8221;, carefully before you invest in our securities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our common stock is listed
on The Nasdaq Capital Market under the symbol &#8220;FORD.&#8221; On June 9, 2025, the last reported sales price of our common stock on
The Nasdaq Capital Market was $6.47 per share.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b>Investing in our securities
involves a high degree of risk. You should review carefully the risks and uncertainties described under the heading &#8220;<i><a href="#s1_006">Risk
Factors</a></i>&#8221; beginning on page 6 of this prospectus, and under similar headings in any amendment or supplement to this prospectus
or in any other documents incorporated by reference into this prospectus.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b>NEITHER THE SECURITIES
AND EXCHANGE COMMISSION NOR ANY STATE SECURITIES COMMISSION HAS APPROVED OR DISAPPROVED OF THESE SECURITIES OR PASSED UPON THE ADEQUACY
OR ACCURACY OF THIS PROSPECTUS. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">The date of this prospectus
is June [<span style="font-family: Symbol">&#183;</span>], 2025.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo; Options: Hidden -->&#160;<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="s1_001"></span>TABLE OF CONTENTS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="padding-bottom: 1pt; width: 93%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center; width: 7%"><b>Page</b></td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="text-align: left"><a href="#s1_002">About This Prospectus</a></td>
    <td style="text-align: center"><span style="font-size: 10pt">1</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: left"><a href="#s1_003">Cautionary Statement Regarding Forward Looking Statements</a></td>
    <td style="text-align: center"><span style="font-size: 10pt">1</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="text-align: left"><a href="#s1_004">Prospectus Summary</a></td>
    <td style="text-align: center"><span style="font-size: 10pt">2</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: left"><a href="#s1_005">The Offering</a></td>
    <td style="text-align: center">5</td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="text-align: left"><a href="#s1_006">Risk Factors</a></td>
    <td style="text-align: center"><span style="font-size: 10pt">6</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: left"><a href="#s1_007">The Committed Equity Financing</a></td>
    <td style="text-align: center"><span style="font-size: 10pt">11</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="text-align: left"><a href="#s1_008">Use of Proceeds</a></td>
    <td style="text-align: center"><span style="font-size: 10pt">16</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: left"><a href="#s1_009">Market Information</a></td>
    <td style="text-align: center"><span style="font-size: 10pt">16</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="text-align: left"><a href="#s1_010">Dividend Policy</a></td>
    <td style="text-align: center"><span style="font-size: 10pt">16</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: left"><a href="#s1_011">The Selling Stockholder</a></td>
    <td style="text-align: center"><span style="font-size: 10pt">17</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="text-align: left"><a href="#s1_012">Plan of Distribution</a></td>
    <td style="text-align: center"><span style="font-size: 10pt">19</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: left"><a href="#s1_013">Description of Capital Stock</a></td>
    <td style="text-align: center"><span style="font-size: 10pt">21</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="text-align: left"><a href="#s1_014">Certain Provisions of New York Law and of Our Charter and Bylaws</a></td>
    <td style="text-align: center">22</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: left"><a href="#s1_015">Legal Matters</a></td>
    <td style="text-align: center">24</td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="text-align: left"><a href="#s1_016">Experts</a></td>
    <td style="text-align: center"><span style="font-size: 10pt">24</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: left"><a href="#s1_017">Where You Can Find Additional Information</a></td>
    <td style="text-align: center"><span style="font-size: 10pt">24</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="text-align: left"><a href="#s1_018">Incorporation of Certain Information by Reference</a></td>
    <td style="text-align: center"><span style="font-size: 10pt">25</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b></b></p>

<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: LowerRoman; Value: 1; Name: PageNo -->i<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><span id="s1_002"></span>About This Prospectus</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This prospectus is part of
a registration statement that we have filed with the SEC pursuant to which the Selling Stockholder named herein may, from time to time,
offer and sell or otherwise dispose of the securities covered by this prospectus. You should not assume that the information contained
in this prospectus is accurate on any date subsequent to the date set forth on the front cover of this prospectus or that any information
we have incorporated by reference is correct on any date subsequent to the date of the document incorporated by reference, even though
this prospectus is delivered or securities are sold or otherwise disposed of on a later date. It is important for you to read and consider
all information contained in this prospectus, including the Information Incorporated by Reference herein, in making your investment decision.
You should also read and consider the information in the documents to which we have referred you under the captions &#8220;<a href="#s1_017">Where You Can Find More Information</a>&#8221; and &#8220;<a href="#s1_018">Incorporation of Certain Information by Reference</a>&#8221; in this prospectus.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Neither we nor the Selling
Stockholder have authorized any dealer, salesman or other person to give any information or to make any representation other than those
contained or incorporated by reference in this prospectus. You must not rely upon any information or representation not contained or incorporated
by reference in this prospectus. This prospectus does not constitute an offer to sell or the solicitation of an offer to buy any of our
securities other than the securities covered hereby, nor does this prospectus constitute an offer to sell or the solicitation of an offer
to buy any securities in any jurisdiction to any person to whom it is unlawful to make such offer or solicitation in such jurisdiction.
Persons who come into possession of this prospectus in jurisdictions outside the United States are required to inform themselves about,
and to observe, any restrictions as to the offering and the distribution of this prospectus applicable to those jurisdictions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We further note that the representations,
warranties and covenants made in any agreement that is filed as an exhibit to any document that is incorporated by reference in the accompanying
prospectus were made solely for the benefit of the parties to such agreement, including, in some cases, for the purpose of allocating
risk among the parties to such agreements, and should not be deemed to be a representation, warranty or covenant to you. Moreover, such
representations, warranties or covenants were accurate only as of the date when made. Accordingly, such representations, warranties and
covenants should not be relied on as accurately representing the current state of our affairs.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The information in this prospectus
is accurate as of the date on the front cover. Information incorporated by reference into this prospectus is accurate as of the date of
the document from which the information is incorporated. You should not assume that the information contained in this prospectus is accurate
as of any other date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Unless the context otherwise
indicates, when used in this prospectus, the terms the &#8220;Company,&#8221; &#8220;Forward,&#8221; &#8220;we,&#8221; &#8220;us,&#8221;
&#8220;our,&#8221; and similar terms refer to Forward Industries, Inc., a New York corporation and our subsidiaries Intelligent Product
Solutions, Inc. (&#8220;IPS&#8221;), and Kablooe, Inc. (&#8220;Kablooe&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><span id="s1_003"></span>Cautionary Statement
Regarding Forward-Looking Statements</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">This prospectus includes forward-looking
statements including, but not limited to, statements regarding our liquidity, anticipated capital expenditures, and expected sales to
the Selling Stockholder.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">All statements other than
statements of historical facts contained in this prospectus, including statements regarding our future financial position, liquidity,
business strategy and plans and objectives of management for future operations, are forward-looking statements. The words &#8220;believe,&#8221;
&#8220;may,&#8221; &#8220;estimate,&#8221; &#8220;continue,&#8221; &#8220;anticipate,&#8221; &#8220;intend,&#8221; &#8220;should,&#8221;
&#8220;plan,&#8221; &#8220;could,&#8221; &#8220;target,&#8221; &#8220;potential,&#8221; &#8220;is likely,&#8221; &#8220;will,&#8221; &#8220;expect&#8221;
and similar expressions, as they relate to us, are intended to identify forward-looking statements. We have based these forward-looking
statements largely on our current expectations and projections about future events and financial trends that we believe may affect our
financial condition, results of operations, business strategy and financial needs. These forward-looking statements are subject to a number
of risks, uncertainties and assumptions, including those described in &#8220;<a href="#s1_006">Risk Factors</a>&#8221; and elsewhere in this prospectus and
in our filings with the SEC.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b>We expressly disclaim any
obligation or undertaking to update or revise any forward-looking statements contained herein to reflect events or circumstances after
the date on which such statements were made or to reflect the occurrence of unanticipated events, except as may be required by applicable
securities laws.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 4 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Value: 1; Name: PageNo -->1<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="s1_004"></span>PROSPECTUS SUMMARY</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><i>This
summary highlights information contained elsewhere in this prospectus or incorporated by reference. It may not contain all of the information
that you should consider before investing in our securities. You should read this entire prospectus carefully, including the &#8220;<a href="#s1_006">Risk
Factors</a>&#8221; section, and the financial statements and related notes included or incorporated by reference herein. This prospectus
includes forward-looking statements that involve risks and uncertainties. See &#8220;<a href="#s1_003">Cautionary Statement Regarding
Forward-Looking Statements</a>.&#8221;</i></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><i></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Corporate Information</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Our company was formed under the
laws of the state of New York in 1961. Our address is 700 Veterans Memorial Highway, Suite 100, Hauppauge, New York 11788, and our telephone
number is (631) 547-3055. Our website address is www.forwardindustries.com. Our website and the information contained on, or that can
be accessed through, our website is not deemed to be incorporated by reference into, and does not constitute part of, this prospectus.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Our Company </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Forward is an engineering
design company serving top-tier customers worldwide. The Company provides hardware and software product design and engineering services
to customers predominantly located in the U.S.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We provide a complete range
of design, engineering and development services with respect to a diverse array of consumer and industrial electronics products. These
include but are not limited to medical products, smart displays, beverage vending, enterprise and mobile software applications, lighting,
security and detections systems, cameras, wearables and vehicle controls. Solutions in these and other areas are designed and developed
in-house, beginning at product concept, extending through design, engineering and prototype, and final design for manufacturing and computer-aided
design files.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>The C/M Capital Transaction</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">On May 16, 2025, the Company and
C/M Capital entered into the Purchase Agreement which provides that subject to the terms and conditions set forth therein, the Company
may sell to C/M Capital up to $35,000,000 in aggregate gross proceeds from sales of the Company&#8217;s common stock, par value $0.01
per share (the &#8220;Purchase Shares&#8221;) or an amount of shares of common stock not exceeding the Exchange Cap (as defined below).
As consideration for the Selling Stockholder&#8217;s execution and delivery of the Purchase Agreement, we have agreed to issue to the
Selling Stockholder, (i) on the execution date of the Purchase Agreement, an amount of shares of common stock equal to 0.5% of the Available
Amount (as defined in the Purchase Agreement) (24,929 shares) and (ii) <span style="background-color: white">simultaneously with the delivery
of any and all Purchase Shares purchased under the Purchase Agreement, a number of shares of common stock equal to 1% of the number of
Purchase Shares actually sold in each sale under the Purchase Agreement (the &#8220;Commitment Shares&#8221; and, together with the Purchase
Shares, the &#8220;Securities&#8221;).</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Additionally, on May 16, 2025,
the Company and C/M Capital entered into the Registration Rights Agreement, pursuant to which the Company agreed to file a registration
statement with the SEC covering the resale of shares of common stock that are issued to C/M Capital under the Purchase Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="background-color: white">We
do not have a right to commence any sales of common stock to the Selling Stockholder under the Purchase Agreement until the Commencement
Date (as defined in the Purchase Agreement). Over the 36-month period from and after the Commencement Date (unless the Purchase Agreement
is terminated earlier in accordance with its terms), the Selling Stockholder has no right to require us to sell any shares of common stock
to the Selling Stockholder, but subject to the satisfaction of the conditions set forth in the Purchase Agreement, the Selling Stockholder
is obligated to make purchases as we direct in accordance with the terms of the Purchase Agreement. There are no upper limits on the price
per share that the Selling Stockholder must pay for shares of common stock. Actual sales of shares of common stock to the Selling Stockholder
will depend on a variety of factors to be determined by us from time to time, including, among others, market conditions, the trading
price of our common stock and determinations by us as to the appropriate sources of funding for us and our operations</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 5 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="background-color: white">At
any time from and after the Commencement Date, on any business day on which the previous business day&#8217;s closing sale price of common
stock was equal to or greater than $1.00 (the &#8220;Fixed Purchase Date&#8221;), we may direct the Selling Stockholder to purchase a
specified number of shares of common stock (a &#8220;Fixed Purchase&#8221;) not to exceed on any single business day the lesser of (i)
$400,000 of shares of common stock or (ii) 10,000 shares of common stock, at a purchase price equal to the lesser of 95% of (i) the lowest
sale price of the common stock on the trading day immediately prior to such applicable Fixed Purchase Date or (ii) the daily volume weighted
average price (the &#8220;VWAP&#8221;) of the common stock for the five trading days immediately preceding the applicable Fixed Purchase
Date for such Fixed Purchase.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="background-color: white">In
addition, at any time from and after the Commencement Date, on any business day on which the previous business day&#8217;s closing sale
price of the common stock is equal to or greater than $1.00 and such business day is also the Purchase Date for a Fixed Purchase of an
amount of shares of Common Stock not less than the applicable Fixed Purchase Share Limit (as defined in the Purchase Agreement) (the &#8220;VWAP
Purchase Date&#8221;), we may also direct the Selling Stockholder to purchase an additional number of shares of common stock (a &#8220;VWAP
Purchase&#8221;) at a purchase price equal to the lesser of 95% of (i) the closing price of a share of common stock on the trading day
immediately prior to such applicable VWAP Purchase Date and (ii) the lowest sale price of the common stock on such applicable VWAP Purchase
Date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="background-color: white">At
any time from and after the Commencement Date, on any business day that is also the VWAP Purchase Date for a VWAP Purchase, we may also
direct the Selling Stockholder to purchase, on such same business day (the &#8220;Additional VWAP Purchase Date&#8221; and</span>, together
with a <span style="background-color: white">Fixed Purchased Date and a VWAP Purchase Date, a &#8220;Purchase Date&#8221;), an additional
number of shares of common stock (an &#8220;Additional VWAP Purchase&#8221; and</span>, together with a <span style="background-color: white">Fixed
Purchase and a VWAP Purchase, a &#8220;Purchase&#8221;) at a purchase price equal to the lesser of 95% of (i) the closing price of a share
of common stock on the business day immediately prior to such applicable Additional VWAP Purchase Date and (ii) the lowest sale price
of the common stock on such applicable Additional VWAP Purchase Date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="background-color: white">If
we make certain issuances of our securities within three business days after a Purchase Date and such securities are issued at prices
(the &#8220;New Issuance Price&#8221;) less than the prices to be paid by the Selling Stockholder in such Fixed Purchase, VWAP Purchase
or Additional VWAP Purchase, the purchase price for such applicable Fixed Purchase, VWAP Purchase and Additional VWAP Purchase would be
reduced to the New Issuance Price, subject to the terms and conditions set forth in the Purchase Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="background-color: white">Under
the Purchase Agreement, in no event may the aggregate amount of Purchase Shares submitted in any single or combination of VWAP Purchase
notices and/or Additional VWAP Purchase notices on a particular date require a payment from the Selling Stockholder to us that exceeds
$2,000,000, unless such limitation is waived by the Selling Stockholder.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="background-color: white">In
no event shall we issue or sell any shares of common stock pursuant to the Purchase Agreement to the extent that after giving effect
thereto, the aggregate number of shares of common stock that would be issued pursuant to the Purchase Agreement (including the Commitment
Shares) would exceed 19.99% of the total number of shares of common stock issued and outstanding immediately preceding the execution
of the Purchase Agreement (the &#8220;Exchange Cap&#8221;), subject to adjustment as set forth in the Purchase Agreement, unless and
until (i) we obtain the approval of the issuance of such shares by our stockholders in accordance with the applicable stock exchange
rules or (ii) the average price paid for all shares of common stock issued under the Purchase Agreement (including Commitment Shares)
is equal to or in excess of $7.10 which is the lower of (A) the closing price on the Nasdaq Capital Market on May 15, 2025 and (B) the
average of the closing prices of the common stock for the five business days immediately preceding May 16, 2025, as calculated in accordance
with the rules of the Nasdaq Capital Market, such that the sales of such common stock to the Selling Stockholder would not count toward
the Exchange Cap because they are &#8220;at market&#8221; under applicable stock exchange rules.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="background-color: white">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="background-color: white"></span>In addition, the Selling Stockholder
is not obligated to buy any shares of common stock pursuant to the Purchase Agreement if such shares of common stock, when aggregated
with all other common stock then beneficially owned by the Selling Stockholder and its affiliates (as calculated pursuant to Section
13(d) of the Securities Exchange Act of 1934, and Rule 13d-3 promulgated thereunder), would result in the Selling Stockholder beneficially
owning common stock in excess of 4.99% of the then-outstanding shares of common stock (the &#8220;Beneficial Ownership Limitation&#8221;),
provided, however, the Selling Stockholder may increase the Beneficial Ownership Limitation up to 9.99% at its sole discretion upon sixty-one
days&#8217; prior written notice to us.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 6 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The net proceeds under the Purchase
Agreement to us will depend on the frequency and prices at which we sell shares of our stock to the Selling Stockholder. We intend to
use the net proceeds for working capital and general corporate purposes. We will retain broad discretion over the use of the net proceeds
from this offering.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have the right to terminate
the Purchase Agreement at any time, upon one business days&#8217; notice, at no cost or penalty. During any Suspension Event (as defined
in the Purchase Agreement), while the Selling Stockholder does not have the right to terminate the Purchase Agreement, we may not initiate
any Purchase until such Suspension Event has been cured in accordance with the terms of the Purchase Agreement. In addition, in the event
of bankruptcy proceedings by or against us, the Purchase Agreement will automatically terminate in accordance with its terms.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">There are substantial risks to our stockholders as a result of the sale and issuance
of common stock to the Selling Stockholder under the Purchase Agreement, including but not limited to the following: substantial dilution,
significant declines in our stock price and our inability to draw sufficient funds when needed. See
&#8220;<a href="#s1_006">Risk Factors</a>.&#8221; The sale of our common stock to the Selling Stockholder under the Purchase Agreement will not affect the rights
or privileges of our other stockholders, except that the economic and voting interests of our existing stockholders will be diluted as
a result of any such sale. Although the number of shares of common stock that our other stockholders own will not decrease, the shares
owned by our other stockholders will represent a smaller percentage of our total outstanding shares after any such sale to the Selling
Stockholder under the Purchase Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 7 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="s1_005"></span>THE OFFERING</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>The following summary
contains basic information about this offering. The summary is not intended to be complete. You should read the full text and more
specific details contained elsewhere in this prospectus.</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="vertical-align: top; width: 40%; text-align: justify"><b>Common stock offered by the Selling Stockholder</b></td>
    <td style="width: 2%; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; width: 58%; text-align: justify">273,000 shares of our common stock, consisting of (i) up to 245,571
Purchase Shares that may be issued by us to the Selling Stockholder, from time to time at our sole discretion, pursuant to the Purchase
Agreement, and (ii) up to 27,429 Commitment Shares of which 24,929 shares of common stock are outstanding.</td></tr>
  <tr>
    <td style="vertical-align: top; text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top; text-align: justify"><b>Common stock outstanding immediately prior to this offering</b></td>
    <td>&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">1,125,998 shares </td></tr>
  <tr>
    <td style="vertical-align: top; text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify"><b>Common stock outstanding immediately following this offering</b></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">1,374,069 shares</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top; text-align: justify"><b>Terms of the offering</b>&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">The Selling Stockholder will determine when and how it will dispose of any
    shares of our common stock that are registered under this prospectus for resale. See &#8220;<a href="#s1_012">Plan of Distribution</a>.&#8221;</td></tr>
  <tr>
    <td style="vertical-align: top; text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top; text-align: justify"><b>Use of proceeds</b></td>
    <td style="text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">We will not receive any of the proceeds from the sale of shares of our common
stock offered by the Selling Stockholder. Additionally, we will not receive any proceeds from the issuance or sale of any Commitment
Shares. We may receive up to $35,000,000 in aggregate gross proceeds from the Selling Stockholder under the Purchase Agreement in connection
with sales of our shares of our common stock to the Selling Stockholder pursuant to the Purchase Agreement after the date of this prospectus.
However, the actual proceeds may be less than this amount depending on the number of shares of our common stock sold and the price at
which the shares of our common stock are sold. We intend to use of the net proceeds that we receive under the Purchase Agreement for
working capital and other general corporate purposes. However, as of the date of this prospectus, we cannot specify with certainty all
of the particular uses, and the respective amounts we may allocate to those uses, for any net proceeds we receive. See &#8220;<a href="#s1_008">Use
of Proceeds</a>&#8221; on page 16 of this prospectus.</td></tr>
  <tr>
    <td style="vertical-align: top; text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top; text-align: justify"><b>Stock Symbol</b></td>
    <td style="text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">FORD</td></tr>
  <tr>
    <td style="vertical-align: top; text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top; text-align: justify"><b>Transfer Agent and Registrar</b></td>
    <td style="text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">Equiniti Trust Company, LLC</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Outstanding Shares</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The number of shares of our common
stock to be outstanding after this offering assumes 1,125,998 shares of our common stock outstanding as of June 9, 2025, and excludes:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 3%">&#160;</td>
    <td style="width: 3%"><span style="font-family: Symbol; font-size: 10pt">&#183;</span></td>
    <td style="width: 94%; text-align: justify"><span style="font-size: 10pt">132,113 shares of our common stock issuable upon the exercise of options at a weighted-average exercise price of $8.52 per share;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Symbol; font-size: 10pt">&#183;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">118,611 shares of our common stock issuable upon the exercise of warrants outstanding as of at an average exercise price of $7.20; and</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Symbol; font-size: 10pt">&#183;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">1,243,000 shares of our common stock available for future issuance under our 2021 Equity Incentive Plan.</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Unless otherwise indicated, all information in this
prospectus assumes no exercise or settlement of outstanding options or warrants.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b></b></p>

<!-- Field: Page; Sequence: 8 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="s1_006"></span>RISK FACTORS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Investing in our securities
involves risks. Before purchasing the securities offered by this prospectus you should carefully read the risk factors incorporated by
reference in this prospectus from our Annual Report on Form 10-K for the year ended September 30, 2024 filed with the SEC on December
27, 2024, as well as the risks, uncertainties and additional information set forth in the other documents incorporated by reference in
this prospectus that we file with the SEC after the date of this prospectus and which are deemed incorporated by reference in this
prospectus, and the information contained in any applicable prospectus supplement. For a description of these reports and documents, and
information about where you can find them, see &#8220;<a href="#s1_018">Incorporation of Certain Information by Reference</a>.&#8221; The risks and uncertainties
we discuss in this prospectus and in the documents incorporated by reference in this prospectus are those that we currently believe may
materially affect our company. Additional risks not presently known, or currently deemed immaterial, also could materially and adversely
affect our financial condition, results of operations, business and prospects.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span id="s1_019"></span>Risks Related to the Committed Equity Financing</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>It is not possible to predict the actual
number of shares of our common stock, if any, we will sell under the Purchase Agreement, or the actual gross proceeds resulting from those
sales or the dilution to you from those sales. Further, we may not have access to the full amount available under the Purchase Agreement.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Pursuant to the Purchase Agreement,
the Selling Stockholder shall, subject to the restrictions and satisfaction of the conditions in the Purchase Agreement, purchase from
us up to the lesser of (a) $35,000,000 of shares of common stock and (b) the Exchange Cap, upon the terms and subject to the conditions
and limitations set forth in the Purchase Agreement (such amount, the &#8220;Commitment Amount&#8221;); provided, however, that such limitations
will not apply if we obtain stockholder approval to issue additional shares of common stock and, accordingly, we have registered 273,000
shares for issuance under the Purchase Agreement and resale pursuant to this prospectus, assuming that such stockholder approval is obtained.
The shares of our common stock that may be issued under the Purchase Agreement may be sold, subject to the restrictions and satisfaction
of the conditions in the Purchase Agreement, by us to the Selling Stockholder at our discretion from time to time from the Commencement
Date (as defined below) until the earliest to occur of (i) the first day of the month next following the 36-month anniversary of the Commencement
Date, (ii) the date on which the Selling Stockholder shall have purchased the Commitment Amount, and (iii) the Purchase Agreement is otherwise
terminated in accordance with its terms.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We do not have a right to
commence any sales of common stock to the Selling Stockholder under the Purchase Agreement until the time when all of the conditions to
our right to commence sales of common stock to the Selling Stockholder set forth in the Purchase Agreement have been satisfied, or the
Commencement Date, including the effectiveness of the registration statement of which this prospectus forms a part. Over the 36-month
period from and after the Commencement Date, we will generally have the right to control the timing and amount of any sales of our common
stock to the Selling Stockholder under the Purchase Agreement. Sales of our common stock, if any, to the Selling Stockholder under the
Purchase Agreement will depend upon market conditions, our capital needs, alternative financing options, and other factors to be determined
by us in our sole discretion. We may ultimately decide to sell to the Selling Stockholder all, some or none of the common stock that may
be available for us to sell to the Selling Stockholder pursuant to the Purchase Agreement. Accordingly, we cannot guarantee that we will
be able to sell all of the Commitment Amount or how much in proceeds we may obtain under the Purchase Agreement. If we cannot sell securities
under the Committed Equity Financing, we may be required to utilize more costly and time-consuming means of accessing the capital markets,
which could have a material adverse effect on our liquidity and cash position.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Because the purchase price
per share of common stock to be paid by the Selling Stockholder for the common stock that we may elect to sell to the Selling Stockholder
under the Purchase Agreement, if any, will fluctuate based on the market prices of our common stock at the time we make such election,
it is not possible for us to predict, as of the date of this prospectus and prior to any such sales, the number of shares of common stock
that we will sell to the Selling Stockholder under the Purchase Agreement, the purchase price per share that the Selling Stockholder will
pay for shares of common stock purchased from us under the Purchase Agreement, or the aggregate gross proceeds that we will receive from
those purchases the Selling Stockholder under the Purchase Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 9 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">We
                                            are registering 273,000 shares of our common stock under this prospectus. As of June 9,
                                            2025, there were 1,125,998 shares of common stock outstanding. If all of the 273,000 shares
                                            of our common stock offered for resale by the Selling Stockholder under this prospectus were
                                            issued and outstanding as of June 9, 2025, such shares would represent approximately
                                            19.9% of total number of shares of our common stock outstanding.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The actual number of shares of
our common stock issuable will vary depending on the then current market price of shares of our common stock sold to the Selling Stockholder
in this offering and the number of shares of our common stock we ultimately elect to sell to the Selling Stockholder under the Purchase
Agreement. If it becomes necessary for us to issue and sell to the Selling Stockholder under the Purchase Agreement more than the amount
of purchase shares being registered for resale under this prospectus in order to receive aggregate gross proceeds equal to $35,000,000
under the Purchase Agreement, we must file with the SEC one or more additional registration statements to register under the Securities
Act the resale by the Selling Stockholder of any such additional shares of our common stock we wish to sell from time to time under the
Purchase Agreement, which the SEC must declare effective, in each case before we may elect to sell any additional shares of our common
stock under the Purchase Agreement. Under applicable Nasdaq rules, in no event may we issue to the Selling Stockholder shares of our common
stock representing more than 19.99% of the total number of shares of common stock outstanding immediately prior to the execution of the
Purchase Agreement, or approximately 220,000 shares of common stock, unless (i) we obtain the approval of the issuance of additional shares
by our stockholders in accordance with the applicable stock exchange rules or (ii) the average price paid for all shares of common stock
issued under the Purchase Agreement (including both Purchase Shares and Commitment Shares) is equal to or greater than $7.10, which is
a price equal to the lower of (A) the Nasdaq Official Closing Price immediately preceding the execution of the Purchase Agreement and
(B) the average Nasdaq Official Closing Price of our common stock for the five trading days immediately preceding the execution of the
Purchase Agreement, as calculated in accordance with the rules of Nasdaq, such that the sales of such common stock to the Selling Stockholder
would not count toward such limit because they are &#8220;at market&#8221; under applicable stock exchange rules.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, the Selling Stockholder
is not obligated to buy any common stock under the Purchase Agreement if such shares, when aggregated with all other common stock then
beneficially owned by the Selling Stockholder and its affiliates (as calculated pursuant to Section 13(d) of the Securities Exchange Act,
and Rule 13d-3 promulgated thereunder), would result in the Selling Stockholder beneficially owning common stock in excess of 4.99% of
the then-outstanding shares of common stock, or the Beneficial Ownership Limitation; provided, however, the Selling Stockholder may increase
the Beneficial Ownership Limitation up to 9.99% at its sole discretion upon sixty-one days&#8217; prior written notice to us. Our inability
to access a portion or the full amount available under the Purchase Agreement, in the absence of any other financing sources, could have
a material adverse effect on our business or results of operation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>The Selling Stockholder will pay less than
the then-prevailing market price for our common stock, which could cause the price of our common stock to decline.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The purchase price of our
common stock to be sold to the Selling Stockholder under the Purchase Agreement is derived from the market price of our common stock on
Nasdaq. Shares to be sold to the Selling Stockholder pursuant to the Purchase Agreement will be purchased at a discounted price.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For example, we may effect
sales to the Selling Stockholder pursuant to a Fixed Purchase Notice  at a purchase price equal to the lesser of 95%
of (i) the lowest sale price of a share of common stock on the business day immediately preceding the applicable Fixed Purchase Date and
(ii) the daily volume weighted average price of the common stock for the five trading days immediately preceding the applicable Fixed
Purchase Date. This pricing mechanism means that shares will always be sold at a 5% or greater discount to market price. See &#8220;<a href="#s1_007">The Committed Equity Financing</a>&#8221; for more information.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As a result of this pricing
structure, the Selling Stockholder may sell the shares they receive immediately after receipt of such shares, which could cause the price
of our common stock to decrease. This immediate resale could create downward pressure on our stock price.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 10 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span id="s1_020"></span>Investors who buy shares of common stock
from the Selling Stockholder at different times will likely pay different prices.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the Purchase Agreement,
we have discretion (subject to the restrictions and satisfaction of the conditions in the Purchase Agreement) to vary the timing, price
and number of shares of common stock we sell to the Selling Stockholder. If and when we elect to sell shares of common stock to the Selling
Stockholder pursuant to the Purchase Agreement, after the Selling Stockholder has acquired such shares, the Selling Stockholder may resell
all, some or none of such shares at any time or from time to time in its sole discretion and at different prices. As a result, investors
who purchase shares from the Selling Stockholder in this offering at different times will likely pay different prices for those shares,
and so may experience different levels of dilution and in some cases substantial dilution and different outcomes in their investment results.
Investors may experience a decline in the value of the shares they purchase from the Selling Stockholder in this offering as a result
of future sales made by us to the Selling Stockholder at prices lower than the prices such investors paid for their shares in this offering.
In addition, if we sell a substantial number of shares to the Selling Stockholder under the Purchase Agreement, or if investors expect
that we will do so, the actual sales of shares or the mere existence of our arrangements with the Selling Stockholder may make it more
difficult for us to sell equity or equity-related securities in the future at a time and at a price that we might otherwise wish to effect
such sales.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Future resales and/or issuances of shares
of common stock, including pursuant to this prospectus, or the perception that such sales may occur, may cause the market price of our
shares to drop significantly.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On May 16, 2025, we entered
into the Purchase Agreement, pursuant to which the Selling Stockholder shall, subject to the restrictions and satisfaction of the conditions
in the Purchase Agreement, purchase from us up to an aggregate of $35,000,000 of shares of common stock, upon the terms and subject to
the conditions and limitations set forth in the Purchase Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The shares of our common stock
that may be issued under the Purchase Agreement may be sold, subject to the restrictions and satisfaction of the conditions in the Purchase
Agreement, by us to the Selling Stockholder at our discretion from time to time from the date of effectiveness of the registration statement
of which this prospectus forms a part until the earliest to occur of (i) the first day of the month next following the 36-month anniversary
of the Commencement Date, (ii) the date on which the Selling Stockholder shall have purchased the Commitment Amount, or (iii) the Purchase
Agreement is otherwise terminated in accordance with its terms.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The purchase price for shares
of our common stock that we may sell to the Selling Stockholder under the Purchase Agreement will fluctuate based on the trading price
of shares of our common stock. Depending on market liquidity at the time, sales of shares of our common stock may cause the trading price
of shares of our common stock to decrease. We generally have the right to control the timing and amount of any future sales of shares
of our common stock to the Selling Stockholder. Additional sales of shares of our common stock, if any, to the Selling Stockholder will
depend upon market conditions and other factors to be determined by us. We may ultimately decide to sell to the Selling Stockholder all,
some or none of the additional shares of our common stock that may be available for us to sell pursuant to the Purchase Agreement. If
and when we do sell shares of our common stock to the Selling Stockholder, after the Selling Stockholder has acquired shares of our common
stock, the Selling Stockholder may resell all, some, or none of such shares of our common stock at any time or from time to time in its
discretion and at different prices. Therefore, sales to the Selling Stockholder by us could result in substantial dilution to the interests
of other holders of shares of our common stock. In addition, if we sell a substantial number of shares of our common stock to the Selling
Stockholder under the Purchase Agreement, or if investors expect that we will do so, the shares held by the Selling Stockholder will represent
a significant portion of our public float and may result in substantial decreases to the price of our common stock. The actual sales of
shares of our common stock or the mere existence of our arrangement with the Selling Stockholder may also make it more difficult for us
to sell equity or equity-related securities in the future at a time and at a price that we might otherwise wish to affect such sales</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, shares of our
common stock issuable upon exercise or vesting of incentive awards under our incentive plans are, once issued, eligible for sale in the
public market, subject to any lock-up agreements and, in some cases, limitations on volume and manner of sale applicable to affiliates
under Rule 144. Furthermore, shares of our common stock reserved for future issuance under our incentive plan may become available for
sale in future.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 11 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We may use proceeds from sales of our common
stock made pursuant to the Purchase Agreement in ways with which you may not agree or in ways which may not yield a significant return.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We will have broad discretion
over the use of proceeds from sales of our common stock made pursuant to the Purchase Agreement, including for any of the purposes described
in the section entitled &#8220;<a href="#s1_008">Use of Proceeds</a>,&#8221; and you will not have the opportunity, as part of your investment decision, to
assess whether the proceeds are being used appropriately. Because of the number and variability of factors that will determine our use
of the net proceeds, their ultimate use may vary substantially from their currently intended use. While we expect to use the net proceeds
from this offering as set forth in &#8220;<a href="#s1_008">Use of Proceeds</a>,&#8221; we are not obligated to do so. The failure by us to apply these funds
effectively could harm our business, and the net proceeds may be used for corporate purposes that do not increase our operating results
or enhance the value of our common stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Risks Related to Our Financial Position and
Capital Needs</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b><i>If we do not raise
debt or equity capital, we may not be able to pay all of our contractual obligations.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">The extent
we rely on the Selling Stockholder as a source of funding will depend on a number of factors including, the prevailing market price of
our common stock and volume of trading and the extent to which we are able to secure working capital from other sources. If obtaining
sufficient funding from the Selling Stockholder does not occur for any reason including the Selling Stockholder suffering liquidity issues
or failure of the Company to keep the registration statement current, we will need to secure another source of funding in order to pay
off our contractual obligations. Should the financing we require be unavailable or prohibitively expensive when we require it, such circumstances
would likely have a material adverse effect on our business, operating results, financial condition and prospects.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our auditors have issued a &#8220;going
concern&#8221; audit opinion.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27.5pt">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Our independent auditors have
indicated in their report on our September 30, 2024 and September 30, 2023 financial statements that there is substantial doubt about
our ability to continue as a going concern. A &#8220;going concern&#8221; opinion indicates that the financial statements have been prepared
assuming we will continue as a going concern for one year from the date the financial statements are issued and do not include any adjustments
to reflect the possible future effects on the recoverability and classification of assets, or the amounts and classification of liabilities
that may result if we do not continue as a going concern. Therefore, you should not rely on our balance sheet as an indication of the
amount of proceeds that would be available to satisfy claims of creditors, and potentially be available for distribution to stockholders,
in the event of liquidation.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 12 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Risks Related to Our Common Stock</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Due to factors beyond our control, our stock
price may be volatile.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Any of the following factors
could affect the market price of our common stock:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 9%"/><td style="width: 3%"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify; width: 88%">Our failure to increase revenue in each succeeding quarter and achieve and thereafter maintain profitability;</td></tr>
<tr style="vertical-align: top">
<td/><td><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">Our failure to meet our revenue and earnings guidance or our failure to meet financial analysts&#8217;
performance expectations;</td></tr>
<tr style="vertical-align: top">
<td/><td><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">Cybersecurity breaches;</td></tr>
<tr style="vertical-align: top">
<td/><td><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">The loss of customers or our failure to attract more customers;</td></tr>
<tr style="vertical-align: top">
<td/><td><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">Creditworthiness and solvency of clients;</td></tr>
<tr style="vertical-align: top">
<td/><td><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">Loss of key employees;</td></tr>
<tr style="vertical-align: top">
<td/><td><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">The sale of a large amount of common stock by our stockholders;</td></tr>
<tr style="vertical-align: top">
<td/><td><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">Our announcement of a pending or completed acquisition or our failure to complete a proposed acquisition;</td></tr>
<tr style="vertical-align: top">
<td/><td><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">An adverse court ruling or regulatory action;</td></tr>
<tr style="vertical-align: top">
<td/><td><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">Changes in regulatory practices, including tariffs and taxes;</td></tr>
<tr style="vertical-align: top">
<td/><td><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">Changes in market valuations of similar companies;</td></tr>
<tr style="vertical-align: top">
<td/><td><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">Short selling activities;</td></tr>
<tr style="vertical-align: top">
<td/><td><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">Our announcement of any financing or a change in the direction of our business;</td></tr>
<tr style="vertical-align: top">
<td/><td><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">Announcements by us, or our competitors, of significant contracts, acquisitions, commercial relationships,
joint ventures or capital commitments; or</td></tr>
<tr style="vertical-align: top">
<td/><td><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">Other forces outside of our control such as inflation, Federal Reserve interest rate increases and the
recessionary environment it could bring, geopolitical turmoil and other developments that could adversely impact the U.S. and global economies
and erode investor sentiment.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the past, following periods
of volatility in the market price of a company&#8217;s securities, securities class action litigation has often been instituted. A securities
class action suit against us could result in substantial costs and divert our management&#8217;s time and attention, which would otherwise
be used to benefit our business.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 13 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="s1_007"></span>THE COMMITTED EQUITY FINANCING</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Overview</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On May 16, 2025, we entered
into the Purchase Agreement with the Selling Stockholder. Sales of our common stock to the Selling Stockholder under the Purchase Agreement,
and the timing of any sales, will be determined by us from time to time in our sole discretion and will depend on a variety of factors,
including, among other things, market conditions, the trading price of our common stock and determinations by us regarding the use of
proceeds from any sale of such common stock. The net proceeds from any sales under the Committed Equity Financing will depend on the frequency
with, and prices at which, the shares of common stock are sold to the Selling Stockholder. To the extent we sell shares under the Purchase
Agreement, we currently plan to use the net proceeds for working capital and other general corporate purposes.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">In accordance with our obligations
under the Purchase Agreement, or the Registration Rights Agreement, pursuant to which we agreed to provide the Selling Stockholder with
customary registration rights related to the shares issued under the Purchase Agreement, we have filed a registration statement of which
this prospectus forms a part in order to register the resale of up to: (i) 245,571 Purchase Shares that we may elect, in our sole discretion,
to issue and sell to the Selling Stockholder, from time to time after the Commencement Date upon the terms and subject to the conditions
and limitations of the Purchase Agreement, subject to applicable stock exchange rules; and (ii) 2,500 Commitment Shares that may be issued
to the Selling Stockholder in connection with related issuances and sales of Purchase Shares as consideration for the Selling Stockholder&#8217;s
execution and delivery of the Purchase Agreement.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under applicable Nasdaq rules,
in no event may we issue to the Selling Stockholder shares of our common stock representing more than 19.99% of the total number of shares
of common stock outstanding immediately prior to the date of the Purchase Agreement, unless we obtain prior stockholder approval or if
such approval is not required in accordance with the applicable Nasdaq rules. In addition, the Selling Stockholder is not obligated to
buy any common stock under the Purchase Agreement if such shares, when aggregated with all other common stock then beneficially owned
by the Selling Stockholder and its respective affiliates (as calculated pursuant to Section 13(d) of the Exchange Act and Rule 13d-3 promulgated
thereunder), would result in the Selling Stockholder beneficially owning common stock in excess of 4.99% of the then-outstanding shares
of common stock, or the Beneficial Ownership Limitation; provided, however, the Selling Stockholder may increase the Beneficial Ownership
Limitation up to 9.99% at its sole discretion upon sixty-one days&#8217; prior written notice to us. Our inability to access a portion
or the full amount available under the Purchase Agreement, in the absence of any other financing sources, could have a material adverse
effect on our business or results of operation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Purchase Agreement and
Registration Rights Agreement contain customary registration rights, representations, warranties, conditions and indemnification obligations
by each party. The representations, warranties and covenants contained in such agreements were made only for purposes of such agreements
and as of specific dates, were solely for the benefit of the parties to such agreements and are subject to certain important limitations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Purchase Agreement</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Pursuant to the Purchase Agreement,
the Selling Stockholder shall subject to the restrictions and satisfaction of the conditions in the Purchase Agreement, purchase from
us up to the lesser of (i) $35,000,000 in aggregate value of shares of our common stock and (ii) the Exchange Cap, upon the terms and
subject to the conditions and limitations set forth in the Purchase Agreement, or the Commitment Amount; provided, however, that such
limitations will not apply if we obtain stockholder approval to issue additional shares of common stock. The shares of our common stock
that may be issued under the Purchase Agreement may be sold, subject to the restrictions and satisfaction of the conditions in the Purchase
Agreement, by us to the Selling Stockholder at our discretion from time to time from the Commencement Date until the earliest to occur
of (i) the first day of the month next following the 36-month anniversary of the Commencement Date, (ii) the date on which the Selling
Stockholder shall have purchased the Commitment Amount, (iii) the ninetieth day after the date on which, pursuant to or within the meaning
of any bankruptcy law, we commence a voluntary case or any person commences a proceeding against us, in each case that is not discharged
or dismissed prior to such ninetieth day, and (iv) the date on which, pursuant to or within the meaning of any bankruptcy law, a custodian
is appointed for us or for all or substantially all of our property, or we make a general assignment for the benefit of our creditors,
or each, a Termination Event.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 14 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Purchases of Shares of Our Common Stock Under
the Purchase Agreement</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">During the term described above,
on any business day on which the closing sale price of the common stock on Nasdaq is equal to or greater than $1.00, we will have the
right, but not the obligation, from time to time at our sole discretion, subject to the restrictions and satisfaction of the conditions
in the Purchase Agreement, to direct the Selling Stockholder, by delivery of an irrevocable written notice (a &#8220;Fixed Purchase Notice&#8221;),
to purchase a number of shares of our common stock, or the Fixed Purchase, not to exceed, on any trading day, the lesser of (i) $400,000
worth of shares of Common Stock or (ii) 10,000 shares of Common Stock, at a purchase price equal to the lesser of 95% <span style="background-color: white">(i)
lowest sale price of the common stock on the trading day immediately prior to such applicable Fixed Purchase Date or (ii) the daily VWAP
of the common stock for the five trading days immediately preceding the applicable Purchase Date for such Fixed Purchase.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">In addition, at any time from
and after the Commencement Date, on any business day on which the closing sale price of the common stock is equal to or greater than $1.00
and such business day is also the Fixed Purchase Date for a Fixed Purchase of an amount of shares of common stock not less than the applicable
<span style="background-color: white">Fixed Purchase Share Limit</span> (calculated as of the applicable Fixed Purchase Date), we may
also direct the Selling Stockholder, by delivery of a VWAP Purchase Notice, to purchase, on the immediately following business day (the
&#8220;VWAP Purchase Date&#8221;), an additional number of shares of common stock in an amount not in excess of the lesser of (i) 300%
of the number of shares of common stock directed by us to be purchased by the Selling Stockholder for the applicable Fixed Purchase and
(ii) 30% of the trading volume in our common stock on Nasdaq during the applicable VWAP Purchase Period on the applicable VWAP Purchase
Date, at a purchase price equal to the lesser of 95% of (i) the closing sale price of the common stock on the business day immediately
preceding the applicable VWAP Purchase Date and (ii) the lowest sale price of the common stock during the applicable VWAP Purchase Period.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">At any time from and after
the Commencement Date, on any business day that is also the VWAP Purchase Date for a VWAP Purchase, we may also direct the Selling Stockholder,
by delivery of an irrevocable written notice, (an &#8220;Additional VWAP Purchase Notice&#8221; and, together with a Fixed Purchase Notice
and a VWAP Purchase Notice, a &#8220;Purchase Notice&#8221;), to purchase, on the same business day (the &#8220;Additional VWAP Purchase
Date&#8221; and, together with a Fixed Purchase Date and a VWAP Purchase Date, the &#8220;Purchase Dates&#8221;), an additional number
of shares of common stock in an amount equal to the lesser of (i) 300% of the number of shares of common stock directed by us to be purchased
by the Selling Stockholder pursuant to the corresponding Fixed Purchase and (ii) 30% of the trading volume in our common stock on Nasdaq
during the applicable Additional VWAP Purchase Period on the applicable Additional VWAP Purchase Date, at a purchase price equal to the
lesser of 95% of (i) the closing sale price of the common stock on the business day immediately preceding the applicable Additional VWAP
Purchase Date and (ii) the lowest sale price of the common stock during the applicable Additional VWAP Purchase Period.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Notwithstanding the above,
in no event may the aggregate amount of Purchase Shares submitted in any single or combination of VWAP Purchase notices and/or Additional
VWAP Purchase notices on a particular date require a payment from the Selling Stockholder to us that exceeds $2,000,000, unless such limitation
is waived by the Selling Stockholder.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For purposes of the Purchase
Agreement, &#8220;VWAP&#8221; shall mean the daily volume weighted average price of the common stock on Nasdaq as reported by Bloomberg
through its &#8220;AQR&#8221; function.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">All such determinations shall
be appropriately adjusted for any sales of shares of common stock through block transactions, any reorganization, non-cash dividend, stock
split, reverse stock split, stock combination, recapitalization or other similar transaction during such period.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Commitment Shares and Fees</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">In connection with entering
into the ELOC Agreement, the Company agreed to immediately issue to the Purchaser, 24,929 shares of common stock as commitment shares
and, thereafter an amount of shares equal to 1% of the Available Amount, which shall be issued in a pro rated fashion simultaneously with
the delivery of any and all Purchase Shares purchased under the ELOC Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">We have paid the Selling Stockholder
$25,000 in cash as reimbursement for the reasonable, out-of-pocket expenses incurred by the Selling Stockholder, including the legal fees
and disbursements of the Selling Stockholder&#8217;s legal counsel, in connection with its due diligence investigation and the preparation,
negotiation and execution of the Purchase Agreement.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 15 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Conditions Precedent to Commencement</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our right to commence delivering
Purchase Notices under the Purchase Agreement and the Selling Stockholder&#8217;s obligation to accept such Purchase Notices, are subject
to the initial satisfaction, at the Commencement Date, of the conditions precedent thereto set forth in the Purchase Agreement, which
conditions include, among others, the following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 3%"/><td style="width: 3%"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify; width: 94%">the accuracy in all material respects of our representations and warranties included in the Purchase Agreement;</td></tr>
<tr style="vertical-align: top">
<td/><td><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">this prospectus, in final form, and all reports, schedules, registrations, forms, statements, information
and other documents required to have been filed by us with the SEC pursuant to the reporting requirements of the Exchange Act having been
so filed;</td></tr>
<tr style="vertical-align: top">
<td/><td><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">the common stock not having been suspended by the SEC, Nasdaq or FINRA and there not having been imposed
any suspension of, or restriction on, accepting additional deposits of common stock by The Depository Trust Company;</td></tr>
<tr style="vertical-align: top">
<td/><td><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">no condition, occurrence, state of facts or event constituting a Material Adverse Effect (as defined in
the Purchase Agreement) shall have occurred and be continuing;</td></tr>
<tr style="vertical-align: top">
<td/><td><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">customary compliance with laws and bankruptcy-related conditions; and</td></tr>
<tr style="vertical-align: top">
<td/><td><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">the receipt by the Selling Stockholder of a customary legal opinion, as required under the Purchase Agreement.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Termination of the Purchase Agreement</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Unless earlier terminated as provided in the Purchase
Agreement, the Purchase Agreement will terminate automatically on the earliest to occur of:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 3%"/><td style="width: 3%"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify; width: 94%">the first day of the month immediately following the 36-month anniversary of the Commencement Date;</td></tr>
<tr style="vertical-align: top">
<td/><td><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">the date on which the Selling Stockholder shall have purchased the Commitment Amount;</td></tr>
<tr style="vertical-align: top">
<td/><td><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">the ninetieth day after the date on which, pursuant to or within the meaning of any bankruptcy law, we
commence a voluntary case or any person commences a proceeding against us, in each case that is not discharged or dismissed prior to such
ninetieth day; and</td></tr>
<tr style="vertical-align: top">
<td/><td><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">the date on which, pursuant to or within the meaning of any bankruptcy law, a custodian is appointed for
us or for all or substantially all of our property, or we make a general assignment for the benefit of our creditors.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have the right to terminate
the Purchase Agreement at any time after the Commencement Date, at no cost or penalty, upon one business day&#8217;s prior written notice
to the Selling Stockholder, provided that we have satisfied all outstanding payment and delivery obligations related to any Purchase Shares
issued to the Selling Stockholder prior to the effective date of such termination. We or the Selling Stockholder may also terminate the
Purchase Agreement at the close of business on the one year anniversary of the signing of the Purchase Agreement or thereafter, in the
event the Commencement Date shall not have occurred prior to such one year anniversary due to our failure to satisfy the conditions precedent
to commencement. We and the Selling Stockholder may also terminate the Purchase Agreement at any time by mutual written consent. No termination
of the Purchase Agreement by us or by the Selling Stockholder will affect any of our respective rights and obligations under (i) the Purchase
Agreement with respect to any pending Purchase, and both we and the Selling Stockholder have agreed to complete our respective obligations
with respect to any such pending Purchase under the Purchase Agreement, and (ii) the Registration Rights Agreement, which shall survive
any termination of the Purchase Agreement. Further, no termination of the Purchase Agreement will be deemed to release us or the Selling
Stockholder from any liability for intentional misrepresentation or willful breach of the Purchase Agreement, the Registration Rights
Agreement or any other related transaction documents.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Dilutive Issuances and Purchase Price Adjustment</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For as long as the Selling
Stockholder owns any of our common stock, if within three business days immediately following a Purchase Date, we issue securities at
prices (the &#8220;New Issuance Price&#8221;) less than the prices to be paid by the Selling Stockholder in such Fixed Purchase, VWAP
Purchase or Additional VWAP Purchase, the purchase price for such applicable Fixed Purchase, VWAP Purchase or Additional VWAP Purchase
would be reduced to the New Issuance Price, subject to the terms and conditions set forth in the Purchase Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 16 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>No Short-Selling or Hedging</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Selling Stockholder has
agreed that neither it nor any entity managed or controlled by it will engage in, directly or indirectly, any (A) &#8220;short sale&#8221;
(as such term is defined in Rule 200 of Regulation SHO of the Exchange Act) of our common stock or (B) hedging transaction, which, with
respect to items (A) and (B), establishes a net short position with respect to the common stock, during the term of the Purchase Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Effects of Sales of our Common Stock under
the Purchase Agreement on Our Stockholders</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The common stock being registered
for resale in this offering may be issued and sold by us to the Selling Stockholder from time to time at our discretion, during the terms
described above. The resale by the Selling Stockholder of a significant quantity of shares registered for resale in this offering at any
given time, or the perception that these sales may occur, could cause the market price of our common stock to decline and to be highly
volatile. Sales of our common stock, if any, to the Selling Stockholder under the Purchase Agreement will be determined by us in our sole
discretion, subject to the satisfaction of certain conditions in the Purchase Agreement, and will depend upon market conditions and other
factors. We may ultimately decide to sell to the Selling Stockholder all, some or none of the common stock that may be available for us
to sell to the Selling Stockholder pursuant to the Purchase Agreement. If we elect to sell common stock to the Selling Stockholder pursuant
to the Purchase Agreement, after the Selling Stockholder has acquired such shares, the Selling Stockholder may resell all, some or none
of such common stock at any time or from time to time in its discretion and at different prices. As a result, investors who purchase common
stock from the Selling Stockholder in this offering at different times will likely pay different prices for those shares of common stock,
and so may experience different levels of dilution and in some cases substantial dilution and different outcomes in their investment results.
See &#8220;<i><a href="#s1_020">Risk Factors-Risks Related to the Committed Equity Financings-Investors who buy shares of common stock from the Selling Stockholder at different times will likely pay different prices</a></i>.&#8221;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Investors may experience a
decline in the value of the common stock they purchase from the Selling Stockholder in this offering as a result of future sales made
by us to the Selling Stockholder at prices lower than the prices such investors paid for their shares in this offering. In addition, if
we sell a substantial number of shares of common stock to the Selling Stockholder under the Purchase Agreement, or if investors expect
that we will do so, the actual sales of common stock or the mere existence of our arrangement with the Selling Stockholder may make it
more difficult for us to sell equity or equity-related securities in the future at a time and at a price that we might otherwise wish
to effect such sales.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Because the purchase price
per share to be paid by the Selling Stockholder for the common stock that we may elect to sell to the Selling Stockholder under the Purchase
Agreement, if any, will fluctuate based on the market prices of our common stock at the time we make such election, as of the date of
this prospectus, it is not possible for us to predict the number of shares of common stock that we will sell to the Selling Stockholder
under the Purchase Agreement, the actual purchase price per share to be paid by the Selling Stockholder for those shares of common stock,
or the actual gross proceeds to be raised by us from those sales, if any.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b></b>The number of
shares of common stock ultimately offered for sale by the Selling Stockholder for resale under this prospectus is dependent upon the number
of shares of common stock, if any, we ultimately sell to the Selling Stockholder under the Purchase Agreement. Further, if and when we
elect to sell shares of common stock to the Selling Stockholder pursuant to the Purchase Agreement, after the Selling Stockholder has
acquired such shares, the Selling Stockholder may resell all, some, or none of such shares of common stock at any time or from time to
time in its discretion and at different prices.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The issuance of our shares
of common stock to the Selling Stockholder pursuant to the Purchase Agreement will not affect the rights or privileges of our existing
stockholders, except that the economic and voting interests of each of our existing stockholders will be diluted. Although the number
of shares of common stock that our existing stockholders own will not decrease, the shares of common stock owned by our existing stockholders
will represent a smaller percentage of our total outstanding shares of common stock after any such issuance.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 17 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The following table sets forth
the amount of gross proceeds we may receive from the Selling Stockholder from our sale of Purchase Shares that we may issue and sell to
the Selling Stockholder from time to time under the Purchase Agreement at various assumed purchase prices. The table does not give effect
to the issuance of any Commitment Shares.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td colspan="3" style="border-bottom: black 1pt solid">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Assumed Purchase</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Price Per Share</p></td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt">Total Number<br/>
of Purchase Shares<br/>
to be Issued</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt">Percentage of<br/>
Outstanding Common Stock After Giving Effect<br/>
to the Issuance of<br/>
the Purchase Shares to the Selling Stockholder (1)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt">Proceeds from the Sale of the Purchase Shares to the Selling Stockholder</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #EEEEEE">
    <td style="width: 1%"><span style="font-size: 10pt">$</span></td>
    <td style="width: 12%; text-align: right"><span style="font-size: 10pt">1.00</span></td>
    <td style="width: 10%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 22%; text-align: right"><span style="font-size: 10pt">245,571</span></td>
    <td style="width: 5%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 19%; text-align: right"><span style="font-size: 10pt">18.0%</span></td>
    <td style="width: 5%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><span style="font-size: 10pt">$</span></td>
    <td style="width: 19%; text-align: right"><span style="font-size: 10pt">245,571</span></td>
    <td style="width: 1%">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td><span style="font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-size: 10pt">5.00</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">245,571</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">18.0%</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-size: 10pt">1,227,855</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #EEEEEE">
    <td><span style="font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-size: 10pt">6.47 </span></td>
    <td><span style="font-size: 10pt">&#160;(2)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">245,571</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">18.0%</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-size: 10pt">1,588,844</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td><span style="font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-size: 10pt">7.10</span></td>
    <td><span style="font-size: 10pt">&#160;(3)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">245,571</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">18.0%</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-size: 10pt">1,743,554</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #EEEEEE">
    <td><span style="font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-size: 10pt">8.00</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">245,571</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">18.0%</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-size: 10pt">1,964,568</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td><span style="font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-size: 10pt">9.00</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">245,571</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">18.0%</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-size: 10pt">2,210,139</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #EEEEEE">
    <td><span style="font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-size: 10pt">10.00</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">245,571</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">18.0%</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-size: 10pt">2,455,710</span></td>
    <td>&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-right: 0; margin-bottom: 0; text-align: left">__________</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 3%">&#160;</td>
    <td style="width: 3%"><span style="font-size: 10pt">(1)</span></td>
    <td style="text-align: justify; width: 94%"><span style="font-size: 10pt">The denominator is based on 1,371,569 shares of our common
stock outstanding as of June 9, 2025, adjusted to include the issuance of the number of Purchase Shares set forth in the adjacent column
which we would have issued to the Selling Stockholder based on the applicable assumed purchase price per share.</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-size: 10pt">(2)</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Represents the last reported sales price of our common stock on June
9, 2025, as reported by Nasdaq.</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-size: 10pt">(3)</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Represents the minimum price for which the average price paid for all shares of common stock issued under the Purchase Agreement must be in order for the sales to be considered &#8220;at market&#8221; under applicable stock exchange rules and therefore not subject to the Exchange Cap.</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 18 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="s1_008"></span>USE OF PROCEEDS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">We will not receive any of the
proceeds from the sale of shares of our common stock offered by the Selling Stockholder. In addition, we will not receive any proceeds
from the issuance or sale of the Commitment Shares. We may receive up to $35,000,000 in aggregate gross proceeds from sales of shares
of our common stock to the Selling Stockholder pursuant to the Purchase Agreement after the date of this prospectus. However, the actual
proceeds may be less than this amount depending on the number of shares of our common stock sold and the price at which the shares of
our common stock are sold.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">We intend to use the proceeds
for working capital and other general corporate purposes. Our expected use of the net proceeds from this offering represents our intentions
based upon our current plans and business conditions. As of the date of this prospectus, we cannot predict with certainty all of the particular
uses for the net proceeds from this offering or the specific amounts to be spent on the uses described above. As a result, our management
will retain broad discretion over the allocation of the net proceeds from this offering.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pending the uses described
above, we plan to invest the net proceeds from this offering in short-term, interest-bearing obligations, investment-grade instruments
or other securities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="s1_009"></span>MARKET INFORMATION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our common stock is listed
on The Nasdaq Capital Market under the symbol &#8220;FORD.&#8221;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On June 9, 2025, the last
reported sale price of our common stock on Nasdaq was $6.47 per share. As of June 9, 2025, we had approximately 40 stockholders of record.
The actual number of holders of our common stock is greater than this number of record holders and includes stockholders who are beneficial
owners, but whose shares are held in street name by brokers or held by other nominees. This number of holders of record also does not
include stockholders whose shares may be held in trust by other entities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="s1_010"></span>DIVIDEND POLICY</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We do not expect to pay any
cash dividends to our stockholders in the foreseeable future. Payment of future cash dividends, if any, will be at the discretion of our
board of directors and will depend on a number of factors, including our results of operations, financial condition, future prospects,
contractual restrictions, restrictions imposed by applicable law, and other factors our board of directors deems relevant<b>.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 19 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="s1_011"></span>THE SELLING STOCKHOLDER</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">This prospectus relates to the
possible resale from time to time by the Selling Stockholder of any or all shares of our common stock that have been or may be issued
by us to the Selling Stockholder under the Purchase Agreement. Such shares of our common stock include (i) up to 245,571 Purchase Shares
that we may elect, in our sole discretion, to issue and sell to the Selling Stockholder, from time to time from and after the Commencement
Date under the Purchase Agreement; and (ii) up to 2,500 Commitment Shares that may be issued to the Selling Stockholder in connection
with related issuances and sales of Purchase Shares as consideration for the Selling Stockholder&#8217;s execution and delivery of the
Purchase Agreement.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As used in this prospectus,
the term &#8220;Selling Stockholder&#8221; includes the Selling Stockholder listed in the table below, and its permitted pledgees, donees,
transferees, assignees, successors, designees, successors-in-interest and others who later come to hold any of the Selling Stockholder&#8217;s
interest in the shares of common stock in accordance with the terms of the applicable agreements governing their respective registration
rights, other than through a public sale. This prospectus also covers any additional securities that may become issuable by reason of
stock splits, stock dividends or other similar transactions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For additional
information regarding the issuance of common stock covered by this prospectus, see the section entitled &#8220;<i><a href="#s1_007">Committed
Equity Financing</a>&#8221;</i> above. We are registering the shares of common stock pursuant to the provisions of the Purchase Agreement
and the Registration Rights Agreement in order to permit the Selling Stockholder to offer the shares for resale from time to time.
Except for the transactions contemplated by the Purchase Agreement and the Registration Rights Agreement, the Selling Stockholder
has not had any material relationship with us within the past three years.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The
table below presents information regarding the Selling Stockholder and the shares of common stock that it may offer from time to time
under this prospectus. This table is prepared based on information supplied to us by the selling stockholder, and reflects holdings as
of June 9, 2025. The number of shares in the column &#8220;Maximum Number of Shares of Common Stock to be Offered Pursuant to this Prospectus&#8221;
represents all of the shares of common stock that the Selling Stockholder may offer under this prospectus. The Selling Stockholder may
sell some, all or none of its shares in this offering. We do not know how long the Selling Stockholder will hold the shares before selling
them, and we currently have no agreements, arrangements or understandings with the Selling Stockholder regarding the sale of any of the
shares.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Beneficial ownership is determined
in accordance with Rule 13d-3(d) promulgated by the SEC under the Exchange Act, and includes shares of common stock with respect to which
the Selling Stockholder has voting and investment power. The percentage of common stock beneficially owned by the Selling Stockholder
prior to the offering shown in the table below is based on an aggregate of 1,125,998 shares of our common stock outstanding on June 9,
2025. Because the purchase price of the common stock issuable under the Purchase Agreement is determined on each Fixed Purchase Date,
with respect to a Fixed Purchase, on the applicable VWAP Purchase Date, with respect to a VWAP Purchase, and on the applicable Additional
VWAP Purchase Date, with respect to an Additional VWAP Purchase, the number of shares that may actually be sold by us to the Selling
Stockholder under the Purchase Agreement may be fewer than the number of shares being offered by this prospectus. The fourth column assumes
the sale of all of the shares offered by the Selling Stockholder pursuant to this prospectus.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We may amend or supplement
this prospectus from time to time in the future to update or change the Selling Stockholder list and the securities that may be resold.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 20 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Please see the section titled
&#8220;<i><a href="#s1_012">Plan of Distribution</a></i>&#8221; for further information regarding the Selling Stockholder&#8217;s method of distributing these
securities</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Name of Selling Stockholder</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Number of Shares of<br/> Common Stock Owned<br/> Prior to Offering</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Maximum Number of Shares of Common Stock to be Offered Pursuant to this Prospectus</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Number of Shares<br/> of Common Stock Owned After Offering</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Number <span style="font-size: 10pt">(1)</span></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Percent<span style="font-size: 10pt"> (2)</span></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2">&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Number <span style="font-size: 10pt">(3)</span></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Percent<span style="font-size: 10pt"> (4)</span></td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 25%; text-align: center">C/M Capital Master Fund, LP (4)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 11%; text-align: right">24,929</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 11%; text-align: right">2.2%</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 11%; text-align: right">273,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 11%; text-align: right">0</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 11%; text-align: right">0%</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="text-align: justify; font-size: 10pt; width: 5%">(1)</td>
    <td style="text-align: justify; font-size: 10pt; width: 95%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; border-right-width: 0in; border-right-color: Black; border-left-width: 0in; border-left-color: Black">In accordance with Rule 13d-3(d) under the Exchange Act, we
                                                            have excluded from the number of shares beneficially owned prior to the offering all of the shares that the Selling Stockholder may
                                                            be required to purchase under the Purchase Agreement, because the issuance of such shares is solely at our discretion and is subject
                                                            to conditions contained in the Purchase Agreement, the satisfaction of which are entirely outside of the Selling Stockholder&#8217;s
                                                            control, including the registration statement that includes this prospectus becoming and remaining effective. Furthermore, the Fixed
                                                            Purchases, VWAP Purchase, or Additional VWAP Purchase, as applicable, of common stock is subject to certain agreed upon maximum
                                                            amount limitations set forth in the Purchase Agreement. Also, the Purchase Agreement prohibits us from issuing and selling any of
                                                            our common stock to the Selling Stockholder to the extent such shares, when aggregated with all other common stock then beneficially
                                                            owned by the Selling Stockholder, would cause the Selling Stockholder beneficial ownership of our common stock to exceed the
                                                            Beneficial Ownership Limitation (as defined in the Purchase Agreement)</p>
</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify; font-size: 10pt">&#160;</td>
    <td style="text-align: justify; font-size: 10pt">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify; font-size: 10pt">(2)</td>
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; border-right-width: 0in; border-right-color: Black; border-left-width: 0in; border-left-color: Black">Applicable
percentage ownership is based on 1,125,998<span style="font-family: Times New Roman, Times, Serif">&#160;</span>shares of our common
stock outstanding as of June 9, 2025.</p></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify; font-size: 10pt">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify; font-size: 10pt">(3)</td>
    <td style="text-align: justify; font-size: 10pt">Assumes the sale of all shares being offered pursuant to this prospectus.</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify; font-size: 10pt">&#160;</td>
    <td style="text-align: justify; font-size: 10pt">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify; font-size: 10pt">(4)</td>
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; border-right-width: 0in; border-right-color: Black; border-left-width: 0in; border-left-color: Black">The
    business address of C/M Capital Master Fund, LP is 1111 Brickell Avenue, Suite 2920, Miami, Florida 33131. As of the date of the
    Purchase Agreement, C/M Capital Master Fund, LP did not beneficially own any shares of our common stock. Thomas Walsh and Jonathan
    Juchno are the Managing Partners of C/M Capital Master Fund, LP, and therefore may be deemed to have shared voting and investment
    power over securities owned directly and indirectly by C/M Capital Master Fund, LP. C/M Capital Master Fund, LP is not a registered
    broker-dealer or an affiliate of a registered broker-dealer. The foregoing should not be construed in and of itself as an admission
    by Mr. Walsh and Mr. Juchno as to beneficial ownership of the securities beneficially owned directly or indirectly by C/M Capital
    Master Fund, LP. Does not include shares of common stock issuable under Series B Preferred Stock beneficially owned by C/M Capital.</p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 21 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>



<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: justify"></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><span id="s1_012"></span>Plan of Distribution</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The shares of common stock
offered by this prospectus are being offered by the Selling Stockholder. The shares may be sold or distributed from time to time by the
Selling Stockholder directly to one or more purchasers or through brokers, dealers, or underwriters who may act solely as agents at market
prices prevailing at the time of sale, at prices related to the prevailing market prices, at negotiated prices, or at fixed prices, which
may be changed. The sale of our common stock offered by this prospectus could be effected in one or more of the following methods:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="text-align: justify; width: 0.25in"><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ordinary brokers&#8217;
transactions;</span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">transactions involving
cross or block trades;</span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">through brokers, dealers,
or underwriters who may act solely as agents;</span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;at the market&#8221;
into an existing market for our common stock;</span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in other ways
not involving market makers or established business markets, including direct sales to purchasers or sales effected through agents;</span></td></tr>

<tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in privately negotiated
transactions; or</span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">any combination of the
foregoing.</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In order to comply with the
securities laws of certain states, if applicable, the shares may be sold only through registered or licensed brokers or dealers. In addition,
in certain states, the shares may not be sold unless they have been registered or qualified for sale in the state or an exemption from
the state&#8217;s registration or qualification requirement is available and complied with.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Selling Stockholder may be
deemed to be an &#8220;underwriter&#8221; within the meaning of Section 2(a)(11) of the Securities Act.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Selling Stockholder has
informed us that it intends to use one or more registered broker-dealers to effectuate all sales, if any, of our common stock that it
has acquired and may in the future acquire from us pursuant to the Purchase Agreement. Such sales will be made at prices and at terms
then prevailing or at prices related to the then current market price. Each such registered broker-dealer will be an underwriter within
the meaning of Section 2(a)(11) of the Securities Act. The Selling Stockholder has informed us that each such broker-dealer will receive
commissions from the Selling Stockholder that will not exceed customary brokerage commissions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Brokers, dealers, underwriters
or agents participating in the distribution of our common stock offered by this prospectus may receive compensation in the form of commissions,
discounts, or concessions from the purchasers, for whom the broker-dealers may act as agent, of the shares sold by the Selling Stockholder
through this prospectus. The compensation paid to any such particular broker-dealer by any such purchasers of our common stock sold by
the selling stockholder may be less than or in excess of customary commissions. Neither we nor the Selling Stockholder can presently estimate
the amount of compensation that any agent will receive from any purchasers of our common stock sold by the Selling Stockholder.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We know of no existing arrangements
between the Selling Stockholder or any other stockholder, broker, dealer, underwriter or agent relating to the sale or distribution of
our common stock offered by this prospectus.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We may from time to time file
with the SEC one or more supplements to this prospectus or amendments to the registration statement of which this prospectus forms a part
to amend, supplement or update information contained in this prospectus, including, if and when required under the Securities Act, to
disclose certain information relating to a particular sale of shares offered by this prospectus by the Selling Stockholder, including
the names of any brokers, dealers, underwriters or agents participating in the distribution of such shares by the Selling Stockholder,
any compensation paid by the Selling Stockholder to any such brokers, dealers, underwriters or agents, and any other required information.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 22 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We will pay the expenses incident
to the registration under the Securities Act of the offer and sale of our common stock covered by this prospectus by the Selling Stockholder.
As consideration for its irrevocable commitment to purchase our common stock under the Purchase Agreement, we have agreed to issue to
the Selling Stockholder 1.0% of the shares of common stock issued in each Fixed Purchase, VWAP Purchase or Additional VWAP Purchase, as
the case may be. We have also agreed to pay to the Selling Stockholder $25,000 in cash as reimbursement for the reasonable, out-of-pocket
expenses incurred by the Selling Stockholder, including the legal fees and disbursements of the Selling Stockholder&#8217;s legal counsel,
in connection with its due diligence investigation of the Company and in connection with the preparation, negotiation and execution of
the Purchase Agreement. See &#8220;<i><a href="#s1_007">The Committed Equity Financing</a></i>&#8221; for more information.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We also have agreed to indemnify
the Selling Stockholder and certain other persons against certain liabilities in connection with the offering of our common stock offered
hereby, including liabilities arising under the Securities Act or, if such indemnity is unavailable, to contribute amounts required to
be paid in respect of such liabilities. The Selling Stockholder has agreed to indemnify us against liabilities under the Securities Act
that may arise from certain written information furnished to us by the Selling Stockholder specifically for use in this prospectus or,
if such indemnity is unavailable, to contribute amounts required to be paid in respect of such liabilities. Insofar as indemnification
for liabilities arising under the Securities Act may be permitted to our directors, officers, and controlling persons, we have been advised
that in the opinion of the SEC this indemnification is against public policy as expressed in the Securities Act and is therefore, unenforceable.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Selling Stockholder has
represented to us that at no time prior to the date of the Purchase Agreement has the Selling Stockholder or its agents, representatives
or affiliates engaged in or effected, in any manner whatsoever, directly or indirectly, any short sale (as such term is defined in Rule
200 of Regulation SHO of the Exchange Act) of our common stock or any hedging transaction, which establishes a net short position with
respect to our common stock. The Selling Stockholder has agreed that during the term of the Purchase Agreement, neither the Selling Stockholder,
nor any of its agents, representatives or affiliates will enter into or effect, directly or indirectly, any of the foregoing transactions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have advised the Selling
Stockholder that it is required to comply with Regulation M promulgated under the Exchange Act. With certain exceptions, Regulation M
precludes the Selling Stockholder, any affiliated purchasers, and any broker-dealer or other person who participates in the distribution
from bidding for or purchasing, or attempting to induce any person to bid for or purchase any security which is the subject of the distribution
until the entire distribution is complete. Regulation M also prohibits any bids or purchases made in order to stabilize the price of a
security in connection with the distribution of that security. All of the foregoing may affect the marketability of the securities offered
by this prospectus.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This offering will terminate
on the date that all of our common stock offered by this prospectus have been sold by the Selling Stockholder.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 23 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span id="s1_013"></span>DESCRIPTION OF CAPITAL STOCK</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are authorized to issue
40,000,000 shares of common stock, par value $0.01 per share, and 4,000,000 shares of preferred stock, par value $0.01 per share.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Common Stock</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are authorized to issue
40,000,000 shares of common stock, par value $0.01 per share. The holders of common stock are entitled to one vote per share on all matters
submitted to a vote of stockholders, including the election of directors. There is no cumulative voting in the election of directors.
In the event of our liquidation or dissolution, holders of common stock are entitled to share ratably in all assets remaining after payment
of liabilities and the liquidation preferences of any outstanding shares of preferred stock. Holders of common stock have no preemptive
rights and have no right to convert their common stock into any other securities and there are no redemption provisions applicable to
our common stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The holders of common stock
are entitled to any dividends that may be declared by the Company&#8217;s Board of Directors (the &#8220;Board&#8221;) out of funds legally
available for payment of dividends subject to the prior rights of holders of preferred stock and any contractual restrictions we have
against the payment of dividends on common stock. We do not plan to pay dividends on our common stock in the foreseeable future.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">As
of June 9, 2025, we had 1,125,998 shares of common stock outstanding. In addition, as of that date, there were approximately 251,000
shares of common stock issuable upon exercise of outstanding warrants and stock options.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 24 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="s1_014"></span>CERTAIN PROVISIONS OF NEW YORK LAW AND OF OUR
CHARTER AND BYLAWS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Anti-Takeover Effects of New York Law</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 912 of the New York
Business Corporation Law (the &#8220;NYBCL&#8221;) prohibits a business combination, such as a merger, consolidation, recapitalization,
asset sale or disposition of stock, with any &#8220;interested shareholder&#8221; for a period of five years from the date that the interested
shareholder first became an interested shareholder unless:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.75in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">the business combination, or the acquisition of stock that resulted in the interested shareholder first
becoming an interested shareholder, was approved by Forward&#8217;s Board   prior to the interested shareholder becoming an
interested shareholder;</td></tr>
<tr style="vertical-align: top">
<td style="width: 0.75in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">the business combination is approved by the disinterested stockholders at a meeting of Forward&#8217;s
stockholders called no earlier than five years after the date that the interested shareholder first became an interested shareholder;
or</td></tr>
<tr style="vertical-align: top">
<td style="width: 0.75in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: left">the business combination meets certain &#8220;fair price&#8221; valuation requirements.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">An &#8220;interested stockholder&#8221;
is any person that is the beneficial owner of 20% or more of the outstanding voting stock of Forward or is an affiliate or associate of
Forward that at any time during the prior five years was the beneficial owner, directly or indirectly, of 20% or more of the then outstanding
voting stock of Forward. The definition of &#8220;combination&#8221; contained in the statute is sufficiently broad to cover virtually
any kind of transaction that would allow a potential acquirer to use the corporation&#8217;s assets to finance the acquisition or otherwise
to benefit its own interests rather than the interests of the corporation and its other stockholders.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The effect of New York&#8217;s
business combination law is to potentially discourage parties interested in taking control of the Company from doing so if they cannot
obtain the approval of our Board or stockholders.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">In addition, under New York law
(a) directors may be removed for cause by vote of the stockholders, and (b) directors may be removed without cause by vote of the stockholders
only if specifically authorized by the Certificate of Incorporation or bylaws. Further, removal of directors with or without cause is
subject to: (1) if a corporation has cumulative voting, no director may be removed when the votes cast against such director&#8217;s removal
would be sufficient to elect such director if voted cumulatively at an election at which the same total number of votes were cast and
the entire Board, or class of directors of which he is a member, were then being elected; and (2) when, pursuant to the certificate of
incorporation, the holders of any class of shares are entitled to elect one or more directors, any director so elected may be removed
only by the vote of the holders of such class. Any such removal requires the affirmative vote of stockholders representing not less than
two-thirds of the voting power of the shares entitled to vote.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Certificate of Incorporation and Bylaws</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Provisions of our Certificate
of Incorporation and Bylaws may delay or discourage transactions involving an actual or potential change in our control or change in our
management, including transactions in which stockholders might otherwise receive a premium for their shares, or transactions that our
stockholders might otherwise deem to be in their best interests. Therefore, these provisions could adversely affect the price of our common
stock. Among other things, our Certificate of Incorporation and Bylaws:</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 3%; text-align: justify; font-size: 10pt">&#160;</td>
    <td style="width: 3%; text-align: justify; font-size: 10pt"><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify; font-size: 10pt; width: 94%">permit our Board to issue up to 4,000,000 shares of preferred stock, without further stockholder approval, with such rights, preferences and privileges as our Board may designate in accordance with applicable law, including rights relating to acquisitions or changes in control;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify; font-size: 10pt">&#160;</td>
    <td style="text-align: justify; font-size: 10pt">&#160;</td>
    <td style="text-align: justify; font-size: 10pt">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify; font-size: 10pt">&#160;</td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify; font-size: 10pt">provide that the authorized number of directors may be changed only by a resolution adopted by the Board;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify; font-size: 10pt">&#160;</td>
    <td style="text-align: justify; font-size: 10pt">&#160;</td>
    <td style="text-align: justify; font-size: 10pt">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify; font-size: 10pt">&#160;</td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify; font-size: 10pt">provide that, for interim periods before the next meeting of the stockholders held for the election of directors, all vacancies, including newly created directorships, may, except as otherwise required by law, be filled by the affirmative vote of a majority of directors then in office, even if less than a quorum;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify; font-size: 10pt">&#160;</td>
    <td style="text-align: justify; font-size: 10pt">&#160;</td>
    <td style="text-align: justify; font-size: 10pt">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify; font-size: 10pt">&#160;</td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify; font-size: 10pt">do not provide for cumulative voting rights (therefore allowing the holders of a majority of the shares of common stock entitled to vote in any election of directors to elect all of the directors standing for election, if they should so choose);</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify; font-size: 10pt">&#160;</td>
    <td style="text-align: justify; font-size: 10pt">&#160;</td>
    <td style="text-align: justify; font-size: 10pt">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify; font-size: 10pt">&#160;</td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify; font-size: 10pt">provide that special meetings of stockholders may be called only by the President, the Chairman of the Board, by the Board of Directors pursuant to a resolution adopted by the majority of the &#8220;entire board&#8221; (as defined in the  Bylaws), or Qualified Shareholders (as defined in the Bylaws) holding at least 30% of all votes entitled to be cast on any issue proposed to be considered at the special meeting;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify; font-size: 10pt">&#160;</td>
    <td style="text-align: justify; font-size: 10pt">&#160;</td>
    <td style="text-align: justify; font-size: 10pt">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify; font-size: 10pt">&#160;</td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify; font-size: 10pt">provide advance notice provisions applicable to a stockholder who wishes to nominate a director or propose other business to be considered at a stockholders&#8217; meeting.</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 25 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><b>Listings</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our common stock is traded
on The Nasdaq Capital Market under the symbol &#8220;FORD.&#8221;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><b>Transfer Agent</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The transfer agent for our
common stock is Equiniti Trust Company, LLC.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Disclosure of Commission Position on Indemnification
for Securities Act Liabilities</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Insofar as indemnification
for liabilities arising under the Securities Act may be permitted to our directors, officers and controlling persons pursuant to the foregoing
provisions, we have been informed that in the opinion of the SEC such indemnification is against public policy as expressed in the Securities
Act and is, therefore, unenforceable.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><b></b></p>

<!-- Field: Page; Sequence: 26 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="s1_015"></span>LEGAL MATTERS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The validity of the securities
offered hereby will be passed upon for us by Nason, Yeager, Gerson, Harris &amp; Fumero, P.A., Palm Beach Gardens, Florida.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="s1_016"></span>EXPERTS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The consolidated financial
statements of Forward Industries, Inc. and Subsidiaries for the years ended September 30, 2024 and 2023, have been audited by CohnReznick
LLP, independent registered public accounting firm, as set forth in their report thereon appearing in Forward Industries, Inc. and Subsidiaries&#8217;
Annual report on Form 10-K for the year ended September 30, 2024, and incorporated by reference herein. Such consolidated financial statements
are incorporated by reference herein in reliance upon such report, which includes an explanatory paragraph on Forward Industries, Inc.
and Subsidiaries&#8217; ability to continue as a going concern, given on the authority of such firm as experts in accounting and auditing.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><span id="s1_017"></span>Where You Can Find
More Information</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We file annual, quarterly,
and other reports, proxy statements and other information with the SEC. Our Annual Report on Form 10-K, Quarterly Reports on Form 10-Q,
and Current Reports on Form 8-K, including any amendments to those reports, and other information that we file with or furnish to the
SEC pursuant to Section 13(a) or 15(d) of the Exchange Act are available free of charge on our website and through the SEC&#8217;s Electronic
Data Gathering, Analysis, and Retrieval system (EDGAR). The SEC maintains an Internet site that contains reports, proxy and information
statements, and other information regarding issuers that file electronically with the SEC at&#160;https://www.sec.gov. You may access
the registration statement, of which this prospectus is a part, at the SEC&#8217;s website.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We make available through
our website, free of charge, copies of our SEC filings as soon as reasonably practicable after we electronically file or furnish them
to the SEC on our website,&#160;https://www.forwardindustries.com. We have not incorporated by reference into this prospectus the information
on our website, and you should not consider it to be a part of this prospectus.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This prospectus forms part
of a registration statement we have filed with the SEC relating to, among other things, the common stock. As permitted by SEC rules, this
prospectus does not contain all the information we have included in the registration statement and the accompanying exhibits and schedules
we have filed with the SEC. You may refer to the registration statement, exhibits and schedules for more information about us and the
common stock. The statements this prospectus make pertaining to the content of any contract, agreement or other document that is an exhibit
to the registration statement necessarily are summaries of their material provisions, and we qualify them in their entirety by reference
to those exhibits for complete statements of their provisions. The registration statement, exhibits and schedules are available through
the SEC&#8217;s website.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 27 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><b><span id="s1_018"></span>INCORPORATION OF CERTAIN INFORMATION
BY REFERENCE</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The SEC maintains an Internet
site that contains reports, proxy and information statements, and other information regarding issuers that file electronically with the
SEC at&#160;<i>www.sec.gov</i>. The SEC allows us to &#8220;incorporate by reference&#8221; the information in certain documents that
we file with it, which means that we can disclose important information to you by referring you to documents previously filed with the
SEC. The information incorporated by reference is considered to be part of this prospectus, and the information that we subsequently file
with the SEC will automatically update and supersede this information. This prospectus incorporates by reference the Company&#8217;s documents
listed below and all documents subsequently filed by us with the SEC pursuant to Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act
prior to the termination of the offering of the securities described in this prospectus (other than documents or information deemed to
have been furnished and not filed in accordance with SEC rules, unless otherwise expressly incorporated by reference herein):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 3%"/><td style="width: 3%"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify; width: 94%"><a href="https://www.sec.gov/Archives/edgar/data/38264/000168316824009011/forward_i10k-093024.htm">Annual Report on Form 10-K</a> for Fiscal Year ended September 30, 2024 filed with the SEC on December 27,
2024 and <a href="https://www.sec.gov/Archives/edgar/data/38264/000168316825000424/forward_10ka1-093024.htm">Form 10-K/A</a> for the fiscal year ended September 30, 2024 filed with the SEC on January 17, 2025;</td></tr>
<tr style="vertical-align: top">
<td/><td><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">Our quarterly reports on Form 10-Q filed on <a href="https://www.sec.gov/Archives/edgar/data/38264/000168316825000993/forward_i10q-123124.htm">February 13, 2025</a>, and <a href="https://www.sec.gov/Archives/edgar/data/38264/000168316825003548/forward_i10q-033125.htm">May 14, 2025</a>;</td></tr>
<tr style="vertical-align: top">
<td/><td><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">Our current reports on Form 8-K (including 8-K/A) filed on <a href="https://www.sec.gov/Archives/edgar/data/38264/000168316825000650/forward_8k.htm">February
                                                                 3, 2025</a>, <a href="https://www.sec.gov/Archives/edgar/data/38264/000168316825000992/forward_8k.htm">February 13, 2025</a>, <a href="https://www.sec.gov/Archives/edgar/data/38264/000168316825001267/forward_8k.htm">February
                                                                 27, 2025</a>, <a href="https://www.sec.gov/Archives/edgar/data/38264/000168316825001658/forward_8k.htm">March 17, 2025</a>, <a href="https://www.sec.gov/Archives/edgar/data/38264/000168316825001830/forward_8k.htm">March
                                                                 24, 2025</a>, <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/38264/000168316825002064/forward_8k.htm">March 31, 2025</a>, <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/38264/000168316825002108/forward_8k.htm">March
                                                                 31, 2025</a>, <a href="https://www.sec.gov/Archives/edgar/data/38264/000168316825002225/forward_8k.htm">April 2, 2025</a>, <a href="https://www.sec.gov/Archives/edgar/data/38264/000168316825003025/forward_8k.htm">May
                                                                 1, 2025</a>, <a href="https://www.sec.gov/Archives/edgar/data/38264/000168316825003287/forward_8k.htm">May 8, 2025</a>, <a href="https://www.sec.gov/Archives/edgar/data/38264/000168316825003941/forward_8k.htm">May
                                                                 22, 2025</a>, <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/38264/000168316825003989/forward_8k.htm">May 23, 2025</a> and
                                                                 <a href="http://www.sec.gov/Archives/edgar/data/38264/000168316825004223/forward_8k.htm">June 4, 2025</a> (other than information furnished under Item 2.02 or Item 7.01 of Form 8-K and exhibits relating to such information,
                                                                 which is neither filed nor incorporated by reference herein); and</td></tr>
<tr style="vertical-align: top">
<td/><td><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">The description of our securities contained in <a href="https://www.sec.gov/Archives/edgar/data/38264/000168316819004079/ford_ex0401.htm">Exhibit 4.1</a> to our Form 10-K
filed with the Commission on December 27, 2019, as updated by any amendments and reports filed for the purpose of updating such description;
and</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">To the extent that any information
contained in any Current Report on Form 8-K, or any exhibit thereto, was furnished, rather than filed, with the SEC, that information
or exhibit is specifically not incorporated by reference in this document.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">You may obtain copies of these
documents free of charge on our website, www.forwardindustries.com, as soon as reasonably practicable after they have been filed with
the SEC and through the SEC&#8217;s website, www.sec.gov. You may also obtain such documents by submitting a written request either to
the Company at 700 Veterans Memorial Highway, Suite 100, Hauppauge, New York 11788, Attention: Kathleen Weisberg or an oral request by
calling the Company at (631) 547-3055. The Company will provide to each person, including any beneficial owner, to whom a prospectus is
delivered, a copy of any or all of the reports that have been incorporated by reference in the prospectus contained in the registration
statement but not delivered with the prospectus upon oral or written request, at no cost to the requester, by contacting the Company as
noted above.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b></b></p>

<!-- Field: Page; Sequence: 28 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>PROSPECTUS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Forward Industries, Inc.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Offering of 273,000 shares
of common stock</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>_______ __, 2025</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b></b></p>

<!-- Field: Page; Sequence: 29 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo; Options: Hidden -->&#160;<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>PART II</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>INFORMATION NOT REQUIRED IN THE PROSPECTUS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item 13. Other Expenses of Issuance and Distribution.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table sets forth
the costs and expenses payable by us in connection with the issuance and distribution of the securities being registered hereunder. All
of the amounts shown are estimates, except for the SEC Registration Fees.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify; font-size: 10pt">SEC registration fees</td>
    <td style="text-align: justify; font-size: 10pt">&#160;</td>
    <td style="text-align: justify; font-size: 10pt">$</td>
    <td style="text-align: right; font-size: 10pt">258.30</td>
    <td style="text-align: justify; font-size: 10pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 82%; text-align: justify; font-size: 10pt">Printing expenses</td>
    <td style="width: 1%; text-align: justify; font-size: 10pt">&#160;</td>
    <td style="width: 1%; text-align: justify; font-size: 10pt">$</td>
    <td style="width: 15%; text-align: right; font-size: 10pt">(1)</td>
    <td style="width: 1%; text-align: justify; font-size: 10pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify; font-size: 10pt">Accounting fees and expenses</td>
    <td style="text-align: justify; font-size: 10pt">&#160;</td>
    <td style="text-align: justify; font-size: 10pt">$</td>
    <td style="text-align: right; font-size: 10pt">(1)</td>
    <td style="text-align: justify; font-size: 10pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; font-size: 10pt">Legal fees and expenses</td>
    <td style="text-align: justify; font-size: 10pt">&#160;</td>
    <td style="text-align: justify; font-size: 10pt">$</td>
    <td style="text-align: right; font-size: 10pt">(1)</td>
    <td style="text-align: justify; font-size: 10pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-bottom: 1pt; text-align: justify; font-size: 10pt">Miscellaneous</td>
    <td style="padding-bottom: 1pt; text-align: justify; font-size: 10pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: justify; font-size: 10pt">$</td>
    <td style="border-bottom: Black 1pt solid; text-align: right; font-size: 10pt">(1)</td>
    <td style="padding-bottom: 1pt; text-align: justify; font-size: 10pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt; text-align: justify; font-size: 10pt">Total</td>
    <td style="padding-bottom: 2.5pt; text-align: justify; font-size: 10pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: justify; font-size: 10pt">$</td>
    <td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 10pt">(1)</td>
    <td style="padding-bottom: 2.5pt; text-align: justify; font-size: 10pt">&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item 14. Indemnification of Directors and Officers.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our Certificate of Incorporation
and Bylaws provide for indemnification of our officers, directors and agents to the fullest extent permitted under the NYBCL.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">NYBCL Section 721 provides
that the indemnification and advancement of expenses granted pursuant to, or provided by, this article shall not be deemed exclusive of
any other rights to which a director or officer seeking indemnification or advancement of expenses may be entitled, whether contained
in the certificate of incorporation or the by-laws or, when authorized by such certificate of incorporation or by-laws, (i) a resolution
of shareholders, (ii) a resolution of directors, or (iii) an agreement providing for such indemnification, provided that no indemnification
may be made to or on behalf of any director or officer if a judgment or other final adjudication adverse to the director or officer establishes
that his acts were committed in bad faith or were the result of active and deliberate dishonesty and were material to the cause of action
so adjudicated, or that he personally gained in fact a financial profit or other advantage to which he was not legally entitled. Nothing
contained in this article shall affect any rights to indemnification to which corporate personnel other than directors and officers may
be entitled by contract or otherwise under law.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">NYBCL Section 722(a) provides
that a corporation shall indemnify any director or officer of a corporation against judgments, fines, amounts paid in settlement, and
expenses, including attorneys&#8217; fees, actually and necessarily incurred by such person in connection with the defense of any action,
suit or proceeding to the extent that such director or officer acted in good faith and in a manner not opposed to the best interests of
the corporation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">NYBCL Section 722(b) provides
that a corporation may indemnify any person made, or threatened to be made, a party to an action by or in the right of the corporation
to procure a judgment in its favor by reason of the fact that he, his testator or intestate, is or was a director or officer of the corporation,
or is or was serving at the request of the corporation as a director or officer of any other corporation of any type or kind, domestic
or foreign, of any partnership, joint venture, trust, employee benefit plan or other enterprise, against amounts paid in settlement and
reasonable expenses, including attorneys&#8217; fees, actually and necessarily incurred by him in connection with the defense or settlement
of such action, or in connection with an appeal therein, if such director or officer acted, in good faith, for a purpose which he reasonably
believed to be in, or, in the case of service for any other corporation or any partnership, joint venture, trust, employee benefit plan
or other enterprise, not opposed to, the best interests of the corporation, except that no indemnification under this paragraph shall
be made in respect of (1) a threatened action, or a pending action which is settled or otherwise disposed of, or (2) any claim, issue
or matter as to which such person shall have been adjudged to be liable to the corporation, unless and only to the extent that the court
in which the action was brought, or, if no action was brought, any court of competent jurisdiction, determines upon application that,
in view of all the circumstances of the case, the person is fairly and reasonably entitled to indemnity for such portion of the settlement
amount and expenses as the court deems proper.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 30; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">NYBCL Section 723 provides
that a person who has been successful, on the merits or otherwise, in the defense of a civil or criminal action or proceeding of the character
described in Section 722, or in defense of any claim, issue or matter therein, shall be entitled to indemnification as authorized in such
section. Except as provided in the immediately preceding sentence, any indemnification provided for in Section 722 or otherwise permitted
by Section 721, (unless ordered by a court under Section 724 of the NYBCL), shall be made by the Corporation only if authorized in the
specific case:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(1) By the board of directors
acting by a quorum consisting of directors who are not parties to such action or proceeding for which indemnification is sought, upon
a finding that the person seeking indemnification has met the standard of conduct set forth in Section 722 or established pursuant to
Section 721 or,</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(2) If a quorum under the
immediately preceding subparagraph is not obtainable or, even if obtainable, a quorum of disinterested directors so directs:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(A) by the board upon the
opinion in writing of independent legal counsel that indemnification is proper in the circumstances because the applicable standard of
conduct set forth in said first two paragraphs has been met by such person, or</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(B) by the shareholders upon
a finding that the person has met the applicable standard of conduct set forth in said first two paragraphs.&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Insofar as indemnification for
liabilities arising under the Securities Act may be permitted to directors, officers or persons controlling us pursuant to the foregoing
provisions, the SEC has taken the position that, such indemnification is against public policy as expressed in the Securities Act and
is therefore unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant
of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit
or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, we will,
unless in the opinion of our counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction
the question of whether such indemnification by us is against public policy as expressed in the Securities Act and we will be governed
by the final adjudication of such issue.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item 15. Recent Sales of Unregistered Securities</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following list sets forth information regarding
all securities sold or granted by us within the last three years that were not registered under the Securities Act and the consideration,
if any, received by us for such securities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Effective May 16, 2025, the Company issued the
Commitment Shares to the Selling Stockholder. The Commitment Shares were issued without registration under the Securities Act, in reliance
on the exemptions provided by Section 4(a)(2) of the Securities Act as transactions not involving a public offering and Rule 506 promulgated
under the Securities Act as a sale to an accredited investor, and in reliance on similar exemptions under applicable state laws.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item 16. Exhibits and Financial Statement Schedules</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a) See the Exhibit Index on the page immediately
preceding the signature page hereto for a list of exhibits filed as part of this registration statement on Form S-1, which Exhibit Index
is incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b) No financial statement schedules are provided
because the information called for is not required or is shown either in the financial statements or the notes thereto.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item 17. Undertakings </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The undersigned registrant
hereby undertakes:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(1) To file, during any period
in which offers or sales are being made, a post-effective amendment to this registration statement:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(i) To include any prospectus
required by section 10(a)(3) of the Securities Act;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 31; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(ii) To reflect in the prospectus
any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof)
which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding
the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed
that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the
form of prospectus filed with the Securities and Exchange Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume
and price represent no more than a 20 percent change in the maximum aggregate offering price set forth in the &#8220;Calculation of Registration
Fee&#8221; table in the effective registration statement; and</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(iii) To include any material
information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to
such information in the registration statement; provided, however, that paragraphs (1)(i), (1)(ii) and (1)(iii) above do not apply if
the information required to be included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished
to the Securities and Exchange Commission by the registrant pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of
1934 that are incorporated by reference in the registration statement, or is contained in a form of prospectus filed pursuant to Rule
424(b) that is part of the registration statement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(2) That, for the purpose
of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a new registration statement
relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide
offering thereof.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(3) To remove from registration
by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(4) That, for the purpose
of determining liability under the Securities Act to any purchaser:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(A) Each prospectus filed
by the registrant pursuant to Rule 424(b)(3) shall be deemed to be part of the registration statement as of the date the filed prospectus
was deemed part of and included in the registration statement; and</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(B) Each prospectus required
to be filed pursuant to Rule 424(b)(2), (b)(5) or (b)(7) as part of a registration statement in reliance on Rule 430B relating to an offering
made pursuant to Rule 415(a)(1)(i), (vii), or (x) for the purpose of providing the information required by Section 10(a) of the Securities
Act shall be deemed to be part of and included in the registration statement as of the earlier of the date such form of prospectus is
first used after effectiveness or the date of the first contract of sale of securities in the offering described in the prospectus. As
provided in Rule 430B, for liability purposes of the issuer and any person that is at that date an underwriter, such date shall be deemed
to be a new effective date of the registration statement relating to the securities in the registration statement to which that prospectus
relates, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.&#160;<i>Provided</i>,&#160;<i>however</i>,
that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated
or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as
to a purchaser with a time of contract of sale prior to such effective date, supersede or modify any statement that was made in the registration
statement or prospectus that was part of the registration statement or made in any such document immediately prior to such effective date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(5) That, for purposes of
determining any liability under the Securities Act, each filing of the registrant&#8217;s annual report pursuant to Section 13(a) or 15(d)
of the Exchange Act (and, where applicable, each filing of an employee benefit plan&#8217;s annual report pursuant to Section 15(d) of
the Exchange Act) that is incorporated by reference in the registration statement shall be deemed to be a new registration statement relating
to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering
thereof.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(6) Insofar as indemnification
for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the registrant pursuant
to any charter provision, by law or otherwise, the registrant has been advised that in the opinion of the Securities and Exchange Commission
such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a
claim for indemnification against such liabilities (other than payment by the registrant of expenses incurred or paid by a director, officer
or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer
or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the
matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification
by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 32; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>EXHIBIT INDEX</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b></b></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="5" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 9pt"><b>Incorporated by Reference</b></span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; text-align: center; width: 6%"><span style="font-size: 9pt"><b>Exhibit<br/>
    No.</b></span></td>
    <td style="text-align: center; width: 1%"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: left; width: 54%"><span style="font-size: 9pt"><b>Exhibit Description</b></span></td>
    <td style="text-align: justify; width: 1%"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: center; width: 8%"><span style="font-size: 9pt"><b>Form</b></span></td>
    <td style="text-align: center; width: 1%"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: center; width: 10%"><span style="font-size: 9pt"><b>Date</b></span></td>
    <td style="text-align: center; width: 1%"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: center; width: 9%"><span style="font-size: 9pt"><b>Number</b></span></td>
    <td style="text-align: justify; width: 1%"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: center; width: 8%"><span style="font-size: 9pt"><b>Filed or<br/>
    Furnished<br/>
    Herewith</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: right"><span style="font-size: 9pt">2.1</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt"><a href="http://www.sec.gov/Archives/edgar/data/38264/000100329718000005/ex2-1.htm">Stock
    Purchase Agreement dated January 18, 2018 - Intelligent Product Solutions, Inc.+</a></span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">8-K</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">1/18/18</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">2.1</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: right"><span style="font-size: 9pt">2.2</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt"><a href="http://www.sec.gov/Archives/edgar/data/38264/000168316820002782/forward_8k-ex9901.htm">Asset
    Purchase Agreement dated August 17, 2020 - Kablooe, Inc.+</a></span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">8-K</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">8/17/20</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">2.1</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: right"><span style="font-size: 9pt">3.1</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt"><a href="http://www.sec.gov/Archives/edgar/data/38264/000100329710000300/exhibit3i.htm">Restated
    Certificate of Incorporation</a></span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">10-K</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">12/8/10</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">3(i)</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: right"><span style="font-size: 9pt">3.2</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt"><a href="http://www.sec.gov/Archives/edgar/data/38264/000100329713000150/es3-1.htm">Certificate
    of Amendment of the Certificate of Incorporation - Series A Participating Preferred Stock </a></span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">8-K</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">4/26/13</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">3.1</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: right"><span style="font-size: 9pt">3.3</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt"><a href="http://www.sec.gov/Archives/edgar/data/38264/000100329713000316/es3-1.htm">Certificate
    of Amendment of the Certificate of Incorporation - 6% Senior Convertible Preferred Stock</a></span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">8-K</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">7/3/13</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">3.1</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: right"><span style="font-size: 9pt">3.4</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt"><a href="https://www.sec.gov/Archives/edgar/data/38264/000168316824004362/forward_ex0301.htm">Certificate
    of Amendment of the Certificate of Incorporation - Reverse Stock Split</a></span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">8-K</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">6/20/24</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">3.1</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: right"><span style="font-size: 9pt">3.5</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt"><a href="https://www.sec.gov/Archives/edgar/data/38264/000168316824004696/forward_ex0401.htm">Certificate
    of Amendment of the Certificate of Incorporation - Series A-1 Convertible Preferred Stock</a></span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">8-K</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">7/8/24</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">4.1</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: right"><span style="font-size: 9pt">3.6</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt"><a href="https://www.sec.gov/Archives/edgar/data/38264/000168316824006943/forward_ex0401.htm">Certificate
    of Amendment of the Certificate of Incorporation - Increasing the Authorized Series A-1</a></span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">8-K</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">10/4/24</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">4.1</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: right"><span style="font-size: 9pt">3.7</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt"><a href="forward_ex0307.htm">Certificate of Amendment of the Certificate
    of Incorporation &#8211; Series B</a></span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">Filed</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: right"><span style="font-size: 9pt">3.8</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt"><a href="http://www.sec.gov/Archives/edgar/data/38264/000100329714000579/ex3-ii.htm">Third
    Amended and Restated Bylaws, as of May 28, 2014</a></span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">10-K</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">12/10/14</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">3(ii)</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: right"><span style="font-size: 9pt">4.1</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt"><a href="http://www.sec.gov/Archives/edgar/data/38264/000168316819004079/ford_ex0401.htm">Description
    of securities registered under Section 12 of the Exchange Act of 1934</a></span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">10-K</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">12/27/19</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">4.1</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: right"><span style="font-size: 9pt">4.2</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">Promissory Note dated January 18, 2018 - Forward Industries (Asia-Pacific)
    Corporation (as amended and restated)</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">8-K</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">5/22/25</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">10.3</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: right"><span style="font-size: 9pt">5.1</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt"><a href="forward_ex0501.htm">Opinion of Nason Yeager Gerson Harris &amp;
    Fumero P.A.</a></span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">Filed</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: right"><span style="font-size: 9pt">10.1</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt"><a href="http://www.sec.gov/Archives/edgar/data/38264/000100329719000016/exhibit4-3.htm">2011
    Long-Term Incentive Plan, as amended</a></span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">10-Q</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">2/14/19</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">4.3</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: right"><span style="font-size: 9pt">10.2</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt"><a href="https://www.sec.gov/Archives/edgar/data/38264/000168316820004438/forward_ex0401.htm">2021
    Equity Incentive Plan</a></span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">8-K</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">12/23/20</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">4.1</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: right"><span style="font-size: 9pt">10.3</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt"><a href="https://www.sec.gov/Archives/edgar/data/38264/000168316821006416/forward_ex1004a.htm">Form
    of Employment Agreement dated May 26, 2021 - Paul Severino</a>*</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">10-K</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">12/16/21</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">10.4(a)</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: right"><span style="font-size: 9pt">10.4</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt"><a href="http://www.sec.gov/Archives/edgar/data/38264/000100329718000112/ex10-5.htm">Summary
    of Employment Arrangement - Terence Wise*</a></span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">10-K</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">12/21/23</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">10.4</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: right"><span style="font-size: 9pt">10.5</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt"><a href="http://www.sec.gov/Archives/edgar/data/38264/000168316820002160/forward_8k-ex1001.htm">Employment
    Agreement dated July 1, 2023 - Kathleen Weisberg*</a></span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">8-K</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">6/30/23</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">10.1</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: right"><span style="font-size: 9pt">10.9</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt"><a href="https://www.sec.gov/Archives/edgar/data/38264/000168316822003502/forward_ex1001.htm">Consultancy
    Agreement dated March 1, 2022 - Justwise Group Ltd.</a></span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">10-Q</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">5/12/22</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">10.1</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: right"><span style="font-size: 9pt">10.10</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt"><a href="https://www.sec.gov/Archives/edgar/data/38264/000168316822008471/forward_ex1011.htm">Consultancy
    Agreement dated September 1, 2022 - Justwise Group Ltd.</a></span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">10-K</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">12/16/22</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">10.11</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: right"><span style="font-size: 9pt">10.10(a)</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt"><a href="https://www.sec.gov/Archives/edgar/data/38264/000168316823007729/forward_ex1004.htm">Extension
    to the Consultancy Agreement - Justwise Group Ltd.</a></span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">8-K</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">11/8/23</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">10.4</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: right"><span style="font-size: 9pt">10.11</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt"><a href="https://www.sec.gov/Archives/edgar/data/38264/000168316822008471/forward_ex1012.htm">Employment
    Agreement dated January 18, 2018 - Robert Wild</a> *</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">10-K</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">12/16/22</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">10.12</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: right"><span style="font-size: 9pt">10.12</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt"><a href="https://www.sec.gov/Archives/edgar/data/38264/000168316822008471/forward_ex1013.htm">Employment
    Agreement dated August 17, 2020 - Tom KraMer</a> *</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">10-K</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">12/16/22</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">10.13</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: right"><span style="font-size: 9pt">10.13</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt"><a href="https://www.sec.gov/Archives/edgar/data/38264/000168316823007729/forward_ex1001.htm">Buying
    Agency and Supply Agreement dated November 2, 2023 - Forward Industries (Asia-Pacific) Corporation</a>+</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">8-K</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">11/8/23</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">10.1</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: right"><span style="font-size: 9pt">10.13(a)</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt"><a href="https://www.sec.gov/Archives/edgar/data/38264/000168316824008222/forward_ex1001.htm">Amendment
    to the Buying Agency and Supply Agreement - November 2024</a></span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">8-K</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">11/18/24</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">10.1</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: right"><span style="font-size: 9pt">10.14</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt"><a href="https://www.sec.gov/Archives/edgar/data/38264/000168316823007729/forward_ex1002.htm">Deferred
    Payment Agreement - Forward Industries (Asia - Pacific) Corporation</a></span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">8-K</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">11/8/23</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">10.2</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: right"><span style="font-size: 9pt">10.15</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt"><a href="https://www.sec.gov/Archives/edgar/data/38264/000168316824004696/forward_ex1001.htm">Account
    Payables Conversion Agreement - Forward Industries (Asia- Pacific) Corporation - July 2024</a></span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">8-K</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">7/8/24</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">10.1</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: right"><span style="font-size: 9pt">10.16</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt"><a href="https://www.sec.gov/Archives/edgar/data/38264/000168316824006943/forward_ex1001.htm">Account
    Payables Conversion Agreement - Forward Industries (Asia-Pacific) Corporation - September 2024</a></span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">8-K</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">10/4/24</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">10.1</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: right"><span style="font-size: 9pt">10.17</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">Securities Purchase Agreement dated May 16, 2025, by and between C/M Capital
    Master Fund, LP and Forward Industries, Inc. - ELOC</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">8-K</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">5/22/25</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">10.4</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: right"><span style="font-size: 9pt">10.18</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">Registration Rights Agreement dated May 16, 2025, by and between C/M Capital
    Master Fund, LP and Forward Industries, Inc. - ELOC</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">8-K</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">5/22/25</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">10.5</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: right"><span style="font-size: 9pt">10.19</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">OEM Transaction Agreement dated May 16, 2025</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">8-K</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">5/22/25</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">10.1</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: right"><span style="font-size: 9pt">10.20</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt"><a href="forward_ex1020.htm">Form of Securities Purchase Agreement dated
    May 23, 2025 &#8211; Series B</a></span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">Filed</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: right"><span style="font-size: 9pt">10.21</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt"><a href="forward_ex1021.htm">Form of Registration Rights Agreement dated
    May 23, 2025 &#8211; Series B</a></span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">Filed</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: right"><span style="font-size: 9pt">10.22</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt"><a href="forward_ex1022.htm">Form of Warrant dated May 23, 2025</a></span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">Filed</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: right"><span style="font-size: 9pt">21.1</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt"><a href="forward_ex2101.htm">List of Subsidiaries</a></span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">Filed</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: right"><span style="font-size: 9pt">23.1</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><a href="forward_ex2301.htm"><span style="font-size: 9pt">Consent of Independent Registered Public Accounting Firm</span></a></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">Filed</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: right"><span style="font-size: 9pt">23.2</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">Consent of Nason Yeager Gerson Harris &amp; Fumero P.A. (Contained in <a href="forward_ex0501.htm">Exhibit
    5.1</a>)</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: right"><span style="font-size: 9pt">107</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt"><a href="forward_ex107.htm">Filing Fee Table</a></span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 9pt">Filed</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;______________________</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">+&#160;&#160;&#160;Certain schedules, appendices and
exhibits to this agreement have been omitted in accordance with Item 601 of Regulation S-K. A copy of any omitted schedule and/or exhibit
will be furnished supplementally to the Securities and Exchange Commission staff upon request.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b></b></p>

<!-- Field: Page; Sequence: 33; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SIGNATURES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the requirements of the Securities
Act of 1933, the registrant has duly caused this registration Statement to be signed on its behalf by the undersigned, thereunto duly
authorized in the City of Hauppauge, State of New York on June 10, 2025.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="text-align: justify">&#160;</td>
    <td colspan="2" style="text-align: justify"><b>FORWARD INDUSTRIES, INC.</b></td></tr>
  <tr>
    <td colspan="2" style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top; width: 55%; text-align: justify">&#160;</td>
    <td style="vertical-align: top; width: 5%; text-align: justify">By:&#160;&#160;&#160;</td>
    <td style="vertical-align: bottom; width: 40%; text-align: justify"><span style="text-decoration: underline">/s/<i>Michael Pruitt</i></span></td></tr>
  <tr>
    <td colspan="2" style="vertical-align: top; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">Michael Pruitt</td></tr>
  <tr>
    <td colspan="2" style="vertical-align: top; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">Interim Chief Executive Officer (Principal Executive Officer)</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Pursuant to the requirements of the Securities Act
of 1933, this registration statement has been signed by the following persons in the capacities and on the dates indicated.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; width: 23%; text-align: center"><b>Signature</b></td>
    <td style="width: 2%; text-align: justify">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 52%; text-align: center"><b>Title</b></td>
    <td style="width: 2%; text-align: justify">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 21%; text-align: center"><b>Date</b></td></tr>
  <tr>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: justify">&#160;</td></tr>
  <tr>
    <td style="border-bottom: black 1pt solid; vertical-align: top; text-align: justify"><i>/s/ Michael Pruitt</i></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: center">Interim Chief Executive Officer </td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: center">June 10, 2025</td></tr>
  <tr>
    <td style="vertical-align: top; text-align: justify">Michael Pruitt</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td></tr>
  <tr>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: justify">&#160;</td></tr>
  <tr>
    <td style="border-bottom: black 1pt solid; vertical-align: top; text-align: justify"><i>/s/ Kathleen Weisberg</i></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: center">Chief Financial Officer (Principal Financial and Accounting Officer)</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: center">June 10, 2025</td></tr>
  <tr>
    <td style="vertical-align: top; text-align: justify">Kathleen Weisberg</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td></tr>
  <tr>
    <td style="border-bottom: black 1pt solid; vertical-align: top; text-align: justify"><i>/s/ Sharon Hrynkow </i></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: center">Director</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: center">June 10, 2025</td></tr>
  <tr>
    <td style="text-align: justify">Sharon Hrynkow</td>
    <td style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: justify">&#160;</td></tr>
  <tr>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: justify">&#160;</td></tr>
  <tr>
    <td style="border-bottom: black 1pt solid; vertical-align: top; text-align: justify"><i>/s/ Keith Johnson</i></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: center">Director</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: center">June 10, 2025</td></tr>
  <tr>
    <td style="text-align: justify">Keith Johnson </td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: justify">&#160;</td></tr>
  <tr>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: justify">&#160;</td></tr>
  <tr>
    <td style="border-bottom: black 1pt solid; vertical-align: top; text-align: justify"><i>/s/ Sangita Shah</i></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: center">Director</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: center">June 10, 2025</td></tr>
  <tr>
    <td style="text-align: justify">Sangita Shah</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: justify">&#160;</td></tr>
  <tr>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: justify">&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<!-- Field: Page; Sequence: 34; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjdEKwjAMRb9g/xD6LNoVFNmjY4o4RYaIr2XLpLg1I606P8m/tG6IIRCSe0+uEBOxobVpkOGyKnI4Yds12iMUWCOjLTE40u0ugTALvBrnWVs/rD8wpcBgYBZTWYb74HwYh1UCcj5Ty5mag4wTtYTjXkRfPSVbmwqtN7oBbSs4MnVs0Gt+jR9OuidL7WtIOiM7QzaBeCpH+Q1KxgoO9NBP4puDPE9FNBkqEhumexdcWe/RfknIGmxDnBvpf0cfzv5KYg== -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.7
<SEQUENCE>2
<FILENAME>forward_ex0307.htm
<DESCRIPTION>CERTIFICATE OF AMENDMENT OF THE CERTIFICATE OF INCORPORATION - SERIES B
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; text-align: right"><B>Exhibit 3.7</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; color: #0C0A0C"><B>CERTIFICATE OF AMENDMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; color: #0C0A0C"><B>OF THE </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; color: #0C0A0C"><B>CERTIFICATE OF INCORPORATION </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; color: #0C0A0C"><B>OF </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; color: #0C0A0C"><B>FORWARD INDUSTRIES, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; color: #0C0A0C"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; color: #0C0A0C"><B>Under Section 805 of the Business
Corporation Law</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 30.2pt 0 245.35pt; text-indent: -105.55pt; color: #0C0A0C">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">I, Kathleen Weisberg, hereby certify
that I am the Chief Financial Officer of Forward Industries, Inc. (the &ldquo;<B>Corporation</B>&rdquo;), a corporation organized and
existing under the Business Corporation Law of the State of New York (the &ldquo;<B>NYBCL</B>&rdquo;)<B>, and </B>hereby certify as follows,
pursuant to Sections 502 and 805 of the NYBCL:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">1.</TD><TD STYLE="text-align: justify">The current name of the Corporation is: Forward Industries, Inc. The name under which the Corporation
was originally formed is Progress Heat Sealing Co., Inc.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 2.25pt; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">2.</TD><TD STYLE="text-align: justify">The original Certificate of Incorporation was filed with the Department of State on March 6, 1961.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">3.</TD><TD STYLE="text-align: justify">This Certificate of Amendment to the Certificate of Incorporation was authorized by the vote of the Board
of Directors of the Corporation (&ldquo;<B>Board</B>&rdquo;) pursuant to Section 502 of the NYBCL.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">4.</TD><TD STYLE="text-align: justify">The corporation is authorized to issue 44,000,000 shares, consisting of 40,000,000 shares of common stock,
par value $0.01 per share (&ldquo;Common Stock&rdquo;) and 4,000,000 shares of preferred stock, par value $0.01 per share (&ldquo;Preferred
Stock&rdquo;), of which Preferred Stock there are 100,000 shares of Preferred Stock designated as Series A Participating Preferred Stock
(&ldquo;Series A&rdquo;), par value $0.01 per share and 6,700 shares are designated as Series A-1 Convertible Preferred Stock (&ldquo;Series
A-1&rdquo;).&nbsp; Immediately prior to the filing of this Certificate of Amendment to the Certificate of Incorporation (the &ldquo;Effective
Time&rdquo;), there are (i) 100,000 shares of Series A authorized and there are no shares of Series A issued and outstanding and (ii)
6,700 shares of Series A-1 are authorized and there are 4,925 shares of Series A-1 issued and outstanding. An amendment of the Corporation&rsquo;s
Certificate of Incorporation effected by this Certificate of Amendment to add the designations, rights and preferences of a new series
of Preferred Stock, par value $0.01 per share, designated as Series B Convertible Preferred Stock, is hereby made.&nbsp; Immediately prior
to the Effective Time, the Corporation did not have any shares of Series B Convertible Preferred Stock authorized, or issued and outstanding.
Immediately after the Effective Time, there will be 4,000,000 shares of Preferred Stock authorized, of which 100,000 shares of Series
A are authorized with no shares of Series A issued and outstanding (100,000 shares of Series A unissued), 6,700 shares of Series A-1 are
authorized with 4,925 shares issued and outstanding (1,775 shares of Series A-1 unissued) and 1,000,000 shares of Series B Convertible
Preferred Stock authorized with no shares issued and outstanding (1,000,000 shares of Series B Convertible Preferred Stock unissued).&nbsp;
This Certificate of Amendment is only designating the Series B Convertible Preferred and is not changing any class from one to another,
redesignating any shares or creating any other classes or series, or changing the amount of shares authorized or outstanding of any other
series.&nbsp; After the Effective Time, the Corporation&rsquo;s authorized shares remain at 44,000,000 shares, consisting of 40,000,000
shares of Common Stock and 4,000,000 shares of Preferred Stock.&nbsp; Additionally, after the Effective Time, of the 4,000,000 shares
of Preferred Stock: (i) 1,106,700 shares have been designated a Series (100,000 shares of Series A, 6,700 shares of Series A-1 and 1,000,000
shares of Series B) and (ii) the remaining 2,893,300 shares are authorized but unissued and unclassified. The rate of change for all classes
is one for one.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">To effect the foregoing, Article SIXTH of the Corporation&rsquo;s
Certificate of Incorporation, relating to the Series B Convertible Preferred Stock, is hereby added, and all subsequent Articles of the
Corporation&rsquo;s Certificate of Incorporation are renumbered accordingly. Article SIXTH shall read in its entirety as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify">SIXTH: The Corporation is authorized
to issue 44,000,000 shares, consisting of 40,000,000 shares of common stock, par value $0.01 per share (&ldquo;Common Stock&rdquo;) and
4,000,000 shares of preferred stock, par value $0.01 per share (&ldquo;Preferred Stock&rdquo;), of which 4,000,000 shares of Preferred
Stock there are (i) 100,000 shares of Preferred Stock designated as Series A Participating Preferred Stock, par value $0.01 per share;
&nbsp;(ii) 6,700 shares are designated as Series A-1 Convertible Preferred Stock, par value $0.01 per share; and (iii) 3,893,300 shares
of Preferred Stock are undesignated.&nbsp; Of these 3,893,300 shares of undesignated&nbsp;Preferred Stock, the Corporation&rsquo;s Board
has designated 1,000,000 of such shares as Series B Convertible Preferred Stock, par value $0.01 per share, at a conversion rate of 1
to 1 (leaving 2,893,300&nbsp;shares of Preferred Stock as undesignated), and such 1,000,000 shares of Series B Convertible Preferred Stock,
par value $0.01 shall have the following designations, rights, preferences and limitations:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">1.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Designation and Number of Shares</U>. There shall hereby be created and established a series of preferred stock of the Corporation
designated as &ldquo;Series B Convertible Preferred Stock&rdquo; (the &ldquo;<B>Series B Convertible Preferred Stock</B>&rdquo;). The
authorized number of shares of Series B Convertible Preferred Stock (the &ldquo;<B>Preferred Shares</B>&rdquo;) shall be 1,000,000 shares.
Each Preferred Share shall have a par value of $0.01 per share. Capitalized terms not defined herein shall hav<FONT STYLE="color: #242328">e</FONT>
the meaning as <FONT STYLE="color: #242328">s</FONT>et forth in Section 33 below or the Preferred Stock Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; color: #0C0A0C">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">2.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Ranking</U>. Except to the extent that the Buyer (as defined in the Preferred Stock Purchase Agreement) expressly consent to
the creation of Parity Stock (as defined below) or Senior Preferred Stock (as defined below) in accordance with Section 16, all shares
of capital stock of the Corporation shall be junior in rank to all Preferred Share<FONT STYLE="color: #242328">s </FONT>with respect t<FONT STYLE="color: #242328">o
</FONT>the preferences as to dividends, distributions and payments upon the liquidation<FONT STYLE="color: #242328">, </FONT>dissolution
and winding up of the Corporation (such junior s<FONT STYLE="color: #242328">t</FONT>ock is referred to herein collectively as &ldquo;<B>Junior
Stock</B>&rdquo;). <FONT STYLE="color: #242328">F</FONT>or the avoidance of doubt, the Preferred Shares will, with r<FONT STYLE="color: #242328">es</FONT>pect
to dividend right<FONT STYLE="color: #242328">s</FONT> and <FONT STYLE="color: #242328">ri</FONT>ghts on liquidation, winding-up and d<FONT STYLE="color: #242328">i</FONT>ssolution,
rank (A) junior to the S<FONT STYLE="color: #242328">e</FONT>nior Pre<FONT STYLE="color: #242328">fe</FONT>rred Sto<FONT STYLE="color: #242328">c</FONT>k,
(B) on pari<FONT STYLE="color: #242328">ty </FONT>with the Parity Stock and (C) senior to the Junior Stock. The right<FONT STYLE="color: #242328">s
</FONT>of all such shares of capital stock of the Corporation shall be subject to the rights, powers<FONT STYLE="color: #444246">, </FONT>preferences,
and privileges of the Preferred Shares. Without limiting any other provision of this Certificate of Desi<FONT STYLE="color: #242328">g</FONT>nation<FONT STYLE="color: #242328">s</FONT>,
without the prior e<FONT STYLE="color: #242328">x</FONT>press consent of the Buyer<FONT STYLE="color: #242328">, v</FONT>oting s<FONT STYLE="color: #242328">e</FONT>parately
as a <FONT STYLE="color: #242328">s</FONT>in<FONT STYLE="color: #242328">g</FONT>l<FONT STYLE="color: #242328">e </FONT>cla<FONT STYLE="color: #242328">s</FONT>s<FONT STYLE="color: #242328">,
</FONT>th<FONT STYLE="color: #242328">e</FONT> Corporation shall not hereafter authorize or issue any additional or other shares of capital
stock that is (i) of senior rank to the Preferred Shares in respect of the preferences as to dividends, distributions and payments upon
the liquidation, dissolution and winding up of the Corporation (collectively, the &ldquo;<B>Senior Preferred Stock</B>&rdquo;) (ii) of
pari passu rank to the Preferred Shares in respect of the preferences as to dividends, distributions and payments upon the liquidation,
dissolution and winding up of the Corporation (collectively, the &ldquo;<B>Parity Stock</B>&rdquo;) or (iii) any Junior Stock having a
maturity date or any other date requiring redemption or repayment of such shares of Junior Stock that is prior to the second anniversary
of the Initial Issuance Date. In the event of the merger or consolidation or other business combination or reorganization of the Corporation
with or into another corporation, the Preferred Shares shall maintain their relative rights, powers, designations, privileges, and preferences
provided for herein and no such merger or consolidation shall result inconsistent therewith.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">3.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Dividends</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(a)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>From and after the first date of issuance of any Preferred Shares (the &ldquo;<B>Initial Issuance Date</B>&rdquo;), the Preferred
Shares shall commence accruing dividends (&ldquo;<B>Dividends</B>&rdquo;) at the Dividend Rate computed on the basis of a 360-day year
and twelve 30-day months. Dividends shall be payable in arrears on the first Trading Day of each Fiscal Quarter (each, a &ldquo;<B>Dividend
Date</B>&rdquo;) with the first Dividend Date being the first Trading Day of the initial Fiscal Quarter commencing after the Initial Issuance
Date. Dividends shall be payable on each Dividend Date, to each record holder (each, a &ldquo;<B>Holder</B>&rdquo;, and collectively,
the &ldquo;<B>Holders</B>&rdquo;) of Preferred Shares on the applicable Dividend Date, in shares of Common Stock (&ldquo;<B>Dividend Shares</B>&rdquo;)
so long as there has been no Equity Conditions Failure; provided however, that the Corporation may, at its option following notice to
each Holder, capitalize such Dividend by increasing the Stated Value of each Preferred Share on such Dividend Date (&ldquo;<B>Capitalized
Dividend</B>&rdquo;) or in a combination of a Capitalized Dividend and a payment in Dividend Shares. The Corporation shall deliver a written
notice (each, a &ldquo;<B>Dividend Election Notice</B>&rdquo;) to each Holder of the Preferred Shares on or prior to the tenth (10<SUP>th</SUP>)
Trading Day immediately prior to the applicable Dividend Date (each, a &ldquo;<B>Dividend Notice Due Date</B>&rdquo;) (the date such notice
is delivered to all of the Holders, the &ldquo;<B>Dividend Notice Date</B>&rdquo;) which notice (i) either (A) confirms that Dividend
to be paid on such Dividend Date shall be paid entirely in Dividend Shares or (B) elects to effect a Capitalized Dividend or a combination
of Capitalized Dividend and a payment in Dividend Shares and specifies the amount of Dividend that shall be a Capitalized Dividend and
the amount of Dividend, if any, that shall be paid in Dividend Shares and (ii) certifies that there has been no Equity Conditions Failure.
If an Equity Conditions Failure has occurred as of the Dividend Notice Date, then unless the Corporation has elected to effect a Capitalized
Dividend, the Dividend Election Notice shall indicate that unless such applicable Holder waives the Equity Conditions Failure, the Dividend
shall be effected as a Capitalized Dividend. Notwithstanding anything herein to the contrary, if no Equity Conditions Failure has occurred
as of the Dividend Notice Date, but an Equity Conditions Failure occurs at any time prior to the Dividend Date, (A) the Corporation shall
provide each Holder a subsequent notice to that effect and (B) unless such applicable Holder waives the Equity Conditions Failure, the
Dividend shall be paid to such Holder in cash. Dividends to be paid on a Dividend Date in Dividend Shares shall be paid in a number of
fully paid and nonassessable shares (rounded to the nearest whole share) of Common Stock equal to the quotient of (1) the amount of Dividend
payable on such Dividend Date less any Capitalized Dividend and (2) the Dividend Conversion Price in effect on the applicable Dividend
Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(b)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>When any Dividend Shares are to be paid on an Dividend Date to a Holder, the Corporation shall (i) (A) provided that the Corporation&rsquo;s
transfer agent (the &ldquo;<B>Transfer Agent</B>&rdquo;) is participating in the Depository Trust Company (&ldquo;<B>DTC</B>&rdquo;) Fast
Automated Securities Transfer Program (&ldquo;<B>FAST</B>&rdquo;), credit such aggregate number of Dividend Shares to which such Holder
shall be entitled to such Holder&rsquo;s or its designee&rsquo;s balance account with DTC through its Deposit/Withdrawal at Custodian
system, or (B) if the Transfer Agent is not participating in FAST, issue and deliver on the applicable Dividend Date, to the address set
forth in the register maintained by the Corporation for such purpose pursuant to the Preferred Stock Purchase Agreement or to such address
as specified by such Holder in writing to the Corporation at least two (2) Business Days prior to the applicable Dividend Date, a certificate,
registered in the name of such Holder or its designee, for the number of Dividend Shares to which such Holder shall be entitled and (ii)
with respect to each Dividend Date, increase the Stated Value of the Preferred Shares by the amount of any Capitalized Dividend.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(c)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Prior to the payment of Dividends on a Dividend Date, Dividends on the Preferred Shares shall accrue at the Dividend Rate and be
payable by way of inclusion of the Dividends in the Conversion Amount on each Conversion Date in accordance with Section 4(b) or upon
any required payment upon any Bankruptcy Triggering Event. From and after the occurrence and during the continuance of any Triggering
Event, the Dividend Rate in effect with respect to such determination shall automatically be increased to the Default Rate. In the event
that such Triggering Event is subsequently cured (and no other Triggering Event then exists (including, without limitation, for the Corporation&rsquo;s
failure to pay such Dividends at the Default Rate on the applicable Dividend Date)), the adjustment referred to in the preceding sentence
shall cease to be effective as of the calendar day immediately following the date of such cure; provided that the Dividends as calculated
and unpaid at such increased rate during the continuance of such Triggering Event shall continue to apply to the extent relating to the
days after the occurrence of such Triggering Event through and including the date of such cure of such Triggering Event.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">4.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Conversion</U>. At any time after the Initial Issuance Date, each Preferred Share shall be convertible into validly issued,
fully paid and non-assessable shares of Common Stock (the &ldquo;<B>Conversion Shares</B>&rdquo;), on the terms and conditions set forth
in this Section 4.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(a)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Holder&rsquo;s Conversion Right</U>. Subject to the provisions of Section 4(d), at any time or times on or after the Initial
Issuance Date, each Holder shall be entitled to convert any portion of the outstanding Preferred Shares held by such Holder into validly
issued, fully paid and non-assessable Conversion Shares in accordance with Section 4(c) at the Conversion Rate (as defined below). The
Corporation shall not issue any fraction of a share of Common Stock upon any conversion. If the issuance would result in the issuance
of a fraction of a share of Common Stock, the Corporation shall round such fraction of a share of Common Stock up to the nearest whole
share. The Corporation shall pay any and all transfer, stamp, issuance and similar taxes, costs and expenses (including, without limitation,
fees and expenses of the Transfer Agent that may be payable with respect to the issuance and delivery of Common Stock upon conversion
of any Preferred Shares).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(b)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Conversion Rate</U>. Except as otherwise provided herein, the number of Conversion Shares issuable upon conversion of any Preferred
Share pursuant to this Section 4 shall be determined by dividing (x) the Conversion Amount of such Preferred Share by (y) the Conversion
Price (the &ldquo;<B>Conversion Rate</B>&rdquo;)<B>.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(i)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>For purposes of this Certificate of Designations, the term &ldquo;<B>Conversion Amount</B>&rdquo; means, with respect to each Preferred
Share, as of the applicable date of determination, the sum of (1) the Stated Value thereof <U>plus</U> (2) any Additional Amount thereon
as of such date of determination <U>plus</U> (3) any other amounts owed to such Holder pursuant to this Certificate of Designations or
any other Transaction Document.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(ii)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>For purposes of this Certificate of Designations, the term &ldquo;<B>Conversion Price</B>&rdquo; means, with respect to each Preferred
Share, as of any Conversion Date or other date of determination, $4.50, subject to adjustment as provided herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(c)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Mechanics of Conversion.</U> The conversion of each Preferred Share shall be conducted in the following manner:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(i)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Optional Conversion.</U> To convert one or more Preferred Shares into Conversion Shares on any date (a &ldquo;<B>Conversion
Date</B>&rdquo;), a Holder shall deliver (whether via electronic mail or otherwise), for receipt on or prior to 11:59 p.m., New York time,
on such date, a copy of an executed notice of conversion of the Preferred Share(s) subject to such conversion in a form reasonably acceptable
to the Corporation (the &ldquo;<B>Conversion Notice&rdquo;)</B>:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in">If required by Section 4(c)(ii),
within two (2) Trading Days following a conversion of any such Preferred Shares as aforesaid, such Holder shall surrender to a nationally
recognized overnight delivery service for delivery to the Corporation the original certificates, if any, representing the Preferred Shares
(the &ldquo;<B>Preferred Share Certificates</B>&rdquo;) so converted as aforesaid (or an indemnification undertaking with respect to the
Preferred Shares in the case of its loss, theft or destruction as contemplated by Section 19(b)). On or before the first (1st) Trading
Day following the date of receipt of a Conversion Notice, the Corporation shall transmit by electronic mail an acknowledgment of confirmation
and representation as to whether such shares of Common Stock may then be resold pursuant to Rule 144 or an effective and available registration
statement, in a form reasonably acceptable to the Corporation, of receipt of such Conversion Notice to such Holder and the Transfer Agent,
which confirmation shall constitute an instruction to the Transfer Agent to process such Conversion Notice in accordance with the terms
set forth herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in">On or before the first (1st)
Trading Day following each date on which the Corporation has received a Conversion Notice (or such earlier date as required pursuant to
the 1934 Act or other applicable law, rule or regulation for the settlement of a trade initiated on the applicable Conversion Date of
such Conversion Shares issuable pursuant to such Conversion Notice) (the &ldquo;<B>Share Delivery Deadline</B>&rdquo;)<B>, </B>the Corporation
shall (1) provided that the Transfer Agent is participating in FAST and such shares of Common Stock (i) (A) may then be sold by the applicable
Holder pursuant to an available and effective registration statement and (B) such Holder provides such documentation or other information
evidencing the sale of the shares of Common Stock as the Corporation, the Transfer Agent or legal counsel to the Corporation shall reasonably
request (which, for the avoidance of doubt, shall not include the requirement of a medallion guarantee or a legal opinion) or (ii) may
be sold by such Holder pursuant to Rule 144 of the 1933 Act, as applicable (the &ldquo;<B>Resale Eligibility Conditions</B>&rdquo;), credit
such aggregate number of Conversion Shares to which such Holder shall be entitled pursuant to such conversion to such Holder&rsquo;s or
its designee&rsquo;s balance account with DTC through its Deposit/Withdrawal at Custodian system, or (2) if the Transfer Agent is not
participating in FAST or the Resale Eligibility Conditions are not satisfied, upon the request of such Holder, issue and deliver (via
reputable overnight courier) to the address as specified in such Conversion Notice, a certificate, registered in the name of such Holder
or its designee, for the number of Conversion Shares to which such Holder shall be entitled. If the number of Preferred Shares represented
by the Preferred Share Certificate(s) submitted for conversion pursuant to Section 4(c)(ii) is greater than the number of Preferred Shares
being converted, then the Corporation shall, as soon as practicable and in no event later than two (2) Trading Days after receipt of the
Preferred Share Certificate(s) and at its own expense, issue and mail to such Holder (or its designee) by overnight courier service a
new Preferred Share Certificate or a new Book-Entry (in either case, in accordance with Section 19(d)) representing the number of Preferred
Shares not converted. The Person or Persons entitled to receive the Conversion Shares issuable upon a conversion of Preferred Shares shall
be treated for all purposes as the record holder or holders of such Conversion Shares on the Conversion Date. Notwithstanding the foregoing,
if a Holder delivers a Conversion Notice to the Corporation prior to the date of issuance of Preferred Shares to such Holder, whereby
such Holder elects to convert such Preferred Shares pursuant to such Conversion Notice, the Share Delivery Deadline with respect to any
such Conversion Notice shall be the later of (x) the date of issuance of such Preferred Shares and (y) the first (1st) Trading Day after
the date of such Conversion Notice. Notwithstanding anything to the contrary contained in this Certificate of Designations or the Registration
Rights Agreement, after the effective date of a Registration Statement (as defined in the Registration Rights Agreement) and prior to
a Holder&rsquo;s receipt of the notice of a Grace Period (as defined in the Registration Rights Agreement), the Corporation shall cause
the Transfer Agent to deliver unlegended shares of Common Stock to such Holder (or its designee) in connection with any sale of Registrable
Securities (as defined in the Registration Rights Agreement) with respect to which such Holder has entered into a contract for sale, and
delivered a copy of the prospectus included as part of the particular Registration Statement to the extent applicable, and for which such
Holder has not yet settled.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(ii)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Corporation&rsquo;s Failure to Timely Convert.</U> If the Corporation shall fail, for any reason or for no reason, on or prior
to the applicable Share Delivery Deadline, either (I) if the Transfer Agent is not participating in FAST or the Resale Eligibility Conditions
are not satisfied, to issue and deliver to such Holder (or its designee) a certificate for the number of Conversion Shares to which such
Holder is entitled and register such Conversion Shares on the Corporation&rsquo;s share register or, if the Transfer Agent is participating
in FAST and the Resale Eligibility Conditions are satisfied, to credit such Holder&rsquo;s or its designee&rsquo;s balance account with
DTC for such number of Conversion Shares to which such Holder is entitled upon such Holder&rsquo;s conversion of any Conversion Amount
(as the case may be) or (II) if the Registration Statement covering the resale of the Conversion Shares that are the subject of the Conversion
Notice (the &ldquo;<B>Unavailable Conversion Shares</B>&rdquo;) is not available for the resale of such Unavailable Conversion Shares
and the Corporation fails to promptly, but in no event later than as required pursuant to the Registration Rights Agreement (x) notify
such Holder and (y) deliver the shares of Common Stock electronically without any restrictive legend by crediting such aggregate number
of shares of Common Stock to which such Holder is entitled pursuant to such conversion to such Holder&rsquo;s or its designee&rsquo;s
balance account with DTC through its Deposit/Withdrawal At Custodian system (the event described in the immediately foregoing clause (II)
is hereinafter referred to as a &ldquo;<B>Notice Failure</B>&rdquo; and together with the event described in clause (I) above, a &ldquo;<B>Conversion
Failure</B>&rdquo;), and if on or after such Share Delivery Deadline such Holder acquires (in an open market transaction, stock loan or
otherwise) shares of Common Stock corresponding to all or any portion of the number of Conversion Shares issuable upon such conversion
that such Holder is entitled to receive from the Corporation and has not received from the Corporation in connection with such Conversion
Failure or Notice Failure, as applicable (a &ldquo;<B>Buy-In</B>&rdquo;), then, in addition to all other remedies available to such Holder,
the Corporation shall, within two (2) Business Days after receipt of such Holder&rsquo;s request and in such Holder&rsquo;s discretion,
either: (I) pay cash to such Holder in an amount equal to such Holder&rsquo;s total purchase price (including brokerage commissions, stock
loan costs and other out-of-pocket expenses, if any) for the shares of Common Stock so acquired (including, without limitation, by any
other Person in respect, or on behalf, of such Holder) (the &ldquo;<B>Buy-In Price</B>&rdquo;), at which point the Corporation&rsquo;s
obligation to so issue and deliver such certificate (and to issue such Conversion Shares) or credit to the balance account of such Holder
or such Holder&rsquo;s designee, as applicable, with DTC for the number of Conversion Shares to which such Holder is entitled upon such
Holder&rsquo;s conversion hereunder (as the case may be) (and to issue such Conversion Shares) shall terminate, or (II) promptly honor
its obligation to so issue and deliver to such Holder a certificate or certificates representing such Conversion Shares or credit the
balance account of such Holder or such Holder&rsquo;s designee, as applicable, with DTC for the number of Conversion Shares to which such
Holder is entitled upon such Holder&rsquo;s conversion hereunder (as the case may be) and pay cash to such Holder in an amount equal to
the excess (if any) of the Buy-In Price over the product of (x) such number of shares of Common Stock multiplied by (y) the lowest Closing
Sale Price of the Common Stock on any Trading Day during the period commencing on the date of the applicable Conversion Notice and ending
on the date of such issuance and payment under this clause (II) (each, a &ldquo;<B>Buy-In Payment Amount</B>&rdquo;). In addition to the
foregoing, if on or prior to the Share Delivery Deadline either (A) the Transfer Agent is not participating in FAST or the Resale Eligibility
Conditions are not satisfied, the Corporation shall fail to issue and deliver to such Holder (or its designee) a certificate and register
such Conversion Shares on the Corporation&rsquo;s share register or, if the Transfer Agent is participating in the FAST and the Resale
Eligibility Conditions are satisfied, the Transfer Agent shall fail to credit the balance account of such Holder or such Holder&rsquo;s
designee, as applicable, with DTC for the number of Conversion Shares to which such Holder is entitled upon such Holder&rsquo;s conversion
hereunder or pursuant to the Corporation&rsquo;s obligation pursuant to clause (ii) below or (B) a Notice Failure occurs, then, in addition
to all other remedies available to such Holder, (X) the Corporation shall pay in cash to such Holder on each day after the Share Delivery
Deadline that the issuance of such Conversion Shares is not timely effected an amount equal to 1% of the product of (A) the sum of the
number of Conversion Shares not issued to such Holder on or prior to the Share Delivery Deadline and to which such Holder is entitled,
multiplied by (B) any trading price of the Common Stock selected by such Holder in writing as in effect at any time during the period
beginning on the applicable Conversion Date and ending on the applicable Share Delivery Deadline and (Y) such Holder, upon written notice
to the Corporation, may void its Conversion Notice with respect to, and retain or have returned, as the case may be, all, or any portion,
of such Preferred Shares that has not been converted pursuant to such Conversion Notice; provided that the voiding of a Conversion Notice
shall not affect the Corporation&rsquo;s obligations to make any payments which have accrued prior to the date of such notice pursuant
to this Section 4(c)(ii) or otherwise. Nothing herein shall limit a Holder&rsquo;s right to pursue any other remedies available to it
hereunder, at law or in equity, including, without limitation, a decree of specific performance and/or injunctive relief with respect
to the Corporation&rsquo;s failure to timely deliver certificates representing Conversion Shares (or to electronically deliver such Conversion
Shares) upon the conversion of the Preferred Shares as required pursuant to the terms hereof. Notwithstanding anything herein to the contrary,
with respect to any given Notice Failure and/or Conversion Failure, as applicable, this Section 4(c)(ii) shall not apply to a Holder to
the extent the Corporation has already paid such amounts in full to such Holder with respect to such Notice Failure and/or Conversion
Failure, as applicable, pursuant to the analogous sections of the Preferred Stock Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(iii)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Registration: Book-Entry.</U> At the time of issuance of any Preferred Shares hereunder, the applicable Holder may, by written
request (including by electronic-mail) to the Corporation, elect to receive such Preferred Shares in the form of one or more Preferred
Share Certificates or in Book-Entry form. The Corporation (or the Transfer Agent, as custodian for the Preferred Shares) shall maintain
a register (the &ldquo;<B>Register</B>&rdquo;) for the recordation of the names and addresses of the Holders of each Preferred Share and
the Stated Value of the Preferred Shares and whether the Preferred Shares are held by such Holder in Preferred Share Certificates or in
Book-Entry form (the &ldquo;<B>Registered Preferred Shares</B>&rdquo;). The entries in the Register shall be conclusive and binding for
all purposes absent manifest error. The Corporation and each Holder of the Preferred Shares shall treat each Person whose name is recorded
in the Register as the owner of a Preferred Share for all purposes (including, without limitation, the right to receive payments and Dividends
hereunder) notwithstanding notice to the contrary. A Registered Preferred Share may be assigned, transferred or sold only by registration
of such assignment or sale on the Register. Upon its receipt of a written request to assign, transfer or sell one or more Registered Preferred
Shares by such Holder thereof, the Corporation shall record the information contained therein in the Register and issue one or more new
Registered Preferred Shares in the same aggregate Stated Value as the Stated Value of the surrendered Registered Preferred Shares to the
designated assignee or transferee pursuant to Section 19, provided that if the Corporation does not so record an assignment, transfer
or sale (as the case may be) of such Registered Preferred Shares within two (2) Business Days of such a request, then the Register shall
be automatically deemed updated to reflect such assignment, transfer or sale (as the case may be). Notwithstanding anything to the contrary
set forth in this Section 4, following conversion of any Preferred Shares in accordance with the terms hereof, the applicable Holder shall
not be required to physically surrender such Preferred Shares held in the form of a Preferred Share Certificate to the Corporation unless
(A) the full or remaining number of Preferred Shares represented by the applicable Preferred Share Certificate are being converted (in
which event such certificate(s) shall be delivered to the Corporation as contemplated by this Section 4(c)(ii)) or (B) such Holder has
provided the Corporation with prior written notice (which notice may be included in a Conversion Notice) requesting reissuance of Preferred
Shares upon physical surrender of the applicable Preferred Share Certificate. Each Holder and the Corporation shall maintain records showing
the Stated Value and Dividends converted and/or paid (as the case may be) and the dates of such conversions and/or payments (as the case
may be) or shall use such other method, reasonably satisfactory to such Holder and the Corporation, so as not to require physical surrender
of a Preferred Share Certificate upon conversion. If the Corporation does not update the Register to record such Stated Value and Dividends
converted and/or paid (as the case may be) and the dates of such conversions and/or payments (as the case may be) within two (2) Business
Days of such occurrence, then the Register shall be automatically deemed updated to reflect such occurrence. In the event of any dispute
or discrepancy, the records of the Corporation establishing the number of Preferred Shares to which the record holder is entitled shall
be controlling and determinative in the absence of manifest error. A Holder and any transferee or assignee, by acceptance of a certificate,
acknowledge and agree that, by reason of the provisions of this paragraph, following conversion of any Preferred Shares, the number of
Preferred Shares represented by such certificate may be less than the number of Preferred Shares stated on the face thereof. Each Preferred
Share Certificate shall bear the following legend:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 8.25pt 0 121.1pt; text-align: justify; text-indent: 0.1pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 1in 0 0.5in; text-align: justify; text-indent: -0.05pt">ANY TRANSFEREE OR
ASSIGNEE OF THIS CERTIFICATE SHOULD CAREFULLY REVIEW THE TERMS OF THE CORPORATION&rsquo;S CERTIFICATE OF DESIGNATIONS RELATING TO THE
SHARES OF SERIES B CONVERTIBLE PREFERRED STOCK REPRESENTED BY THIS CERTIFICATE, INCLUDING SECTION 4(c)(ii) THEREOF. THE NUMBER OF SHARES
OF SERIES B CONVERTIBLE PREFERRED STOCK REPRESENTED BY THIS CERTIFICATE MAY BE LESS THAN THE NUMBER OF SHARES OF SERIES B CONVERTIBLE
PREFERRED STOCK STATED ON THE FACE HEREOF PURSUANT TO SECTION 4(c)(ii) OF THE CERTIFICATE OF DESIGNATIONS RELATING TO THE SHARES OF SERIES
B CONVERTIBLE PREFERRED STOCK REPRESENTED BY THIS CERTIFICATE.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 1in 0 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(iv)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Pro Rata Conversion; Disputes.</U> In the event that the Corporation receives a Conversion Notice from more than one Holder
for the same Conversion Date and the Corporation can convert some, but not all, of such Preferred Shares submitted for conversion, the
Corporation shall convert from each Holder electing to have Preferred Shares converted on such date a pro rata amount of such Holder&rsquo;s
Preferred Shares submitted for conversion on such date based on the number of Preferred Shares submitted for conversion on such date by
such Holder relative to the aggregate number of Preferred Shares submitted for conversion on such date. In the event of a dispute as to
the number of Conversion Shares issuable to a Holder in connection with a conversion of Preferred Shares, the Corporation shall issue
to such Holder the number of Conversion Shares not in dispute and resolve such dispute in accordance with Section 24. If a Conversion
Notice delivered to the Corporation would result in a breach of Section 4(d) below, and the applicable Holder does not elect in writing
to withdraw, in whole, such Conversion Notice, the Corporation shall hold such Conversion Notice in abeyance until such time as such Conversion
Notice may be satisfied without violating Section 4(d) below (with such calculations thereunder made as of the date such Conversion Notice
was initially delivered to the Corporation).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(d)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Limitation on Beneficial Ownership.</U> The Corporation shall not effect the conversion of any of the Preferred Shares held
by a Holder, and such Holder shall not have the right to convert any of the Preferred Shares held by such Holder pursuant to the terms
and conditions of this Certificate of Designations and any such conversion shall be null and void and treated as if never made, to the
extent that after giving effect to such conversion, such Holder together with the other Attribution Parties collectively would beneficially
own in excess of 1.5% (the &ldquo;<B>Maximum Percentage</B>&rdquo;) of the shares of Common Stock outstanding immediately after giving
effect to such conversion. For purposes of the foregoing sentence, the aggregate number of shares of Common Stock beneficially owned by
such Holder and the other Attribution Parties shall include the number of shares of Common Stock held by such Holder and all other Attribution
Parties <U>plus</U> the number of shares of Common Stock issuable upon conversion of the Preferred Shares with respect to which the determination
of such sentence is being made, but shall exclude shares of Common Stock which would be issuable upon (A) conversion of the remaining,
nonconverted Preferred Shares beneficially owned by such Holder or any of the other Attribution Parties and (B) exercise or conversion
of the unexercised or nonconverted portion of any other securities of the Corporation (including, without limitation, any convertible
notes, convertible preferred stock or warrants, including the Preferred Shares and the Warrants) beneficially owned by such Holder or
any other Attribution Party subject to a limitation on conversion or exercise analogous to the limitation contained in this Section 4(d).
For purposes of this Section 4(d), beneficial ownership shall be calculated in accordance with Section 13(d) of the 1934 Act. For the
avoidance of doubt, the calculation of the Maximum Percentage shall take into account the concurrent exercise and/or conversion, as applicable,
of the unexercised or unconverted portion of any other securities of the Corporation beneficially owned by such Holder and/or any other
Attribution Party, as applicable. For purposes of determining the number of outstanding shares of Common Stock a Holder may acquire upon
the conversion of such Preferred Shares without exceeding the Maximum Percentage, such Holder may rely on the number of outstanding shares
of Common Stock as reflected in (x) the Corporation&rsquo;s most recent Annual Report on Form 10-K, Quarterly Report on Form 10-Q, Current
Report on Form 8-K or other public filing with the SEC, as the case may be, (y) a more recent public announcement by the Corporation or
(z) any other written notice by the Corporation or the Transfer Agent, if any, setting forth the number of shares of Common Stock outstanding
(the &ldquo;<B>Reported Outstanding Share Number</B>&rdquo;). If the Corporation receives a Conversion Notice from a Holder at a time
when the actual number of outstanding shares of Common Stock is less than the Reported Outstanding Share Number, the Corporation shall
notify such Holder in writing of the number of shares of Common Stock then outstanding and, to the extent that such Conversion Notice
would otherwise cause such Holder&rsquo;s beneficial ownership, as determined pursuant to this Section 4(d), to exceed the Maximum Percentage,
such Holder must notify the Corporation of a reduced number of shares of Common Stock to be purchased pursuant to such Conversion Notice.
For any reason at any time, upon the written or oral request of any Holder, the Corporation shall within one (1) Business Day confirm
orally and in writing or by electronic mail to such Holder the number of shares of Common Stock then outstanding. In any case, the number
of outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise of securities of the Corporation,
including such Preferred Shares, by such Holder and any other Attribution Party since the date as of which the Reported Outstanding Share
Number was reported. In the event that the issuance of shares of Common Stock to a Holder upon conversion of such Preferred Shares results
in such Holder and the other Attribution Parties being deemed to beneficially own, in the aggregate, more than the Maximum Percentage
of the number of outstanding shares of Common Stock (as determined under Section 13(d) of the 1934 Act), the number of shares so issued
by which such Holder&rsquo;s and the other Attribution Parties&rsquo; aggregate beneficial ownership exceeds the Maximum Percentage (the
&ldquo;<B>Excess Shares</B>&rdquo;) shall be deemed null and void and shall be cancelled ab initio, and such Holder shall not have the
power to vote or to transfer the Excess Shares. With the prior written consent of the Corporation, any Holder may from time to time increase
(with such increase not effective until the sixty-first (61st) day after delivery of such notice) or decrease the Maximum Percentage of
such Holder to any other percentage not in excess of 9.99% as specified in such notice; provided that (i) any such increase in the Maximum
Percentage will not be effective until the sixty-first (61<SUP>st</SUP>) day after such notice is delivered to the Corporation and (ii)
any such increase or decrease will apply only to such Holder and the other Attribution Parties and not to any other Holder that is not
an Attribution Party of such Holder. For purposes of clarity, the shares of Common Stock issuable to a Holder pursuant to the terms of
this Certificate of Designations in excess of the Maximum Percentage shall not be deemed to be beneficially owned by such Holder for any
purpose including for purposes of Section 13(d) or Rule 16a-l(a)(l) of the 1934 Act. No prior inability to convert such Preferred Shares
pursuant to this paragraph shall have any effect on the applicability of the provisions of this paragraph with respect to any subsequent
determination of convertibility. The provisions of this paragraph shall not be construed and implemented in a manner otherwise than in
strict conformity with the terms of this Section 4(d) to the extent necessary to correct this paragraph (or any portion of this paragraph)
which may be defective or inconsistent with the intended beneficial ownership limitation contained in this Section 4(d) or to make changes
or supplements necessary or desirable to properly give effect to such limitation. The limitation contained in this paragraph may not be
waived and shall apply to a successor holder of such Preferred Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(e)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Mandatory Conversion.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(i)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>General.</U> If at any time (i) the Closing Sale Price of the Common Stock listed on the Principal Market exceeds 200% of the
then applicable Conversion Price for five (5) consecutive Trading Days (each, a &ldquo;<B>Mandatory Conversion Measuring Period</B>&rdquo;),
(ii) the average daily dollar trading value (as reported on Bloomberg) of the Common Stock exceeds $1,000,000 for such Mandatory Conversion
Measuring Period, (iii) a registration statement covering the resale of all shares of Common Stock issuable upon conversion of the Preferred
Shares is effective, and (iv) no Equity Conditions Failure then exists, the Corporation shall have the right to require each Holder to
convert all, or any number, of the Preferred Shares, as designated in the Mandatory Conversion Notice (as defined below) into fully paid,
validly issued and nonassessable shares of Common Stock in accordance with Section 4(c) hereof at the Conversion Rate as of the Mandatory
Conversion Date (as defined below) (a &ldquo;<B>Mandatory Conversion</B>&rdquo;). The Corporation may exercise its right to require conversion
under this Section 4(e) by delivering within five (5) Trading Days following the end of such Mandatory Conversion Measuring Period a written
notice thereof by electronic mail and overnight courier to all, but not less than all, of the Holders and the Transfer Agent (the &ldquo;<B>Mandatory
Conversion Notice</B>&rdquo; and the date all of the Holders received such notice by electronic mail is referred to as the &ldquo;<B>Mandatory
Conversion Notice Date</B>&rdquo;). The Mandatory Conversion Notice shall be irrevocable. The Mandatory Conversion Notice shall state
(i) the Trading Day selected for the Mandatory Conversion in accordance with this Section 4(e), which Trading Day shall be no less than
two (2) Trading Days and no more than fifteen (15) Trading Days following the Mandatory Conversion Notice Date (the &ldquo;<B>Mandatory
Conversion Date</B>&rdquo;)<B>, </B>(ii) the aggregate number of the Preferred Shares subject to mandatory conversion from each Holder
pursuant to this Section 4(e), (iii) the number of shares of Common Stock to be issued to such Holder on the Mandatory Conversion Date
and (iv) that there has been no Equity Conditions Failure. Notwithstanding the foregoing, the Corporation may effect only one (1) Mandatory
Conversion during any twenty (20) consecutive Trading Days. Notwithstanding anything herein to the contrary, (i) if the Closing Sale Price
of the Common Stock listed on the Principal Market fails to exceed the Conversion Price by 200% for each Trading Day commencing on the
Mandatory Conversion Notice Date and ending and including the Trading Day immediately prior to the applicable Mandatory Conversion Date,
(ii) the daily dollar trading value (as reported on Bloomberg) of the Common Stock fails to exceed $1,000,000 for such Mandatory Conversion
Measuring Period, (iii) a registration statement covering the resale of all shares of Common Stock issuable upon conversion of the Preferred
Shares is not effective (each a &ldquo;<B>Mandatory Conversion Price Failure</B>&rdquo;) or an Equity Conditions Failure occurs at any
time prior to the Mandatory Conversion Date, (A) the Corporation shall provide each Holder a subsequent notice to that effect and (B)
unless such Holder waives the applicable Equity Conditions Failure and/or Mandatory Conversion Price Failure, as applicable, the Mandatory
Conversion shall be cancelled and the applicable Mandatory Conversion Notice of such Holder shall be null and void and (iv) at any time
prior to the date of consummation of the Mandatory Conversion the Preferred Shares subject to such Mandatory Conversion may be converted,
in whole or in part, by any Holder into shares of Common Stock pursuant to Section 44. Notwithstanding the foregoing, any Preferred Shares
subject to a Mandatory Conversion may be converted by a Holder hereunder prior to the applicable Mandatory Conversion Date and such aggregate
number of Preferred Shares converted hereunder on or after the Mandatory Conversion Notice Date and prior to such Mandatory Conversion
Date shall reduce the aggregate number of Preferred Shares of such Holder required to be converted on such Mandatory Conversion Date.
For the avoidance of doubt, the Corporation shall have no right to effect a Mandatory Conversion if any Triggering Event has occurred
and continuing, but any Triggering Event shall have no effect upon any Holder&rsquo;s right to convert Preferred Shares in its discretion.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(ii)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Pro Rata Conversion Requirement.</U> If the Corporation elects to cause a Mandatory Conversion of any Preferred Shares pursuant
to this Section 4(e), then it must simultaneously take the same action in the same proportion with respect to all Holders of Preferred
Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(f)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Right of Alternate Conversion Upon a Triggering Event</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(i)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>General.</U> Subject to Section 4(d), at any time after the earlier of a Holder&rsquo;s receipt of a Triggering Event Notice
(as defined below) and such Holder becoming aware of a Triggering Event (such earlier date, the &ldquo;<B>Alternate Conversion Right Commencement
Date</B>&rdquo;) and ending (such ending date, the &ldquo;<B>Alternate Conversion Right Expiration Date</B>&rdquo;, and each such period,
an &ldquo;<B>Alternate Conversion Right Period</B>&rdquo;) on the twentieth (20<SUP>th</SUP>) Trading Day after the later of (x) the date
such Triggering Event is cured and (y) such Holder&rsquo;s receipt of a Triggering Event Notice that includes (I) a reasonable description
of the applicable Triggering Event, (II) a certification as to whether, in the reasonable opinion of the Corporation, such Triggering
Event is capable of being cured and, if applicable, a reasonable description of any existing plans of the Corporation to cure such Triggering
Event and (III) a certification as to the date the Triggering Event occurred and, if cured on or prior to the date of such Triggering
Event Notice, the applicable Alternate Conversion Right Expiration Date, such Holder may, at such Holder&rsquo;s option, by delivery of
a Conversion Notice to the Corporation (the date of any such Conversion Notice, each an &ldquo;<B>Alternate Conversion Date</B>&rdquo;)<B>,
</B>convert all, or any number of Preferred Shares held by such Holder into shares of Common Stock at the Alternate Conversion Price (each,
an &ldquo;<B>Alternate Conversion</B>&rdquo;)<B>.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><B></B></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(ii)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Mechanics of Alternate Conversion.</U> On any Alternate Conversion Date, a Holder may voluntarily convert any number of Preferred
Shares held by such Holder pursuant to Section 4(c) (with &ldquo;Alternate Conversion Price&rdquo; replacing &ldquo;Conversion Price&rdquo;
for all purposes hereunder with respect to such Alternate Conversion and with &ldquo;the applicable Required Premium multiplied by the
Conversion Amount&rdquo; replacing &ldquo;Conversion Amount&rdquo; in clause (x) of the definition of Conversion Rate in Section 4(b)
above with respect to such Alternate Conversion) by designating in the Conversion Notice delivered pursuant to this Section 4(f)(ii) of
this Certificate of Designations that such Holder is electing to use the Alternate Conversion Price for such conversion; provided that
in the event of the Conversion Floor Price Condition, on the applicable Alternate Conversion Date the Stated Value of the remaining Preferred
Shares of such Holder shall automatically increase, pro rata, by the applicable Alternate Conversion Floor Amount or, at the Corporation&rsquo;s
option, the Corporation shall deliver the applicable Alternate Conversion Floor Amount to such applicable Holder on the applicable Alternate
Conversion Date. Notwithstanding anything to the contrary in this Section 4(f)(ii), but subject to Section 4(d), until the Corporation
delivers to such Holder the shares of Common Stock to which such Holder is entitled pursuant to the applicable Alternate Conversion of
such Holder&rsquo;s Preferred Shares, such Preferred Shares may be converted by such Holder into shares of Common Stock pursuant to Section
4(c) without regard to this Section 4(f)(ii). In the event of an Alternate Conversion pursuant to this Section 4(f)(ii) of all, or any
portion, of any Preferred Shares of a Holder, such Holder&rsquo;s damages would be uncertain and difficult to estimate because of the
parties&rsquo; inability to predict future interest rates and the uncertainty of the availability of a suitable substitute investment
opportunity for such Holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">5.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Triggering Events</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(a)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>General.</U> Each of the following events shall constitute a &ldquo;<B>Triggering Event</B>&rdquo; and each of the events in
clauses 5(a)(x), 5(a)(xi), and 5(a)(xii), shall constitute a &ldquo;<B>Bankruptcy Triggering Event</B>&rdquo;<B>:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(i)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>the failure of the applicable Registration Statement (as defined in the Registration Rights Agreement) to be filed with the SEC
on or prior to the date that is five (5) days after the applicable Filing Deadline (as defined in the Registration Rights Agreement) or
the failure of the applicable Registration Statement to be declared effective by the SEC on or prior to the date that is five (5) days
after the applicable Effectiveness Deadline (as defined in the Registration Rights Agreement);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(ii)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>while the applicable Registration Statement is required to be maintained effective pursuant to the terms of the Registration Rights
Agreement, the effectiveness of the applicable Registration Statement lapses for any reason (including, without limitation, the issuance
of a stop order) or such Registration Statement (or the prospectus contained therein) is unavailable to any holder of Registrable Securities
(as defined in the Registration Rights Agreement) for sale of all of such holder&rsquo;s Registrable Securities in accordance with the
terms of the Registration Rights Agreement, and such lapse or unavailability continues for a period of ten (10) consecutive days or for
more than an aggregate of twenty (20) days in any 365-day period (excluding days during an Allowable Grace Period (as defined in the Registration
Rights Agreement));</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(iii)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>the suspension from trading or the failure of the Common Stock to be trading or listed (as applicable) on an Eligible Market for
a period of five (5) consecutive Trading Days;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(iv)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>the Corporation&rsquo;s (A) failure to cure a Conversion Failure or a Delivery Failure (as defined in the Warrants) by delivery
of the required number of shares of Common Stock within five (5) Trading Days after the applicable Conversion Date or exercise date (as
the case may be) or (B) notice, written or oral, to any holder of Preferred Shares or Warrants, including, without limitation, by way
of public announcement or through any of its agents, at any time, of its intention not to comply, as required, with a request for exercise
of any Warrants for Warrant Shares in accordance with the provisions of the Warrants or a request for conversion of any Preferred Shares
into shares of Common Stock that is requested in accordance with the provisions of this Certificate of Designations, other than pursuant
to Section 4(c)(iv) hereof;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(v)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>except to the extent the Corporation is in compliance with Section 12(b) below, at any time following the tenth (10<SUP>th</SUP>)
consecutive day that a Holder&rsquo;s Authorized Share Allocation (as defined in Section 12(a) below) is less than the sum of (A) 300%
of the number of shares of Common Stock that such Holder would be entitled to receive upon a conversion, in full, of all of the Preferred
Shares then held by such Holder (assuming conversions at the Floor Price then in effect without regard to any limitations on conversion
set forth in this Certificate of Designations) and (B) 100% of the number of shares of Common Stock that such Holder would then be entitled
to receive upon exercise in full of such Holder&rsquo;s Warrants (without regard to any limitations on exercise set forth in the Warrants);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(vi)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>the Board fails to declare any Dividend to be paid on the applicable Dividend Date in accordance with Section 3;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(vii)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>the Corporation&rsquo;s failure to pay to any Holder any Dividend on any Dividend Date (whether or not declared by the Board) or
any other amount when and as due under this Certificate of Designations, the Preferred Stock Purchase Agreement or any other Transaction
Document or any other agreement, document, certificate or other instrument delivered in connection with the transactions contemplated
hereby and thereby (in each case, whether or not permitted pursuant to the NYBCL), except, in the case of a failure to pay Dividends when
and as due, in each such case only if such failure remains uncured for a period of at least two (2) Trading Days;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(viii)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>the Corporation fails to remove any restrictive legend on any certificate or any shares of Common Stock issued to the applicable
Holder upon conversion or exercise (as the case may be) of any Securities (as defined in the Preferred Stock Purchase Agreement) acquired
by such Holder under the Transaction Documents as and when required by such Securities or the Preferred Stock Purchase Agreement, as applicable,
unless otherwise then prohibited by applicable federal securities laws, and any such failure remains uncured for at least five (5) days;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(ix)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>the occurrence of any default under, redemption of or acceleration prior to maturity of at least an aggregate of $1,000,000 of
Indebtedness (as defined in the Preferred Stock Purchase Agreement) of the Corporation or any of its Subsidiaries;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(x)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>bankruptcy, insolvency, reorganization or liquidation proceedings or other proceedings for the relief of debtors shall be instituted
by or against the Corporation or any Subsidiary and, if instituted against the Corporation or any Subsidiary by a third party, shall not
be dismissed within thirty (30) days of their initiation;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(xi)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>the commencement by the Corporation or any Subsidiary of a voluntary case or proceeding under any applicable federal, state or
foreign bankruptcy, insolvency, reorganization or other similar law or of any other case or proceeding to be adjudicated a bankrupt or
insolvent, or the consent by it to the entry of a decree, order, judgment or other similar document in respect of the Corporation or any
Subsidiary in an involuntary case or proceeding under any applicable federal, state or foreign bankruptcy, insolvency, reorganization
or other similar law or to the commencement of any bankruptcy or insolvency case or proceeding against it, or the filing by it of a petition
or answer or consent seeking reorganization or relief under any applicable federal, state or foreign law, or the consent by it to the
filing of such petition or to the appointment of or taking possession by a custodian, receiver, liquidator, assignee, trustee, sequestrator
or other similar official of the Corporation or any Subsidiary or of any substantial part of its property, or the making by it of an assignment
for the benefit of creditors, or the execution of a composition of debts, or the occurrence of any other similar federal, state or foreign
proceeding, or the admission by it in writing of its inability to pay its debts generally as they become due, the taking of corporate
action by the Corporation or any Subsidiary in furtherance of any such action or the taking of any action by any Person to commence a
Uniform Commercial Code foreclosure sale or any other similar action under federal, state or foreign law;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(xii)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>document in the entry by a court of (i) a decree, order, judgment or other similar respect of the Corporation or any Subsidiary
of a voluntary or involuntary case or proceeding under any applicable federal, state or foreign bankruptcy, insolvency, reorganization
or other similar law or (ii) a decree, order, judgment or other similar document adjudging the Corporation or any Subsidiary as bankrupt
or insolvent, or approving as properly filed a petition seeking liquidation, reorganization, arrangement, adjustment or composition of
or in respect of the Corporation or any Subsidiary under any applicable federal, state or foreign law or (iii) a decree, order, judgment
or other similar document appointing a custodian, receiver, liquidator, assignee, trustee, sequestrator or other similar official of the
Corporation or any Subsidiary or of any substantial part of its property, or ordering the winding up or liquidation of its affairs, and
the continuance of any such decree, order, judgment or other similar document or any such other decree, order, judgment or other similar
document unstayed and in effect for a period of thirty (30) consecutive days;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(xiii)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>a final judgment or judgments for the payment of money aggregating in excess of $1,000,000 are rendered against the Corporation
and/or any of its Subsidiaries and which judgments are not, within thirty (30) days after the entry thereof, bonded, discharged, settled
or stayed pending appeal, or are not discharged within thirty (30) days after the expiration of such stay; provided, however, any judgment
which is covered by insurance or an indemnity from a credit worthy party shall not be included in calculating the $1,000,000 amount set
forth above so long as the Corporation provides each Holder a written statement from such insurer or indemnity provider (which written
statement shall be reasonably satisfactory to each Holder) to the effect that such judgment is covered by insurance or an indemnity and
the Corporation or such Subsidiary (as the case may be) will receive the proceeds of such insurance or indemnity within thirty (30) days
of the issuance of such judgment;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(xiv)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>the Corporation and/or any Subsidiary, individually or in the aggregate, either (i) fails to pay, when due, or within any applicable
grace period, any payment with respect to any Indebtedness due to any third party (other than, with respect to unsecured Indebtedness
only, payments contested by the Corporation and/or such Subsidiary (as the case may be) in good faith by proper proceedings and with respect
to which adequate reserves have been set aside for the payment thereof in accordance with GAAP) or is otherwise in breach or violation
of any agreement for monies owed or owing in an amount in excess of $1,000,000, which breach or violation permits the other party thereto
to declare a default or otherwise accelerate amounts due thereunder, or (ii) suffer to exist any other circumstance or event that would,
with or without the passage of time or the giving of notice, result in a default or event of default under any agreement binding the Corporation
or any Subsidiary, which default or event of default would or is likely to have a material adverse effect on the business, assets, operations
(including results thereof), liabilities, properties, condition (including financial condition) or prospects of the Corporation or any
of its Subsidiaries, individually or in the aggregate;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(xv)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>other than as specifically set forth in another clause of this Section 5(a), the Corporation or any Subsidiary breaches any representation
or warranty in any material respect (other than representations or warranties subject to material adverse effect or materiality, which
may not be breached in any respect) or any covenant or other term or condition of any Transaction Document, except, in the case of a breach
of a covenant or other term or condition that is curable, only if such breach remains uncured for a period of two (2) consecutive Trading
Days;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(xvi)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>a false or inaccurate certification (including a false or inaccurate deemed certification) by the Corporation that either (A) the
Equity Conditions are satisfied, (B) there has been no Equity Conditions Failure, or (C) as to whether any Triggering Event has occurred;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(xvii)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>any breach or failure in any respect by the Corporation or any Subsidiary to comply with any provision of Section 13 of this Certificate
of Designations;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(xviii)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>any Preferred Shares remain outstanding on or after May 16, 2027;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(xix)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>any Change of Control occurs without the prior written consent of the Buyer, which consent shall not be unreasonably withheld,
conditioned or delayed;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(xx)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>any Material Adverse Effect (as defined in the Preferred Stock Purchase Agreement) occurs; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(xxi)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>any provision of any Transaction Document shall at any time for any reason (other than pursuant to the express terms thereof) cease
to be valid and binding on or enforceable against the Corporation, or the validity or enforceability thereof shall be contested, directly
or indirectly, by the Corporation or any Subsidiary, or a proceeding shall be commenced by the Corporation or any Subsidiary or any governmental
authority having jurisdiction over any of them, seeking to establish the invalidity or unenforceability thereof or the Corporation or
any of its Subsidiaries shall deny in writing that it has any liability or obligation purported to be created under one or more Transaction
Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Notwithstanding any provision to the contrary in this
Certificate of Designations, any failure by the Corporation to pay a payable or debt owed to a related party of the Corporation shall
not be deemed a Triggering Event under this Certificate of Designations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(b)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Notice of a Triggering Event.</U> Upon the occurrence of a Triggering Event with respect to the Preferred Shares, the Corporation
shall within two (2) Business Days deliver written notice thereof via electronic mail and overnight courier (with next day delivery specified)
(a &ldquo;<B>Triggering Event Notice</B>&rdquo;) to each Holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">6.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Rights Upon Fundamental Transactions</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(a)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Assumption.</U> The Corporation shall not enter into or be party to a Fundamental Transaction unless the Successor Entity assumes
in writing all of the obligations of the Corporation under this Certificate of Designations and the other Transaction Documents in accordance
with the provisions of this Section 6 pursuant to written agreements in form and substance reasonably satisfactory to the Buyer, including
agreements to deliver to each holder of Preferred Shares in exchange for such Preferred Shares a security of the Successor Entity evidenced
by a written instrument substantially similar in form and substance to this Certificate of Designations, including, without limitation,
having a stated value and dividend rate equal to the stated value and dividend rate of the Preferred Shares held by the Holders and having
similar ranking to the Preferred Shares, and reasonably satisfactory to the Buyer. Upon the occurrence of any Fundamental Transaction,
the Successor Entity shall succeed to, and be substituted for (so that from and after the date of such Fundamental Transaction, the provisions
of this Certificate of Designations and the other Transaction Documents referring to the &ldquo;Corporation&rdquo; shall refer instead
to the Successor Entity), and may exercise every right and power of the Corporation and shall assume all of the obligations of the Corporation
under this Certificate of Designations and the other Transaction Documents with the same effect as if such Successor Entity had been named
as the Corporation herein and therein. In addition to the foregoing, upon consummation of a Fundamental Transaction, the Successor Entity
shall deliver to each Holder confirmation that there shall be issued upon conversion of the Preferred Shares at any time after the consummation
of such Fundamental Transaction, in lieu of the shares of Common Stock (or other securities, cash, assets or other property (except such
items still issuable under Sections 7 and 15, which shall continue to be receivable thereafter)) issuable upon the conversion of the Preferred
Shares prior to such Fundamental Transaction, such shares of the publicly traded common stock (or their equivalent) of the Successor Entity
(including its Parent Entity) which each Holder would have been entitled to receive upon the happening of such Fundamental Transaction
had all the Preferred Shares held by each Holder been converted immediately prior to such Fundamental Transaction (without regard to any
limitations on the conversion of the Preferred Shares contained in this Certificate of Designations), as adjusted in accordance with the
provisions of this Certificate of Designations. Notwithstanding the foregoing, such Holder may elect, at its sole option, by delivery
of written notice to the Corporation to waive this Section 6 to permit the Fundamental Transaction without the assumption of the Preferred
Shares. The provisions of this Section 6 shall apply similarly and equally to successive Fundamental Transactions and shall be applied
without regard to any limitations on the conversion of the Preferred Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(b)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Notice of a Change of Control; Change of Control Election Notice.</U> No sooner than the earlier of (x) twenty (20) Trading
Days prior to the consummation of a Change of Control or (y) the public announcement of the entry into an agreement with respect to a
Change of Control, nor later than ten (10) Trading Days prior to the consummation of a Change of Control (the &ldquo;<B>Change of Control
Date</B>&rdquo;)<B>, </B>the Corporation shall deliver written notice thereof via electronic mail and overnight courier to each Holder
(a &ldquo;<B>Change of Control Notice</B>&rdquo;). At any time during the period beginning after a Holder&rsquo;s receipt of a Change
of Control Notice or such Holder becoming aware of a Change of Control if a Change of Control Notice is not delivered to such Holder in
accordance with the immediately preceding sentence (as applicable) and ending on twenty (20) Trading Days after the later of (A) the date
of consummation of such Change of Control or (B) the date of receipt of such Change of Control Notice or (C) the date of the announcement
of such Change of Control, such Holder may require, by delivering written notice thereof (&ldquo;<B>Change of Control Election Notice</B>&rdquo;)
to the Corporation (which Change of Control Election Notice shall indicate the number of Preferred Shares subject to such election), to
have the Corporation exchange such Holder&rsquo;s Preferred Shares designated in such Change of Control Election Notice for consideration
equal to the Change of Control Election Price (as defined below), to be satisfied at the Corporation&rsquo;s election (such election to
pay in cash or by delivery of the Rights (as defined below), a &ldquo;<B>Consideration Election</B>&rdquo;)<B>,</B> in either (I) rights
(with a beneficial ownership limitation in the form of Section 4(d) hereof, <I>mutatis mutandis)</I> (collectively, the &ldquo;<B>Rights</B>&rdquo;)<B>,
</B>convertible in whole, or in part, at any time, without the requirement to pay any additional consideration, at the option of the Buyer,
into such Corporate Event Consideration (as defined below) applicable to such Change of Control equal in value to the Change of Control
Election Price (as determined with the fair market value of the aggregate number of Successor Shares (as defined below) issuable upon
conversion of the Rights to be determined in increments of 10% (or such greater percentage as the applicable Holder may notify the Corporation
from time to time) of the portion of the Change of Control Election Price attributable to such Successor Shares (the &ldquo;<B>Successor
Share Value Increment</B>&rdquo;)<B>, </B>with the aggregate number of Successor Shares issuable upon exercise of the Rights with respect
to the first Successor Share Value Increment determined based on 70% of the VWAP of the Successor Shares on the date the Rights are issued
and on each of the nine (9) subsequent Trading Days, in each case, the aggregate number of additional Successor Shares issuable upon exercise
of the Rights shall be determined based upon a Successor Share Value Increment at 70% of the VWAP of the Successor Shares in effect for
such corresponding Trading Day (such ten (10) Trading Day period commencing on, and including, the date the Rights are issued, the &ldquo;<B>Rights
Measuring Period</B>&rdquo;))<B>, </B>or (II) in cash; provided, that the Corporation shall not consummate a Change of Control if the
Corporate Event Consideration includes capital stock or other equity interest (the &ldquo;<B>Successor Shares</B>&rdquo;) either in an
entity that is not listed on an Eligible Market or an entity in which the daily share volume for the applicable Successor Shares for each
of the twenty (20) Trading Days prior to the date of consummation of such Change of Control is less than the aggregate number of Successor
Shares issuable to all Holders upon conversion in full of the applicable Rights (without regard to any limitations on conversion therein,
assuming the exercise in full of the Rights on the date of issuance of the Rights and assuming the VWAP of the Successor Shares for each
Trading Day in the Rights Measuring Period is the VWAP on the Trading Day ended immediately prior to the time of consummation of the Change
of Control). The Corporation shall give each Holder written notice of each Consideration Election at least twenty (20) Trading Days prior
to the time of consummation of such Change of Control. Payment of such amounts or delivery of the Rights, as applicable, shall be made
by the Corporation (or at the Corporation&rsquo;s direction) to each Holder on the later of (x) the second (2nd) Trading Day after the
date of such request and (y) the date of consummation of such Change of Control (or, with respect to any Right, if applicable, such later
time that holders of shares of Common Stock are initially entitled to receive Corporate Event Consideration with respect to the shares
of Common Stock of such holder). Any Corporate Event Consideration included in the Rights, if any, pursuant to this Section 6(b) is <I>pari
passu </I>with the Corporate Event Consideration to be paid to holders of shares of Common Stock and the Corporation shall not permit
a payment of any Corporate Event Consideration to the holders of shares of Common Stock without on or prior to such time delivering the
Right to the Holders in accordance herewith. Cash payments, if any, required by this Section 6(b) shall have priority to payments to all
other stockholders of the Corporation in connection with such Change of Control. Notwithstanding anything to the contrary in this Section
6(b), but subject to Section 4(d), until the applicable Change of Control Election Price is paid in full to the applicable Holder in cash
or Corporate Event Consideration in accordance herewith, the Preferred Shares submitted by such Holder for exchange or payment, as applicable,
under this Section 6(b) may be converted, in whole or in part, by such Holder into Common Stock pursuant to Section 4 or in the event
the Conversion Date is after the consummation of such Change of Control, stock or equity interests of the Successor Entity substantially
equivalent to the Corporation&rsquo;s shares of Common Stock pursuant to Section 6. In the event of the Corporation&rsquo;s repayment
or exchange, as applicable, of any of the Preferred Shares under this Section 6(b), such Holder&rsquo;s damages would be uncertain and
difficult to estimate because of the parties&rsquo; inability to predict future interest rates and the uncertainty of the availability
of a suitable substitute investment opportunity for a Holder. Accordingly, any Required Premium due under this Section 6(b) is intended
by the parties to be, and shall be deemed, a reasonable estimate of such Holder&rsquo;s actual loss of its investment opportunity and
not as a penalty. Notwithstanding anything herein to the contrary, in connection with any redemption hereunder at a time a Holder is entitled
to receive a cash payment under any of the other Transaction Documents, at the option of such Holder delivered in writing to the Corporation,
the applicable redemption price hereunder shall be increased by the amount of such cash payment owed to such Holder under such other Transaction
Document and, upon payment in full or conversion in accordance herewith, shall satisfy the Corporation&rsquo;s payment obligation under
such other Transaction Document.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">7.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Rights Upon Issuance of Purchase Rights and Other Corporate Events</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(a)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Purchase Rights.</U> In addition to any adjustments pursuant to Section 8 and Section 16 below, if at any time the Corporation
grants, issues or sells any Options, Convertible Securities or rights to purchase stock, warrants, securities or other property pro rata
to all or substantially all of the record holders of any class of Common Stock (the &ldquo;<B>Purchase Rights</B>&rdquo;)<B>,</B> then
each Holder will be entitled to acquire, upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which such Holder
could have acquired if such Holder had held the number of shares of Common Stock acquirable upon complete conversion of all the Preferred
Shares (without taking into account any limitations or restrictions on the convertibility of the Preferred Shares and assuming for such
purpose that all the Preferred Shares were converted at the Alternate Conversion Price as of the applicable record date) held by such
Holder immediately prior to the date on which a record is taken for the grant, issuance or sale of such Purchase Rights, or, if no such
record is taken, the date as of which the record holders of shares of Common Stock are to be determined for the grant, issue or sale of
such Purchase Rights; provided, however, to the extent that such Holder&rsquo;s right to participate in any such Purchase Right would
result in such Holder and the other Attribution Parties exceeding the Maximum Percentage, then such Holder shall not be entitled to participate
in such Purchase Right to such extent of the Maximum Percentage (and shall not be entitled to beneficial ownership of such shares of Common
Stock as a result of such Purchase Right (and beneficial ownership) to such extent of any such excess) and such Purchase Right to such
extent shall be held in abeyance (and, if such Purchase Right has an expiration date, maturity date or other similar provision, such term
shall be extended by such number of days held in abeyance, if applicable) for the benefit of such Holder until such time or times, if
ever, as its right thereto would not result in such Holder and the other Attribution Parties exceeding the Maximum Percentage, at which
time or times such Holder shall be granted such right (and any Purchase Right granted, issued or sold on such initial Purchase Right or
on any subsequent Purchase Right held similarly in abeyance (and, if such Purchase Right has an expiration date, maturity date or other
similar provision, such term shall be extended by such number of days held in abeyance, if applicable)) to the same extent as if there
had been no such limitation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(b)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Other Corporate Events.</U> In addition to and not in substitution for any other rights hereunder, prior to the consummation
of any Fundamental Transaction pursuant to which holders of shares of Common Stock are entitled to receive securities or other assets
with respect to or in exchange for shares of Common Stock (a &ldquo;<B>Corporate Event</B>&rdquo;)<B>,</B> the Corporation shall make
appropriate provision to ensure that each Holder will thereafter have the right, at such Holder&rsquo;s option, to receive upon a conversion
of all the Preferred Shares held by such Holder (i) such securities or other assets (the &ldquo;<B>Corporate Event Consideration</B>&rdquo;)
to which such Holder would have been entitled with respect to such shares of Common Stock had such shares of Common Stock been held by
such Holder upon the consummation of such Corporate Event (without taking into account any limitations or restrictions on the convertibility
of the Preferred Shares set forth in this Certificate of Designations) or (ii) in lieu of the shares of Common Stock otherwise receivable
upon such conversion, such securities or other assets received by the holders of shares of Common Stock in connection with the consummation
of such Corporate Event in such amounts as such Holder would have been entitled to receive had the Preferred Shares held by such Holder
initially been issued with conversion rights for the form of such consideration (as opposed to shares of Common Stock) at a conversion
rate for such consideration commensurate with the Conversion Rate of an Alternate Conversion. Provision made pursuant the preceding sentence
shall be in a form and substance reasonably satisfactory to the Buyer. The provisions of this Section 7 shall apply similarly and equally
to successive Corporate Events and shall be applied without regard to any limitations on the conversion of the Preferred Shares set forth
in this Certificate of Designations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">8.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Rights Upon Issuance of Other Securities</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(a)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Adjustment of Conversion Price upon Issuance of Common Stock.</U> If and whenever on or after the Subscription Date the Corporation
grants, issues or sells (or enters into any agreement to grant, issue or sell), or in accordance with this Section 8(a) is deemed to have
granted, issued or sold, any shares of Common Stock (including the granting, issuance or sale of shares of Common Stock owned or held
by or for the account of the Corporation, but excluding any Excluded Securities granted, issued or sold or deemed to have been granted,
issued or sold) for a consideration per share (the &ldquo;<B>New Issuance Price</B>&rdquo;) less than a price equal to the Conversion
Price in effect immediately prior to such granting, issuance or sale or deemed granting, issuance or sale (such Conversion Price then
in effect is referred to herein as the &ldquo;<B>Applicable Price</B>&rdquo;) (the foregoing a &ldquo;<B>Dilutive Issuance</B>&rdquo;)<B>,
</B>then, immediately after such Dilutive Issuance, the Conversion Price then in effect shall be reduced to an amount equal to the New
Issuance Price. For all purposes of the foregoing (including, without limitation, determining the adjusted Conversion Price and the New
Issuance Price under this Section 8(a)), the following shall be applicable:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(i)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Issuance of Options.</U> If the Corporation in any manner grants, issues or sells (or enters into any agreement to grant, issue
or sell) any Options and the lowest price per share for which one share of Common Stock is at any time issuable upon the exercise of any
such Option or upon conversion, exercise or exchange of any Convertible Securities issuable upon exercise of any such Option or otherwise
pursuant to the terms thereof is less than the Applicable Price, then such share of Common Stock shall be deemed to be outstanding and
to have been issued and sold by the Corporation at the time of the granting, issuance or sale of such Option for such price per share.
For purposes of this Section 8(a)(i), the lowest price per share for which one share of Common Stock is at any time issuable upon the
exercise of any such Option or upon conversion, exercise or exchange of any Convertible Securities issuable upon exercise of any such
Option or otherwise pursuant to the terms thereof shall be equal to (1) the lower of (x) the sum of the lowest amounts of consideration
(if any) received or receivable by the Corporation with respect to any one share of Common Stock upon the granting, issuance or sale of
such Option, upon exercise of such Option and upon conversion, exercise or exchange of any Convertible Security issuable upon exercise
of such Option or otherwise pursuant to the terms thereof and (y) the lowest exercise price set forth in such Option for which one share
of Common Stock is issuable (or may become issuable assuming all possible market conditions) upon the exercise of any such Options or
upon conversion, exercise or exchange of any Convertible Securities issuable upon exercise of any such Option or otherwise pursuant to
the terms thereof, minus (2) the sum of all amounts paid or payable to the holder of such Option (or any other Person) with respect to
any one share of Common Stock upon the granting, issuance or sale of such Option, upon exercise of such Option and upon conversion, exercise
or exchange of any Convertible Security issuable upon exercise of such Option or otherwise pursuant to the terms thereof plus the value
of any other consideration (including, without limitation, consideration consisting of cash, debt forgiveness, assets or any other property)
received or receivable by, or benefit conferred on, the holder of such Option (or any other Person). Except as contemplated below, no
further adjustment of the Conversion Price shall be made upon the actual issuance of such share of Common Stock or of such Convertible
Securities upon the exercise of such Options or otherwise pursuant to the terms thereof or upon the actual issuance of such shares of
Common Stock upon conversion, exercise or exchange of such Convertible Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(ii)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Issuance of Convertible Securities.</U> If the Corporation in any manner issues or sells (or enters into any agreement to issue
or sell) any Convertible Securities and the lowest price per share for which one share of Common Stock is at any time issuable upon the
conversion, exercise or exchange thereof or otherwise pursuant to the terms thereof is less than the Applicable Price, then such share
of Common Stock shall be deemed to be outstanding and to have been issued and sold by the Corporation at the time of the issuance or sale
(or the time of execution of such agreement to issue or sell, as applicable) of such Convertible Securities for such price per share.
For the purposes of this Section 8(a)(ii), the lowest price per share for which one share of Common Stock is at any time issuable upon
the conversion, exercise or exchange thereof or otherwise pursuant to the terms thereof shall be equal to (1) the lower of (x) the sum
of the lowest amounts of consideration (if any) received or receivable by the Corporation with respect to one share of Common Stock upon
the issuance or sale (or pursuant to the agreement to issue or sell, as applicable) of the Convertible Security and upon conversion, exercise
or exchange of such Convertible Security or otherwise pursuant to the terms thereof and (y) the lowest conversion price set forth in such
Convertible Security for which one share of Common Stock is issuable (or may become issuable assuming all possible market conditions)
upon conversion, exercise or exchange thereof or otherwise pursuant to the terms thereof minus (2) the sum of all amounts paid or payable
to the holder of such Convertible Security (or any other Person) with respect to any one share of Common Stock upon the issuance or sale
(or the agreement to issue or sell, as applicable) of such Convertible Security plus the value of any other consideration received or
receivable (including, without limitation, any consideration consisting of cash, debt forgiveness, assets or other property) by, or benefit
conferred on, the holder of such Convertible Security (or any other Person). Except as contemplated below, no further adjustment of the
Conversion Price shall be made upon the actual issuance of such shares of Common Stock upon conversion, exercise or exchange of such Convertible
Securities or otherwise pursuant to the terms thereof, and if any such issuance or sale of such Convertible Securities is made upon exercise
of any Options for which adjustment of the Conversion Price has been or is to be made pursuant to other provisions of this Section 8(a),
except as contemplated below, no further adjustment of the Conversion Price shall be made by reason of such issuance or sale.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(iii)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Change in Option Price or Rate of Conversion.</U> If the purchase or exercise price provided for in any Options, the additional
consideration, if any, payable upon the issue, conversion, exercise or exchange of any Convertible Securities, or the rate at which any
Convertible Securities are convertible into or exercisable or exchangeable for shares of Common Stock increases or decreases at any time
(other than proportional changes in conversion or exercise prices, as applicable, in connection with an event referred to in Section 8(a)
below), the Conversion Price in effect at the time of such increase or decrease shall be adjusted to the Conversion Price which would
have been in effect at such time had such Options or Convertible Securities provided for such increased or decreased purchase price, additional
consideration or increased or decreased conversion rate (as the case may be) at the time initially granted, issued or sold. For purposes
of this Section 8(a)(iii), if the terms of any Option or Convertible Security (including, without limitation, any Option or Convertible
Security that was outstanding as of the Subscription Date) are increased or decreased in the manner described in the immediately preceding
sentence, then such Option or Convertible Security and the shares of Common Stock deemed issuable upon exercise, conversion or exchange
thereof shall be deemed to have been issued as of the date of such increase or decrease. No adjustment pursuant to this Section 8(a) shall
be made if such adjustment would result in an increase of the Conversion Price then in effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(iv)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Calculation of Consideration Received.</U> If any Option and/or Convertible Security and/or Adjustment Right is issued in connection
with the issuance or sale or deemed issuance or sale of any other securities of the Corporation (as determined by the Required Holder,
the &ldquo;<B>Primary Security</B>&rdquo;<B>, </B>and such Option and/or Convertible Security and/or Adjustment Right, the &ldquo;<B>Secondary
Securities</B>&rdquo;)<B>, </B>together comprising one integrated transaction (or one or more transactions if such issuances or sales
or deemed issuances or sales of securities of the Corporation either (A) have at least one investor or purchaser in common, (B) are consummated
in reasonable proximity to each other and/or (C) are consummated under the same plan of financing), the aggregate consideration per share
of Common Stock with respect to such Primary Security shall be deemed to be equal to the difference of (x) the lowest price per share
for which one share of Common Stock was issued (or was deemed to be issued pursuant to Section 8(a)(i) or 8(a)(ii) above, as applicable)
in such integrated transaction solely with respect to such Primary Security, minus (y) with respect to such Secondary Securities, the
sum of (I) the Black Scholes Consideration Value of each such Option, if any, (II) the fair market value (as determined by the Required
Holder in good faith) or the Black Scholes Consideration Value, as applicable, of such Adjustment Right, if any, and (III) the fair market
value (as determined by the Required Holder) of such Convertible Security, if any, in each case, as determined on a per share basis in
accordance with this Section 8(a)(iv). If any shares of Common Stock, Options or Convertible Securities are issued or sold or deemed to
have been issued or sold for cash, the consideration received therefor (for the purpose of determining the consideration paid for such
Common Stock, Option or Convertible Security, but not for the purpose of the calculation of the Black Scholes Consideration Value) will
be deemed to be the net amount of consideration received by the Corporation therefor. If any shares of Common Stock, Options or Convertible
Securities are issued or sold for a consideration other than cash, the amount of such consideration received by the Corporation (for the
purpose of determining the consideration paid for such Common Stock, Option or Convertible Security, but not for the purpose of the calculation
of the Black Scholes Consideration Value) will be the fair value of such consideration, except where such consideration consists of publicly
traded securities, in which case the amount of consideration received by the Corporation for such securities will be the arithmetic average
of the VWAPs of such security for each of the five (5) Trading Days immediately preceding the date of receipt. If any shares of Common
Stock, Options or Convertible Securities are issued to the owners of the non-surviving entity in connection with any merger in which the
Corporation is the surviving entity, the amount of consideration therefor (for the purpose of determining the consideration paid for such
Common Stock, Option or Convertible Security, but not for the purpose of the calculation of the Black Scholes Consideration Value) will
be deemed to be the fair value of such portion of the net assets and business of the non-surviving entity as is attributable to such shares
of Common Stock, Options or Convertible Securities (as the case may be). The fair value of any consideration other than cash or publicly
traded securities will be determined jointly by the Corporation and the Required Holder. If such parties are unable to reach agreement
within ten (10) days after the occurrence of an event requiring valuation (the &ldquo;<B>Valuation Event</B>&rdquo;)<B>, </B>the fair
value of such consideration will be determined within five (5) Trading Days after the tenth(10<SUP>th</SUP>) day following such Valuation
Event by an independent, reputable appraiser jointly selected by the Corporation and the Required Holder. The determination of such appraiser
shall be final and binding upon all parties absent manifest error and the fees and expenses of such appraiser shall be borne by the Corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(v)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Record Date.</U> If the Corporation takes a record of the holders of shares of Common Stock for the purpose of entitling them
(A) to receive a dividend or other distribution payable in shares of Common Stock, Options or in Convertible Securities or (B) to subscribe
for or purchase shares of Common Stock, Options or Convertible Securities, then such record date will be deemed to be the date of the
issuance or sale of the shares of Common Stock deemed to have been issued or sold upon the declaration of such dividend or the making
of such other distribution or the date of the granting of such right of subscription or purchase (as the case may be).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(b)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Adjustment of Conversion Price upon Subdivision or Combination of Common Stock</U>. Without limiting any provision of Section
7 or Section 16, if the Corporation at any time on or after the Subscription Date subdivides (by any stock split, stock dividend, stock
combination, recapitalization or other similar transaction) one or more classes of its outstanding shares of Common Stock into a greater
number of shares, the Conversion Price in effect immediately prior to such subdivision will be proportionately reduced. Without limiting
any provision of Section 7 or Section 16, if the Corporation at any time on or after the Subscription Date combines (by any stock split,
stock dividend, stock combination, recapitalization or other similar transaction) one or more classes of its outstanding shares of Common
Stock into a smaller number of shares, the Conversion Price in effect immediately prior to such combination will be proportionately increased.
Any adjustment pursuant to this Section 8(a) shall become effective immediately after the effective date of such subdivision or combination.
If any event requiring an adjustment under this Section 8(a) occurs during the period that a Conversion Price is calculated hereunder,
then the calculation of such Conversion Price shall be adjusted appropriately to reflect such event.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(c)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Holder&rsquo;s Right of Adjusted Conversion Price.</U> In addition to and not in limitation of the other provisions of this
Section 8(b), if the Corporation in any manner issues or sells or enters into any agreement to issue or sell, any Common Stock, Options
or Convertible Securities (other than a Permitted Equity Line (as defined in the Preferred Stock Purchase Agreement)) (any such securities,
&ldquo;<B>Variable Price Securities</B>&rdquo;) after the Subscription Date that are issuable pursuant to such agreement or convertible
into or exchangeable or exercisable for shares of Common Stock at a price which varies or may vary with the market price of the shares
of Common Stock, including by way of one or more reset(s) to a fixed price, but exclusive of such formulations reflecting share splits,
share combinations, and share dividends (each of the formulations for such variable price being herein referred to as, the &ldquo;<B>Variable
Price</B>&rdquo;)<B>, </B>the Corporation shall provide written notice thereof via electronic mail and overnight courier to each Holder
no later than one Business Day following the date of such agreement and/or the issuance of such shares of Common Stock, Convertible Securities
or Options, as applicable. From and after the date the Corporation enters into such agreement or issues any such Variable Price Securities,
each Holder shall have the right, but not the obligation, in its sole discretion to substitute the Variable Price for the Conversion Price
upon conversion of the Preferred Shares by designating in the Conversion Notice delivered upon any conversion of Preferred Shares that
solely for purposes of such conversion such Holder is relying on the Variable Price rather than the Conversion Price then in effect. A
Holder&rsquo;s election to rely on a Variable Price for a particular conversion of Preferred Shares shall not obligate such Holder to
rely on a Variable Price for any future conversions of Preferred Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(d)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Calculations.</U> All calculations under this Section 8 shall be made by rounding to the nearest cent or the nearest 1/100<SUP>th</SUP>
of a share, as applicable. The number of shares of Common Stock outstanding at any given time shall not include shares owned or held by
or for the account of the Corporation, and the disposition of any such shares shall be considered an issue or sale of Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(e)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Voluntary Adjustment by Corporation.</U> Subject to the rules and regulations of the Principal Market, the Corporation may at
any time any Preferred Shares remain outstanding, with the prior written consent of the Required Holder, reduce the then current Conversion
Price to any amount and for any period of time deemed appropriate by the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(f)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT><U>Adjustments.</U> If on the Applicable Date (the &ldquo;<B>Adjustment Date</B>&rdquo;), the Conversion Price then in effect is
greater than the greater of (A) the Floor Price, and (B) the Closing Sale Price on the Trading Day immediately prior to the Applicable
Date (the &ldquo;<B>Adjustment Price</B>&rdquo;), on the Adjustment Date the Conversion Price shall automatically lower to the Adjustment
Price.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(g)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Exchange Right.</U> Notwithstanding anything herein to the contrary, if the Corporation or any of its Subsidiaries consummates
any Subsequent Placement (other than with respect to Excluded Securities (as defined in the Preferred Stock Purchase Agreement)), and
a Holder elects in writing to the Corporation to participate in such Subsequent Placement, each such Holder may, at the option of such
Holder as elected in writing to the Corporation, exchange all, or any part, of the Preferred Shares of such Holder into the securities
in such Subsequent Placement (with the aggregate amount of such securities to be issued in such exchange equal to such aggregate amount
of such securities with a purchase price valued at 125% of the Conversion Amount of the Preferred Shares delivered by such Holder in exchange
therefor).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(h)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Conversion Floor and Ceiling Price.</U> Prior to the Stockholder Approval Date (as defined in the Preferred Stock Purchase Agreement),
no adjustment pursuant to this Section 8 shall cause the Conversion Price to be less than $1.00 (as adjusted for any stock dividend, stock
split, stock combination, recapitalization, reclassification or similar transaction occurring after the date of the Preferred Stock Purchase
Agreement) (the &ldquo;<B>Conversion Floor Price</B>&rdquo;) or higher than $4.50 (as adjusted for any stock dividend, stock split, stock
combination, reclassification or similar transaction occurring after the date of the Preferred Stock Purchase Agreement) (the &ldquo;<B>Conversion
Ceiling Price</B>&rdquo;). As of the Stockholder Approval Date, any Dilutive Issuances or other events that would have resulted in an
adjustment to the Conversion Price prior to the Stockholder Approval Date, but for the application of this Section 8(h), shall adjust
the Conversion Price hereunder as if such Dilutive Issuances and/or other events, as applicable, occurred on the Stockholder Approval
Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">9.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Repricing</U>. The Conversion Price shall be subject to additional adjustment as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(a)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Upon the effectiveness of a registration statement registering the resale by the Holders of the Registrable Securities (as defined
in the Registration Rights Agreement), the Conversion Price shall equal the lower of (a) the original Conversion Price or (b) the VWAP
of the Common Stock for the five (5) Trading Days immediately preceding the effective date of such registration statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(b)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT> On the one-year anniversary of the Initial Issuance Date, the Conversion Price shall be adjusted to equal the lower of (x) the
then-current Conversion Price or (y) the closing price of the Common Stock on such anniversary date (subject to compliance with applicable
securities laws and stock exchange listing requirements); provided, however, that in no event shall any adjusted conversion price be less
than $1.00 per share (subject to appropriate adjustment for stock splits, stock dividends, combinations and other similar events).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">10.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>[RESERVED].</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">11.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Noncircumvention</U>. The Corporation hereby covenants and agrees that the Corporation will not, by amendment of its Certificate
of Incorporation, bylaws or through any reorganization, transfer of assets, consolidation, merger, scheme of arrangement, dissolution,
issue or sale of securities, or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of
this Certificate of Designations, and will at all times in good faith carry out all the provisions of this Certificate of Designations
and take all action as may be required to protect the rights of the Holders hereunder. Without limiting the generality of the foregoing
or any other provision of this Certificate of Designations or the other Transaction Documents, the Corporation (a) shall not increase
the par value of any shares of Common Stock receivable upon the conversion of any Preferred Shares above the Conversion Price then in
effect, (b) shall take all such actions as may be necessary or appropriate in order that the Corporation may validly and legally issue
fully paid and non-assessable shares of Common Stock upon the conversion of Preferred Shares and (c) shall, so long as any Preferred Shares
are outstanding, take all action necessary to reserve and keep available out of its authorized and unissued shares of Common Stock, solely
for the purpose of effecting the conversion of the Preferred Shares, the maximum number of shares of Common Stock as shall from time to
time be necessary to effect the conversion of the Preferred Shares then outstanding (without regard to any limitations on conversion contained
herein). Notwithstanding anything herein to the contrary, if after the sixty (60) calendar day anniversary of the Initial Issuance Date,
each Holder is not permitted to convert such Holder&rsquo;s Preferred Shares in full for any reason (other than pursuant to restrictions
set forth in Section 4(d) hereof), the Corporation shall use its best efforts to promptly remedy such failure, including, without limitation,
obtaining such consents or approvals as necessary to effect such conversion into shares of Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">12.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Authorized Shares.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(a)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Reservation.</U> So long as any Preferred Shares remain outstanding, the Corporation shall at all times reserve at least 300%
of the number of shares of Common Stock as shall from time to time be necessary to effect the conversion, including without limitation,
Alternate Conversions, of all of the Preferred Shares then outstanding at the Alternate Conversion Price then in effect (without regard
to any limitations on conversions) (the &ldquo;<B>Required Reserve Amount</B>&rdquo;). The Required Reserve Amount (including, without
limitation, each increase in the number of shares so reserved) shall be allocated pro rata among the Holders based on the number of the
Preferred Shares held by each Holder on the Initial Issuance Date or increase in the number of reserved shares, as the case may be (the
&ldquo;<B>Authorized Share Allocation</B>&rdquo;). In the event that a Holder shall sell or otherwise transfer any of such Holder&rsquo;s
Preferred Shares, each transferee shall be allocated a pro rata portion of such Holder&rsquo;s Authorized Share Allocation. Any shares
of Common Stock reserved and allocated to any Person which ceases to hold any Preferred Shares shall be allocated to the remaining Holders
of Preferred Shares, pro rata based on the number of the Preferred Shares then held by the Holders. Notwithstanding the foregoing, a Holder
may allocate its Authorized Share Allocation to any other of the securities of the Corporation held by such Holder (or any of its designees)
by delivery of a written notice to the Corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(b)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Insufficient Authorized Shares.</U> If, notwithstanding Section 12(a) and not in limitation thereof, at any time while any of
the Preferred Shares remain outstanding the Corporation does not have a sufficient number of authorized and unreserved shares of Common
Stock to satisfy its obligation to reserve for issuance upon conversion of the Preferred Shares at least a number of shares of Common
Stock equal to the Required Reserve Amount (an &ldquo;<B>Authorized Share Failure</B>&rdquo;), then the Corporation shall immediately
take all action necessary to increase the Corporation&rsquo;s authorized shares of Common Stock to an amount sufficient to allow the Corporation
to reserve the Required Reserve Amount for the Preferred Shares then outstanding. Without limiting the generality of the foregoing sentence,
as soon as practicable after the date of the occurrence of an Authorized Share Failure, but in no event later than ninety (90) days after
the occurrence of such Authorized Share Failure, the Corporation shall hold a meeting of its stockholders for the approval of an increase
in the number of authorized shares of Common Stock. In connection with such meeting, the Corporation shall provide each stockholder with
a proxy statement and shall use its best efforts to solicit its stockholders&rsquo; approval of such increase in authorized shares of
Common Stock and to cause its board of directors to recommend to the stockholders that they approve such proposal (or, if a majority of
the voting power then in effect of the capital stock of the Corporation consents to such increase, in lieu of such proxy statement, deliver
to the stockholders of the Corporation an information statement that has been filed with (and either approved by or not subject to comments
from) the SEC with respect thereto). Notwithstanding the foregoing, if at any such time of an Authorized Share Failure, the Corporation
is able to obtain the written consent of a majority of the shares of its issued and outstanding shares of Common Stock to approve the
increase in the number of authorized shares of Common Stock, the Corporation may satisfy this obligation by obtaining such consent and
submitting for filing with the SEC an Information Statement on Schedule 14C. In the event that the Corporation is prohibited from issuing
shares of Common Stock to a Holder upon any conversion due to the failure by the Corporation to have sufficient shares of Common Stock
available out of the authorized but unissued shares of Common Stock (such unavailable number of shares of Common Stock, the &ldquo;<B>Authorized
Failure Shares</B>&rdquo;), in lieu of delivering such Authorized Failure Shares to such Holder, the Corporation shall pay cash in exchange
for the redemption of such portion of the Conversion Amount of the Preferred Shares convertible into such Authorized Failure Shares at
a price equal to the sum of (i) the product of (x) such number of Authorized Failure Shares and (y) the greatest Closing Sale Price of
the Common Stock on any Trading Day during the period commencing on the date such Holder delivers the applicable Conversion Notice with
respect to such Authorized Failure Shares to the Corporation and ending on the date of such issuance and payment under this Section 11(a);
and (ii) to the extent such Holder purchases (in an open market transaction or otherwise) shares of Common Stock to deliver in satisfaction
of a sale by such Holder of Authorized Failure Shares, any brokerage commissions and other out-of-pocket expenses, if any, of such Holder
incurred in connection therewith. Nothing contained in Section 11(a) or this Section 11(b) shall limit any obligations of the Corporation
under any provision of the Preferred Stock Purchase Agreement or Registration Rights Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">13.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Voting Rights.</U> The holders of the Preferred Shares shall have no voting power and no right to vote on any matter at any
time, either as a separate series or class or together with any other series or class of share of capital stock, and shall not be entitled
to call a meeting of such holders for any purpose nor shall they be entitled to participate in any meeting of the holders of Common Stock,
except as provided in this Section 17 and Section 21 or as otherwise required by applicable law, including without limitation the NYBCL.
To the extent that under the NYBCL the vote of the holders of the Preferred Shares, voting separately as a class or series, as applicable,
is required to authorize a given action of the Corporation, the affirmative vote or consent of the Buyer of the Preferred Shares, voting
together in the aggregate and not in separate series unless required under the NYBCL, represented at a duly held meeting at which a quorum
is presented or by written consent of the Buyer (except as otherwise may be required under the NYBCL), voting together in the aggregate
and not in separate series unless required under the NYBCL, shall constitute the approval of such action by both the class or the series,
as applicable. Holders of the Preferred Shares shall be entitled to written notice of all stockholder meetings or written consents (and
copies of proxy materials and other information sent to stockholders) with respect to which they would be entitled to vote, which notice
would be provided pursuant to the Corporation&rsquo;s bylaws (the &ldquo;<B>Bylaws</B>&rdquo;) and the NYBCL.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">14.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Covenants.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(a)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Incurrence of Indebtedness</U>. The Corporation shall not, and the Corporation shall cause each of its Subsidiaries to not,
directly or indirectly, incur or guarantee, assume or suffer to exist any Indebtedness (other than Permitted Indebtedness).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(b)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Existence of Liens.</U> The Corporation shall not, and the Corporation shall cause each of its Subsidiaries to not, directly
or indirectly, allow or suffer to exist any mortgage, lien, pledge, charge, security interest or other encumbrance upon or in any property
or assets (including accounts and contract rights) owned by the Corporation or any of its Subsidiaries (collectively, &ldquo;<B>Liens</B>&rdquo;)
other than Permitted Liens.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(c)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Restricted Payments and Investments.</U> The Corporation shall not, and the Corporation shall cause each of its Subsidiaries
to not, directly or indirectly, redeem, defease, repurchase, repay or make any payments in respect of, by the payment of cash or cash
equivalents (in whole or in part, whether by way of open market purchases, tender offers, private transactions or otherwise), all or any
portion of any Indebtedness (other pursuant to this Certificate of Designations) whether by way of payment in respect of principal of
(or premium, if any) or interest on, such Indebtedness or make any Investment, as applicable, if at the time such payment with respect
to such Indebtedness and/or Investment, as applicable, is due or is otherwise made or, after giving effect to such payment, (i) an event
constituting a Triggering Event has occurred and is continuing or (ii) an event that with the passage of time and without being cured
would constitute a Triggering Event has occurred and is continuing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(d)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Restriction on Redemption and Cash Dividends.</U> The Corporation shall not, and the Corporation shall cause each of its Subsidiaries
to not, directly or indirectly, redeem, repurchase or declare or pay any cash dividend or distribution on any of its capital stock (other
than as required by this Certificate of Designations).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(e)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Restriction on Transfer of Assets.</U> The Corporation shall not, and the Corporation shall cause each of its Subsidiaries to
not, directly or indirectly, sell, lease, license, assign, transfer, spin-off, split-off, close, convey or otherwise dispose of any assets
or rights of the Corporation or any Subsidiary owned or hereafter acquired whether in a single transaction or a series of related transactions,
other than (i) sales, leases, licenses, assignments, transfers, conveyances and other dispositions of such assets or rights by the Corporation
and its Subsidiaries in the ordinary course of business consistent with its past practice and (ii) sales of inventory and product in the
ordinary course of business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(f)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Intentionally omitted. </U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(g)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Preservation of Existence, Etc.</U> The Corporation shall maintain and preserve, and cause each of its Subsidiaries to maintain
and preserve, its existence, rights and privileges, and become or remain, and cause each of its Subsidiaries to become or remain, duly
qualified and in good standing in each jurisdiction in which the character of the properties owned or leased by it or in which the transaction
of its business makes such qualification necessary, except where the failure to become or remain duly qualified or in good standing could
not reasonably be expected to result in a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(h)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Maintenance of Properties, Etc.</U> The Corporation shall maintain and preserve, and cause each of its Subsidiaries to maintain
and preserve, all of its material properties which are necessary or useful in the proper conduct of its business in good working order
and condition, ordinary wear and tear excepted, and comply, and cause each of its Subsidiaries to materially comply, at all times with
the provisions of all leases to which it is a party as lessee or under which it occupies property, so as to prevent any loss or forfeiture
thereof or thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(i)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Maintenance of Intellectual Property.</U> The Corporation will, and will cause each of its Subsidiaries to, take all action
necessary or advisable to maintain all of the Intellectual Property Rights of the Corporation and/or any of its Subsidiaries that are
necessary or material to the conduct of its business in full force and effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(j)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Maintenance of insurance.</U> The Corporation shall maintain, and cause each of its Subsidiaries to maintain, insurance with
reputable insurance companies or associations (including, without limitation, comprehensive general liability, hazard, rent and business
interruption insurance) with respect to its properties (including all real properties leased or owned by it) and business, in such amounts
and covering such risks as is required by any Governmental Authority having jurisdiction with respect thereto or as is carried generally
in accordance with sound business practice by companies in similar businesses similarly situated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(k)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Transactions with Affiliates. </U>Except with respect to a contemplated transaction with Forward China involving the sale of
assets in the OEM business (&ldquo;OEM Asset Sale&rdquo;) or other transactions with Forward China with respect to (i) current outstanding
debt and (ii) payables related to the OEM business, the Corporation shall not, nor shall it permit any of its Subsidiaries to, enter into,
renew, extend or be a party to, any transaction or series of related transactions (including, without limitation, the purchase, sale,
lease, transfer or exchange of property or assets of any kind or the rendering of services of any kind) with any affiliate, except transactions
in the ordinary course of business in a manner and to an extent consistent with past practice and necessary or desirable for the prudent
operation of its business, for fair consideration and on terms no less favorable to it or its Subsidiaries than would be obtainable in
a comparable arm&rsquo;s length transaction with a Person that is not an affiliate thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(l)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Restricted Issuances.</U> The Corporation shall not, directly or indirectly, without the prior written consent of the Buyer,
(i) issue any Preferred Shares (other than as contemplated by the Preferred Stock Purchase Agreement and this Certificate of Designations),
or (ii) issue any other securities that would cause a breach or default under this Certificate of Designations or the Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(m)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Stay. Extension and Usury Laws.</U> To the extent that it may lawfully do so, the Corporation (A) agrees that it will not at
any time insist upon, plead, or in any manner whatsoever claim or take the benefit or advantage of, any stay, extension or usury law (wherever
or whenever enacted or in force) that may affect the covenants or the performance of this Certificate of Designations; and (B) expressly
waives all benefits or advantages of any such law and agrees that it will not, by resort to any such law, hinder, delay or impede the
execution of any power granted to the Holders by this Certificate of Designations, but will suffer and permit the execution of every such
power as though no such law has been enacted.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(n)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Taxes.</U> The Corporation and its Subsidiaries shall pay when due all material taxes, fees or other charges of any nature whatsoever
(together with any related interest or penalties) now or hereafter imposed or assessed against the Corporation and its Subsidiaries or
their respective assets or upon their ownership, possession, use, operation or disposition thereof or upon their rents, receipts or earnings
arising therefrom (except where the failure to pay would not, individually or in the aggregate, have a material effect on the Corporation
or any of its Subsidiaries). The Corporation and its Subsidiaries shall file on or before the due date therefor all personal property
tax returns (except where the failure to file would not, individually or in the aggregate, have a material effect on the Corporation or
any of its Subsidiaries). Notwithstanding the foregoing, the Corporation and its Subsidiaries may contest, in good faith and by appropriate
proceedings, taxes for which they maintain adequate reserves therefor in accordance with GAAP.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(o)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>PCAOB Registered Auditor.</U> At all times any Preferred Shares remain outstanding, the Corporation shall have engaged an independent
auditor to audit its financial statements that is registered with (and in compliance with the rules and regulations of) the Public Company
Accounting Oversight Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(p)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Independent Investigation.</U> At the request of the Buyer either (x) at any time when a Triggering Event has occurred and is
continuing, (y) upon the occurrence of an event that with the passage of time or giving of notice would constitute a Triggering Event
or (z) at any time such Buyer reasonably believe a Triggering Event may have occurred or be continuing, the Corporation shall hire an
independent, reputable investment bank selected by the Corporation and approved by such Holder (such approval not to be unreasonably withheld,
conditioned or delayed, and shall be deemed given if no objection is raised within five (5) business days of notification) to investigate
as to whether any breach of this Certificate of Designations has occurred (the &ldquo;<B>Independent Investigator</B>&rdquo;). If the
Independent Investigator determines that such breach of this Certificate of Designations has occurred, the Independent Investigator shall
notify the Corporation of such breach and the Corporation shall deliver written notice to each Holder of such breach. In connection with
such investigation, the Independent Investigator may, during normal business hours, inspect all contracts, books, records, personnel,
offices and other facilities and properties of the Corporation and its Subsidiaries and, to the extent available to the Corporation after
the Corporation uses reasonable efforts to obtain them, the records of its accountants and any books of account, records, reports and
other papers not contractually required of the Corporation to be confidential or secret, or subject to attorney-client or other evidentiary
privilege, and the Independent Investigator may make such copies and inspections thereof as the Independent Investigator may reasonably
request. The Corporation shall furnish the Independent Investigator with such financial and operating data and other information with
respect to the business and properties of the Corporation as the Independent Investigator may reasonably request. The Corporation shall
permit the Independent Investigator to discuss the affairs, finances and accounts of the Corporation with, and to make proposals and furnish
advice with respect thereto to, the Corporation&rsquo;s officers, directors, key employees and independent public accountants or any of
them (and by this provision the Corporation authorizes said accountants to discuss with such Independent Investigator the finances and
affairs of the Corporation and any Subsidiaries), all at such reasonable times, upon reasonable notice, and as often as may be reasonably
requested.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 21 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">15.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Liquidation. Dissolution. Winding-Up.</U> In the event of a Liquidation Event, the Holders shall be entitled to receive in cash
out of the assets of the Corporation, whether from capital or from earnings available for distribution to its stockholders (the &ldquo;<B>Liquidation
Funds</B>&rdquo;), before any amount shall be paid to the holders of any of shares of Junior Stock, but pari passu with any Parity Stock
then outstanding, an amount per Preferred Share equal to the sum of (i) the Black Scholes Value (as defined in the Warrants) with respect
to the outstanding portion of all Warrants held by such Holder (without regard to any limitations on the exercise thereof) as of the date
of such event and (ii) the greater of (A) 125% of the Conversion Amount of such Preferred Share on the date of such payment and (B) the
amount per share such Holder would receive if such Holder converted such Preferred Share into Common Stock immediately prior to the date
of such payment, provided that if the Liquidation Funds are insufficient to pay the full amount due to the Holders and holders of shares
of Parity Stock, then each Holder and each holder of Parity Stock shall receive a percentage of the Liquidation Funds equal to the full
amount of Liquidation Funds payable to such Holder and such holder of Parity Stock as a liquidation preference, in accordance with their
respective certificate of designations (or equivalent), as a percentage of the full amount of Liquidation Funds payable to all holders
of Preferred Shares and all holders of shares of Parity Stock. To the extent necessary, the Corporation shall cause such actions to be
taken by each of its Subsidiaries so as to enable, to the maximum extent permitted by law, the proceeds of a Liquidation Event to be distributed
to the Holders in accordance with this Section 14. All the preferential amounts to be paid to the Holders under this Section 14 shall
be paid or set apart for payment before the payment or setting apart for payment of any amount for, or the distribution of any Liquidation
Funds of the Corporation to the holders of shares of Junior Stock in connection with a Liquidation Event as to which this Section 14 applies.
Upon payment in full of the Black Scholes Value (as defined in the Warrants) of such Warrants pursuant to this Section 14, such Warrants
shall be deemed repurchased by the Corporation and no longer exercisable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">16.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Distribution of Assets.</U> In addition to any adjustments pursuant to Section 7 and Section 8, if the Corporation shall declare
or make any dividend or other distributions of its assets (or rights to acquire its assets) to any or all holders of shares of Common
Stock, by way of return of capital or otherwise (including without limitation, any distribution of cash, stock or other securities, property
or options by way of a dividend, spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction)
(the &ldquo;<B>Distributions</B>&rdquo;), then each Holder, as holders of Preferred Shares, will be entitled to such Distributions as
if such Holder had held the number of shares of Common Stock acquirable upon complete conversion of the Preferred Shares (without taking
into account any limitations or restrictions on the convertibility of the Preferred Shares and assuming for such purpose that the Preferred
Share was converted at the Alternate Conversion Price as of the applicable record date) immediately prior to the date on which a record
is taken for such Distribution or, if no such record is taken, the date as of which the record holders of Common Stock are to be determined
for such Distributions <U>(provided, however,</U> that to the extent that such Holder&rsquo;s right to participate in any such Distribution
would result in such Holder and the other Attribution Parties exceeding the Maximum Percentage, then such Holder shall not be entitled
to participate in such Distribution to such extent of the Maximum Percentage (and shall not be entitled to beneficial ownership of such
shares of Common Stock as a result of such Distribution (and beneficial ownership) to such extent of any such excess) and the portion
of such Distribution shall be held in abeyance for the benefit of such Holder until such time or times as its right thereto would not
result in such Holder and the other Attribution Parties exceeding the Maximum Percentage, at which time or times, if any, such Holder
shall be granted such Distribution (and any Distributions declared or made on such initial Distribution or on any subsequent Distribution
held similarly in abeyance) to the same extent as if there had been no such limitation).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">17.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Vote to Change the Terms of or Issue Preferred Shares</U>. In addition to any other rights provided by law, except where the
vote or written consent of the holders of a greater number of shares is required by law or by another provision of the Certificate of
Incorporation, without first obtaining the affirmative vote at a meeting duly called for such purpose or the written consent without a
meeting of the Buyer, voting together as a single class, the Corporation shall not: (a) amend or repeal any provision of, or add any provision
to, its Certificate of Incorporation or bylaws, or file any certificate of designations or articles of amendment of any series of shares
of preferred stock, if such action would adversely alter or change in any respect the preferences, rights, privileges or powers, or restrictions
provided for the benefit of the Preferred Shares hereunder, regardless of whether any such action shall be by means of amendment to the
Certificate of Incorporation or by merger, consolidation or otherwise; (b) increase or decrease (other than by conversion) the authorized
number of shares of Series B Convertible Preferred Stock; (c) without limiting any provision of Section2, create or authorize (by reclassification
or otherwise) any new class or series of Senior Preferred Stock or Parity Stock; (d) purchase, repurchase or redeem any shares of Junior
Stock (other than pursuant to the terms of the Corporation&rsquo;s equity incentive plans and options and other equity awards granted
under such plans (that have in good faith been approved by the Board)); (e) without limiting any provision of Section 2, pay dividends
or make any other distribution on any shares of any Junior Stock; (f) issue any Preferred Shares other than as contemplated hereby or
pursuant to the Preferred Stock Purchase Agreement; or (g) without limiting any provision of Section 15, whether or not prohibited by
the terms of the Preferred Shares, circumvent a right of the Preferred Shares hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 22 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">18.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Transfer of Preferred Shares</U>. A Holder may offer, sell or transfer some or all of its Preferred Shares without the consent
of the Corporation subject only to the provisions of Section 5 of the Preferred Stock Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">19.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Reissuance of Preferred Share Certificates and Book Entries</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(a)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Transfer</U>. If any Preferred Shares are to be transferred, the applicable Holder shall surrender the applicable Preferred
Share Certificate to the Corporation (or, if the Preferred Shares are held in Book-Entry form, a written instruction letter to the Corporation),
whereupon the Corporation will forthwith issue and deliver upon the order of such Holder a new Preferred Share Certificate (in accordance
with Section 19(d)) (or evidence of the transfer of such Book-Entry), registered as such Holder may request, representing the outstanding
number of Preferred Shares being transferred by such Holder and, if less than the entire outstanding number of Preferred Shares is being
transferred, a new Preferred Share Certificate (in accordance with Section 19(d)) to such Holder representing the outstanding number of
Preferred Shares not being transferred (or evidence of such remaining Preferred Shares in a Book-Entry for such Holder). Such Holder and
any assignee, by acceptance of the Preferred Share Certificate or evidence of Book-Entry issuance, as applicable, acknowledge and agree
that, by reason of the provisions of Section 4(c)(i) following conversion of any of the Preferred Shares, the outstanding number of Preferred
Shares represented by the Preferred Shares may be less than the number of Preferred Shares stated on the face of the Preferred Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(b)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Lost, Stolen or Mutilated Preferred Share Certificate</U>. Upon receipt by the Corporation of evidence reasonably satisfactory
to the Corporation of the loss, theft, destruction or mutilation of a Preferred Share Certificate (as to which a written certification
and the indemnification contemplated below shall suffice as such evidence), and, in the case of loss, theft or destruction, of any indemnification
undertaking by the applicable Holder to the Corporation in customary and reasonable form and, in the case of mutilation, upon surrender
and cancellation of such Preferred Share Certificate, the Corporation shall execute and deliver to such Holder a new Preferred Share Certificate
(in accordance with Section 19(d)) representing the applicable outstanding number of Preferred Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(c)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Preferred Share Certificate and Book-Entries Exchangeable for Different Denominations and Forms</U>. Each Preferred Share Certificate
is exchangeable, upon the surrender hereof by the applicable Holder at the principal office of the Corporation, for a new Preferred Share
Certificate or Preferred Share Certificate(s) or new Book-Entry (in accordance with Section 19(d)) representing, in the aggregate, the
outstanding number of the Preferred Shares in the original Preferred Share Certificate, and each such new Preferred Share Certificate
and/or new Book-Entry, as applicable, will represent such portion of such outstanding number of Preferred Shares from the original Preferred
Share Certificate as is designated in writing by such Holder at the time of such surrender. Each Book-Entry may be exchanged into one
or more new Preferred Share Certificates or split by the applicable Holder by delivery of a written notice to the Corporation into two
or more new Book-Entries (in accordance with Section 19(d)) representing, in the aggregate, the outstanding number of the Preferred Shares
in the original Book-Entry, and each such new Book-Entry and/or new Preferred Share Certificate, as applicable, will represent such portion
of such outstanding number of Preferred Shares from the original Book-Entry as is designated in writing by such Holder at the time of
such surrender.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(d)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Issuance of New Preferred Share Certificate or Book-Entry.</U> Whenever the Corporation is required to issue a new Preferred
Share Certificate or a new Book-Entry pursuant to the terms of this Certificate of Designations, such new Preferred Share Certificate
or new Book-Entry (i) shall represent, as indicated on the face of such Preferred Share Certificate or in such Book-Entry, as applicable,
the number of Preferred Shares remaining outstanding (or in the case of a new Preferred Share Certificate or new Book-Entry being issued
pursuant to Section 19(a) or Section 19(c), the number of Preferred Shares designated by such Holder) which, when added to the number
of Preferred Shares represented by the other new Preferred Share Certificates or other new Book-Entry, as applicable, issued in connection
with such issuance, does not exceed the number of Preferred Shares remaining outstanding under the original Preferred Share Certificate
or original Book-Entry, as applicable, immediately prior to such issuance of new Preferred Share Certificate or new Book-Entry, as applicable,
and (ii) shall have an issuance date, as indicated on the face of such new Preferred Share Certificate or in such new Book-Entry, as applicable,
which is the same as the issuance date of the original Preferred Share Certificate or in such original Book-Entry, as applicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 23 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">20.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Remedies. Characterizations. Other Obligations. Breaches and Injunctive Relief</U>. The remedies provided in this Certificate
of Designations shall be cumulative and in addition to all other remedies available under this Certificate of Designations and any of
the other Transaction Documents, at law or in equity (including a decree of specific performance and/or other injunctive relief), and
nothing herein shall limit any Holder&rsquo;s right to pursue actual and consequential damages for any failure by the Corporation to comply
with the terms of this Certificate of Designations. No failure on the part of a Holder to exercise, and no delay in exercising, any right,
power or remedy hereunder shall operate as a waiver thereof; nor shall any single or partial exercise by such Holder of any right, power
or remedy preclude any other or further exercise thereof or the exercise of any other right, power or remedy. In addition, the exercise
of any right or remedy of a Holder at law or equity or under this Certificate of Designations or any of the documents shall not be deemed
to be an election of such Holder&rsquo;s rights or remedies under such documents or at law or equity. The Corporation covenants to each
Holder that there shall be no characterization concerning this instrument other than as expressly provided herein. Amounts set forth or
provided for herein with respect to payments, conversion and the like (and the computation thereof) shall be the amounts to be received
by a Holder and shall not, except as expressly provided herein, be subject to any other obligation of the Corporation (or the performance
thereof). No failure on the part of a Holder to exercise, and no delay in exercising, any right, power or remedy hereunder shall operate
as a waiver thereof; nor shall any single or partial exercise by such Holder of any right, power or remedy preclude any other or further
exercise thereof or the exercise of any other right, power or remedy. In addition, the exercise of any right or remedy of any Holder at
law or equity or under Preferred Shares or any of the documents shall not be deemed to be an election of such Holder&rsquo;s rights or
remedies under such documents or at law or equity. The Corporation acknowledges that a breach by it of its obligations hereunder will
cause irreparable harm to the Holders and that the remedy at law for any such breach may be inadequate. The Corporation therefore agrees
that, in the event of any such breach or threatened breach, each Holder shall be entitled, in addition to all other available remedies,
to specific performance and/or temporary, preliminary and permanent injunctive or other equitable relief from any court of competent jurisdiction
in any such case without the necessity of proving actual damages and without posting a bond or other security. The Corporation shall provide
all information and documentation to a Holder that is requested by such Holder to enable such Holder to confirm the Corporation&rsquo;s
compliance with the terms and conditions of this Certificate of Designations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">21.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Payment of Collection. Enforcement and Other Costs.</U> If (a) any Preferred Shares are placed in the hands of an attorney for
collection or enforcement or is collected or enforced through any legal proceeding or a Holder otherwise takes action to collect amounts
due under this Certificate of Designations with respect to the Preferred Shares or to enforce the provisions of this Certificate of Designations
or (b) there occurs any bankruptcy, reorganization, receivership of the Corporation or other proceedings affecting Corporation creditors&rsquo;
rights and involving a claim under this Certificate of Designations, then the Corporation shall pay the costs reasonably incurred by such
Holder for such collection, enforcement or action or in connection with such bankruptcy, reorganization, receivership or other proceeding,
including, without limitation, attorneys&rsquo; fees and disbursements. The Corporation expressly acknowledges and agrees that no amounts
due under this Certificate of Designations with respect to any Preferred Shares shall be affected, or limited, by the fact that the purchase
price paid for each Preferred Share was less than the original Stated Value thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">22.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Construction; Headings</U>. This Certificate of Designations shall be deemed to be jointly drafted by the Corporation and the
Holders and shall not be construed against any such Person as the drafter hereof. The headings of this Certificate of Designations are
for convenience of reference and shall not form part of, or affect the interpretation of, this Certificate of Designations. Unless the
context clearly indicates otherwise, each pronoun herein shall be deemed to include the masculine, feminine, neuter, singular and plural
forms thereof. The terms &ldquo;including,&rdquo; &ldquo;includes,&rdquo; &ldquo;include&rdquo; and words of like import shall be construed
broadly as if followed by the words &ldquo;without limitation.&rdquo; The terms &ldquo;herein,&rdquo; &ldquo;hereunder,&rdquo; &ldquo;hereto&rdquo;
and words of like import refer to this entire Certificate of Incorporation instead of just the provision in which they are found. Unless
expressly indicated otherwise, all section references are to sections of this Certificate of Designations. Terms used in this Certificate
of Designations and not otherwise defined herein, but defined in the other Transaction Documents, shall have the meanings ascribed to
such terms on the Initial Issuance Date in such other Transaction Documents unless otherwise consented to in writing by the Buyer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">23.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Failure or Indulgence Not Waiver.</U> No failure or delay on the part of a Holder in the exercise of any power, right or privilege
hereunder shall operate as a waiver thereof, nor shall any single or partial exercise of any such power, right or privilege preclude other
or further exercise thereof or of any other right, power or privilege. No waiver shall be effective unless it is in writing and signed
by an authorized representative of the waiving party. This Certificate of Designations shall be deemed to be jointly drafted by the Corporation
and all Holders and shall not be construed against any Person as the drafter hereof. Notwithstanding the foregoing, nothing contained
in this Section 23 shall permit any waiver of any provision of Section 4(d).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 24 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">24.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Dispute Resolution.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(a)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Submission to Dispute Resolution.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(i)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>In the case of a dispute relating to a Closing Bid Price, a Closing Sale Price, a Conversion Price, a Dividend Conversion Price,
an Alternate Conversion Price, a VWAP or a fair market value or the arithmetic calculation of a Conversion Rate (including, without limitation,
a dispute relating to the determination of any of the foregoing), the Corporation or the applicable Holder (as the case may be) shall
submit the dispute to the other party via electronic mail (A) if by the Corporation, within two (2) Business Days after the occurrence
of the circumstances giving rise to such dispute or (B) if by such Holder at any time after such Holder learned of the circumstances giving
rise to such dispute. If such Holder and the Corporation are unable to promptly resolve such dispute relating to such Closing Bid Price,
such Closing Sale Price, such Conversion Price, such Dividend Conversion Price, such Alternate Conversion Price, such VWAP or such fair
market value, or the arithmetic calculation of such Conversion Rate, at any time after the second (2<SUP>nd</SUP>) Business Day following
such initial notice by the Corporation or such Holder (as the case may be) of such dispute to the Corporation or such Holder (as the case
may be), then such Holder may, with the consent of the Corporation (not to be unreasonably withheld, conditioned or delayed), select an
independent, reputable investment bank reasonably acceptable to both parties to resolve such dispute.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(ii)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Such Holder and the Corporation shall each deliver to such investment bank (A) a copy of the initial dispute submission so delivered
in accordance with the first sentence of this Section 23 and (B) written documentation supporting its position with respect to such dispute,
in each case, no later than 5:00 p.m. (New York time) by the fifth (5<SUP>th</SUP>) Business Day immediately following the date on which
such Holder selected such investment bank (the &ldquo;<B>Dispute Submission Deadline</B>&rdquo;) (the documents referred to in the immediately
preceding clauses (A) and (B) are collectively referred to herein as the &ldquo;<B>Required Dispute Documentation</B>&rdquo;) (it being
understood and agreed that if either such Holder or the Corporation fails to so deliver all of the Required Dispute Documentation by the
Dispute Submission Deadline, then the party who fails to so submit all of the Required Dispute Documentation shall no longer be entitled
to (and hereby waives its right to) deliver or submit any written documentation or other support to such investment bank with respect
to such dispute and such investment bank shall resolve such dispute based solely on the Required Dispute Documentation that was delivered
to such investment bank prior to the Dispute Submission Deadline). Unless otherwise agreed to in writing by both the Corporation and such
Holder or otherwise requested by such investment bank, neither the Corporation nor such Holder shall be entitled to deliver or submit
any written documentation or other support to such investment bank in connection with such dispute (other than the Required Dispute Documentation).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(iii)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>The Corporation and such Holder shall cause such investment bank to determine the resolution of such dispute and notify the Corporation
and such Holder of such resolution no later than ten (10) Business Days immediately following the Dispute Submission Deadline. The fees
and expenses of such investment bank shall be borne by the party in whose favor the investment bank decides such dispute or, in the event
that the investment bank determines that the applicable calculation is in between the amounts submitted by the Corporation and such Holder,
then half of such fees and expenses shall be borne by the Corporation and half of such fees and expenses shall be borne by the Holder,
and such investment bank&rsquo;s resolution of such dispute shall be final and binding upon all parties absent manifest error.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(b)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Miscellaneous</U>. The Corporation expressly acknowledges and agrees that (i) this Section 24 constitutes an agreement to arbitrate
between the Corporation and each Holder (and constitutes an arbitration agreement) under the rules then in effect under Delaware Rapid
Arbitration Act, as amended, (ii) the terms of this Certificate of Designations and each other applicable Transaction Document shall serve
as the basis for the selected investment bank&rsquo;s resolution of the applicable dispute, such investment bank shall be entitled (and
is hereby expressly authorized) to make all findings, determinations and the like that such investment bank determines are required to
be made by such investment bank in connection with its resolution of such dispute and in resolving such dispute such investment bank shall
apply such findings, determinations and the like to the terms of this Certificate of Designations and any other applicable Transaction
Documents, (iii) the applicable Holder (and only such Holder with respect to disputes solely relating to such Holder), in its sole discretion,
shall have the right to submit any dispute described in this Section 24 to any state or federal court sitting in Wilmington Delaware,
in lieu of utilizing the procedures set forth in this Section 24 and (iv) nothing in this Section 23 shall limit such Holder from obtaining
any injunctive relief or other equitable remedies (including, without limitation, with respect to any matters described in this Section
24).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 25 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">25.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Notices: Currency: Payments.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(a)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Any notices, consents, waivers or other communications required or permitted to be given under the terms of this Certificate of
Designations must be in writing and will be deemed to have been delivered on the earliest of: (i) upon receipt, when delivered personally;
(ii) upon receipt, when sent by electronic mail with confirmation of receipt from the recipient, or if no such confirmation is received,
upon receipt, when sent by electronic mail provided that (i) such sent email is kept on file (whether electronically or otherwise) by
the sending party and (ii) the sending party does not receive an automatically generated message from the recipient&rsquo;s email server
that such e-mail could not be delivered to such recipient; or (iii) one (1) Business Day after deposit with an overnight courier service
with next day delivery specified, in each case, properly addressed to the party to receive the same. The mailing address and e-mail address
for any such communications to the Corporation shall be: 700 Veterans Memorial Highway, Suite 100, Hauppauge, New York, 11788 Attention:
Kathleen Weisberg e-mail address: Kweisberg@forwardindustries.com, or such other mailing address and/or e-mail address as the Corporation
has specified by written notice given to each of the Holders in accordance with this Section 25 not later than five (5) days prior to
the effectiveness of such change. The mailing address and e-mail address for any such communications to any Holder shall be as set forth
on such Holder&rsquo;s respective signature page to the Preferred Stock Purchase Agreement, or such other mailing address and/or e-mail
address as such Holder has specified by written notice given to the Corporation in accordance with this Section 24 not later than five
(5) days prior to the effectiveness of such change. Written confirmation of receipt (A) given by the recipient of such notice, consent,
waiver or other communication, (B) mechanically or electronically generated by the sender&rsquo;s e-mail containing the time, date and
recipient&rsquo;s e-mail or (C) provided by an overnight courier service shall be rebuttable evidence of personal service, receipt by
e-mail or receipt from an overnight courier service in accordance with clause (i), (ii) or (iii) above, respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(b)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>The Corporation shall provide each Holder with prompt written notice of all actions taken pursuant to this Certificate of Designations,
including in reasonable detail a description of such action and the reason therefore. Without limiting the generality of the foregoing,
the Corporation shall give written notice to each Holder (i) immediately upon any adjustment of the Conversion Price, setting forth in
reasonable detail, and certifying, the calculation of such adjustment and (ii) at least fifteen (15) days prior to the date on which the
Corporation closes its books or takes a record (A) with respect to any dividend or distribution upon the Common Stock, or (B) for determining
rights to vote with respect to any Fundamental Transaction, dissolution or liquidation, provided in each case that such information shall
be made known to the public prior to or in conjunction with such notice being provided to such Holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(c)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Currency</U>. All dollar amounts referred to in this Certificate of Designations are in United States Dollars (&ldquo;<B>U.S.
Dollars</B>&rdquo;), and all amounts owing under this Certificate of Designations shall be paid in U.S. Dollars. All amounts denominated
in other currencies (if any) shall be converted into the U.S. Dollar equivalent amount in accordance with the Exchange Rate on the date
of calculation. &ldquo;<B>Exchange Rate</B>&rdquo; means, in relation to any amount of currency to be converted into U.S. Dollars pursuant
to this Certificate of Designations, the U.S. Dollar exchange rate as published in the Wall Street Journal on the relevant date of calculation
(it being understood and agreed that where an amount is calculated with reference to, or over, a period of time, the date of calculation
shall be the final date of such period of time).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(d)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Payments</U>. Whenever any payment of cash is to be made by the Corporation to any Person pursuant to this Certificate of Designations,
unless otherwise expressly set forth herein, such payment shall be made in lawful money of the United States of America by wire transfer
of immediately available funds pursuant to wire transfer instructions that Holder shall provide to the Corporation in writing from time
to time. Whenever any amount expressed to be due by the terms of this Certificate of Designations is due on any day which is not a Business
Day, the same shall instead be due on the next succeeding day which is a Business Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">26.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Waiver of Notice.</U> To the extent permitted by law, the Corporation hereby irrevocably waives demand, notice, presentment,
protest and all other demands and notices in connection with the delivery, acceptance, performance, default or enforcement of this Certificate
of Designations and the Preferred Stock Purchase Agreement, except for any notices expressly required under this Certificate of Designations
or the Preferred Stock Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 26 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">27.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Governing Law.</U> This Certificate of Designations shall be construed and enforced in accordance with, and all questions concerning
the construction, validity, interpretation and performance of this Certificate of Designations shall be governed by, the internal laws
of the State of New York, without giving effect to any choice of law or conflict of law provision or rule (whether of the State of New
York or any other jurisdictions) that would cause the application of the laws of any jurisdictions other than the State of New York. Nothing
contained herein shall be deemed to limit in any way any right to serve process in any manner permitted by law. Nothing contained herein
shall be deemed to limit in any way any right to serve process in any manner permitted by law. Nothing contained herein (i) shall be deemed
or operate to preclude any Holder from bringing suit or taking other legal action against the Corporation in any other jurisdiction to
collect on the Corporation&rsquo;s obligations to such Holder, to realize on any collateral or any other security for such obligations,
or to enforce a judgment or other court ruling in favor of such Holder or (ii) shall limit, or shall be deemed or construed to limit,
any provision of Section 23 above. <B>THE CORPORATION AND EACH HOLDER HEREBY IRREVOCABLY WAIVES ANY RIGHT IT MAY HAVE TO, AND AGREES NOT
TO REQUEST, A JURY TRIAL FOR THE ADJUDICATION OF ANY DISPUTE HEREUNDER OR IN CONNECTION WITH OR ARISING OUT OF THIS CERTIFICATE OF DESIGNATIONS
OR ANY TRANSACTION CONTEMPLATED HEREBY.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">28.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Judgment Currency</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(a)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>If for the purpose of obtaining or enforcing judgment against the Corporation in any court in any jurisdiction it becomes necessary
to convert into any other currency (such other currency being hereinafter in this Section 28 referred to as the &ldquo;<B>Judgment Currency</B>&rdquo;)
an amount due in U.S. Dollars under this Certificate of Designations, the conversion shall be made at the Exchange Rate prevailing on
the Trading Day immediately preceding:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(i)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>the date actual payment of the amount due, in the case of any proceeding in the courts of New York or in the courts of any other
jurisdiction that will give effect to such conversion being made on such date: or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(ii)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>the date on which the foreign court determines, in the case of any proceeding in the courts of any other jurisdiction (the date
as of which such conversion is made pursuant to this Section 28(a)(ii) being hereinafter referred to as the &ldquo;<B>Judgment Conversion
Date</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(b)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>If in the case of any proceeding in the court of any jurisdiction referred to in clause (ii) of Section 27 above, there is a change
in the Exchange Rate prevailing between the Judgment Conversion Date and the date of actual payment of the amount due, the applicable
party shall pay such adjusted amount as may be necessary to ensure that the amount paid in the Judgment Currency, when converted at the
Exchange Rate prevailing on the date of payment, will produce the amount of US dollars which could have been purchased with the amount
of Judgment Currency stipulated in the judgment or judicial order at the Exchange Rate prevailing on the Judgment Conversion Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(c)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Any amount due from the Corporation under this provision shall be due as a separate debt and shall not be affected by judgment
being obtained for any other amounts due under or in respect of this Certificate of Designations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">29.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Taxes</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(a)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>All payments made by the Corporation hereunder or under any other Transaction Document shall be made in accordance with the terms
of the respective Transaction Document and shall be made without set-off, counterclaim, withholding, deduction or other defense. Without
limiting the foregoing, all such payments shall be made free and clear of and without deduction or withholding for any present or future
taxes, levies, imposts, deductions, charges or withholdings, and all liabilities with respect thereto, excluding (i) taxes imposed on
the net income of a Holder by the jurisdiction in which such Holder is organized or where it has its principal lending office, (ii) with
respect to any payments made by the Corporation hereunder, taxes (including, but not limited to, backup withholding) to the extent such
taxes are imposed due to the failure of the applicable recipient of such payment to provide the Corporation with whichever (if any) is
applicable of valid and properly completed and executed IRS Forms W-9, W-8BEN, W-8BEN-E, W- 8ECI, and/or W-8IMY, when requested in writing
by the Corporation, and (iii) with respect to any payments made by the Corporation, taxes to the extent such taxes are imposed due to
the failure of the applicable recipient of such payment to comply with FATCA (all such nonexcluded taxes, levies, imposts, deductions,
charges, withholdings and liabilities, collectively or individually, &ldquo;<B>Taxes</B>&rdquo;). If the Corporation shall be required
to deduct or to withhold any Taxes from or in respect of any amount payable hereunder or under any other Transaction Document:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 27 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(i)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>the amount so payable shall be increased to the extent necessary so that after making all required deductions and withholdings
(including Taxes on amounts payable to a Holder pursuant to this sentence) such Holder receives an amount equal to the sum it would have
received had no such deduction or withholding been made,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(ii)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>the Corporation shall make such deduction or withholding,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(iii)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>the Corporation shall pay the full amount deducted or withheld to the relevant Governmental Authority in accordance with applicable
law, and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(iv)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>as promptly as possible thereafter, the Corporation shall send such Holder an official receipt (or, if an official receipt is not
available, such other documentation as shall be satisfactory to such Holder, as the case may be) showing payment. In addition, the Corporation
agrees to pay any present or future stamp or documentary taxes or any other excise or property taxes, charges or similar levies that arise
from any payment made hereunder or from the execution, delivery, registration or enforcement of, or otherwise with respect to, this Preferred
Shares or any other Transaction Document (collectively, &ldquo;<B>Other Taxes</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(b)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>The Corporation hereby indemnifies and agrees to hold each Holder and each of their affiliates and their respective officers, directors,
employees, agents and advisors (each, an &ldquo;<B>Indemnified Party</B>&rdquo;) each Indemnified Party harmless from and against Taxes
or Other Taxes (including, without limitation, any Taxes or Other Taxes imposed by any jurisdiction on amounts payable under this Section
29) paid by any Indemnified Party as a result of any payment made hereunder or from the execution, delivery, registration or enforcement
of, or otherwise with respect to, this Preferred Shares or any other Transaction Document, and any liability (including penalties, interest
and expenses for nonpayment, late payment or otherwise) arising therefrom or with respect thereto, whether or not such Taxes or Other
Taxes were correctly or legally asserted. This indemnification shall be paid within thirty (30) days from the date on which such Holder
makes written demand therefor, accompanied by reasonable documentation supporting such demand, which demand shall identify the nature
and amount of such Taxes or Other Taxes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(c)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>If the Corporation fails to perform any of its obligations under this Section 28, the Corporation shall indemnify such Holder for
any taxes, interest or penalties that may become payable as a result of any such failure. The obligations of the Corporation under this
Section 29 shall survive the repayment and/or conversion, as applicable, in full of the Preferred Shares and all other amounts payable
with respect thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(d)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>If any Indemnified Party determines, in its sole discretion exercised in good faith, that it has received a refund of any Taxes
as to which it has been indemnified pursuant to this Section 29 (including by the payment of additional amounts pursuant to this Section
29), it shall pay to the indemnifying party an amount equal to such refund (but only to the extent of indemnity payments made under this
Section 29 with respect to the Taxes giving rise to such refund), net of all out-of-pocket expenses (including taxes) of such Indemnified
Party and without interest (other than any interest paid by the relevant Governmental Authority with respect to such refund). Such indemnifying
party, upon the request of such Indemnified Party, shall repay to such Indemnified Party the amount paid over pursuant to this paragraph
(d) (plus any penalties, interest, or other charges imposed by the relevant Governmental Authority) in the event that such Indemnified
Party is required to repay such refund to such Governmental Authority. Notwithstanding anything to the contrary in this paragraph (d),
in no event will the Indemnified Party be required to pay any amount to an indemnifying party pursuant to this paragraph (d) the payment
of which would place the Indemnified Party in a less favorable net after-Tax position than the Indemnified Party would have been in if
the Tax subject to indemnification and giving rise to such refund had not been deducted, withheld or otherwise imposed and the indemnification
payments or additional amounts with respect to such Tax had never been paid. This paragraph (d) shall not be construed to require any
Indemnified Party to make available its Tax returns (or any other information relating to its Taxes that it deems confidential) to the
indemnifying party or any other Person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 28 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">30.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Severability.</U> If any provision of this Certificate of Designations is prohibited by law or otherwise determined to be invalid
or unenforceable by a court of competent jurisdiction, the provision that would otherwise be prohibited, invalid or unenforceable shall
be deemed amended to apply to the broadest extent that it would be valid and enforceable, and the invalidity or unenforceability of such
provision shall not affect the validity of the remaining provisions of this Certificate of Designations so long as this Certificate of
Designations as so modified continues to express, without material change, the original intentions of the parties as to the subject matter
hereof and the prohibited nature, invalidity or unenforceability of the provision(s) in question does not substantially impair the respective
expectations or reciprocal obligations of the parties or the practical realization of the benefits that would otherwise be conferred upon
the parties. The parties will endeavor in good faith negotiations to replace the prohibited, invalid or unenforceable provision(s) with
a valid provision(s), the effect of which comes as close as possible to that of the prohibited, invalid or unenforceable provision(s).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">31.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Maximum Payments.</U> Nothing contained herein shall be deemed to establish or require the payment of a rate of interest or
other charges in excess of the maximum permitted by applicable law. In the event that the rate of interest required to be paid or other
charges hereunder exceed the maximum permitted by such law, any payments in excess of such maximum shall be credited against amounts owed
by the Corporation to the applicable Holder and thus refunded to the Corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">32.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Stockholder Matters; Amendment.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(a)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Stockholder Matters.</U> Any stockholder action, approval or consent required, desired or otherwise sought by the Corporation
pursuant to the NYBCL, the Certificate of Incorporation, this Certificate of Designations or otherwise with respect to the issuance of
Preferred Shares may be effected by written consent of the Corporation&rsquo;s stockholders or at a duly called meeting of the Corporation&rsquo;s
stockholders, all in accordance with the applicable rules and regulations of the NYBCL. This provision is intended to comply with the
applicable sections of the NYBCL permitting stockholder action, approval and consent effected by written consent in lieu of a meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(b)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Amendment.</U> Except for Section 4(d) hereunder, which may not be amended or waived hereunder, this Certificate of Designations
or any provision hereof may be amended by obtaining the affirmative vote at a meeting duly called for such purpose, or written consent
without a meeting in accordance with the NYBCL, of the Buyer, voting separate as a single class, and with such other stockholder approval,
if any, as may then be required pursuant to the NYBCL and the Certificate of Incorporation. Except (a) to the extent otherwise expressly
provided in this Certificate of Designations or the Certificate of Incorporation with respect to voting or approval rights of a particular
class or series of capital stock or (b) to the extent otherwise provided pursuant to the NYBCL, the holders of each outstanding class
or series of shares of the Corporation shall not be entitled to vote as a separate voting group on any amendment to the terms of this
Certificate of Designations with respect to which such class or series would otherwise be entitled under the NYBCL to vote as a separate
voting group.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">33.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Certain Defined Terms.</U> For purposes of this Certificate of Designations, the following terms shall have the following meanings:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(a)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B>1933 Act</B>&rdquo; means the Securities Act of 1933, as amended, and the rules and regulations thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(b)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B>1934 Act</B>&rdquo; means the Securities Exchange Act of 1934, as amended, and the rules and regulations thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(c)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B>Additional Amount</B>&rdquo; means, as of the applicable date of determination, with respect to each Preferred Share,
all declared and unpaid Dividends on such Preferred Share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(d)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B>Adjustment Right</B>&rdquo; means any right granted with respect to any securities issued in connection with, or with
respect to, any issuance or sale (or deemed issuance or sale in accordance with Section 8(a)) of shares of Common Stock (other than rights
of the type described in Section 7(a) hereof) that could result in a decrease in the net consideration received by the Corporation in
connection with, or with respect to, such securities (including, without limitation, any cash settlement rights, cash adjustment or other
similar rights).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 29 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(e)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B>Affiliate</B>&rdquo; <B>or </B>&ldquo;<B>Affiliated</B>&rdquo; means, with respect to any Person, any other Person that
directly or indirectly controls, is controlled by, or is under common control with, such Person, it being understood for purposes of this
definition that &ldquo;control&rdquo; of a Person means the power directly or indirectly either to vote 10% or more of the stock having
ordinary voting power for the election of directors of such Person or direct or cause the direction of the management and policies of
such Person whether by contract or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(f)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B>Alternate Conversion Price</B>&rdquo; means, with respect to any Alternate Conversion that price which shall be the lowest
of (i) the applicable Conversion Price as in effect on the applicable Conversion Date of the applicable Alternate Conversion, and (ii)
the greater of (x) the Floor Price and (y) the lowest VWAP of the Common Stock during the five (5) consecutive Trading Day period ending
and including the Trading Day immediately preceding the delivery or deemed delivery of the applicable Conversion Notice (such period,
the &ldquo;<B>Alternate Conversion Measuring Period</B>&rdquo;)<B>.</B> All such determinations to be appropriately adjusted for any stock
dividend, stock split, stock combination, reclassification or similar transaction that proportionately decreases or increases the Common
Stock during such Alternate Conversion Measuring Period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(g)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B>Alternate Conversion Floor Amount</B>&rdquo; means an amount equal to the product obtained by multiplying (A) the higher
of (I) the highest price that the Common Stock trades at on the Trading Day immediately preceding the relevant Alternate Conversion Date
and (II) the applicable Alternate Conversion Price and (B) the difference obtained by subtracting (I) the number of shares of Common Stock
delivered (or to be delivered) to such Holder on the applicable Share Delivery Deadline with respect to such Alternate Conversion from
(II) the quotient obtained by dividing (x) the applicable Conversion Amount that such Holder has elected to be the subject of the applicable
Alternate Conversion, by (y) the applicable Alternate Conversion Price without giving effect to clause (x) of such definition.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(h)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B>Applicable Date</B>&rdquo; means the earlier of (x) the first date on which the resale by the Holders of all the Common
Stock underlying the Preferred Shares as required to be filed under the Registration Rights Agreement is declared effective by the SEC
(and each prospectus contained therein is available for use on such date) or (y) the first date on which all of the Common Stock underlying
the Preferred Shares held by the Holder are eligible to be resold by the Holder pursuant to Rule 144 (or, if a Current Public Information
Failure as defined in the Registration Rights Agreement has occurred and is continuing, such later date after which the Corporation has
cured such Current Public Information Failure).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(i)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B>Approved Stock Plan</B>&rdquo; means any employee benefit plan or agreement which has been approved by the Board prior
to or subsequent to the Subscription Date pursuant to which shares of Common Stock, restricted stock units, and standard options to purchase
Common Stock may be issued to any employee, officer, consultant or director for services provided to the Corporation in their capacity
as such.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(j)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B>Attribution Parties</B>&rdquo; means, collectively, the following Persons and entities: (i) any investment vehicle, including,
any funds, feeder funds or managed accounts, currently, or from time to time after the Initial Issuance Date, directly or indirectly managed
or advised by a Holder&rsquo;s investment manager or any of its Affiliates or principals, (ii) any direct or indirect Affiliates of such
Holder or any of the foregoing, (iii) any Person acting or who could be deemed to be acting as a Group together with such Holder or any
of the foregoing and (iv) any other Persons whose beneficial ownership of the Corporation&rsquo;s Common Stock would or could be aggregated
with such Holder&rsquo;s and the other Attribution Parties for purposes of Section 13(d) of the 1934 Act. For clarity, the purpose of
the foregoing is to subject collectively such Holder and all other Attribution Parties to the Maximum Percentage.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(k)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B>Black Scholes Consideration Value</B>&rdquo; means the value of the applicable Option, Convertible Security or Adjustment
Right (as the case may be) as of the date of issuance thereof calculated using the Black Scholes Option Pricing Model obtained from the
&ldquo;OV&rdquo; function on Bloomberg utilizing (i) an underlying price per share equal to the Closing Sale Price of the Common Stock
on the Trading Day immediately preceding the public announcement of the execution of definitive documents with respect to the issuance
of such Option, Convertible Security or Adjustment Right (as the case may be), (ii) a risk free interest rate corresponding to the U.S.
Treasury rate for a period equal to the remaining term of such Option, Convertible Security or Adjustment Right (as the case may be) as
of the date of issuance of such Option, Convertible Security or Adjustment Right (as the case may be), (iii) a zero cost of borrow and
(iv) an expected volatility equal to the greater of 100% and the 100 day volatility obtained from the &ldquo;HVT&rdquo; function on Bloomberg
(determined utilizing a 365 day annualization factor) as of the Trading Day immediately following the date of issuance of such Option,
Convertible Security or Adjustment Right (as the case may be).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 30 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(l)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B>Bloomberg</B>&rdquo; means Bloomberg, L.P.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(m)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B>Book-Entry</B>&rdquo; means each entry on the Register evidencing one or more Preferred Shares held by a Holder in lieu
of a Preferred Share Certificate issuable hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(n)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B>Business Day</B>&rdquo; means any day other than Saturday, Sunday or other day on which commercial banks in The City
of New York are authorized or required by law to remain closed; <U>provided, however,</U> for clarification, commercial banks shall not
be deemed to be authorized or required by law to remain closed due to &ldquo;stay at home&rdquo;, &ldquo;shelter-in place&rdquo;, &ldquo;non-essential
employee&rdquo; or any other similar orders or restrictions or the closure of any physical branch locations at the direction of any Governmental
Authority so long as the electronic funds transfer systems (including for wire transfers) of commercial banks in The City of New York
generally are open for use by customers on such day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(o)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B>Change of Control</B>&rdquo; means any Fundamental Transaction other than (i) any merger of the Corporation or any of
its, direct or indirect, wholly-owned Subsidiaries with or into any of the foregoing Persons, (ii) any reorganization, recapitalization
or reclassification of the shares of Common Stock in which holders of the Corporation&rsquo;s voting power immediately prior to such reorganization,
recapitalization or reclassification continue after such reorganization, recapitalization or reclassification to hold publicly traded
securities and, directly or indirectly, are, in all material respects, the holders of the voting power of the surviving entity (or entities
with the authority or voting power to elect the members of the board of directors (or their equivalent if other than a corporation) of
such entity or entities) after such reorganization, recapitalization or reclassification, or (iii) pursuant to a migratory merger effected
solely for the purpose of changing the jurisdiction of incorporation of the Corporation or any of its Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(p)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B>Change of Control Election Price</B>&rdquo; means, with respect to any given Change of Control, such price equal to the
greatest of (i) the product of (A) the Required Premium multiplied by (B) the Conversion Amount of the Preferred Shares subject to the
applicable election, as applicable, (ii) the product of (A) the Conversion Amount of the Preferred Shares being redeemed or exchanged,
as applicable, multiplied by (B) the quotient determined by dividing (1) the greatest Closing Sale Price of the shares of Common Stock
during the period beginning on the date immediately preceding the earlier to occur of (1) the consummation of the applicable Change of
Control and (2) the public announcement of such Change of Control and ending on the date such Holder delivers the Change of Control Election
Notice by (2)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>1</SUP></FONT> the Alternate Conversion
Price then in effect, and (iii) the product of (A) the Conversion Amount of the Preferred Shares being redeemed multiplied by (B) the
quotient of (1) the aggregate cash consideration and the aggregate cash value of any non-cash consideration per share of Common Stock
to be paid to such holders of the shares of Common Stock upon consummation of such Change of Control (any such non-cash consideration
constituting publicly-traded securities shall be valued at the highest of the Closing Sale Price of such securities as of the Trading
Day immediately prior to the consummation of such Change of Control, the Closing Sale Price of such securities on the Trading Day immediately
following the public announcement of such proposed Change of Control and the Closing Sale Price of such securities on the Trading Day
immediately prior to the public announcement of such proposed Change of Control) divided by (2) the Conversion Price then in effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(q)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B>Closing Bid Price</B>&rdquo; and &ldquo;<B>Closing Sale Price</B>&rdquo; means, for any security as of any date, the
last closing bid price and last closing trade price, respectively, for such security on the Principal Market, as reported by Bloomberg,
or, if the Principal Market begins to operate on an extended hours basis and does not designate the closing bid price or the closing trade
price (as the case may be) then the last bid price or last trade price, respectively, of such security prior to 4:00:00 p.m., New York
time, as reported by Bloomberg, or, if the Principal Market is not the principal securities exchange or trading market for such security,
the last closing bid price or last trade price, respectively, of such security on the principal securities exchange or trading market
where such security is listed or traded as reported by Bloomberg, or if the foregoing do not apply, the last closing bid price or last
trade price, respectively, of such security in the over-the-counter market on the electronic bulletin board for such security as reported
by Bloomberg, or, if no closing bid price or last trade price, respectively, is reported for such security by Bloomberg, the average of
the bid prices, or the ask prices, respectively, of any market makers for such security as reported in The Pink Open Market (or a similar
organization or agency succeeding to its functions of reporting prices). If the Closing Bid Price or the Closing Sale Price cannot be
calculated for a security on a particular date on any of the foregoing bases, the Closing Bid Price or the Closing Sale Price (as the
case may be) of such security on such date shall be the fair market value as mutually determined by the Corporation and the Buyer. If
the Corporation and the Buyer are unable to agree upon the fair market value of such security, then such dispute shall be resolved in
accordance with the procedures in Section 23. All such determinations shall be appropriately adjusted for any stock splits, stock dividends,
stock combinations, recapitalizations or other similar transactions during such period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>1</SUP></FONT>
Note to Draft: This &ldquo;(2)&rdquo; follows a &ldquo;(2)&rdquo; and does not appear that it should be changed to &ldquo;(3)&rdquo;.
Please confirm required change.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 31 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(r)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B>Closing Date</B>&rdquo; shall have the meaning set forth in the Preferred Stock Purchase Agreement, which date is the
date the Corporation initially issued the Preferred Shares and the Warrants pursuant to the terms of the Preferred Stock Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(s)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B>Code</B>&rdquo; means the Internal Revenue Code of 1986, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(t)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B>Common Stock</B>&rdquo; means (i) the Corporation&rsquo;s shares of common stock, $0.01 par value per share, and (ii)
any capital stock into which such common stock shall have been changed or any share capital resulting from a reclassification of such
common stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(u)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B>Contingent Obligation</B>&rdquo; means, as to any Person, any direct or indirect liability, contingent or otherwise,
of that Person with respect to any Indebtedness, lease, dividend or other obligation of another Person if the primary purpose or intent
of the Person incurring such liability, or the primary effect thereof, is to provide assurance to the obligee of such liability that such
liability will be paid or discharged, or that any agreements relating thereto will be complied with, or that the holders of such liability
will be protected (in whole or in part) against loss with respect thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(v)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B>Conversion Floor Price Condition</B>&rdquo; means that the relevant Alternate Conversion Price is being determined based
on clause (x) of such definitions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(w)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B>Convertible Securities</B>&rdquo; means any stock or other security (other than Options) that is at any time and under
any circumstances, directly or indirectly, convertible into, exercisable or exchangeable for, or which otherwise entitles the holder thereof
to acquire, any shares of Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(x)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B>Default Rate</B>&rdquo; means, with respect to any determination of the aggregate amount of outstanding accrued and unpaid
Dividend hereunder, the sum of (x) the applicable Dividend Rate in effect for such determination and (y) eighteen (18%) per annum.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(y)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B>Dividend Conversion Price</B>&rdquo; means, with respect to any given Dividend Date, that price which shall be the lowest
of (i) the applicable Conversion Price as in effect on the applicable Dividend Date, (ii) the lowest VWAP of the Common Stock during the
five (5) consecutive Trading Day period ending and including the Trading Day immediately preceding the applicable Dividend Date (such
period, the &ldquo;<B>Dividend Conversion Measuring Period</B>&rdquo;)<B>.</B> All such determinations to be appropriately adjusted for
any stock dividend, stock split, stock combination, reclassification or similar transaction that proportionately decreases or increases
the Common Stock during such Dividend Conversion Measuring Period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(z)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B>Dividend Rate</B>&rdquo; means, as of any date of determination, 10% per annum; provided, further, that the foregoing
rate shall be subject to adjustment from time to time in accordance with Section 3.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(aa)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B>Eligible Market</B>&rdquo; means The New York Stock Exchange, the NYSE American, the Nasdaq Global Select Market, the
Nasdaq Global Market, and the Nasdaq Capital Market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 32 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(bb)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B>Equity Conditions</B>&rdquo; means, with respect to a given date of determination: (i) on each day during the period
beginning thirty calendar days prior to such applicable date of determination and ending on and including such applicable date of determination
either (x) one or more Registration Statements filed pursuant to the Registration Rights Agreement shall be effective and the prospectus
contained therein shall be available on such applicable date of determination (with, for the avoidance of doubt, any shares of Common
Stock previously sold pursuant to such prospectus deemed unavailable) for the resale of all shares of Common Stock to be issued in connection
with the event requiring this determination, as applicable, in the event requiring this determination at the Alternate Conversion Price
then in effect (without regard to any limitations on conversion set forth herein) (each, a &ldquo;<B>Required Minimum Securities Amount</B>&rdquo;),
in each case, in accordance with the terms of the Registration Rights Agreement and there shall not have been during such period any Grace
Periods (as defined in the Registration Rights Agreement) or (y) all Registrable Securities shall be eligible for sale pursuant to Rule
144 (as defined in the Preferred Stock Purchase Agreement) without the need for registration under any applicable federal or state securities
laws (in each case, disregarding any limitation on conversion of the Preferred Shares, other issuance of securities with respect to the
Preferred Shares and exercise of the Warrants) and no Current Information Failure (as defined in the Registration Rights Agreement) exists
or is continuing; (ii) on each day during the period beginning thirty calendar days prior to the applicable date of determination and
ending on and including the applicable date of determination (the &ldquo;<B>Equity Conditions Measuring Period</B>&rdquo;), the Common
Stock (including all shares of Common Stock issued or issuable upon conversion of the Preferred Shares and exercise of the Warrants) is
listed or designated for quotation (as applicable) on an Eligible Market and shall not have been suspended from trading on an Eligible
Market (other than suspensions of not more than two (2) days and occurring prior to the applicable date of determination due to business
announcements by the Corporation) nor shall delisting or suspension by an Eligible Market have been threatened (with a reasonable prospect
of delisting occurring after giving effect to all applicable notice, appeal, compliance and hearing periods) or reasonably likely to occur
or pending as evidenced by (A) a writing by such Eligible Market or (B) the Corporation falling below the minimum listing maintenance
requirements of the Eligible Market on which the Common Stock is then listed or designated for quotation, as applicable; (iii) during
the Equity Conditions Measuring Period, the Corporation shall have delivered all shares of Common Stock issuable upon conversion of the
Preferred Shares on a timely basis as set forth in Section 4 hereof and all other shares of capital stock required to be delivered by
the Corporation on a timely basis as set forth in the other Transaction Documents; (iv) any shares of Common Stock to be issued in connection
with the event requiring determination may be issued in full without violating Section 4(d) hereof; (v) any shares of Common Stock to
be issued in connection with the event requiring determination may be issued in full without violating the rules or regulations of the
Eligible Market on which the Common Stock is then listed or designated for quotation (as applicable); (vi) intentionally omitted; (vii)
the Corporation shall have no knowledge of any fact that would reasonably be expected to cause (1) any Registration Statement required
to be filed pursuant to the Registration Rights Agreement to not be effective or the prospectus contained therein to not be available
for the resale of the applicable Required Minimum Securities Amount of Registrable Securities in accordance with the terms of the Registration
Rights Agreement or (2) any Registrable Securities to not be eligible for sale pursuant to Rule 144 without the need for registration
under any applicable federal or state securities laws (in each case, disregarding any limitation on conversion of the Preferred Shares,
other issuance of securities with respect to the Preferred Shares and exercise of the Warrants) and no Current Information Failure exists
or is continuing, (viii) none of the Holders shall be in possession of any material, non-public information provided to any of them by
the Corporation, any of its Subsidiaries or any of their respective affiliates, employees, officers, representatives, agents or the like;
(ix) on each day during the Equity Conditions Measuring Period, the Corporation otherwise shall have been in compliance with each, and
shall not have breached any representation or warranty in any material respect (other than representations or warranties subject to material
adverse effect or materiality, which may not be breached in any respect) or any covenant or other term or condition of any Transaction
Document, including, without limitation, the Corporation shall not have failed to timely make any payment pursuant to any Transaction
Document; (x) there shall not have occurred any Volume Failure as of such applicable date of determination; (xi) on the applicable date
of determination (A) no Authorized Share Failure shall exist or be continuing and the applicable Required Minimum Securities Amount of
shares of Common Stock are available under the certificate of incorporation of the Corporation and reserved by the Corporation to be issued
pursuant to this Certificate of Designations and the Warrants and (B) all shares of Common Stock to be issued in connection with the event
requiring this determination may be issued in full without resulting in an Authorized Share Failure; (xii) on each day during the Equity
Conditions Measuring Period, there shall not have occurred and there shall not exist a Triggering Event or an event that with the passage
of time or giving of notice would constitute a Triggering Event; (xiii) the shares of Common Stock issuable pursuant to the event requiring
the satisfaction of the Equity Conditions are duly authorized and listed and eligible for trading without restriction on an Eligible Market
or (xiv) the Corporation shall have obtained the Stockholder Approval.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 33 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(cc)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B>Equity Conditions Failure</B>&rdquo; means that on any day during the period commencing on the first Trading Day in the
applicable Mandatory Conversion Measuring Period through the applicable Mandatory Conversion Date, the Equity Conditions have not been
satisfied (or waived in writing by the applicable Holder).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(dd)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B>Excluded Securities</B>&rdquo; means (i) shares of Common Stock, restricted stock units or standard options to purchase
Common Stock issued to directors, officers or employees of the Corporation for services rendered to the Corporation in their capacity
as such pursuant to an Approved Stock Plan (as defined above), provided that the exercise price of any such options is not lowered, none
of such options are amended to increase the number of shares issuable thereunder and none of the terms or conditions of any such options
are otherwise materially changed in any manner that adversely affects any of the Holders; (ii) shares of Common Stock issued upon the
conversion or exercise, as applicable, of Convertible Securities or Options (other than standard options to purchase Common Stock issued
pursuant to an Approved Stock Plan that are covered by clause (i) above) issued prior to the Subscription Date, provided that the conversion
price or exercise price, as applicable, of any such Convertible Securities or Options (other than standard options to purchase Common
Stock issued pursuant to an Approved Stock Plan that are covered by clause (i) above) is not lowered, none of such Convertible Securities
or Options (other than standard options to purchase Common Stock issued pursuant to an Approved Stock Plan that are covered by clause
(i) above) are amended to increase the number of shares issuable thereunder and none of the terms or conditions of any such Convertible
Securities or Options (other than standard options to purchase Common Stock issued pursuant to an Approved Stock Plan that are covered
by clause (i) above) are otherwise materially changed in any manner that adversely affects any of the Holders; (iii) the shares of Common
Stock issuable upon conversion of the Preferred Shares or otherwise pursuant to the terms of this Certificate of Designations; provided,
that the terms of this Certificate of Designations are not amended, modified or changed on or after the Subscription Date (other than
antidilution adjustments pursuant to the terms thereof in effect as of the Subscription Date); (iv) the shares of Common Stock issuable
upon exercise of the Warrants; provided, that the terms of the Warrants are not amended, modified or changed on or after the Subscription
Date (other than antidilution adjustments pursuant to the terms thereof in effect as of the Subscription Date) and (v) shares of Common
Stock issued pursuant to the Permitted Equity Line.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(ee)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B>FATCA</B>&rdquo; means Sections 1471 through 1474 of the Code, as of the date of this Certificate of Designation (or
any amended or successor version that is substantively comparable and not materially more onerous to comply with), any current or future
regulations or official interpretations thereof, any agreements entered into pursuant to Section 1471(b)(l) of the Code and any fiscal
or regulatory legislation, rules or practices adopted pursuant to any intergovernmental agreement, treaty or convention among Governmental
Authorities and implementing such Sections of the Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(ff)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B>Fiscal Quarter</B>&rdquo; means each of the fiscal quarters adopted by the Corporation for financial reporting purposes
that correspond to the Corporation&rsquo;s fiscal year as of the date hereof that ends on December 31.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(gg)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B>Floor Price</B>&rdquo; means $1.00 (as adjusted for stock splits, stock dividends, stock combinations, recapitalizations
and similar events), or, subject to the rules and regulations of the Principal Market, such lower price as the Corporation and the Buyer
may agree, from time to time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 34 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(hh)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B>Fundamental Transaction</B>&rdquo; means (A) that the Corporation shall, directly or indirectly, including through subsidiaries,
Affiliates or otherwise, in one or more related transactions, (i) consolidate or merge with or into (whether or not the Corporation is
the surviving corporation) another Subject Entity, or (ii) sell, assign, transfer, convey or otherwise dispose of all or substantially
all of the properties or assets of the Corporation or any of its &ldquo;significant subsidiaries&rdquo; (as defined in Rule 1-02 of Regulation
S-X) to one or more Subject Entities, or (iii) make, or allow one or more Subject Entities to make, or allow the Corporation to be subject
to or have its Common Stock be subject to or party to one or more Subject Entities making, a purchase, tender or exchange offer that is
accepted by the holders of at least either (x) 50% of the outstanding shares of Common Stock, (y) 50% of the outstanding shares of Common
Stock calculated as if any shares of Common Stock held by all Subject Entities making or party to, or Affiliated with any Subject Entities
making or party to, such purchase, tender or exchange offer were not outstanding; or (z) such number of shares of Common Stock such that
all Subject Entities making or party to, or Affiliated with any Subject Entity making or party to, such purchase, tender or exchange offer,
become collectively the beneficial owners (as defined in Rule 13d-3 under the 1934 Act) of at least 50% of the outstanding shares of Common
Stock, or (iv) consummate a stock or share purchase agreement or other business combination (including, without limitation, a reorganization,
recapitalization, spin-off or scheme of arrangement) with one or more Subject Entities whereby all such Subject Entities, individually
or in the aggregate, acquire, either (x) at least 50% of the outstanding shares of Common Stock, (y) at least 50% of the outstanding shares
of Common Stock calculated as if any shares of Common Stock held by all the Subject Entities making or party to, or Affiliated with any
Subject Entity making or party to, such stock purchase agreement or other business combination were not outstanding; or (z) such number
of shares of Common Stock such that the Subject Entities become collectively the beneficial owners (as defined in Rule 13d-3 under the
1934 Act) of at least 50% of the outstanding shares of Common Stock, or (v) reorganize, recapitalize or reclassify its Common Stock, (B)
that the Corporation shall, directly or indirectly, including through subsidiaries, Affiliates or otherwise, in one or more related transactions,
allow any Subject Entity individually or the Subject Entities in the aggregate to be or become the &ldquo;beneficial owner&rdquo; (as
defined in Rule 13d-3 under the 1934 Act), directly or indirectly, whether through acquisition, purchase, assignment, conveyance, tender,
tender offer, exchange, reduction in outstanding shares of Common Stock, merger, consolidation, business combination, reorganization,
recapitalization, spin-off, scheme of arrangement, reorganization, recapitalization or reclassification or otherwise in any manner whatsoever,
of either (x) at least 50% of the aggregate ordinary voting power represented by issued and outstanding Common Stock, (y) at least 50%
of the aggregate ordinary voting power represented by issued and outstanding Common Stock not held by all such Subject Entities as of
the date of this Certificate of Designations calculated as if any shares of Common Stock held by all such Subject Entities were not outstanding,
or (z) a percentage of the aggregate ordinary voting power represented by issued and outstanding shares of Common Stock or other equity
securities of the Corporation sufficient to allow such Subject Entities to effect a statutory short form merger or other transaction requiring
other stockholders of the Corporation to surrender their shares of Common Stock without approval of the stockholders of the Corporation
or (C) directly or indirectly, including through subsidiaries, Affiliates or otherwise, in one or more related transactions, the issuance
of or the entering into any other instrument or transaction structured in a manner to circumvent, or that circumvents, the intent of this
definition in which case this definition shall be construed and implemented in a manner otherwise than in strict conformity with the terms
of this definition to the extent necessary to correct this definition or any portion of this definition which may be defective or inconsistent
with the intended treatment of such instrument or transaction. For the avoidance of doubt, the OEM Asset Sale shall not be deemed a Fundamental
Transaction under the Transaction Documents.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(ii)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B>GAAP</B>&rdquo; means United States generally accepted accounting principles, consistently applied.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(jj)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B>Going Private Transaction</B>&rdquo; means any Change of Control (i) pursuant to which, the Corporation (and the Successor
Entity, if applicable) ceases to have any securities registered under the 1934 Act or (ii) that results in the purchase and/or cancellation
of all of the Common Stock of the Corporation solely for cash (and not in whole, or in part, for any other securities of any Person).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(kk)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B>Group</B>&rdquo; means a &ldquo;group&rdquo; as that term is used in Section 13(d) of the 1934 Act and as defined in
Rule 13d-5 thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(ll)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B>Governmental Authority</B>&rdquo; means any federal, foreign, state, county, municipal, provincial, or local governmental
authority, court, judicial body, arbitration tribunal, government or self-regulatory organization, commission, tribunal or organization,
or any regulatory, administrative, or other agency, or any political or other subdivision, department, commission, board, bureau, branch,
division, ministry, or instrumentality of any of the foregoing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 35 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(mm)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B>Indebtedness</B>&rdquo; means of any Person means, without duplication (A) all indebtedness for borrowed money, (B) all
obligations issued, undertaken or assumed as the deferred purchase price of property or services, including, without limitation, &ldquo;capital
leases&rdquo; in accordance with United States generally accepted accounting principles consistently applied for the periods covered thereby
(other than trade payables entered into in the ordinary course of business consistent with past practice), (C) all reimbursement or payment
obligations with respect to letters of credit, surety bonds and other similar instruments, (D) all obligations evidenced by notes, bonds,
debentures or similar instruments, including obligations so evidenced incurred in connection with the acquisition of property, assets
or businesses, (E) all indebtedness created or arising under any conditional sale or other title retention agreement, or incurred as financing,
in either case with respect to any property or assets acquired with the proceeds of such indebtedness (even though the rights and remedies
of the seller or bank under such agreement in the event of default are limited to repossession or sale of such property), (F) all monetary
obligations under any leasing or similar arrangement which, in connection with United States generally accepted accounting principles,
consistently applied for the periods covered thereby, is classified as a capital lease, (G) all indebtedness referred to in clauses (A)
through (F) above secured by (or for which the holder of such Indebtedness has an existing right, contingent or otherwise, to be secured
by) any mortgage, deed of trust, lien, pledge, charge, security interest or other encumbrance of any nature whatsoever in or upon any
property or assets (including accounts and contract rights) with respect to any asset or property owned by any Person, even though the
Person which owns such assets or property has not assumed or become liable for the payment of such indebtedness, and (H) all Contingent
Obligations in respect of indebtedness or obligations of others of the kinds referred to in clauses (A) through (G) above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(nn)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B>Intellectual Property Rights</B>&rdquo; means, with respect to the Corporation and its Subsidiaries, all of their rights
or licenses to use all trademarks, trade names, service marks, service mark registrations, service names, original works of authorship,
patents, patent rights, copyrights, inventions, licenses, approvals, governmental authorizations, trade secrets and other intellectual
property rights and all applications and registrations therefor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(oo)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B>Investment</B>&rdquo; means any beneficial ownership (including stock, partnership or limited liability company interests)
of or in any Person, or any loan, advance or capital contribution to any Person or the acquisition of all, or substantially all, of the
assets of another Person or the purchase of any assets of another Person for greater than the fair market value of such assets.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(pp)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B>Liquidation Event</B>&rdquo; means, whether in a single transaction or series of transactions, the voluntary or involuntary
liquidation, dissolution or winding up of the Corporation or such Subsidiaries the assets of which constitute all or substantially all
of the assets of the business of the Corporation and its Subsidiaries, taken as a whole.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(qq)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B>Material Adverse Effect</B>&rdquo; means any material adverse effect on the business, properties, assets, liabilities,
operations, results of operations, condition (financial or otherwise) or prospects of the Corporation and its Subsidiaries, if any, individually
or taken as a whole, or on the transactions contemplated hereby or on the other Transaction Documents (as defined below), or by the agreements
and instruments to be entered into in connection therewith or on the authority or ability of the Corporation to perform its obligations
under the Transaction Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(rr)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B>Options</B>&rdquo; means any rights, warrants or options to subscribe for or purchase shares of Common Stock or Convertible
Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(ss)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B>Parent Entity</B>&rdquo; of a Person means an entity that, directly or indirectly, controls the applicable Person and
whose common stock or equivalent equity security is quoted or listed on an Eligible Market, or, if there is more than one such Person
or Parent Entity, the Person or Parent Entity with the largest public market capitalization as of the date of consummation of the Fundamental
Transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(tt)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B>Permitted Equity Line</B>&rdquo; means any &ldquo;equity line&rdquo; securities purchase agreement by and between the
Corporation and C/M Capital Master Fund, LP or any of its affiliates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(uu)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B>Permitted Indebtedness</B>&rdquo; means (i) Indebtedness set forth on Schedule 3(s) to the Preferred Stock Purchase Agreement,
as in effect as of the Subscription Date, and (ii) Indebtedness secured by Permitted Liens or unsecured but as described in clauses (iv)
and (v) of the definition of Permitted Liens.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 36 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(vv)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B>Permitted Liens</B>&rdquo; means (i) any Lien for taxes not yet due or delinquent or being contested in good faith by
appropriate proceedings for which adequate reserves have been established in accordance with GAAP, (ii) any statutory Lien arising in
the ordinary course of business by operation of law with respect to a liability that is not yet due or delinquent, (iii) any Lien created
by operation of law, such as materialmen&rsquo;s liens, mechanics&rsquo; liens and other similar liens, arising in the ordinary course
of business with respect to a liability that is not yet due or delinquent or that are being contested in good faith by appropriate proceedings,
(iv) Liens (A) upon or in any equipment acquired or held by the Corporation or any of its Subsidiaries to secure the purchase price of
such equipment or Indebtedness incurred solely for the purpose of financing the acquisition or lease of such equipment, or (B) existing
on such equipment at the time of its acquisition, provided that the Lien is confined solely to the property so acquired and improvements
thereon, and the proceeds of such equipment, in either case, with respect to Indebtedness in an aggregate amount not to exceed $1,000,000,
(v) Liens incurred in connection with the extension, renewal or refinancing of the Indebtedness secured by Liens of the type described
in clause (iv) above, provided that any extension, renewal or replacement Lien shall be limited to the property encumbered by the existing
Lien and the principal amount of the Indebtedness being extended, renewed or refinanced does not increase, and (vi) Liens in favor of
customs and revenue authorities arising as a matter of law to secure payments of custom duties in connection with the importation of goods,
and Liens arising from judgments, decrees or attachments in circumstances not constituting a Triggering Event under Section 5(a)(xiii).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(ww)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B>Person</B>&rdquo; means an individual, a limited liability company, a partnership, a joint venture, a corporation, a
trust, an unincorporated organization, any other entity or a government or any department or agency thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(xx)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B>Preferred Stock Purchase Agreement</B>&rdquo; means that certain preferred stock purchase agreement by and among the
Corporation and the initial holders of Preferred Shares, dated as of the Subscription Date, as may be amended from time in accordance
with the terms thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(yy)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B>Principal Market</B>&rdquo; means, as of any time of determination, the principal trading market, if any, in which the
shares of Common Stock then trade.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(zz)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B>Registration Rights Agreement</B>&rdquo; means that certain registration rights agreement, dated as of the Closing Date,
by and among the Corporation and the initial holders of the Preferred Shares relating to, among other things, the registration of the
resale of the Common Stock issuable upon conversion of the Preferred Shares or otherwise pursuant to the terms of this Certificate of
Designations and exercise of the Warrants, as may be amended from time to time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(aaa)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B>Required Holder</B>&rdquo; means C/M Capital Master Fund, LP.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(bbb)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B>Required Premium</B>&rdquo; means 125%.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(ccc)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B>SEC</B>&rdquo; means the United States Securities and Exchange Commission or the successor thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(ddd)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B>Securities</B>&rdquo; shall have the meaning as set forth in the Preferred Stock Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(eee)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B>Stated Value</B>&rdquo; shall mean $1.00 per share, subject to adjustment for stock splits, stock dividends, recapitalizations,
reorganizations, reclassifications, combinations, subdivisions or other similar events occurring after the Initial Issuance Date with
respect to the Preferred Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(fff)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B>Stock Combination Event</B>&rdquo; means the occurrence at any time and from time to time on or after the Subscription
Date of any stock split, stock dividend, stock combination recapitalization or other similar transaction involving the Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(ggg)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B>Subscription Date</B>&rdquo; means May 16, 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(hhh)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B>Subsequent Placement</B>&rdquo; means any direct, or indirect, issuance, offer, sale, grant of any option or right to
purchase, or otherwise disposal of (or announcement of any issuance, offer, sale, grant of any option or right to purchase or other disposition
of) any equity security or any equity-linked or related security (including, without limitation, any &ldquo;equity security&rdquo; (as
that term is defined under Rule 405 promulgated under the 1933 Act), any Convertible Securities, any debt, any preferred stock or any
purchase rights) by the Corporation or any of its Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 37 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(iii)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B>Subject Entity</B>&rdquo; means any Person, Persons or Group or any Affiliate or associate of any such Person, Persons
or Group.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(jjj)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B>Subsidiary</B>&rdquo; shall have the meaning set forth in the Preferred Stock Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(kkk)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B>Successor Entity</B>&rdquo; means the Person (or, if so elected by the Buyer, the Parent Entity) formed by, resulting
from or surviving any Fundamental Transaction or the Person (or, if so elected by the Buyer, the Parent Entity) with which such Fundamental
Transaction shall have been entered into.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(lll)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B>Trading Day</B>&rdquo; means, as applicable, (x) with respect to all price or trading volume determinations relating
to the Common Stock, any day on which the Common Stock is traded on the Principal Market, or, if the Principal Market is not the principal
trading market for the Common Stock, then on the principal securities exchange or securities market on which the Common Stock is then
traded, provided that &ldquo;Trading Day&rdquo; shall not include any day on which the Common Stock is scheduled to trade on such exchange
or market for less than 4.5 hours or any day that the Common Stock is suspended from trading during the final hour of trading on such
exchange or market (or if such exchange or market does not designate in advance the closing time of trading on such exchange or market,
then during the hour ending at 4:00:00 p.m., New York time) unless such day is otherwise designated as a Trading Day in writing by the
applicable Holder or (y) with respect to all determinations other than price determinations relating to the Common Stock, any day on which
The New York Stock Exchange (or any successor thereto) is open for trading of securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(mmm)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;
</FONT>&ldquo;<B>Transaction Documents</B>&rdquo; means the Preferred Stock Purchase Agreement, the Registration Rights Agreement, this
Certificate of Designations, the Warrants and each of the other agreements and instruments entered into or delivered by the Corporation
or any of the Holders in connection with the transactions contemplated by the Preferred Stock Purchase Agreement, all as may be amended
from time to time in accordance with the terms thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(nnn)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B>Volume Failure</B>&rdquo; means, with respect to a particular date of determination, that the aggregate daily dollar
trading volume (as reported on Bloomberg) of the Common Stock on the Principal Market on any Trading Day during the twenty (20) Trading
Day period ending on the Trading Day immediately preceding such date of determination (such period, the &ldquo;<B>Volume Failure Measuring
Period</B>&rdquo;), is less than $1,000.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(ooo)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B>VWAP</B>&rdquo; means, for any security as of any date, the dollar volume- weighted average price for such security on
the Principal Market (or, if the Principal Market is not the principal trading market for such security, then on the principal securities
exchange or securities market on which such security is then traded), during the period beginning at 9:30 a.m., New York time, and ending
at 4:00 p.m., New York time, as reported by Bloomberg through its &ldquo;VAP&rdquo; function (set to 09:30 start time and 16:00 end time)
or, if the foregoing does not apply, the dollar volume-weighted average price of such security in the over-the-counter market on the electronic
bulletin board for such security during the period beginning at 9:30 a.m., New York time, and ending at 4:00 p.m., New York time, as reported
by Bloomberg, or, if no dollar volume-weighted average price is reported for such security by Bloomberg for such hours, the average of
the highest closing bid price and the lowest closing ask price of any of the market makers for such security as reported in The Pink Open
Market (or a similar organization or agency succeeding to its functions of reporting prices). If the VWAP cannot be calculated for such
security on such date on any of the foregoing bases, the VWAP of such security on such date shall be the fair market value as mutually
determined by the Corporation and the Buyer. If the Corporation and the Buyer are unable to agree upon the fair market value of such security,
then such dispute shall be resolved in accordance with the procedures in Section 23. All such determinations shall be appropriately adjusted
for any stock dividend, stock split, stock combination, recapitalization or other similar transaction during such period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(ppp)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B>Warrants</B>&rdquo; has the meaning ascribed to such term in the Preferred Stock Purchase Agreement, and shall include
all warrants issued in exchange therefor or replacement thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(qqq)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B>Warrant Shares</B>&rdquo; means, collectively, the shares of Common Stock issuable upon exercise of the Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 38 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">34.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Disclosure.</U> Upon receipt or delivery by the Corporation of any notice in accordance with the terms of this Certificate of
Designations, unless the Corporation has in good faith determined that the matters relating to such notice do not constitute material,
non-public information relating to the Corporation or any of its Subsidiaries, the Corporation shall on or prior to 9:00 a.m., New York
city time on the second Business Day immediately following such notice delivery date, publicly disclose such material, non-public information
on a Current Report on Form 8-K or otherwise. In the event that the Corporation believes that a notice contains material, non-public information
relating to the Corporation or any of its Subsidiaries, the Corporation so shall indicate to the applicable Holder explicitly in writing
in such notice (or promptly (but no later than the next Business Day) following receipt of notice from such Holder, as applicable), and
in the absence of any such written indication in such notice (or notification from the Corporation promptly (but no later than the next
Business Day) following receipt of notice from such Holder), such Holder shall be entitled to presume that information contained in the
notice does not constitute material, non-public information relating to the Corporation or any of its Subsidiaries. Nothing contained
in this Section 34 shall limit any obligations of the Corporation, or any rights of any Holder, under the Preferred Stock Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">35.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Absence of Trading and Disclosure Restrictions.</U> The Corporation acknowledges and agrees that no Holder is a fiduciary or
agent of the Corporation and that each Holder shall have no obligation to (a) maintain the confidentiality of any information provided
by the Corporation or (b) refrain from trading any securities while in possession of such information in the absence of a written non-disclosure
agreement signed by an officer of such Holder that explicitly provides for such confidentiality and trading restrictions. In the absence
of such an executed, written non disclosure agreement, the Corporation acknowledges that each Holder may freely trade in any securities
issued by the Corporation, may possess and use any information provided by the Corporation in connection with such trading activity, and
may disclose any such information to any third party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 8.2pt 0 48.9pt; text-align: justify; text-indent: 36.15pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 8.2pt 0 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">[The remainder of the page is intentionally left blank]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 154.25pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 39 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, the Corporation
has caused this Certificate of Amendment to be signed by its Chief Financial Officer on this 20<SUP>th</SUP> day of May, 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 3in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 80pt; text-indent: 3.5in">FORWARD INDUSTRIES, INC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 80pt; text-indent: 3.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 80pt; text-indent: 3.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 80pt; text-indent: 3.5in">_____________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 80pt; text-indent: 3.5in">Name: Michael Pruitt</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 80pt; text-indent: 3.5in">Title: Chief Executive Officer</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 40 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>CERTIFICATE OF AMENDMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>OF THE </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>CERTIFICATE OF INCORPORATION </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>OF </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>FORWARD INDUSTRIES, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Under Section 805 of the Business Corporation Law</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Filed by:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Michael Pruitt</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>700 Veterans Memorial Hwy., Ste. 100</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Hauppauge, NY 11788</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 41; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>3
<FILENAME>forward_ex0501.htm
<DESCRIPTION>OPINION OF NASON YEAGER GERSON HARRIS & FUMERO P.A.
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><B>Exhibit 5.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Nason, Yeager, Gerson, Harris &amp; Fumero, P.A.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>3001 PGA Boulevard, Suite 305</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Palm Beach Gardens, Florida 33410</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><BR>
June 10, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Forward Industries, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">700 Veterans Memorial Highway</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Suite 100</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Hauppauge, NY 11788</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Attention: Mr. Michael Pruitt, Interim CEO</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Re: Registration Statement on
Form S-1</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Dear Mr. Pruitt:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">You have advised us that Forward
Industries, Inc. (the &ldquo;Company&rdquo;) is filing with the Securities and Exchange Commission a Registration Statement on Form S-1
in accordance with that certain Securities Purchase Agreement between the Company and C/M Capital Master Fund, L.P. (&ldquo;Selling Stockholder&rdquo;)
dated as of May 16, 2025 (the &ldquo;Agreement&rdquo;) with respect to 273,000 shares of common stock of which 24,929 are outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">In connection with the filing
of this Registration Statement, you have requested that we furnish you with our opinion as to the legality of such shares as shall be
offered by the Selling Stockholder pursuant to the Prospectus which is part of the Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">After having examined the Company&rsquo;s
Certificate of Incorporation, Bylaws, minutes and unanimous consents of the board of directors, the financial statements contained in
the Prospectus, and other relevant corporate documents, and relying upon information supplied by the Company and its stock transfer agent,
we are of the opinion that the 273,000 shares of common stock issued or issuable to the Selling Stockholder are, or will be when issued
in accordance with the terms of the Agreement, validly issued, duly authorized, fully paid and non-assessable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The opinions expressed herein
are limited to the New York Business Corporation Law as currently in effect, and we express no opinion as to the applicability or effect
of any other laws of the State of New York or the laws of any other jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">We hereby consent to being named in the Registration
Statement, to the use of this opinion as Exhibit 5.1 to the Registration Statement and to the reference to our firm under the caption
&ldquo;Legal Matters&rdquo; in the prospectus that is a part of the Registration Statement. This opinion is expressly limited to the
matters set forth above, and we render no opinion, whether by implication or otherwise, as to any other matters relating to the Company
or the securities described herein. In giving such consent, we do not hereby admit that we are acting within the category of persons
whose consent is required under Section 7 of the Securities Act of 1933 or the rules or regulations of the Securities and Exchange Commission
thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 50%; font-size: 10pt">Very truly yours,</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt"><I>/s/ Nason, Yeager, Gerson, Harris &amp; Fumero, P.A. </I></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">Nason, Yeager, Gerson, Harris &amp; Fumero, P.A.</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: justify">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.20
<SEQUENCE>4
<FILENAME>forward_ex1020.htm
<DESCRIPTION>PREFERRED STOCK PURCHASE AGREEMENT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 10.20</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>PREFERRED STOCK PURCHASE AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>THIS PREFERRED STOCK PURCHASE
AGREEMENT</B> (the &ldquo;<B>Agreement</B>&rdquo;), dated as of May 23, 2025 (&ldquo;<B>Execution Date</B>&rdquo;), is by and among <B>FORWARD
INDUSTRIES, INC.</B>, a New York corporation (the &ldquo;<B>Company</B>&rdquo;), and <B>________________</B> (the &ldquo;<B>Buyer</B>&rdquo;).</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B></B>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B><U>RECITALS</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">A.</TD><TD STYLE="text-align: justify">The Company and the Buyer are executing and delivering this Agreement in reliance upon the exemption from
securities registration afforded by Section 4(a)(2) of the Securities Act of 1933, as amended (the &ldquo;<B>1933 Act</B>&rdquo;), and
Rule 506(b) of Regulation D (&ldquo;<B>Regulation&nbsp;D</B>&rdquo;) as promulgated by the United States Securities and Exchange Commission
(the &ldquo;<B>SEC</B>&rdquo;) under the 1933 Act.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">B.</TD><TD STYLE="text-align: justify">The Company has authorized a new series of convertible preferred stock of the Company designated as Series
B Convertible Preferred Stock, $0.01 par value, the terms of which are set forth in the certificate of designation for such series of
Preferred Stock (the &ldquo;<B>Certificate of Designations</B>&rdquo;) in the form attached hereto as <B><U>Exhibit A</U></B> (together
with any convertible preferred shares issued in replacement thereof in accordance with the terms thereof, the &ldquo;<B>Series B Preferred
Stock</B>&rdquo;), which Series B Preferred Stock shall be convertible into shares of Common Stock (such shares of Common Stock issuable
pursuant to the terms of the Certificate of Designations, including, without limitation, upon conversion or otherwise, collectively, the
&ldquo;<B>Conversion Shares</B>&rdquo;), in accordance with the terms of the Certificate of Designations.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">C.</TD><TD STYLE="text-align: justify">The Buyer wishes to purchase, and the Company wishes to sell, upon the terms and conditions stated in
this Agreement, (i) the aggregate number of shares of Series B Preferred Stock (the &ldquo;<B>Preferred Shares</B>&rdquo;) set forth on
the signature page hereto, and (ii) a warrant to initially acquire up to that aggregate number of additional shares of Common Stock set
forth on the signature page hereto, substantially in the form attached hereto as&nbsp;<B><U>Exhibit B</U></B> (the &ldquo;<B>Warrants</B>&rdquo;)
(as exercised, collectively, the &ldquo;<B>Warrant Shares</B>&rdquo;).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">D.</TD><TD STYLE="text-align: justify">At the Closing, the parties hereto shall execute and deliver a Registration Rights Agreement, in the form
attached hereto as <B><U>Exhibit C</U></B> (the &ldquo;<B>Registration Rights Agreement</B>&rdquo;), pursuant to which the Company has
agreed to provide certain registration rights with respect to the Registrable Securities (as defined in the Registration Rights Agreement),
under the 1933 Act and the rules and regulations promulgated thereunder, and applicable state securities laws.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">E.</TD><TD STYLE="text-align: justify">The Preferred Shares, the Conversion Shares, the Warrants and the Warrant Shares are collectively referred
to herein as the &ldquo;<B>Securities</B>.&rdquo;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B><U>AGREEMENT</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">NOW, THEREFORE, in consideration
of the premises and the mutual covenants contained herein and for other good and valuable consideration, the receipt and sufficiency of
which are hereby acknowledged, the Company and the Buyer hereby agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><B>1.</B></TD><TD STYLE="text-align: justify"><B>PURCHASE AND SALE OF PREFERRED SHARES AND WARRANTS.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(a)</TD><TD STYLE="text-align: justify"><U>Purchase of Preferred Shares and Warrants</U>. Subject to the satisfaction (or waiver) of the conditions
set forth in Sections 6 and 7 below, the Company shall issue and the Buyer agrees to purchase from the Company on the Closing Date (as
defined below) the aggregate number of Preferred Shares as is set forth on the signature page to this Agreement, along with Warrants to
initially acquire up to that aggregate number of Warrant Shares as is set forth on the signature page hereto.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(b)</TD><TD STYLE="text-align: justify"><U>Closing</U>. The closing (the &ldquo;<B>Closing</B>&rdquo;) of the purchase of the Preferred Shares
and the Warrants by the Buyer shall occur at the offices of the Company. The date and time of the Closing (the &ldquo;<B>Closing Date</B>&rdquo;)
shall be 10:00 a.m., New York time, on the first (1st) Business Day on which the conditions to the Closing set forth in Sections 6 and
7 below are satisfied or waived (or such other date as is mutually agreed to by the Company and the Buyer). As used herein &ldquo;<B>Business
Day</B>&rdquo; means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized
or required by law to remain closed; <FONT STYLE="background-color: white"><U>provided</U>, <U>however</U>, for clarification, commercial
banks shall not be deemed to be authorized or required by law to remain closed due to &ldquo;stay at home&rdquo;, &ldquo;shelter-in-place&rdquo;,
&ldquo;non-essential employee&rdquo; or any other similar orders or restrictions or the closure of any physical branch locations at the
direction of any governmental authority so long as the electronic funds transfer systems (including for wire transfers) of commercial
banks in The City of New York generally are open for use by customers on such day.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(c)</TD><TD STYLE="text-align: justify"><U>Purchase Price</U>. The aggregate purchase price for the Preferred Shares and the Warrants to be purchased
by the Buyer (the &ldquo;<B>Purchase Price</B>&rdquo;) shall be the amount set forth on the signature page hereto (which shall be subject
to the withholding contemplated by Section 4(g)).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(d)</TD><TD STYLE="text-align: justify"><U>Form of Payment</U>. On the Closing Date, (i) the Buyer shall pay the Purchase Price to the Company
for the Preferred Shares and the Warrants to be issued and sold to the Buyer at the Closing, by wire transfer of immediately available
funds and (ii) the Company shall deliver to the Buyer (A) the aggregate number of Preferred Shares as is set forth on the signature page
hereto, and (B) a Warrant pursuant to which the Buyer shall have the right to initially acquire up to such aggregate number of Warrant
Shares as is set forth on the signature page hereto, in each case, duly executed on behalf of the Company and registered in the name of
the Buyer or its designee.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><B>2.</B></TD><TD STYLE="text-align: justify"><B>BUYER&rsquo;S REPRESENTATIONS AND WARRANTIES.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Buyer represents and warrants
to the Company as of the Execution Date and as of the Closing Date:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(a)</TD><TD STYLE="text-align: justify"><U>Organization; Authority</U>. The Buyer is an entity duly organized, validly existing and in good standing
under the laws of the jurisdiction of its organization with the requisite power and authority to enter into and to consummate the transactions
contemplated by the Transaction Documents (as defined below) to which it is a party and otherwise to carry out its obligations hereunder
and thereunder.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(b)</TD><TD STYLE="text-align: justify"><U>No Public Sale or Distribution</U>. The Buyer (i) is acquiring its Preferred Shares and Warrants, (ii)
upon conversion of its Preferred Shares will acquire the Conversion Shares issuable upon conversion thereof, and (iii) upon exercise of
its Warrants (other than pursuant to a Cashless Exercise (as defined in the Warrants)) will acquire the Warrant Shares issuable upon exercise
thereof, in each case, for its own account and not with a view towards, or for resale in connection with, the public sale or distribution
thereof in violation of applicable securities laws, except pursuant to sales registered or exempted under the 1933 Act; provided, however,
by making the representations herein, the Buyer does not agree, or make any representation or warranty, to hold any of the Securities
for any minimum or other specific term and reserves the right to dispose of the Securities at any time in accordance with or pursuant
to a registration statement or an exemption from registration under the 1933 Act. The Buyer does not presently have any agreement or understanding,
directly or indirectly, with any Person to distribute any of the Securities in violation of applicable securities laws. For purposes of
this Agreement, &ldquo;<B>Person</B>&rdquo; means an individual, a limited liability company, a partnership, a joint venture, a corporation,
a trust, an unincorporated organization, any other entity and any Governmental Entity or any department or agency thereof.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(c)</TD><TD STYLE="text-align: justify"><U>Accredited Investor Status</U>. The Buyer is an &ldquo;accredited investor&rdquo; as that term is defined
in Rule 501(a) of Regulation D.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(d)</TD><TD STYLE="text-align: justify"><U>Reliance on Exemptions</U>. The Buyer understands that the Securities are being offered and sold to
it in reliance on specific exemptions from the registration requirements of United States federal and state securities laws and that the
Company is relying in part upon the truth and accuracy of, and the Buyer&rsquo;s compliance with, the representations, warranties, agreements,
acknowledgments and understandings of the Buyer set forth herein in order to determine the availability of such exemptions and the eligibility
of the Buyer to acquire the Securities.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(e)</TD><TD STYLE="text-align: justify"><U>Information</U>. The Buyer and its advisors, if any, have been furnished with all materials relating
to the business, finances and operations of the Company and materials relating to the offer and sale of the Securities that have been
requested by the Buyer. The Buyer and its advisors, if any, have been afforded the opportunity to ask questions of the Company. Neither
such inquiries nor any other due diligence investigations conducted by the Buyer or its advisors, if any, or its representatives shall
modify, amend or affect the Buyer&rsquo;s right to rely on the Company&rsquo;s representations and warranties contained herein. The Buyer
understands that its investment in the Securities involves a high degree of risk. The Buyer has sought such accounting, legal and tax
advice as it has considered necessary to make an informed investment decision with respect to its acquisition of the Securities.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(f)</TD><TD STYLE="text-align: justify"><U>No Governmental Review</U>. The Buyer understands that no United States federal or state agency or
any other government or governmental agency has passed on or made any recommendation or endorsement of the Securities or the fairness
or suitability of the investment in the Securities nor have such authorities passed upon or endorsed the merits of the offering of the
Securities.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(g)</TD><TD STYLE="text-align: justify"><U>Transfer or Resale</U>. The Buyer understands that except as provided in the Registration Rights Agreement
and as may otherwise be expressly provided in this Agreement: (i) the Securities have not been and are not being registered under the
1933 Act or any state securities laws, and may not be offered for sale, sold, assigned or transferred unless (A) subsequently registered
thereunder, (B) the Buyer shall have delivered to the Company (if requested by the Company) an opinion of counsel, in a form reasonably
acceptable to the Company, to the effect that such Securities to be sold, assigned or transferred may be sold, assigned or transferred
pursuant to an exemption from such registration, or (C) the Buyer provides the Company with reasonable assurance that such Securities
can be sold, assigned or transferred pursuant to Rule 144 or Rule 144A promulgated under the 1933 Act (or a successor rule thereto) (collectively,
&ldquo;<B>Rule 144</B>&rdquo;); (ii) any sale of the Securities made in reliance on Rule 144 may be made only in accordance with the terms
of Rule 144, and further, if Rule 144 is not applicable, any resale of the Securities under circumstances in which the seller (or the
Person through whom the sale is made) may be deemed to be an underwriter (as that term is defined in the 1933 Act) may require compliance
with some other exemption under the 1933 Act or the rules and regulations of the SEC promulgated thereunder; and (iii) neither the Company
nor any other Person is under any obligation to register the Securities under the 1933 Act or any state securities laws or to comply with
the terms and conditions of any exemption thereunder. Notwithstanding the foregoing, the Securities may be pledged in connection with
a bona fide margin account or other loan or financing arrangement secured by the Securities and such pledge of Securities shall not be
deemed to be a transfer, sale or assignment of the Securities hereunder, and no Buyer effecting a pledge of Securities shall be required
to provide the Company with any notice thereof or otherwise make any delivery to the Company pursuant to this Agreement or any other Transaction
Document.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(h)</TD><TD STYLE="text-align: justify"><U>Validity; Enforcement</U>. This Agreement and the Registration Rights Agreement have been duly and
validly authorized, executed and delivered on behalf of the Buyer and shall constitute the legal, valid and binding obligations of the
Buyer enforceable against the Buyer in accordance with their respective terms, except as such enforceability may be limited by general
principles of equity or to applicable bankruptcy, insolvency, reorganization, moratorium, liquidation and other similar laws relating
to, or affecting generally, the enforcement of applicable creditors&rsquo; rights and remedies.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(i)</TD><TD STYLE="text-align: justify"><U>No Conflicts</U>. The execution, delivery and performance by the Buyer of this Agreement and the Registration
Rights Agreement and the consummation by the Buyer of the transactions contemplated hereby and thereby will not (i) result in a violation
of the organizational documents of the Buyer, or (ii) conflict with, or constitute a default (or an event which with notice or lapse of
time or both would become a default) under, or give to others any rights of termination, amendment, acceleration or cancellation of, any
agreement, indenture or instrument to which the Buyer is a party, or (iii) result in a violation of any law, rule, regulation, order,
judgment or decree (including federal and state securities laws) applicable to the Buyer, except in the case of clauses (ii) and (iii)
above, for such conflicts, defaults, rights or violations which could not, individually or in the aggregate, reasonably be expected to
have a material adverse effect on the ability of the Buyer to perform its obligations hereunder.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><B>3.</B></TD><TD STYLE="text-align: justify"><B>REPRESENTATIONS AND WARRANTIES OF THE COMPANY.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company represents and warrants
to the Buyer that, as of the Execution Date and as of the Closing Date:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(a)</TD><TD STYLE="text-align: justify"><U>Organization and Qualification</U>. Each of the Company and each of its Subsidiaries are entities duly
organized and validly existing and in good standing under the laws of the jurisdiction in which they are formed, and have the requisite
power and authority to own their properties and to carry on their business as now being conducted and as presently proposed to be conducted.
Each of the Company and each of its Subsidiaries is duly qualified as a foreign entity to do business and is in good standing in every
jurisdiction in which its ownership of property or the nature of the business conducted by it makes such qualification necessary, except
to the extent that the failure to be so qualified or be in good standing would not reasonably be expected to have a Material Adverse Effect
(as defined below). As used in this Agreement, &ldquo;<B>Material Adverse Effect</B>&rdquo; means any material adverse effect on (i) the
business, properties, assets, liabilities, operations (including results thereof), condition (financial or otherwise) or prospects of
the Company or any Subsidiary, individually or taken as a whole, (ii) the transactions contemplated hereby or in any of the other Transaction
Documents or any other agreements or instruments to be entered into in connection herewith or therewith or (iii) the authority or ability
of the Company or any of its Subsidiaries to perform any of their respective obligations under any of the Transaction Documents (as defined
below). The Company&rsquo;s Subsidiaries are set forth on Schedule 3(a). &ldquo;<B>Subsidiaries</B>&rdquo; means any Person in which the
Company, directly or indirectly, (I) owns any of the outstanding capital stock or holds any equity or similar interest of such Person
or (II) controls or operates all or any part of the business, operations or administration of such Person, and each of the foregoing,
is individually referred to herein as a &ldquo;<B>Subsidiary</B>.&rdquo;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(b)</TD><TD STYLE="text-align: justify"><U>Authorization; Enforcement; Validity</U>. The Company has the requisite power and authority to enter
into and perform its obligations under this Agreement and the other Transaction Documents and to issue the Securities in accordance with
the terms hereof and thereof. Each Subsidiary has the requisite power and authority to enter into and perform its obligations under the
Transaction Documents to which it is a party. The execution and delivery of this Agreement and the other Transaction Documents by the
Company, and the consummation by the Company of the transactions contemplated hereby and thereby (including, without limitation, the issuance
of the Preferred Shares and the reservation for issuance and issuance of the Conversion Shares issuable upon conversion of the Preferred
Shares and the issuance of the Warrants and the reservation for issuance and issuance of the Warrant Shares issuable upon exercise of
the Warrants) have been duly authorized by the Company&rsquo;s board of directors or other governing body, as applicable, and (other than
the filing with the SEC of one or more Registration Statements in accordance with the requirements of the Registration Rights Agreement,
a Form D with the SEC and any other filings as may be required by any state securities agencies) no further filing, consent or authorization
is required by the Company, its Subsidiaries, their respective boards of directors or their stockholders or other governing body. This
Agreement has been, and the other Transaction Documents to which it is a party will be prior to the Closing, duly executed and delivered
by the Company, and each constitutes the legal, valid and binding obligations of the Company, enforceable against the Company in accordance
with its respective terms, except as such enforceability may be limited by general principles of equity or applicable bankruptcy, insolvency,
reorganization, moratorium, liquidation or similar laws relating to, or affecting generally, the enforcement of applicable creditors&rsquo;
rights and remedies and except as rights to indemnification and to contribution may be limited by federal or state securities law. The
Certificate of Designations in the form attached hereto as Exhibit A has been filed with the Secretary of State of the State of New York
and is in full force and effect, enforceable against the Company in accordance with its terms and has not have been amended. &ldquo;<B>Transaction
Documents</B>&rdquo; means, collectively, this Agreement, the Preferred Shares, the Warrants, the Certificate of Designations, the Registration
Rights Agreement, the Irrevocable Transfer Agent Instructions (as defined below) and each of the other agreements and instruments entered
into or delivered by any of the parties hereto in connection with the transactions contemplated hereby and thereby, as may be amended
from time to time.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(c)</TD><TD STYLE="text-align: justify"><U>Issuance of Securities</U>. The issuance of the Preferred Shares and the Warrants are duly authorized
and upon issuance in accordance with the terms of the Transaction Documents shall be validly issued, fully paid and non-assessable and
free from all preemptive or similar rights, mortgages, defects, claims, liens, pledges, charges, taxes, rights of first refusal, encumbrances,
security interests and other encumbrances (collectively &ldquo;<B>Liens</B>&rdquo;) with respect to the issuance thereof. As of the Closing,
the Company shall have reserved from its duly authorized capital stock not less than the sum of (i) 300% of the maximum number of Conversion
Shares issuable upon conversion of the Preferred Shares, and (ii) the maximum number of Warrant Shares initially issuable upon exercise
of the Warrants (without taking into account any limitations on the exercise of the Warrants set forth therein). Upon issuance or conversion
in accordance with the Preferred Shares or exercise in accordance with the Warrants (as the case may be), the Conversion Shares and the
Warrant Shares, respectively, when issued, will be validly issued, fully paid and nonassessable and free from all preemptive or similar
rights or Liens with respect to the issue thereof, with the holders being entitled to all rights accorded to a holder of Common Stock.
Subject to the accuracy of the representations and warranties of the Buyers in this Agreement, the offer and issuance by the Company of
the Securities is exempt from registration under the 1933 Act.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(d)</TD><TD STYLE="text-align: justify"><U>No Conflicts</U>. The execution, delivery and performance of the Transaction Documents by the Company
and the consummation by the Company of the transactions contemplated hereby and thereby (including, without limitation, the issuance of
the Preferred Shares, the Warrants, the Conversion Shares and the Warrant Shares and the reservation for issuance of the Conversion Shares
and the Warrant Shares) will not (i) result in a violation of the Certificate of Incorporation (as defined below) (including, without
limitation, any certificate of designation contained therein), Bylaws (as defined below), certificate of formation, memorandum of association,
articles of association, bylaws or other organizational documents of the Company or any of its Subsidiaries, or any capital stock or other
securities of the Company or any of its Subsidiaries, (ii) conflict with, or constitute a default (or an event which with notice or lapse
of time or both would become a default) in any respect under, or give to others any rights of termination, amendment, acceleration or
cancellation of, any agreement, indenture or instrument to which the Company or any of its Subsidiaries is a party, or (iii) result in
a violation of any law, rule, regulation, order, judgment or decree (including, without limitation, foreign, federal and state securities
laws and regulations and the rules and regulations of the Nasdaq Capital Market (the <B>&ldquo;Principal Market</B>&rdquo;) and including
all applicable foreign, federal and state laws, rules and regulations) applicable to the Company or any of its Subsidiaries or by which
any property or asset of the Company or any of its Subsidiaries is bound or affected.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(e)</TD><TD STYLE="text-align: justify"><U>Consents</U>. Neither the Company nor any Subsidiary is required to obtain any consent from, authorization
or order of, or make any filing or registration with (other than the filing with the SEC of one or more Registration Statements in accordance
with the requirements of the Registration Rights Agreement, a Form D with the SEC and any other filings as may be required by any state
securities agencies), any Governmental Entity (as defined below) or any regulatory or self-regulatory agency or any other Person in order
for it to execute, deliver or perform any of its respective obligations under or contemplated by the Transaction Documents, in each case,
in accordance with the terms hereof or thereof. All consents, authorizations, orders, filings and registrations which the Company or any
Subsidiary is required to obtain pursuant to the preceding sentence have been or will be obtained or effected on or prior to the Closing
Date, and neither the Company nor any of its Subsidiaries are aware of any facts or circumstances which might prevent the Company or any
of its Subsidiaries from obtaining or effecting any of the registration, application or filings contemplated by the Transaction Documents.
The Company is not in violation of the requirements of the Principal Market and has no knowledge of any facts or circumstances which could
reasonably lead to delisting or suspension of the Common Stock in the foreseeable future. &ldquo;<B>Governmental Entity</B>&rdquo; means
any nation, state, county, city, town, village, district, or other political jurisdiction of any nature, federal, state, local, municipal,
foreign, or other government, governmental or quasi-governmental authority of any nature (including any governmental agency, branch, department,
official, or entity and any court or other tribunal), multi-national organization or body; or body exercising, or entitled to exercise,
any administrative, executive, judicial, legislative, police, regulatory, or taxing authority or power of any nature or instrumentality
of any of the foregoing, including any entity or enterprise owned or controlled by a government or a public international organization
or any of the foregoing.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(f)</TD><TD STYLE="text-align: justify"><U>Acknowledgment Regarding Buyer&rsquo;s Purchase of Securities</U>. The Company acknowledges and agrees
that the Buyer is acting solely in the capacity of an arm&rsquo;s length purchaser with respect to the Transaction Documents and the transactions
contemplated hereby and thereby and that no Buyer is (i) an officer or director of the Company or any of its Subsidiaries, (ii) an &ldquo;affiliate&rdquo;
(as defined in Rule 144) of the Company or any of its Subsidiaries or (iii) to its knowledge, a &ldquo;beneficial owner&rdquo; of more
than 10% of the shares of Common Stock (as defined for purposes of Rule 13d-3 of the Securities Exchange Act of 1934, as amended (the
&ldquo;<B>1934 Act</B>&rdquo;)). The Company further acknowledges that no Buyer is acting as a financial advisor or fiduciary of the Company
or any of its Subsidiaries (or in any similar capacity) with respect to the Transaction Documents and the transactions contemplated hereby
and thereby, and any advice given by a Buyer or any of its representatives or agents in connection with the Transaction Documents and
the transactions contemplated hereby and thereby is merely incidental to the Buyer&rsquo;s purchase of the Securities. The Company further
represents to the Buyer that the Company&rsquo;s and each Subsidiary&rsquo;s decision to enter into the Transaction Documents to which
it is a party has been based solely on the independent evaluation by the Company, each Subsidiary and their respective representatives.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(g)</TD><TD STYLE="text-align: justify"><U>No General Solicitation; Placement Agent&rsquo;s Fees</U>. Neither the Company, nor any of its Subsidiaries
or affiliates, nor any Person acting on its or their behalf, has engaged in any form of general solicitation or general advertising (within
the meaning of Regulation D) in connection with the offer or sale of the Securities. The Company shall be responsible for the payment
of any placement agent&rsquo;s fees, financial advisory fees, or brokers&rsquo; commissions (other than for Persons engaged by the Buyer(s)
or its investment advisor) relating to or arising out of the transactions contemplated hereby as disclosed in <U>Schedule 3(g)</U>. The
Company shall pay, and hold the Buyer harmless against, any liability, loss or expense (including, without limitation, attorney&rsquo;s
fees and out-of-pocket expenses) arising in connection with any such claim. Neither the Company nor any of its Subsidiaries has engaged
any placement agent or other agent in connection with the offer or sale of the Securities.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(h)</TD><TD STYLE="text-align: justify"><U>No Integrated Offering</U>. None of the Company, its Subsidiaries or any of their affiliates, nor any
Person acting on their behalf has, directly or indirectly, made any offers or sales of any security or solicited any offers to buy any
security, under circumstances that would require registration of the issuance of any of the Securities under the 1933 Act, whether through
integration with prior offerings or otherwise, or cause this offering of the Securities to require approval of stockholders of the Company
for purposes of the 1933 Act or under any applicable stockholder approval provisions, including, without limitation, under the rules and
regulations of any exchange or automated quotation system on which any of the securities of the Company are listed or designated for quotation.
None of the Company, its Subsidiaries, their affiliates nor any Person acting on their behalf will take any action or steps that would
require registration of the issuance of any of the Securities under the 1933 Act or cause the offering of any of the Securities to be
integrated with other offerings of securities of the Company.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(i)</TD><TD STYLE="text-align: justify"><U>Dilutive Effect</U>. The Company understands and acknowledges that the number of Conversion Shares
and Warrant Shares will increase in certain circumstances. The Company further acknowledges that its obligation to issue the Conversion
Shares pursuant to the terms of the Preferred Shares in accordance with this Agreement and the Certificate of Designations and the Warrant
Shares upon exercise of the Warrants in accordance with this Agreement and the Warrants is, in each case, absolute and unconditional regardless
of the dilutive effect that such issuance may have on the ownership interests of other stockholders of the Company.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(j)</TD><TD STYLE="text-align: justify"><U>Application of Takeover Protections; Rights Agreement</U>. The Company and its board of directors have
taken all necessary action, if any, in order to render inapplicable any control share acquisition, interested stockholder, business combination,
poison pill (including, without limitation, any distribution under a rights agreement), stockholder rights plan or other similar anti-takeover
provision under the Certificate of Incorporation, Bylaws or other organizational documents or the laws of the jurisdiction of its incorporation
or otherwise which is or could become applicable to the Buyer as a result of the transactions contemplated by this Agreement, including,
without limitation, the Company&rsquo;s issuance of the Securities and the Buyer&rsquo;s ownership of the Securities. The Company and
its board of directors have taken all necessary action, if any, in order to render inapplicable any stockholder rights plan or similar
arrangement relating to accumulations of beneficial ownership of shares of Common Stock or a change in control of the Company or any of
its Subsidiaries.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(k)</TD><TD STYLE="text-align: justify"><U>SEC Documents; Financial Statements</U>. Except as disclosed in <U>Schedule 3(k)</U>, during the two
(2) years prior to the Execution Date, the Company has filed all reports, schedules, forms, proxy statements, statements and other documents
required to be filed by it with the SEC pursuant to the reporting requirements of the 1934 Act (all of the foregoing filed prior to the
Execution Date and all exhibits and appendices included therein and financial statements, notes and schedules thereto and documents incorporated
by reference therein being hereinafter referred to as the &ldquo;<B>SEC Documents</B>&rdquo;). The Company has delivered or has made available
to the Buyers or their respective representatives true, correct and complete copies of each of the SEC Documents not available on the
EDGAR system. As of their respective dates, the SEC Documents complied in all material respects with the requirements of the 1934 Act
and the rules and regulations of the SEC promulgated thereunder applicable to the SEC Documents, and none of the SEC Documents, at the
time they were filed with the SEC, contained any untrue statement of a material fact or omitted to state a material fact required to be
stated therein or necessary in order to make the statements therein, in the light of the circumstances under which they were made, not
misleading. As of their respective dates, the financial statements of the Company included in the SEC Documents complied in all material
respects with applicable accounting requirements and the published rules and regulations of the SEC with respect thereto as in effect
as of the time of filing. Such financial statements have been prepared in accordance with generally accepted accounting principles (&ldquo;<B>GAAP</B>&rdquo;),
consistently applied, during the periods involved (except (i) as may be otherwise indicated in such financial statements or the notes
thereto, or (ii) in the case of unaudited interim statements, to the extent they may exclude footnotes or may be condensed or summary
statements) and fairly present in all material respects the financial position of the Company as of the dates thereof and the results
of its operations and cash flows for the periods then ended (subject, in the case of unaudited statements, to normal year-end audit adjustments
which will not be material, either individually or in the aggregate). The reserves, if any, established by the Company or the lack of
reserves, if applicable, are reasonable based upon facts and circumstances known by the Company on the Execution Date and there are no
loss contingencies that are required to be accrued by the Statement of Financial Accounting Standard No. 5 of the Financial Accounting
Standards Board which are not provided for by the Company in its financial statements or otherwise. No other information provided by or
on behalf of the Company to any of the Buyers which is not included in the SEC Documents (including, without limitation, information referred
to in Section&nbsp;2(e) of this Agreement or in the disclosure schedules to this Agreement) contains any untrue statement of a material
fact or omits to state any material fact necessary in order to make the statements therein not misleading, in the light of the circumstance
under which they are or were made. The Company is not currently contemplating to amend or restate any of the financial statements (including,
without limitation, any notes or any letter of the independent accountants of the Company with respect thereto) included in the SEC Documents
(the &ldquo;<B>Financial Statements</B>&rdquo;), nor is the Company currently aware of facts or circumstances which would require the
Company to amend or restate any of the Financial Statements, in each case, in order for any of the Financials Statements to be in compliance
with GAAP and the rules and regulations of the SEC. The Company has not been informed by its independent accountants that they recommend
that the Company amend or restate any of the Financial Statements or that there is any need for the Company to amend or restate any of
the Financial Statements.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(l)</TD><TD STYLE="text-align: justify"><U>Absence of Certain Changes</U>. Except as set forth in the SEC Documents, since the date of the Company&rsquo;s
most recent audited financial statements contained in a Form 10-K, there has been no material adverse change and no material adverse development
in the business, assets, liabilities, properties, operations (including results thereof), condition (financial or otherwise) or prospects
of the Company or any of its Subsidiaries. Since the date of the Company&rsquo;s most recent audited financial statements contained in
a Form 10-K, neither the Company nor any of its Subsidiaries has (i) declared or paid any dividends, (ii) sold any assets, individually
or in the aggregate, outside of the ordinary course of business or (iii) made any capital expenditures, individually or in the aggregate,
outside of the ordinary course of business. Neither the Company nor any of its Subsidiaries has taken any steps to seek protection pursuant
to any law or statute relating to bankruptcy, insolvency, reorganization, receivership, liquidation or winding up, nor does the Company
or any Subsidiary have any knowledge or reason to believe that any of their respective creditors intend to initiate involuntary bankruptcy
proceedings or any actual knowledge of any fact which would reasonably lead a creditor to do so.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(m)</TD><TD STYLE="text-align: justify"><U>No Undisclosed Events, Liabilities, Developments or Circumstances</U>. Except as set forth in the SEC
Documents, no event, liability, development or circumstance has occurred or exists, or is reasonably expected to exist or occur with respect
to the Company, any of its Subsidiaries or any of their respective businesses, properties, liabilities, prospects, operations (including
results thereof) or condition (financial or otherwise), that (i) would be required to be disclosed by the Company under applicable securities
laws on a registration statement on Form S-1 filed with the SEC relating to an issuance and sale by the Company of its Common Stock and
which has not been publicly announced, (ii) could have a material adverse effect on the Buyer&rsquo;s investment hereunder or (iii) could
have a Material Adverse Effect.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(n)</TD><TD STYLE="text-align: justify"><U>Conduct of Business; Regulatory Permits</U>. Neither the Company nor any of its Subsidiaries is in
violation of any term of or in default under its Certificate of Incorporation, any certificate of designation, preferences or rights of
any other outstanding series of preferred stock of the Company or any of its Subsidiaries or Bylaws or their organizational charter, certificate
of formation, memorandum of association, articles of association, Certificate of Incorporation or certificate of incorporation or bylaws,
respectively. Neither the Company nor any of its Subsidiaries is in violation of any judgment, decree or order or any statute, ordinance,
rule or regulation applicable to the Company or any of its Subsidiaries, and neither the Company nor any of its Subsidiaries will conduct
its business in violation of any of the foregoing, except in all cases for possible violations which could not, individually or in the
aggregate, have a Material Adverse Effect. Without limiting the generality of the foregoing, the Company is not in violation of any of
the rules, regulations or requirements of the Principal Market and has no knowledge of any facts or circumstances that could reasonably
lead to delisting or suspension of the Common Stock by the Principal Market in the foreseeable future. Except as set forth in the SEC
Documents, during the two years prior to the Execution Date, (i) the Common Stock has been listed or designated for quotation on the Principal
Market, (ii) trading in the Common Stock has not been suspended by the SEC or the Principal Market and (iii) the Company has received
no communication, written or oral, from the SEC or the Principal Market regarding the suspension or delisting of the Common Stock from
the Principal Market. The Company and each of its Subsidiaries possess all certificates, authorizations and permits issued by the appropriate
regulatory authorities necessary to conduct their respective businesses, except where the failure to possess such certificates, authorizations
or permits would not have, individually or in the aggregate, a Material Adverse Effect, and neither the Company nor any such Subsidiary
has received any notice of proceedings relating to the revocation or modification of any such certificate, authorization or permit. There
is no agreement, commitment, judgment, injunction, order or decree binding upon the Company or any of its Subsidiaries or to which the
Company or any of its Subsidiaries is a party which has or would reasonably be expected to have the effect of prohibiting or materially
impairing any business practice of the Company or any of its Subsidiaries, any acquisition of property by the Company or any of its Subsidiaries
or the conduct of business by the Company or any of its Subsidiaries as currently conducted other than such effects, individually or in
the aggregate, which have not had and would not reasonably be expected to have a Material Adverse Effect on the Company or any of its
Subsidiaries.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(o)</TD><TD STYLE="text-align: justify"><U>Foreign Corrupt Practices</U>. Neither the Company, the Company&rsquo;s subsidiary or any director,
officer, agent, employee, nor any other person acting for or on behalf of the foregoing (individually and collectively, a &ldquo;<B>Company
Affiliate</B>&rdquo;) have violated the U.S. Foreign Corrupt Practices Act (the &ldquo;<B>FCPA</B>&rdquo;) or any other applicable anti-bribery
or anti-corruption laws, nor has any Company Affiliate offered, paid, promised to pay, or authorized the payment of any money, or offered,
given, promised to give, or authorized the giving of anything of value, to any officer, employee or any other person acting in an official
capacity for any Governmental Entity to any political party or official thereof or to any candidate for political office (individually
and collectively, a &ldquo;<B>Government Official</B>&rdquo;) or to any person under circumstances where such Company Affiliate knew or
was aware of a high probability that all or a portion of such money or thing of value would be offered, given or promised, directly or
indirectly, to any Government Official, for the purpose of:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(A)
influencing any act or decision of such Government Official in his/her official capacity, (B) inducing such Government Official to do
or omit to do any act in violation of his/her lawful duty, (C) securing any improper advantage, or (D) inducing such Government Official
to influence or affect any act or decision of any Governmental Entity, or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;assisting
the Company or its Subsidiaries in obtaining or retaining business for or with, or directing business to, the Company or its Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(p)</TD><TD STYLE="text-align: justify"><U>Sarbanes-Oxley Act</U>. The Company and each Subsidiary is in compliance with any and all applicable
requirements of the Sarbanes-Oxley Act of 2002, as amended, and any and all applicable rules and regulations promulgated by the SEC thereunder.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(q)</TD><TD STYLE="text-align: justify"><U>Transactions With Affiliates</U>. Except as set forth in the SEC Documents, no current employee, partner,
director, officer or stockholder (direct or indirect) of the Company or its Subsidiaries, or any associate, or, to the knowledge of the
Company, any former employee, partner, director, officer, stockholder or affiliate of any thereof, or any relative with a relationship
no more remote than first cousin of any of the foregoing, is presently, or has ever been, (i) a party to any transaction with the Company
or its Subsidiaries (including any contract, agreement or other arrangement providing for the furnishing of services by, or rental of
real or personal property from, or otherwise requiring payments to, any such director, officer or stockholder or such associate or affiliate
or relative Subsidiaries (other than for ordinary course services as employees, officers or directors of the Company or any of its Subsidiaries))
or (ii) the direct or indirect owner of an interest in any corporation, firm, association or business organization which is a competitor,
supplier or customer of the Company or its Subsidiaries (except for a passive investment (direct or indirect) in less than 5% of the common
stock of a company whose securities are traded on or quoted through an Eligible Market (as defined in the Certificate of Designations)),
nor does any such Person receive income from any source other than the Company or its Subsidiaries which relates to the business of the
Company or its Subsidiaries or should properly accrue to the Company or its Subsidiaries. No employee, officer, stockholder or director
of the Company or any of its Subsidiaries or member of his or her immediate family is indebted to the Company or its Subsidiaries, as
the case may be, nor, except as disclosed in the SEC Documents, is the Company or any of its Subsidiaries indebted (or committed to make
loans or extend or guarantee credit) to any of them, other than (i) for payment of salary for services rendered, (ii) reimbursement for
reasonable expenses incurred on behalf of the Company, and (iii) for other standard employee benefits made generally available to all
employees or executives (including stock option agreements outstanding under any stock option plan approved by the Board of Directors
of the Company).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(r)</TD><TD STYLE="text-align: justify"><U>Equity Capitalization.</U></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Definitions</U>:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.25in">(A)</TD><TD STYLE="text-align: justify">&ldquo;<B>Common Stock</B>&rdquo; means (x) the Company&rsquo;s shares of common stock, $0.01 par value
per share, and (y) any capital stock into which such common stock shall have been changed or any share capital resulting from a reclassification
of such common stock.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.25in">(B)</TD><TD STYLE="text-align: justify">&ldquo;<B>Preferred Stock</B>&rdquo; means (x) the Company&rsquo;s blank check preferred stock, $0.01
par value per share, the terms of which may be designated by the board of directors of the Company in a certificate of designations and
(y) any capital stock into which such preferred stock shall have been changed or any share capital resulting from a reclassification of
such preferred stock (other than a conversion of such preferred stock into Common Stock in accordance with the terms of such certificate
of designations).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Authorized
and Outstanding Capital Stock</U>. <U>Schedule 3(r)(ii)</U> sets forth as of the Execution Date, the authorized, issued and outstanding
capital stock of the Company as well as all outstanding equity linked securities, including all options, warrants, restricted stock units,
Convertible Securities. No shares of Common Stock are held in the treasury of the Company. &ldquo;<B>Convertible Securities</B>&rdquo;
means any capital stock or other security of the Company or any of its Subsidiaries that is at any time and under any circumstances directly
or indirectly convertible into, exercisable or exchangeable for, or which otherwise entitles the holder thereof to acquire, any capital
stock or other security of the Company (including, without limitation, Common Stock) or any of its Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Valid
Issuance; Available Shares; Affiliates</U>. All of such outstanding shares are duly authorized and have been, or upon issuance will be,
validly issued and are fully paid and nonassessable. The SEC Documents disclose all securities that are , as of the Execution Date, owned
by Persons who are &ldquo;affiliates&rdquo; (as defined in Rule 405 of the 1933 Act and calculated based on the assumption that only officers,
directors and holders of at least 10% of the Company&rsquo;s issued and outstanding Common Stock are &ldquo;affiliates&rdquo; without
conceding that any such Persons are &ldquo;affiliates&rdquo; for purposes of federal securities laws) of the Company or any of its Subsidiaries.
To the Company&rsquo;s knowledge, except as set forth in the SEC Documents, no Person owns 10% or more of the Company&rsquo;s issued and
outstanding shares of Common Stock (calculated based on the assumption that all Convertible Securities (as defined below), whether or
not presently exercisable or convertible, have been fully exercised&nbsp;or converted&nbsp;(as the case may be) taking account of any
limitations on exercise or conversion (including &ldquo;blockers&rdquo;) contained therein without conceding that such identified Person
is a 10% stockholder for purposes of federal securities laws).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">(iv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Existing
Securities; Obligations</U>. Except as disclosed in the SEC Documents: (A) none of the Company&rsquo;s or any Subsidiary&rsquo;s shares,
interests or capital stock is subject to preemptive rights or any other similar rights or Liens suffered or permitted by the Company or
any Subsidiary; (B) there are no outstanding options, warrants, scrip, rights to subscribe to, calls or commitments of any character whatsoever
relating to, or securities or rights convertible into, or exercisable or exchangeable for, any shares, interests or capital stock of the
Company or any of its Subsidiaries, or contracts, commitments, understandings or arrangements by which the Company or any of its Subsidiaries
is or may become bound to issue additional shares, interests or capital stock of the Company or any of its Subsidiaries or options, warrants,
scrip, rights to subscribe to, calls or commitments of any character whatsoever relating to, or securities or rights convertible into,
or exercisable or exchangeable for, any shares, interests or capital stock of the Company or any of its Subsidiaries; (C) other than registration
rights under the Permitted Equity Line (as defined in the Certificate of Designations), there are no agreements or arrangements under
which the Company or any of its Subsidiaries is obligated to register the sale of any of their securities under the 1933 Act (except pursuant
to the Registration Rights Agreement); (D) there are no outstanding securities or instruments of the Company or any of its Subsidiaries
which contain any redemption or similar provisions, and there are no contracts, commitments, understandings or arrangements by which the
Company or any of its Subsidiaries is or may become bound to redeem a security of the Company or any of its Subsidiaries; (E) there are
no securities or instruments containing anti-dilution or similar provisions that will be triggered by the issuance of the Securities;
and (F) neither the Company nor any Subsidiary has any stock appreciation rights or &ldquo;phantom stock&rdquo; plans or agreements or
any similar plan or agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">(v)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Organizational
Documents</U>. The SEC Documents disclose true, correct and complete copies of the Company&rsquo;s Certificate of Incorporation, as amended
and as in effect on the Execution Date (the &ldquo;<B>Certificate of Incorporation</B>&rdquo;), and the Company&rsquo;s bylaws, as amended
and as in effect on the Execution Date (the &ldquo;<B>Bylaws</B>&rdquo;), and the terms of all Convertible Securities and the material
rights of the holders thereof in respect thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(s)</TD><TD STYLE="text-align: justify"><U>Indebtedness and Other Contracts</U>. Neither the Company nor any of its Subsidiaries, (i) except as
disclosed in the SEC Documents, has any outstanding debt securities, notes, credit agreements, credit facilities or other agreements,
documents or instruments evidencing Indebtedness of the Company or any of its Subsidiaries or by which the Company or any of its Subsidiaries
is or may become bound, (ii) is a party to any contract, agreement or instrument, the violation of which, or default under which, by the
other party(ies) to such contract, agreement or instrument could reasonably be expected to result in a Material Adverse Effect, (iii)
to its knowledge has any financing statements securing obligations in any amounts filed in connection with the Company or any of its Subsidiaries;
(iv) is in violation of any term of, or in default under, any contract, agreement or instrument relating to any Indebtedness, except where
such violations and defaults would not result, individually or in the aggregate, in a Material Adverse Effect, or (v) is a party to any
contract, agreement or instrument relating to any Indebtedness, the performance of which, in the judgment of the Company&rsquo;s officers,
has or is expected to have a Material Adverse Effect. Neither the Company nor any of its Subsidiaries have any liabilities or obligations
required to be disclosed in the SEC Documents which are not so disclosed in the SEC Documents, other than those incurred in the ordinary
course of the Company&rsquo;s or its Subsidiaries&rsquo; respective businesses and which, individually or in the aggregate, do not or
could not have a Material Adverse Effect. For purposes of this Agreement: (x) &ldquo;<B>Indebtedness</B>&rdquo; of any Person means, without
duplication (A) all indebtedness for borrowed money, (B) all obligations issued, undertaken or assumed as the deferred purchase price
of property or services (including, without limitation, &ldquo;capital leases&rdquo; in accordance with GAAP) (other than trade payables
entered into in the ordinary course of business consistent with past practice), (C) all reimbursement or payment obligations with respect
to letters of credit, surety bonds and other similar instruments, (D) all obligations evidenced by notes, bonds, debentures or similar
instruments, including obligations so evidenced incurred in connection with the acquisition of property, assets or businesses, (E) all
indebtedness created or arising under any conditional sale or other title retention agreement, or incurred as financing, in either case
with respect to any property or assets acquired with the proceeds of such indebtedness (even though the rights and remedies of the seller
or bank under such agreement in the event of default are limited to repossession or sale of such property), (F) all monetary obligations
under any leasing or similar arrangement which, in connection with GAAP, consistently applied for the periods covered thereby, is classified
as a capital lease, (G) all indebtedness referred to in clauses (A) through (F) above secured by (or for which the holder of such Indebtedness
has an existing right, contingent or otherwise, to be secured by) any Lien upon or in any property or assets (including accounts and contract
rights) owned by any Person, even though the Person which owns such assets or property has not assumed or become liable for the payment
of such indebtedness, and (H) all Contingent Obligations in respect of indebtedness or obligations of others of the kinds referred to
in clauses (A) through (G) above; and (y) &ldquo;<B>Contingent Obligation</B>&rdquo; means, as to any Person, any direct or indirect liability,
contingent or otherwise, of that Person with respect to any Indebtedness, lease, dividend or other obligation of another Person if the
primary purpose or intent of the Person incurring such liability, or the primary effect thereof, is to provide assurance to the obligee
of such liability that such liability will be paid or discharged, or that any agreements relating thereto will be complied with, or that
the holders of such liability will be protected (in whole or in part) against loss with respect thereto. &ldquo;Forward China&rdquo; means
Forward Industries (Asia-Pacific) Corporation, a corporation owned by the Company&rsquo;s former Chief Executive Officer and Chairman
of the Board.&nbsp;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(t)</TD><TD STYLE="text-align: justify"><U>Litigation</U>. Except as set forth in the SEC Documents, there is no action, suit, arbitration, proceeding,
inquiry or investigation before or by the Principal Market, any court, public board, other Governmental Entity, self-regulatory organization
or body pending or, to the knowledge of the Company, threatened against or affecting the Company or any of its Subsidiaries, the Common
Stock or any of the Company&rsquo;s or its Subsidiaries&rsquo; officers or directors, whether of a civil or criminal nature or otherwise,
in their capacities as such. To the Company&rsquo;s knowledge, no director, officer or employee of the Company or any of its subsidiaries
has willfully violated 18 U.S.C. &sect;1519 or engaged in spoliation in reasonable anticipation of litigation. Without limitation of the
foregoing, there has not been, and to the knowledge of the Company, there is not pending or contemplated, any investigation by the SEC
involving the Company, any of its Subsidiaries or any current or former director or officer of the Company or any of its Subsidiaries.
The SEC has not issued any stop order or other order suspending the effectiveness of any registration statement filed by the Company under
the 1933 Act or the 1934 Act. After reasonable inquiry of its employees, the Company is not aware of any fact which might result in or
form the basis for any such action, suit, arbitration, investigation, inquiry or other proceeding. Neither the Company nor any of its
Subsidiaries is subject to any order, writ, judgment, injunction, decree, determination or award of any Governmental Entity.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(u)</TD><TD STYLE="text-align: justify"><U>Insurance</U>. The Company and each of its Subsidiaries are insured by insurers of recognized financial
responsibility against such losses and risks and in such amounts as management of the Company believes to be prudent and customary in
the businesses in which the Company and its Subsidiaries are engaged. In the past three years, neither the Company nor any such Subsidiary
has been refused any material insurance coverage sought or applied for, and neither the Company nor any such Subsidiary has any reason
to believe that it will be unable to renew its existing insurance coverage as and when such coverage expires or to obtain similar coverage
from similar insurers as may be necessary to continue its business at a cost that would not have a Material Adverse Effect.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(v)</TD><TD STYLE="text-align: justify"><U>Employee Relations</U>. Neither the Company nor any of its Subsidiaries is a party to any collective
bargaining agreement or employs any member of a union. No executive officer (as defined in Rule 501(f) promulgated under the 1933 Act)
or other key employee of the Company or any of its Subsidiaries has notified the Company or any such Subsidiary that such officer intends
to leave the Company or any such Subsidiary or otherwise terminate such officer&rsquo;s employment with the Company or any such Subsidiary.
No current (or former) executive officer or other key employee of the Company or any of its Subsidiaries is, or is now expected to be,
in violation of any material term of any employment contract, confidentiality, disclosure or proprietary information agreement, non-competition
agreement, or any other contract or agreement or any restrictive covenant, and the continued employment of each such executive officer
or other key employee (as the case may be) does not subject the Company or any of its Subsidiaries to any liability with respect to any
of the foregoing matters. The Company and its Subsidiaries are in compliance with all federal, state, local and foreign laws and regulations
respecting labor, employment and employment practices and benefits, terms and conditions of employment and wages and hours, except where
failure to be in compliance would not, either individually or in the aggregate, reasonably be expected to result in a Material Adverse
Effect.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(w)</TD><TD STYLE="text-align: justify"><U>Title</U>.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Real
Property</U>. Each of the Company and its Subsidiaries holds good title to all real property, leases in real property, facilities or other
interests in real property owned or held by the Company or any of its Subsidiaries (the &ldquo;<B>Real Property</B>&rdquo;) owned by the
Company or any of its Subsidiaries (as applicable). The Real Property is free and clear of all Liens and is not subject to any rights
of way, building use restrictions, exceptions, variances, reservations, or limitations of any nature except for (a) Liens for current
taxes not yet due and (b) zoning laws and other land use restrictions that do not impair the present or anticipated use of the property
subject thereto. Any Real Property held under lease by the Company or any of its Subsidiaries are held by them under valid, subsisting
and enforceable leases with such exceptions as are not material and do not interfere with the use made and proposed to be made of such
property and buildings by the Company or any of its Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Fixtures
and Equipment</U>. Each of the Company and its Subsidiaries (as applicable) has good title to, or a valid leasehold interest in, the tangible
personal property, equipment, improvements, fixtures, and other personal property and appurtenances that are used by the Company or its
Subsidiary in connection with the conduct of its business (the &ldquo;<B>Fixtures and Equipment</B>&rdquo;). The Fixtures and Equipment
are structurally sound, are in good operating condition and repair, are adequate for the uses to which they are being put, are not in
need of maintenance or repairs except for ordinary, routine maintenance and repairs and are sufficient for the conduct of the Company&rsquo;s
and/or its Subsidiaries&rsquo; businesses (as applicable) in the manner as conducted prior to the Closing. Each of the Company and its
Subsidiaries owns all of its Fixtures and Equipment free and clear of all Liens except for (a) liens for current taxes not yet due and
(b) zoning laws and other land use restrictions that do not impair the present or anticipated use of the property subject thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(x)</TD><TD STYLE="text-align: justify"><U>Intellectual Property Rights</U>. The Company and its Subsidiaries own or possess adequate rights or
licenses to use all trademarks, trade names, service marks, service mark registrations, service names, original works of authorship, patents,
patent rights, copyrights, inventions, licenses, approvals, governmental authorizations, trade secrets and other intellectual property
rights and all applications and registrations therefor (&ldquo;<B>Intellectual Property Rights</B>&rdquo;) necessary to conduct their
respective businesses as now conducted and presently proposed to be conducted. None of the Company&rsquo;s Intellectual Property Rights
have expired or terminated or have been abandoned or are expected to expire or terminate or are expected to be abandoned, within three
years from the date of this Agreement. To the actual knowledge of the Company&rsquo;s executive officers, upon commercially reasonable
investigation, the Company and its Subsidiaries do not infringe any Intellectual Property Rights of others. There is no claim, action
or proceeding being made or brought, or to the knowledge of the Company or any of its Subsidiaries, being threatened, against the Company
or any of its Subsidiaries regarding its Intellectual Property Rights. Neither the Company nor any of its Subsidiaries is aware of any
facts or circumstances which might give rise to any of the foregoing infringements or claims, actions or proceedings. The Company and
its Subsidiaries have taken reasonable security measures to protect the secrecy, confidentiality and value of all of their Intellectual
Property Rights.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(y)</TD><TD STYLE="text-align: justify"><U>Environmental Laws</U>. (i) The Company and its Subsidiaries (A) are in material compliance with any
and all Environmental Laws (as defined below), (B) have received all material permits, licenses or other approvals required of them under
applicable Environmental Laws to conduct their respective businesses and (C) are in material compliance with all terms and conditions
of any such permit, license or approval where, in each of the foregoing clauses (A), (B) and (C), the failure to so comply could be reasonably
expected to have, individually or in the aggregate, a Material Adverse Effect. The term &ldquo;<B>Environmental Laws</B>&rdquo; means
all federal, state, local or foreign laws relating to pollution or protection of human health or the environment (including, without limitation,
ambient air, surface water, groundwater, land surface or subsurface strata), including, without limitation, laws relating to emissions,
discharges, releases or threatened releases of chemicals, pollutants, contaminants, or toxic or hazardous substances or wastes (collectively,
&ldquo;<B>Hazardous Materials</B>&rdquo;) into the environment, or otherwise relating to the manufacture, processing, distribution, use,
treatment, storage, disposal, transport or handling of Hazardous Materials, as well as all authorizations, codes, decrees, demands or
demand letters, injunctions, judgments, licenses, notices or notice letters, orders, permits, plans or regulations issued, entered, promulgated
or approved thereunder.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>No
Hazardous Materials</U>:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 2in"></TD><TD STYLE="width: 0.25in">(A)</TD><TD STYLE="text-align: justify">have been disposed of or otherwise released from any Real Property of the Company or any of its Subsidiaries
in violation of any Environmental Laws; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 72.8pt; text-align: justify; text-indent: 71.2pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 2in"></TD><TD STYLE="width: 0.25in">(B)</TD><TD STYLE="text-align: justify">are present on, over, beneath, in or upon any Real Property or any portion thereof in quantities that
would constitute a violation of any Environmental Laws. No prior use by the Company or any of its Subsidiaries of any Real Property has
occurred that violates any Environmental Laws, which violation would have a material adverse effect on the business of the Company or
any of its Subsidiaries.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 72.8pt; text-align: justify; text-indent: 71.2pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Neither
the Company nor any of its Subsidiaries knows of any other person who or entity which has stored, treated, recycled, disposed of or otherwise
located on any Real Property any Hazardous Materials, including, without limitation, such substances as asbestos and polychlorinated biphenyls.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">(iv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;None
of the Real Properties are on any federal or state &ldquo;Superfund&rdquo; list or Liability Information System (&ldquo;<B>CERCLIS</B>&rdquo;)
list or any state environmental agency list of sites under consideration for CERCLIS, nor subject to any environmental related Liens.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(z)</TD><TD STYLE="text-align: justify"><U>Subsidiary Rights</U>. The Company or one of its Subsidiaries has the unrestricted right to vote, and
(subject to limitations imposed by applicable law) to receive dividends and distributions on, all capital securities of its Subsidiaries
as owned by the Company or such Subsidiary. As of the Execution Date the Company has no Subsidiaries.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(aa)</TD><TD STYLE="text-align: justify"><U>Tax Status</U>. The Company and each of its Subsidiaries (i) has timely made or filed all foreign,
federal and state income and all other tax returns, reports and declarations required by any jurisdiction to which it is subject, (ii)
has timely paid all taxes and other governmental assessments and charges that are material in amount, shown or determined to be due on
such returns, reports and declarations, except those being contested in good faith and (iii) has set aside on its books provision reasonably
adequate for the payment of all taxes for periods subsequent to the periods to which such returns, reports or declarations apply. There
are no unpaid taxes in any material amount claimed to be due by the taxing authority of any jurisdiction, and the officers of the Company
and its Subsidiaries know of no basis for any such claim. The Company is not operated in such a manner as to qualify as a passive foreign
investment company, as defined in Section 1297 of the Internal Revenue Code of 1986, as amended (the &ldquo;<B>Code</B>&rdquo;).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(bb)</TD><TD STYLE="text-align: justify"><U>Internal Accounting and Disclosure Controls</U>. The Company and each of its Subsidiaries maintains
internal control over financial reporting (as such term is defined in Rule 13a-15(f) under the 1934 Act) that is effective to provide
reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes
in accordance with generally accepted accounting principles, including that (i) transactions are executed in accordance with management&rsquo;s
general or specific authorizations, (ii) transactions are recorded as necessary to permit preparation of financial statements in conformity
with GAAP and to maintain asset and liability accountability, (iii) access to assets or incurrence of liabilities is permitted only in
accordance with management&rsquo;s general or specific authorization and (iv) the recorded accountability for assets and liabilities is
compared with the existing assets and liabilities at reasonable intervals and appropriate action is taken with respect to any difference.
The Company maintains disclosure controls and procedures (as such term is defined in Rule 13a-15(e) under the 1934 Act) that are effective
in ensuring that information required to be disclosed by the Company in the reports that it files or submits under the 1934 Act is recorded,
processed, summarized and reported, within the time periods specified in the rules and forms of the SEC, including, without limitation,
controls and procedures designed to ensure that information required to be disclosed by the Company in the reports that it files or submits
under the 1934 Act is accumulated and communicated to the Company&rsquo;s management, including its principal executive officer or officers
and its principal financial officer or officers, as appropriate, to allow timely decisions regarding required disclosure. Neither the
Company nor any of its Subsidiaries has received any notice or correspondence from any accountant, Governmental Entity or other Person
relating to any potential material weakness or significant deficiency in any part of the internal controls over financial reporting of
the Company or any of its Subsidiaries.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(cc)</TD><TD STYLE="text-align: justify"><U>Off Balance Sheet Arrangements</U>. There is no transaction, arrangement, or other relationship between
the Company or any of its Subsidiaries and an unconsolidated or other off balance sheet entity that is required to be disclosed by the
Company in its 1934 Act filings and is not so disclosed or that otherwise could be reasonably likely to have a Material Adverse Effect.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(dd)</TD><TD STYLE="text-align: justify"><U>Investment Company Status</U>. The Company is not, and upon consummation of the sale of the Securities
will not be, an &ldquo;investment company,&rdquo; an affiliate of an &ldquo;investment company,&rdquo; a company controlled by an &ldquo;investment
company&rdquo; or an &ldquo;affiliated person&rdquo; of, or &ldquo;promoter&rdquo; or &ldquo;principal underwriter&rdquo; for, an &ldquo;investment
company&rdquo; as such terms are defined in the Investment Company Act of 1940, as amended.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(ee)</TD><TD STYLE="text-align: justify"><U>Acknowledgement Regarding Buyers&rsquo; Trading Activity</U>. It is understood and acknowledged by
the Company that (i) following the public disclosure of the transactions contemplated by the Transaction Documents, in accordance with
the terms thereof, none of the Buyers have been asked by the Company or any of its Subsidiaries to agree, nor has the Buyer agreed with
the Company or any of its Subsidiaries, to desist from effecting any transactions in or with respect to (including, without limitation,
purchasing or selling, long and/or short) any securities of the Company, or &ldquo;derivative&rdquo; securities based on securities issued
by the Company or to hold any of the Securities for any specified term; (ii) the Buyer, and counterparties in &ldquo;derivative&rdquo;
transactions to which any the Buyer is a party, directly or indirectly, presently may have a &ldquo;short&rdquo; position in the Common
Stock which was established prior to the Buyer&rsquo;s knowledge of the transactions contemplated by the Transaction Documents; and (iii)
the Buyer shall not be deemed to have any affiliation with or control over any arm&rsquo;s length counterparty in any &ldquo;derivative&rdquo;
transaction. The Company further understands and acknowledges that following the public disclosure of the transactions contemplated by
the Transaction Documents pursuant to the Press Release (as defined below) one or more Buyers may engage in hedging and/or trading activities
(including, without limitation, the location and/or reservation of borrowable shares of Common Stock) at various times during the period
that the Securities are outstanding, including, without limitation, during the periods that the value and/or number of the Warrant Shares
or Conversion Shares, as applicable, deliverable with respect to the Securities are being determined and such hedging and/or trading activities
(including, without limitation, the location and/or reservation of borrowable shares of Common Stock), if any, can reduce the value of
the existing stockholders&rsquo; equity interest in the Company both at and after the time the hedging and/or trading activities are being
conducted. The Company acknowledges that such aforementioned hedging and/or trading activities do not constitute a breach of this Agreement,
the Certificate of Designations, the Warrants or any other Transaction Document or any of the documents executed in connection herewith
or therewith.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(ff)</TD><TD STYLE="text-align: justify"><U>Manipulation of Price</U>. Neither the Company nor any of its Subsidiaries has, and, to the knowledge
of the Company, no Person acting on their behalf has, directly or indirectly, (i) taken any action designed to cause or to result in the
stabilization or manipulation of the price of any security of the Company or any of its Subsidiaries to facilitate the sale or resale
of any of the Securities, (ii) sold, bid for, purchased, or paid any compensation for soliciting purchases of, any of the Securities,
(iii) paid or agreed to pay to any Person any compensation for soliciting another to purchase any other securities of the Company or any
of its Subsidiaries or (iv) paid or agreed to pay any Person for research services with respect to any securities of the Company or any
of its Subsidiaries.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(gg)</TD><TD STYLE="text-align: justify"><U>U.S. Real Property Holding Corporation</U>. Neither the Company nor any of its Subsidiaries is, or
has ever been, and so long as any of the Securities are held by any of the Buyers, shall become, a U.S. real property holding corporation
within the meaning of Section&nbsp;897 of the Code, and the Company and each Subsidiary shall so certify upon the Buyer&rsquo;s request.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(hh)</TD><TD STYLE="text-align: justify"><U>Registration Eligibility</U>. The Company is eligible to register the Registrable Securities (defined
in the Registration Rights Agreement) for resale by the Buyer using Form S-1 promulgated under the 1933 Act.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(ii)</TD><TD STYLE="text-align: justify"><U>Transfer Taxes</U>. On the Closing Date, all stock transfer or other taxes (other than income or similar
taxes) which are required to be paid in connection with the issuance, sale and transfer of the Securities to be sold to the Buyer hereunder
will be, or will have been, fully paid or provided for by the Company, and all laws imposing such taxes will be or will have been complied
with.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(jj)</TD><TD STYLE="text-align: justify"><U>Bank Holding Company Act</U>. Neither the Company nor any of its Subsidiaries is subject to the Bank
Holding Company Act of 1956, as amended (the &ldquo;<B>BHCA</B>&rdquo;) and to regulation by the Board of Governors of the Federal Reserve
System (the &ldquo;<B>Federal Reserve</B>&rdquo;). Neither the Company nor any of its Subsidiaries or affiliates owns or controls, directly
or indirectly, five percent (5%) or more of the outstanding shares of any class of voting securities or twenty-five percent (25%) or more
of the total equity of a bank or any entity that is subject to the BHCA and to regulation by the Federal Reserve. Neither the Company
nor any of its Subsidiaries or affiliates exercises a controlling influence over the management or policies of a bank or any entity that
is subject to the BHCA and to regulation by the Federal Reserve.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(kk)</TD><TD STYLE="text-align: justify"><U>Shell Company Status</U>. The Company is not an issuer identified in Rule 144(i).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(ll)</TD><TD STYLE="text-align: justify"><U>Illegal or Unauthorized Payments; Political Contributions</U>. Neither the Company nor any of its Subsidiaries
nor, to the best of the Company&rsquo;s knowledge, any of the officers, directors, employees, agents or other representatives of the Company
or any of its Subsidiaries or any other business entity or enterprise with which the Company or any Subsidiary is or has been affiliated
or associated, has, directly or indirectly, made or authorized any payment, contribution or gift of money, property, or services, whether
or not in contravention of applicable law, (i) as a kickback or bribe to any Person or (ii) to any political organization, or the holder
of or any aspirant to any elective or appointive public office except for personal political contributions not involving the direct or
indirect use of funds of the Company or any of its Subsidiaries.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(mm)&#9;<U>Money Laundering</U>.
The Company and its Subsidiaries are in material compliance with, and have not previously materially violated, the USA Patriot Act of
2001 and all other applicable U.S. and non-U.S. anti-money laundering laws and regulations, including, without limitation, the laws, regulations
and Executive Orders and sanctions programs administered by the U.S. Office of Foreign Assets Control, including, but not limited, to
(i) Executive Order 13224 of September 23, 2001 entitled, &ldquo;Blocking Property and Prohibiting Transactions With Persons Who Commit,
Threaten to Commit, or Support Terrorism&rdquo; (66 Fed. Reg. 49079 (2001)); and (ii) any regulations contained in 31 CFR, Subtitle B,
Chapter V.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(nn)&#9;<U>Management</U>. During
the past five year period, no current or former officer or director or, to the knowledge of the Company, no current ten percent (10%)
or greater stockholder of the Company or any of its Subsidiaries has been the subject of:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;intentionally
omitted;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a
conviction in a criminal proceeding or a named subject of a pending criminal proceeding (excluding traffic violations that do not relate
to driving while intoxicated or driving under the influence);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;any
order, judgment or decree, not subsequently reversed, suspended or vacated, of any court of competent jurisdiction, permanently or temporarily
enjoining any such person from, or otherwise limiting, the following activities:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 2in"></TD><TD STYLE="width: 0.25in">(1)</TD><TD STYLE="text-align: justify">Acting as a futures commission merchant, introducing broker, commodity trading advisor, commodity pool
operator, floor broker, leverage transaction merchant, any other person regulated by the United States Commodity Futures Trading Commission
or an associated person of any of the foregoing, or as an investment adviser, underwriter, broker or dealer in securities, or as an affiliated
person, director or employee of any investment company, bank, savings and loan association or insurance company, or engaging in or continuing
any conduct or practice in connection with such activity;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 1in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 2in"></TD><TD STYLE="width: 0.25in">(2)</TD><TD STYLE="text-align: justify">Engaging in any particular type of business practice; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 1in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 2in"></TD><TD STYLE="width: 0.25in">(3)</TD><TD STYLE="text-align: justify">Engaging in any activity in connection with the purchase or sale of any security or commodity or in connection
with any violation of securities laws or commodities laws;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">(iv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;any
order, judgment or decree, not subsequently reversed, suspended or vacated, of any authority barring, suspending or otherwise limiting
for more than sixty (60) days the right of any such person to engage in any activity described in the preceding sub paragraph, or to be
associated with persons engaged in any such activity;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">(v)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a
finding by a court of competent jurisdiction in a civil action or by the SEC or other authority to have violated any securities law, regulation
or decree and the judgment in such civil action or finding by the SEC or any other authority has not been subsequently reversed, suspended
or vacated; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">(vi)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a
finding by a court of competent jurisdiction in a civil action or by the Commodity Futures Trading Commission to have violated any federal
commodities law, and the judgment in such civil action or finding has not been subsequently reversed, suspended or vacated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(oo)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Stock
Option Plans</U>. Each stock option granted by the Company was granted (i) in accordance with the terms of the applicable stock option
plan of the Company and (ii) with an exercise price at least equal to the fair market value of the Common Stock on the date such stock
option would be considered granted under GAAP and applicable law. No stock option granted under the Company&rsquo;s stock option plan
has been backdated. The Company has not knowingly granted, and there is no and has been no policy or practice of the Company to knowingly
grant, stock options prior to, or otherwise knowingly coordinate the grant of stock options with, the release or other public announcement
of material information regarding the Company or its Subsidiaries or their financial results or prospects.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(pp)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>No Disagreements with
Accountants and Lawyers</U>. There are no material disagreements of any kind presently existing between the Company and the accountants
and lawyers formerly or presently employed by the Company and the Company is current with respect to any fees owed to its accountants
and lawyers which could affect the Company&rsquo;s ability to perform any of its obligations under any of the Transaction Documents. In
addition, on or prior to the Execution Date, the Company had discussions with its accountants about its financial statements previously
filed with the SEC. Based on those discussions, the Company has no reason to believe that it will need to restate any such financial statements
or any part thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(qq)&#9;<U>No Disqualification
Events</U>. With respect to Securities to be offered and sold hereunder in reliance on Rule 506(b) under the 1933 Act (&ldquo;<B>Regulation
D Securities</B>&rdquo;), none of the Company, any of its predecessors, any affiliated issuer, any director, executive officer, other
officer of the Company participating in the offering contemplated hereby, any beneficial owner of 20% or more of the Company&rsquo;s outstanding
voting equity securities, calculated on the basis of voting power, nor any promoter (as that term is defined in Rule 405 under the 1933
Act) connected with the Company in any capacity at the time of sale (each, an &ldquo;<B>Issuer Covered Person</B>&rdquo; and, together,
&ldquo;<B>Issuer Covered Persons</B>&rdquo;) is subject to any of the &ldquo;Bad Actor&rdquo; disqualifications described in Rule 506(d)(1)(i)
to (viii) under the 1933 Act (a &ldquo;<B>Disqualification Event</B>&rdquo;), except for a Disqualification Event covered by Rule 506(d)(2)
or (d)(3). The Company has exercised reasonable care to determine whether any Issuer Covered Person is subject to a Disqualification Event.
The Company has complied, to the extent applicable, with its disclosure obligations under Rule 506(e), and has furnished to the Buyers
a copy of any disclosures provided thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(rr)&#9;<U>Other Covered Persons</U>.
The Company is not aware of any Person that has been or will be paid (directly or indirectly) remuneration for solicitation of Buyer or
potential purchasers in connection with the sale of any Regulation D Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(ss)&#9;<U>No Additional Agreements</U>.
The Company does not have any agreement or understanding with the Buyer with respect to the transactions contemplated by the Transaction
Documents other than as specified in the Transaction Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(tt)&#9;<U>Public Utility Holding
Act</U>. None of the Company nor any of its Subsidiaries is a &ldquo;holding company,&rdquo; or an &ldquo;affiliate&rdquo; of a &ldquo;holding
company,&rdquo; as such terms are defined in the Public Utility Holding Act of 2005.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(uu)&#9;<U>Federal Power Act</U>.
None of the Company nor any of its Subsidiaries is subject to regulation as a &ldquo;public utility&rdquo; under the Federal Power Act,
as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(vv)&#9;<U>Disclosure</U>. The
Company confirms that neither it nor any other Person acting on its behalf has provided any of the Buyers or their agents or counsel with
any information that constitutes or could reasonably be expected to constitute material, non-public information concerning the Company
or any of its Subsidiaries, other than the existence of the transactions contemplated by this Agreement and the other Transaction Documents.
The Company understands and confirms that the Buyer will rely on the foregoing representations in effecting transactions in securities
of the Company. All disclosure provided to the Buyers regarding the Company and its Subsidiaries, their businesses and the transactions
contemplated hereby, including the schedules to this Agreement, furnished by or on behalf of the Company or any of its Subsidiaries is
true and correct and does not contain any untrue statement of a material fact or omit to state any material fact necessary in order to
make the statements made therein, in the light of the circumstances under which they were made, not misleading. All of the written information
furnished after the Execution Date by or on behalf of the Company or any of its Subsidiaries to the Buyer pursuant to or in connection
with this Agreement and the other Transaction Documents, taken as a whole, will be true and correct in all material respects as of the
date on which such information is so provided and will not contain any untrue statement of a material fact or omit to state any material
fact necessary in order to make the statements made therein, in the light of the circumstances under which they were made, not misleading.
Each press release issued by the Company or any of its Subsidiaries during the twelve (12) months preceding the date of this Agreement
did not at the time of release contain any untrue statement of a material fact or omit to state a material fact required to be stated
therein or necessary in order to make the statements therein, in the light of the circumstances under which they are made, not misleading.
No event or circumstance has occurred or information exists with respect to the Company or any of its Subsidiaries or its or their business,
properties, liabilities, prospects, operations (including results thereof) or conditions (financial or otherwise), which, under applicable
law, rule or regulation, requires public disclosure at or before the Execution Date or announcement by the Company but which has not been
so publicly disclosed. The Company acknowledges and agrees that no Buyer makes or has made any representations or warranties with respect
to the transactions contemplated hereby other than those specifically set forth in Section&nbsp;2.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><B>4.</B></TD><TD STYLE="text-align: justify"><B>COVENANTS.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(a)</TD><TD STYLE="text-align: justify"><U>Efforts</U>. The Buyer shall use its commercially reasonable efforts to timely satisfy each of the
covenants hereunder and conditions to be satisfied by it as provided in Section 6 of this Agreement. The Company shall use its best efforts
to timely satisfy each of the covenants hereunder and conditions to be satisfied by it as provided in Section 7 of this Agreement.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(b)</TD><TD STYLE="text-align: justify"><U>Form D and Blue Sky</U>. The Company shall file a Form D with respect to the Securities as required
under Regulation D and to provide a copy thereof to the Buyer promptly after such filing. The Company shall, on or before the Closing
Date, take such action as the Company shall reasonably determine is necessary in order to obtain an exemption for, or to, qualify the
Securities for sale to the Buyers at the Closing pursuant to this Agreement under applicable securities or &ldquo;Blue Sky&rdquo; laws
of the states of the United States (or to obtain an exemption from such qualification), and shall provide evidence of any such action
so taken to the Buyers on or prior to the Closing Date. Without limiting any other obligation of the Company under this Agreement, the
Company shall timely make all filings and reports relating to the offer and sale of the Securities required under all applicable securities
laws (including, without limitation, all applicable federal securities laws and all applicable &ldquo;Blue Sky&rdquo; laws), and the Company
shall comply with all applicable foreign, federal, state and local laws, statutes, rules, regulations and the like relating to the offering
and sale of the Securities to the Buyers.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(c)</TD><TD STYLE="text-align: justify"><U>Reporting Status</U>. Until the date on which the Buyers shall have sold all of the Registrable Securities
(the &ldquo;<B>Reporting Period</B>&rdquo;), the Company shall timely file all reports required to be filed with the SEC pursuant to the
1934 Act, and the Company shall not terminate its status as an issuer required to file reports under the 1934 Act even if the 1934 Act
or the rules and regulations thereunder would no longer require or otherwise permit such termination.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(d)</TD><TD STYLE="text-align: justify"><U>Use of Proceeds</U>. The Company will use the proceeds from the sale of the Securities for general
corporate purposes, but not, directly or indirectly, for (i) except for payments made to Forward China, the satisfaction of any indebtedness
of the Company or any of its Subsidiaries, (ii) the redemption or repurchase of any securities of the Company or any of its Subsidiaries,
or (iii) the settlement of any outstanding litigation.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(e)</TD><TD STYLE="text-align: justify"><U>Financial Information</U>. The Company agrees to send the following to the Buyer during the Reporting
Period (i) unless the following are filed with the SEC through EDGAR and are available to the public through the EDGAR system, within
one (1) Business Day after the filing thereof with the SEC, a copy of its Annual Reports on Form 10-K and Quarterly Reports on Form 10-Q,
any interim reports or any consolidated balance sheets, income statements, stockholders&rsquo; equity statements and/or cash flow statements
for any period other than annual, any Current Reports on Form 8-K and any registration statements (other than on Form S-8) or amendments
filed pursuant to the 1933 Act, (ii) unless the following are either filed with the SEC through EDGAR or are otherwise widely disseminated
via a recognized news release service (such as PR Newswire), on the same day as the release thereof, e-mail copies of all press releases
issued by the Company or any of its Subsidiaries and (iii) unless the following are filed with the SEC through EDGAR, copies of any notices
and other information made available or given to the stockholders of the Company generally, contemporaneously with the making available
or giving thereof to the stockholders.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(f)</TD><TD STYLE="text-align: justify"><U>Listing</U>. The Company shall promptly secure the listing or designation for quotation (as the case
may be) of all of the Registrable Securities upon each national securities exchange and automated quotation system, if any, upon which
the Common Stock is then listed or designated for quotation (as the case may be) (subject to official notice of issuance) and shall maintain
such listing or designation for quotation (as the case may be) of all Registrable Securities from time to time issuable under the terms
of the Transaction Documents on such national securities exchange or automated quotation system. The Company shall maintain the Common
Stock&rsquo;s listing or authorization for quotation (as the case may be) on the Principal Market, The New York Stock Exchange, the NYSE
American, the Nasdaq Capital Market, the Nasdaq Global Market or the Nasdaq Global Select Market (each, an &ldquo;<B>Eligible Market</B>&rdquo;).
Neither the Company nor any of its Subsidiaries shall take any action which could be reasonably expected to result in the delisting or
suspension of the Common Stock on an Eligible Market. The Company shall pay all fees and expenses in connection with satisfying its obligations
under this Section 4(f).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(g)</TD><TD STYLE="text-align: justify"><U>Fees</U>. The Company shall reimburse the Buyer a non-accountable amount of $25,000 for all costs and
expenses incurred by it or its affiliates in connection with the structuring, documentation, negotiation and closing of the transactions
contemplated by the Transaction Documents and shall be withheld by the Buyer from its Purchase Price at the Closing. The Company shall
be responsible for the payment of any placement agent&rsquo;s fees, financial advisory fees, transfer agent fees, DTC (as defined below)
fees or broker&rsquo;s commissions (other than for Persons engaged by the Buyer) relating to or arising out of the transactions contemplated
hereby. The Company shall pay, and hold the Buyer harmless against, any liability, loss or expense (including, without limitation, reasonable
attorneys&rsquo; fees and out-of-pocket expenses) arising in connection with any claim relating to any such payment. Except as otherwise
set forth in the Transaction Documents, each party to this Agreement shall bear its own expenses in connection with the sale of the Securities
to the Buyers.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(h)</TD><TD STYLE="text-align: justify"><U>Pledge of Securities</U>. Notwithstanding anything to the contrary contained in this Agreement, the
Company acknowledges and agrees that the Securities may be pledged by the Buyer in connection with a bona fide margin agreement or other
loan or financing arrangement that is secured by the Securities. The pledge of Securities shall not be deemed to be a transfer, sale or
assignment of the Securities hereunder, and no Buyer effecting a pledge of Securities shall be required to provide the Company with any
notice thereof or otherwise make any delivery to the Company pursuant to this Agreement or any other Transaction Document. The Company
hereby agrees to execute and deliver such documentation as a pledgee of the Securities may reasonably request in connection with a pledge
of the Securities to such pledgee by a Buyer.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(i)</TD><TD STYLE="text-align: justify"><U>Disclosure of Transactions and Other Material Information</U>.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Disclosure
of Transaction</U>. The Company shall, on or before 9:30&nbsp;a.m., New York time, on the fourth (4th) Business Day after the Execution
Date, issue a press release (the &ldquo;<B>Press Release</B>&rdquo;) reasonably acceptable to the Buyer disclosing all the material terms
of the transactions contemplated by the Transaction Documents. On or before 9:30 a.m., New York time, on the fourth (4th) Business Day
after the date of this Agreement, the Company shall file a Current Report on Form 8-K describing all the material terms of the transactions
contemplated by the Transaction Documents in the form required by the 1934 Act and attaching all the material Transaction Documents (including,
without limitation, this Agreement (and all schedules to this Agreement), the form of the Warrants, the form of Certificate of Designations
and the form of the Registration Rights Agreement) (including all attachments, the &ldquo;<B>8-K Filing</B>&rdquo;). From and after the
filing of the 8-K Filing, the Company shall have disclosed all material, non-public information (if any) knowingly provided to any of
the Buyers by the Company or any of its Subsidiaries or any of their respective officers, directors, employees or agents in connection
with the transactions contemplated by the Transaction Documents. In addition, effective upon the filing of the 8-K Filing, the Company
acknowledges and agrees that any and all confidentiality or similar obligations under any agreement, whether written or oral, between
the Company, any of its Subsidiaries or any of their respective officers, directors, affiliates, employees or agents, on the one hand,
and any of the Buyers or any of their affiliates, on the other hand, shall terminate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Limitations
on Disclosure</U>. The Company shall not, and the Company shall cause each of its Subsidiaries and each of its and their respective officers,
directors, employees and agents not to, provide the Buyer with any material, non-public information regarding the Company or any of its
Subsidiaries from and after the Execution Date without the express prior written consent of the Buyer (which may be granted or withheld
in the Buyer&rsquo;s sole discretion). In the event of a breach of any of the foregoing covenants, including, without limitation, Section
4(o) of this Agreement, or any of the covenants or agreements contained in any other Transaction Document, by the Company, any of its
Subsidiaries, or any of its or their respective officers, directors, employees and agents (as determined in the reasonable good faith
judgment of the Buyer), in addition to any other remedy provided herein or in the Transaction Documents, the Buyer shall have the right
to make a public disclosure, in the form of a press release, public advertisement or otherwise, of such breach or such material, non-public
information, as applicable, without the prior approval by the Company, any of its Subsidiaries, or any of its or their respective officers,
directors, employees or agents. No Buyer shall have any liability to the Company, any of its Subsidiaries, or any of its or their respective
officers, directors, employees, affiliates, stockholders or agents, for any such disclosure, except in cases of such Buyer&rsquo;s gross
negligence, willful misconduct, or fraud. To the extent that the Company delivers any material, non-public information to a Buyer without
the Buyer&rsquo;s consent, the Company hereby covenants and agrees that the Buyer shall not have any duty of confidentiality with respect
to, or a duty not to trade on the basis of, such material, non-public information. Subject to the foregoing, neither the Company, its
Subsidiaries nor the Buyer shall issue any press releases or any other public statements with respect to the transactions contemplated
hereby; provided, however, the Company shall be entitled, without the prior approval of the Buyer, to make the Press Release and any press
release or other public disclosure with respect to such transactions (i) in substantial conformity with the 8-K Filing and contemporaneously
therewith and (ii) as is required by applicable law and regulations (provided that in the case of clause (i) the Buyer shall be consulted
by the Company in connection with any such press release or other public disclosure prior to its release). Without the prior written consent
of the applicable Buyer (which may be granted or withheld in the Buyer&rsquo;s sole discretion), the Company shall not (and shall cause
each of its Subsidiaries and affiliates to not) disclose the name of the Buyer in any filing, announcement, release or otherwise. Notwithstanding
anything contained in this Agreement to the contrary and without implication that the contrary would otherwise be true, the Company expressly
acknowledges and agrees that no Buyer shall have (unless expressly agreed to by a particular Buyer after the Execution Date in a written
definitive and binding agreement executed by the Company and such particular Buyer (it being understood and agreed that no Buyer may bind
any other Buyer with respect thereto)), any duty of confidentiality with respect to, or a duty not to trade on the basis of, any material,
non-public information regarding the Company or any of its Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(j)</TD><TD STYLE="text-align: justify"><U>Additional Registration Statements</U>. Except for securities being registered for the Buyer, related
to or unrelated to this Agreement, until the Applicable Date (as defined below) and at any time thereafter while any Registration Statement
is not effective or the prospectus contained therein is not available for use or any Current Public Information Failure (as defined in
the Registration Rights Agreement) exists, the Company shall not file a registration statement or an offering statement under the 1933
Act relating to securities that are not the Registrable Securities, or such supplements or amendments to registration statements that
are outstanding and have been declared effective by the SEC as of the Execution Date (solely to the extent necessary to keep such registration
statements effective and available and not with respect to any Subsequent Placement)). &ldquo;<B>Applicable Date</B>&rdquo; means the
earlier of (x) the first date on which the resale by the Buyers of all the Registrable Securities required to be filed on the initial
Registration Statement (as defined in the Registration Rights Agreement) pursuant to the Registration Rights Agreement is declared effective
by the SEC (and each prospectus contained therein is available for use on such date) or (y) the first date on which all of the Registrable
Securities are eligible to be resold by the Buyers pursuant to Rule 144 (or, if a Current Public Information Failure has occurred and
is continuing, such later date after which the Company has cured such Current Public Information Failure).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(k)</TD><TD STYLE="text-align: justify"><U>Additional Issuance of Securities</U>. So long as the Buyer beneficially owns any Securities, the Company
will not, without the prior written consent of the Buyer, issue any Preferred Shares (other than to the Buyer as contemplated hereby)
and the Company shall not issue any other securities that would cause a breach or default under the Certificate of Designations or the
Warrants. The Company agrees that for the period commencing on the Execution Date and ending on the date immediately following the 90<SUP>th</SUP>&nbsp;Business
Day after the Applicable Date (provided that such period shall be extended by the number of calendar days during such period and any extension
thereof contemplated by this proviso on which any Registration Statement is not effective or any prospectus contained therein is not available
for use or any Current Public Information Failure exists) (the &ldquo;<B>Restricted Period</B>&rdquo;), neither the Company nor any of
its Subsidiaries shall directly or indirectly issue, offer, sell, grant any option or right to purchase, or otherwise dispose of (or announce
any issuance, offer, sale, grant of any option or right to purchase or other disposition of) any equity security or any equity-linked
or related security (including, without limitation, any &ldquo;equity security&rdquo; (as that term is defined under Rule 405 promulgated
under the 1933 Act), any Convertible Securities (as defined below), any debt, any preferred stock or any purchase rights) (any such issuance,
offer, sale, grant, disposition or announcement (whether occurring during the Restricted Period or at any time thereafter) is referred
to as a &ldquo;<B>Subsequent Placement</B>&rdquo;). Notwithstanding the foregoing, this Section 4(k) shall not apply in respect of the
issuance of (i) shares of Common Stock or standard options to purchase Common Stock to directors, officers or employees of the Company
in their capacity as such pursuant to an Approved Stock Plan (as defined below), provided that (1) all such issuances (taking into account
the shares of Common Stock issuable upon exercise of such options) after the Execution Date pursuant to this clause (i) do not, in the
aggregate, exceed more than 5% of the Common Stock issued and outstanding immediately prior to the Execution Date and (2) the exercise
price of any such options is not lowered, none of such options are amended to increase the number of shares issuable thereunder and none
of the terms or conditions of any such options are otherwise materially changed in any manner that adversely affects any of the Buyers;
(ii) shares of Common Stock issued upon the conversion or exercise of Convertible Securities (other than standard options to purchase
Common Stock issued pursuant to an Approved Stock Plan that are covered by clause (i) above) issued prior to the Execution Date, provided
that the conversion, exercise or other method of issuance (as the case may be) of any such Convertible Security is made solely pursuant
to the conversion, exercise or other method of issuance (as the case may be) provisions of such Convertible Security that were in effect
on the date immediately prior to the date of this Agreement, the conversion, exercise or issuance price of any such Convertible Securities
(other than standard options to purchase Common Stock issued pursuant to an Approved Stock Plan that are covered by clause (i) above)
is not lowered, none of such Convertible Securities (other than standard options to purchase Common Stock issued pursuant to an Approved
Stock Plan that are covered by clause (i) above) are amended to increase the number of shares issuable thereunder and none of the terms
or conditions of any such Convertible Securities (other than standard options to purchase Common Stock issued pursuant to an Approved
Stock Plan that are covered by clause (i) above) are otherwise materially changed in any manner that adversely affects any of the Buyers;
(iii) the Conversion Shares, (iv) the Warrant Shares (v) securities issued pursuant to acquisitions or strategic transactions (including,
without limitation, joint venture, co-marketing, co-development or other collaboration agreements) approved by a majority of the disinterested
directors of the Company and (vi) &nbsp;securities issued to third-party service providers provided, further, that such securities are
issued as &ldquo;restricted securities&rdquo; (as defined in Rule 144) (each of the foregoing in clauses (i) through (iv), collectively
the &ldquo;<B>Excluded Securities</B>&rdquo;). &ldquo;<B>Approved Stock Plan</B>&rdquo; means any employee benefit plan which has been
approved by the board of directors of the Company prior to or subsequent to the Execution Date pursuant to which shares of Common Stock
and standard options to purchase Common Stock may be issued to any employee, officer or director for services provided to the Company
in their capacity as such.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(l)</TD><TD STYLE="text-align: justify"><U>Reservation of Shares</U>. So long as any of the Preferred Shares or Warrants remain outstanding, the
Company shall take all action necessary to at all times have authorized, and reserved for the purpose of issuance, no less than the sum
of (i) 300% of the maximum number of shares of Common Stock issuable upon conversion of all the Preferred Shares then outstanding, and
(ii) the maximum number of Warrant Shares issuable upon exercise of all the Warrants then outstanding (without regard to any limitations
on the exercise of the Warrants set forth therein) (collectively, the &ldquo;<B>Required Reserve Amount</B>&rdquo;); provided that at
no time shall the number of shares of Common Stock reserved pursuant to this Section 4(l) be reduced other than proportionally in connection
with any conversion, exercise and/or redemption, as applicable of Preferred Shares and Warrants. If at any time the number of shares of
Common Stock authorized and reserved for issuance is not sufficient to meet the Required Reserve Amount, the Company will promptly take
all corporate action necessary to authorize and reserve a sufficient number of shares, including, without limitation, calling a special
meeting of stockholders to authorize additional shares to meet the Company&rsquo;s obligations pursuant to the Transaction Documents,
in the case of an insufficient number of authorized shares, obtain stockholder approval of an increase in such authorized number of shares,
and voting the management shares of the Company in favor of an increase in the authorized shares of the Company to ensure that the number
of authorized shares is sufficient to meet the Required Reserve Amount.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(m)</TD><TD STYLE="text-align: justify"><U>Conduct of Business</U>. The business of the Company and its Subsidiaries shall not be conducted in
violation of any law, ordinance or regulation of any Governmental Entity, except where such violations would not reasonably be expected
to result, either individually or in the aggregate, in a Material Adverse Effect.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(n)</TD><TD STYLE="text-align: justify"><U>Other Preferred Shares; Variable Securities</U>. So long as any Preferred Shares remain outstanding,
the Company and each Subsidiary shall be prohibited from effecting or entering into an agreement to effect any Subsequent Placement involving
a Variable Rate Transaction. &ldquo;<B>Variable Rate Transaction</B>&rdquo; means a transaction in which the Company or any Subsidiary
(i) issues or sells any Convertible Securities either (A) at a conversion, exercise or exchange rate or other price that is based upon
and/or varies with the trading prices of or quotations for the shares of Common Stock at any time after the initial issuance of such Convertible
Securities, or (B) with a conversion, exercise or exchange price that is subject to being reset at some future date after the initial
issuance of such Convertible Securities or upon the occurrence of specified or contingent events directly or indirectly related to the
business of the Company or the market for the Common Stock, other than pursuant to a customary &ldquo;weighted average&rdquo; anti-dilution
provision or (ii) enters into any agreement (including, without limitation, an equity line of credit or an &ldquo;at-the-market&rdquo;
offering) whereby the Company or any Subsidiary may sell securities at a future determined price (other than standard and customary &ldquo;preemptive&rdquo;
or &ldquo;participation&rdquo; rights). The Buyer shall be entitled to obtain injunctive relief against the Company and its Subsidiaries
to preclude any such issuance, which remedy shall be in addition to any right to collect damages. For the avoidance of doubt, an At-The-Market
Offering shall not be considered a Variable Rate Transaction under the Transaction Documents.&nbsp;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(o)</TD><TD STYLE="text-align: justify"><U>Participation Right</U>. At any time that any of the Preferred Shares remain outstanding, neither the
Company nor any of its Subsidiaries shall, directly or indirectly, effect any Subsequent Placement unless the Company shall have first
complied with this Section 4(o). The Company acknowledges and agrees that the right set forth in this Section 4(o) is a right granted
by the Company, separately, to the Buyer.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;At
least five (5) Business Days prior to any proposed or intended Subsequent Placement, the Company shall deliver to the Buyer a written
notice (each such notice, a &ldquo;<B>Pre-Notice</B>&rdquo;), which Pre-Notice shall not contain any information (including, without limitation,
material, non-public information) other than: (A) if the proposed Offer Notice (as defined below) constitutes or contains material, non-public
information, a statement asking whether the Buyer is willing to accept material non-public information or (B) if the proposed Offer Notice
does not constitute or contain material, non-public information, (x) a statement that the Company proposes or intends to effect a Subsequent
Placement, (y) a statement that the statement in clause (x) above does not constitute material, non-public information and (z) a statement
informing the Buyer that it is entitled to receive an Offer Notice (as defined below) with respect to such Subsequent Placement upon its
written request. Upon the written request of a Buyer within three (3) Business Days after the Company&rsquo;s delivery to the Buyer of
such Pre-Notice, and only upon a written request by the Buyer, the Company shall promptly, but no later than one (1) Business Day after
such request, deliver to the Buyer an irrevocable written notice (the &ldquo;<B>Offer Notice</B>&rdquo;) of any proposed or intended issuance
or sale or exchange (the &ldquo;<B>Offer</B>&rdquo;) of the securities being offered (the &ldquo;<B>Offered Securities</B>&rdquo;) in
a Subsequent Placement, which Offer Notice shall (A) identify and describe the Offered Securities, (B) describe the price and other terms
upon which they are to be issued, sold or exchanged, and the number or amount of the Offered Securities to be issued, sold or exchanged,
(C) identify the Persons (if known) to which or with which the Offered Securities are to be offered, issued, sold or exchanged and (D)
offer to issue and sell to or exchange with the Buyer in accordance with the terms of the Offer up to 30% of the Offered Securities (the
&ldquo;<B>Basic Amount</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;To
accept an Offer, in whole or in part, the Buyer must deliver a written notice to the Company prior to the end of the fifth (5<SUP>th</SUP>)
Business Day after the Buyer&rsquo;s receipt of the Offer Notice (the &ldquo;<B>Offer Period</B>&rdquo;), setting forth the portion of
the Buyer&rsquo;s Basic Amount that the Buyer elects to purchase (the &ldquo;<B>Notice of Acceptance</B>&rdquo;). Notwithstanding the
foregoing, if the Company desires to modify or amend the terms and conditions of the Offer prior to the expiration of the Offer Period,
the Company may deliver to the Buyer a new Offer Notice and the Offer Period shall expire on the fifth (5<SUP>th</SUP>) Business Day after
the Buyer&rsquo;s receipt of such new Offer Notice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company shall have five (5) Business Days from the expiration of the Offer Period above (A) to offer, issue, sell or exchange all or any
part of such Offered Securities as to which a Notice of Acceptance has not been given by the Buyer (the &ldquo;<B>Refused Securities</B>&rdquo;)
pursuant to a definitive agreement(s) (the &ldquo;<B>Subsequent Placement Agreement</B>&rdquo;), but only to the offerees described in
the Offer Notice (if so described therein) and only upon terms and conditions (including, without limitation, unit prices and interest
rates) that are not more favorable to the acquiring Person or Persons or less favorable to the Company than those set forth in the Offer
Notice and (B) to publicly announce (x) the execution of such Subsequent Placement Agreement, and (y) either (I) the consummation of the
transactions contemplated by such Subsequent Placement Agreement or (II) the termination of such Subsequent Placement Agreement, which
shall be filed with the SEC on a Current Report on Form 8-K with such Subsequent Placement Agreement and any documents contemplated therein
filed as exhibits thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">(iv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
the event the Company shall propose to sell less than all the Refused Securities (any such sale to be in the manner and on the terms specified
in Section&nbsp;4(o)(iii) above), then the Buyer may, at its sole option and in its sole discretion, withdraw its Notice of Acceptance
or reduce the number or amount of the Offered Securities specified in its Notice of Acceptance to an amount that shall be not less than
the number or amount of the Offered Securities that the Buyer elected to purchase pursuant to Section&nbsp;4(o)(ii) above multiplied by
a fraction, (i) the numerator of which shall be the number or amount of Offered Securities the Company actually proposes to issue, sell
or exchange (including Offered Securities to be issued or sold to Buyers pursuant to this Section&nbsp;4(o) prior to such reduction) and
(ii) the denominator of which shall be the original amount of the Offered Securities. In the event that the Buyer so elects to reduce
the number or amount of Offered Securities specified in its Notice of Acceptance, the Company may not issue, sell or exchange more than
the reduced number or amount of the Offered Securities unless and until such securities have again been offered to the Buyers in accordance
with Section&nbsp;4(o)(i) above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">(v)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Upon
the closing of the issuance, sale or exchange of all or less than all of the Refused Securities, the Buyer shall acquire from the Company,
and the Company shall issue to the Buyer, the number or amount of Offered Securities specified in its Notice of Acceptance, as reduced
pursuant to Section&nbsp;4(o)(iv) above if the Buyer has so elected, upon the terms and conditions specified in the Offer. The purchase
by the Buyer of any Offered Securities is subject in all cases to the preparation, execution and delivery by the Company and the Buyer
of a separate purchase agreement relating to such Offered Securities reasonably satisfactory in form and substance to the Buyer and its
counsel.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">(vi)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Any
Offered Securities not acquired by a Buyer or other Persons in accordance with this Section&nbsp;4(o) may not be issued, sold or exchanged
until they are again offered to the Buyer under the procedures specified in this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">(vii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company and the Buyer agree that if the Buyer elects to participate in the Offer, (x) neither the Subsequent Placement Agreement with
respect to such Offer nor any other transaction documents related thereto (collectively, the &ldquo;<B>Subsequent Placement Documents</B>&rdquo;)
shall include any term or provision whereby the Buyer shall be required to agree to any restrictions on trading as to any securities of
the Company or be required to consent to any amendment to or termination of, or grant any waiver, release or the like under or in connection
with, any agreement previously entered into with the Company or any instrument received from the Company, and (y) any registration rights
set forth in such Subsequent Placement Documents shall be similar in all material respects to the registration rights contained in the
Registration Rights Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 21 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">(viii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Notwithstanding
anything to the contrary in this Section 4(o) and unless otherwise agreed to by the Buyer, the Company shall either confirm in writing
to the Buyer that the transaction with respect to the Subsequent Placement has been abandoned or shall publicly disclose its intention
to issue the Offered Securities, in either case, in such a manner such that the Buyer will not be in possession of any material, non-public
information, by the fifth (5<SUP>th</SUP>) Business Day following delivery of the Offer Notice. If by such fifth (5<SUP>th</SUP>) Business
Day, no public disclosure regarding a transaction with respect to the Offered Securities has been made, and no notice regarding the abandonment
of such transaction has been received by the Buyer, such transaction shall be deemed to have been abandoned and the Company shall not
provide the Buyer with any material, non-public information with respect to the Company or any of its Subsidiaries. Should the Company
decide to pursue such transaction with respect to the Offered Securities, the Company shall provide the Buyer with another Offer Notice
and the Buyer will again have the right of participation set forth in this Section 4(o). The Company shall not be permitted to deliver
more than one such Offer Notice to the Buyer in any sixty (60) day period, except as expressly contemplated by the last sentence of Section
4(o)(ii).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">(ix)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
restrictions contained in this Section 4(o) shall not apply in connection with the issuance of any Excluded Securities. The Company shall
not circumvent the provisions of this Section 4(o) by providing terms or conditions to one Buyer that are not provided to all.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(p)</TD><TD STYLE="text-align: justify"><U>Dilutive Issuances</U>. For so long as any Preferred Shares or Warrants remain outstanding, the Company
shall not, in any manner, enter into or affect any Dilutive Issuance (as defined in the Certificate of Designations) if the effect of
such Dilutive Issuance is to cause the Company to be required to issue upon conversion of any Preferred Shares or exercise of any Warrant
any shares of Common Stock in excess of that number of shares of Common Stock which the Company may issue upon conversion of the Preferred
Shares and exercise of the Warrants without breaching the Company&rsquo;s obligations under the rules or regulations of the Principal
Market. As long as (i) any Preferred Shares remain outstanding, the Company shall not consummate a Dilutive Issuance at a New Issuance
Price (as defined in the Certificate of Designations) less than the lower of (x) the Conversion Price (as defined in the Certificate of
Designations) then in effect (after giving effect to any antidilution adjustments that may occur as a result of such Dilutive Issuance
in the Certificate of Designations) and (y) the Conversion Floor Price (as defined in the Certificate of Designations) and (ii) any Warrants
remain outstanding, the Company shall not consummate a Dilutive Issuance (as defined in the Warrants) less than the Exercise Price then
in effect (after giving effect to any antidilution adjustments that may occur as a result of such Dilutive Issuance in the Warrants).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(q)</TD><TD STYLE="text-align: justify"><U>Passive Foreign Investment Company</U>. The Company shall conduct its business, and shall cause its
Subsidiaries to conduct their respective businesses, in such a manner as will ensure that the Company will not be deemed to constitute
a passive foreign investment company within the meaning of Section 1297 of the Code.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(r)</TD><TD STYLE="text-align: justify"><U>Restriction on Redemption and Cash Dividends</U>. So long as any Preferred Shares are outstanding,
the Company shall not, directly or indirectly, redeem, or declare or pay any cash dividend or distribution on, any securities of the Company
without the prior express written consent of the Buyer (other than as required by the Certificate of Designations).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(s)</TD><TD STYLE="text-align: justify"><U>Corporate Existence</U>. So long as the Buyer beneficially owns any Preferred Shares or Warrants, the
Company shall not be party to any Fundamental Transaction (as defined in the Certificate of Designations) unless the Company is in compliance
with the applicable provisions governing Fundamental Transactions set forth in the Certificate of Designations and the Warrants.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(t)</TD><TD STYLE="text-align: justify"><U>Stock Splits</U>. Until the Preferred Shares and all preferred shares issued pursuant to the Certificate
of Designations and the Warrants are no longer outstanding, the Company shall not effect any stock combination, reverse stock split or
other similar transaction (or make any public announcement or disclosure with respect to any of the foregoing) without the prior written
consent of the Buyer (as defined below).</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 22 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(u)</TD><TD STYLE="text-align: justify"><U>Conversion and Exercise Procedures</U>. Each of the form of Notice of Exercise (as defined in the Warrants)
included in the Warrants and the form of Conversion Notice (as defined in the Certificate of Designations) included in the Certificate
of Designations set forth the totality of the procedures required of the Buyers in order to exercise the Warrants or convert the Preferred
Shares. Except as provided in Section 5(d), no additional legal opinion, other information or instructions shall be required of the Buyers
to exercise their Warrants or convert their Preferred Shares. The Company shall honor exercises of the Warrants and conversions of the
Preferred Shares and shall deliver the Conversion Shares and Warrant Shares in accordance with the terms, conditions and time periods
set forth in the Certificate of Designations and Warrants. Without limiting the preceding sentences, no ink-original Conversion Notice
or Exercise Notice shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Conversion
Notice or Exercise Notice form be required in order to convert the Preferred Shares or exercise the Warrants.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(v)</TD><TD STYLE="text-align: justify"><U>Regulation M</U>. The Company will not take any action prohibited by Regulation M under the 1934 Act,
in connection with the distribution of the Securities contemplated hereby.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(w)</TD><TD STYLE="text-align: justify"><U>General Solicitation</U>. None of the Company, any of its affiliates (as defined in Rule 501(b) under
the 1933 Act) or any person acting on behalf of the Company or such affiliate will solicit any offer to buy or offer or sell the Securities
by means of any form of general solicitation or general advertising within the meaning of Regulation&nbsp;D, including: (i) any advertisement,
article, notice or other communication published in any newspaper, magazine or similar medium or broadcast over television or radio; and
(ii) any seminar or meeting whose attendees have been invited by any general solicitation or general advertising.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(x)</TD><TD STYLE="text-align: justify"><U>Integration</U>. None of the Company, any of its affiliates (as defined in Rule 501(b) under the 1933
Act), or any person acting on behalf of the Company or such affiliate will sell, offer for sale, or solicit offers to buy or otherwise
negotiate in respect of any security (as defined in the 1933 Act) which will be integrated with the sale of the Securities in a manner
which would require the registration of the Securities under the 1933 Act or require stockholder approval under the rules and regulations
of the Principal Market and the Company will take all action that is appropriate or necessary to assure that its offerings of other securities
will not be integrated for purposes of the 1933 Act or the rules and regulations of the Principal Market, with the issuance of Securities
contemplated hereby.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(y)</TD><TD STYLE="text-align: justify"><U>Notice of Disqualification Events</U>. The Company will notify the Buyers in writing, prior to the
Closing Date of (i) any Disqualification Event relating to any Issuer Covered Person and (ii) any event that would, with the passage of
time, become a Disqualification Event relating to any Issuer Covered Person.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(z)</TD><TD STYLE="text-align: justify"><U>Closing Documents</U>. On or prior to fourteen (14) calendar days after the Closing Date, the Company
agrees to deliver, or cause to be delivered, to the Buyer and Greenberg Traurig, P.A., a complete closing set of the executed Transaction
Documents, Securities and any other document required to be delivered to any party pursuant to Section&nbsp;7 hereof or otherwise.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"></P>

<!-- Field: Page; Sequence: 23 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(aa)</TD><TD STYLE="text-align: justify"><U>Compliance with Rules of Principal Market</U>. Until Stockholder Approval (as defined below) is obtained,
the Company shall not issue any shares of Common Stock upon conversion of the Preferred Shares or exercise of the Warrants, to the extent
that after giving effect thereto, the aggregate number of shares of Common Stock that would be issued pursuant to this Agreement, the
Transaction Documents, and the transactions contemplated hereby and thereby would exceed 19.99% of the number of shares of Common Stock
issued and outstanding immediately prior to the execution of this Agreement), which number of shares shall be reduced, on a share-for-share
basis, by the number of shares of Common Stock issued or issuable pursuant to any transaction or series of transactions that may be aggregated
with the transactions contemplated by this Agreement under applicable rules of the Principal Market (such maximum number of shares, the
&ldquo;<B><U>Exchange Cap</U></B>&rdquo;. As soon as practicable after the Closing Date, but in any event no later than sixty (60) days
thereafter (the &ldquo;<B><U>Stockholder Meeting Deadline</U></B>&rdquo;), the Company shall hold a meeting of its stockholders to seek
approval of a waiver of the Exchange Cap and, if needed, an increase in the authorized number of shares of Common Stock (approval of all
such proposals, the &ldquo;<B><U>Stockholder Approval</U></B>&rdquo;). In connection with such meeting, the Company shall provide each
stockholder of the Company with a proxy statement in compliance with applicable SEC rules and regulations and shall use its best efforts
to solicit the Stockholder Approval and to cause its board of directors to recommend to the Company&rsquo;s stockholders that they approve
such proposal(s). The Company shall be obligated to seek to obtain the Stockholder Approval by the Stockholder Meeting Deadline. If, despite
the Company&rsquo;s best efforts the Stockholder Approval is not obtained on or prior to the Stockholder Meeting Deadline, the Company
shall cause an additional stockholder meeting to be held as soon as possible. If, despite the Company&rsquo;s reasonable best efforts
the Stockholder Approval is not obtained after such subsequent stockholder meetings, the Company shall cause an additional stockholder
meeting to be held semi-annually thereafter until such Stockholder Approval is obtained. For the avoidance of doubt, if the Company fails
to obtain Stockholder Approval, the Exchange Cap shall be applicable for all purposes. The Company shall not issue or sell any shares
of Common Stock pursuant to this Agreement or any of the Transaction Documents if such issuance or sale would reasonably be expected to
result in: (i) a violation of the Securities Act; or (ii) a breach of the rules of the Principal Market. The provisions of this Section
4(aa) shall be implemented in a manner otherwise than in strict conformity with the terms of this Section 4(aa) only if necessary to ensure
compliance with the Securities Act and the applicable rules of the Principal Market. The limitations contained in this Section 4(aa) may
not be waived by the Company or the Buyer.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(bb)</TD><TD STYLE="text-align: justify"><U>Certain Limitations</U>. Notwithstanding anything contained in this Agreement or any Transaction Document
to the contrary, the parties covenant and agree that the Buyer shall not convert any Preferred Shares or exercise any of the Warrants
into shares of Common Stock in excess of the Exchange Cap, unless and until the Company obtains Stockholder Approval in accordance with
the rules of the Principal Market. The Buyer further covenants and agrees not to vote any Common Stock at the meeting of the stockholders
held for the purpose of obtaining such Stockholder Approval.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><B>5.</B></TD><TD STYLE="text-align: justify"><B>REGISTER; TRANSFER AGENT INSTRUCTIONS; LEGEND.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(a)</TD><TD STYLE="text-align: justify"><U>Register</U>. The Company shall maintain at its principal executive offices (or such other office or
agency of the Company as it may designate by notice to each holder of Securities), a register for the Preferred Shares and the Warrants
in which the Company shall record the name and address of the Person in whose name the Preferred Shares and the Warrants have been issued
(including the name and address of each transferee), the aggregate number of Preferred Shares held by such Person, the number of Conversion
Shares issuable pursuant to the terms of the Preferred Shares and the number of Warrant Shares issuable upon exercise of the Warrants
held by such Person. The Company shall keep the register open and available at all times during business hours for inspection of the Buyer
or its legal representatives.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 24 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(b)</TD><TD STYLE="text-align: justify"><U>Transfer Agent Instructions</U>. The Company shall issue irrevocable instructions to its transfer agent
and any subsequent transfer agent (as applicable, the &ldquo;<B>Transfer Agent</B>&rdquo;) in a form acceptable to the Buyer (the &ldquo;<B>Irrevocable
Transfer Agent Instructions</B>&rdquo;) to issue certificates or credit shares to the applicable balance accounts at The Depository Trust
Company (&ldquo;<B>DTC</B>&rdquo;), registered in the name of the Buyer or its respective nominee(s), for the Conversion Shares and the
Warrant Shares in such amounts as specified from time to time by the Buyer to the Company upon conversion of the Preferred Shares or the
exercise of the Warrants (as the case may be). The Company represents and warrants that no instruction other than the Irrevocable Transfer
Agent Instructions referred to in this Section&nbsp;5(b), and stop transfer instructions to give effect to Section 2(g) hereof, will be
given by the Company to its transfer agent with respect to the Securities, and that the Securities shall otherwise be freely transferable
on the books and records of the Company, as applicable, to the extent provided in this Agreement and the other Transaction Documents.
If a Buyer effects a sale, assignment or transfer of the Securities in accordance with Section 2(g), the Company shall permit the transfer
and shall promptly instruct its transfer agent to issue one or more certificates or credit shares to the applicable balance accounts at
DTC in such name and in such denominations as specified by the Buyer to effect such sale, transfer or assignment. In the event that such
sale, assignment or transfer involves Conversion Shares or Warrant Shares sold, assigned or transferred pursuant to an effective registration
statement or in compliance with Rule 144, the transfer agent shall issue such shares to the Buyer, assignee or transferee (as the case
may be) without any restrictive legend in accordance with Section&nbsp;5(d) below. The Company acknowledges that a breach by it of its
obligations hereunder will cause irreparable harm to a Buyer. Accordingly, the Company acknowledges that the remedy at law for a breach
of its obligations under this Section&nbsp;5(b) will be inadequate and agrees, in the event of a breach or threatened breach by the Company
of the provisions of this Section&nbsp;5(b), that a Buyer shall be entitled, in addition to all other available remedies, to an order
and/or injunction restraining any breach and requiring immediate issuance and transfer, without the necessity of showing economic loss
and without any bond or other security being required. The Company shall cause its counsel to issue the legal opinion referred to in the
Irrevocable Transfer Agent Instructions to the Company&rsquo;s transfer agent no later than two Business Days following the effective
date of each registration statement required under the Registration Rights Agreement. Any fees (with respect to the transfer agent, counsel
to the Company or otherwise) associated with the issuance of such opinion or the removal of any legends on any of the Securities shall
be borne by the Company.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(c)</TD><TD STYLE="text-align: justify"><U>Legends</U>. The Buyer understands that the Securities have been issued (or will be issued in the case
of the Conversion Shares and the Warrant Shares) pursuant to an exemption from registration or qualification under the 1933 Act and applicable
state securities laws, and except as set forth below, the Securities shall bear any legend as required by the &ldquo;blue sky&rdquo; laws
of any state and a restrictive legend in substantially the following form (and a stop-transfer order may be placed against transfer of
such stock certificates):</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0.5in 0 1in; text-align: justify">[NEITHER THE ISSUANCE AND SALE OF THE
SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE [CONVERTIBLE] [EXERCISABLE] HAVE BEEN][THE
SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN] REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE
SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION
STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR (B) AN OPINION OF COUNSEL TO THE HOLDER (IF REQUESTED BY
THE COMPANY), IN A FORM REASONABLY ACCEPTABLE TO THE COMPANY, THAT REGISTRATION IS NOT REQUIRED UNDER SAID ACT OR (II) UNLESS SOLD OR
ELIGIBLE TO BE SOLD PURSUANT TO RULE 144 OR RULE 144A UNDER SAID ACT. NOTWITHSTANDING THE FOREGOING, THE SECURITIES MAY BE PLEDGED IN
CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN OR FINANCING ARRANGEMENT SECURED BY THE SECURITIES.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 25 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(d)</TD><TD STYLE="text-align: justify"><U>Removal of Legends</U>. Certificates evidencing Securities shall not be required to contain the legend
set forth in Section&nbsp;5(c) above or any other legend (i) while a registration statement (including a Registration Statement) covering
the resale of such Securities is effective under the 1933 Act, (ii) following any sale of such Securities pursuant to Rule 144 (assuming
the transferor is not an affiliate of the Company), (iii) if such Securities are eligible to be sold, assigned or transferred under Rule
144 (provided that a Buyer provides the Company with reasonable assurances that such Securities are eligible for sale, assignment or transfer
under Rule 144 which shall not include an opinion of Buyer&rsquo;s counsel), (iv) in connection with a sale, assignment or other transfer
(other than under Rule 144), provided that the Buyer provides the Company with an opinion of counsel to the Buyer, in a generally acceptable
form, to the effect that such sale, assignment or transfer of the Securities may be made without registration under the applicable requirements
of the 1933 Act or (v) if such legend is not required under applicable requirements of the 1933 Act (including, without limitation, controlling
judicial interpretations and pronouncements issued by the SEC). If a legend is not required pursuant to the foregoing, the Company shall
no later than two (2) Business Days (or such earlier date as required pursuant to the 1934 Act or other applicable law, rule or regulation
for the settlement of a trade initiated on the date the Buyer delivers such legended certificate representing such Securities to the Company)
following the delivery by a Buyer to the Company or the transfer agent (with notice to the Company) of a legended certificate representing
such Securities (endorsed or with stock powers attached, signatures guaranteed, and otherwise in form necessary to affect the reissuance
and/or transfer, if applicable), together with any other deliveries from the Buyer as may be required above in this Section&nbsp;5(d),
as directed by the Buyer, either: (A) provided that the Company&rsquo;s transfer agent is participating in the DTC Fast Automated Securities
Transfer Program (&ldquo;<B>FAST</B>&rdquo;) and such Securities are Conversion Shares or Warrant Shares, credit the aggregate number
of shares of Common Stock to which the Buyer shall be entitled to the Buyer&rsquo;s or its designee&rsquo;s balance account with DTC through
its Deposit/Withdrawal at Custodian system or (B) if the Company&rsquo;s transfer agent is not participating in FAST, issue and deliver
(via reputable overnight courier) to the Buyer, a certificate representing such Securities that is free from all restrictive and other
legends, registered in the name of the Buyer or its designee (the date by which such credit is so required to be made to the balance account
of the Buyer&rsquo;s or the Buyer&rsquo;s designee with DTC or such certificate is required to be delivered to the Buyer pursuant to the
foregoing is referred to herein as the &ldquo;<B>Required Delivery Date</B>&rdquo;, and the date such shares of Common Stock are actually
delivered without restrictive legend to the Buyer or the Buyer&rsquo;s designee with DTC, as applicable, the &ldquo;<B>Share Delivery
Date</B>&rdquo;). The Company shall be responsible for any transfer agent fees or DTC fees with respect to any issuance of Securities
or the removal of any legends with respect to any Securities in accordance herewith.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 26 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(e)</TD><TD STYLE="text-align: justify"><U>Failure to Timely Deliver; Buy-In</U>. If the Company fails, for any reason or for no reason, to issue
and deliver (or cause to be delivered) to a Buyer (or its designee) by the Required Delivery Date, either (I) if the Transfer Agent is
not participating in FAST, a certificate for the number of Conversion Shares to which the Buyer is entitled and register such Conversion
Shares on the Company&rsquo;s share register or, if the Transfer Agent is participating in FAST, to credit the balance account of the
Buyer or the Buyer&rsquo;s designee with DTC for such number of Conversion Shares submitted for legend removal by the Buyer pursuant to
Section 5(d) above or (II) if the Registration Statement covering the resale of the Conversion Shares or Warrant Shares (as the case may
be) submitted for legend removal by the Buyer pursuant to Section 5(d) above (the &ldquo;<B>Unavailable Shares</B>&rdquo;) is not available
for the resale of such Unavailable Shares and the Company fails to promptly, but in no event later than as required pursuant to the Registration
Rights Agreement (x) so notify the Buyer and (y) deliver the Conversion Shares or Warrant Shares, as applicable, electronically without
any restrictive legend by crediting such aggregate number of Conversion Shares or Warrant Shares (as the case may be) submitted for legend
removal by the Buyer pursuant to Section 5(d) above to the Buyer&rsquo;s or its designee&rsquo;s balance account with DTC through its
Deposit/Withdrawal At Custodian system (the event described in the immediately foregoing clause (II) is hereinafter referred as a &ldquo;<B>Notice
Failure</B>&rdquo; and together with the event described in clause (I) above, a &ldquo;<B>Delivery Failure</B>&rdquo;), then, in addition
to all other remedies available to the Buyer, the Company shall pay in cash to the Buyer on each day after the Share Delivery Date and
during such Delivery Failure an amount (notwithstanding any calculation to the contrary contained in the Certificate of Designation) equal
to 2% of the product of (A) the sum of the number of shares of Common Stock not issued to the Buyer on or prior to the Required Delivery
Date and to which the Buyer is entitled, and (B) any trading price of the Common Stock selected by the Buyer in writing as in effect at
any time during the period beginning on the date of the delivery by the Buyer to the Company of the applicable Conversion Shares or Warrant
Shares (as the case may be) and ending on the applicable Share Delivery Date. In addition to the foregoing, if on or prior to the Required
Delivery Date either (I) if the Transfer Agent is not participating in FAST, the Company shall fail to issue and deliver a certificate
to a Buyer and register such shares of Common Stock on the Company&rsquo;s share register or, if the Transfer Agent is participating in
FAST, credit the balance account of the Buyer or the Buyer&rsquo;s designee with DTC for the number of shares of Common Stock to which
the Buyer submitted for legend removal by the Buyer pursuant to Section 5(d) above (ii) below or (II) a Notice Failure occurs, and if
on or after such Business Day the Buyer acquires (in an open market transaction, stock loan or otherwise) shares of Common Stock to deliver
in satisfaction of a sale by the Buyer of shares of Common Stock submitted for legend removal by the Buyer pursuant to Section 5(d) above
that the Buyer is entitled to receive from the Company (a &ldquo;<B>Buy-In</B>&rdquo;), then the Company shall, within two (2) Business
Days after the Buyer&rsquo;s request and in the Buyer&rsquo;s discretion, either (i) pay cash to the Buyer in an amount equal to the Buyer&rsquo;s
total purchase price (including brokerage commissions, stock loan costs and other out-of-pocket expenses, if any) for the shares of Common
Stock so acquired (including, without limitation, by any other Person in respect, or on behalf, of the Buyer) (the &ldquo;<B>Buy-In Price</B>&rdquo;),
at which point the Company&rsquo;s obligation to so deliver such certificate or credit the Buyer&rsquo;s balance account shall terminate
and such shares shall be cancelled, or (ii) promptly honor its obligation to so deliver to the Buyer a certificate or certificates or
credit the balance account of the Buyer or the Buyer&rsquo;s designee with DTC representing such number of shares of Common Stock that
would have been so delivered if the Company timely complied with its obligations hereunder and pay cash to the Buyer in an amount equal
to the excess (if any) of the Buy-In Price over the product of (A) such number of shares of Conversion Shares or Warrant Shares (as the
case may be) that the Company was required to deliver to the Buyer by the Required Delivery Date multiplied by (B) the lowest closing
sale price of the Common Stock on any Business Day during the period commencing on the date of the delivery by the Buyer to the Company
of the applicable Conversion Shares or Warrant Shares (as the case may be) and ending on the date of such delivery and payment under this
clause (ii). Nothing shall limit the Buyer&rsquo;s right to pursue any other remedies available to it hereunder, at law or in equity,
including, without limitation, a decree of specific performance and/or injunctive relief with respect to the Company&rsquo;s failure to
timely deliver certificates representing shares of Common Stock (or to electronically deliver such shares of Common Stock) as required
pursuant to the terms hereof. Notwithstanding anything herein to the contrary, with respect to any given Notice Failure and/or Delivery
Failure, this Section 5(e) shall not apply to the applicable Buyer the extent the Company has already paid such amounts in full to the
Buyer with respect to such Notice Failure and/or Delivery Failure, as applicable, pursuant to the analogous sections of the Certificate
of Designations or Warrant, as applicable, with respect to the Preferred Shares or Warrants, as applicable, then held by the Buyer.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(f)</TD><TD STYLE="text-align: justify"><U>FAST Compliance</U>. While any Warrants remain outstanding, the Company shall maintain a transfer agent
that participates in FAST.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 27 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><B>6.</B></TD><TD STYLE="text-align: justify"><B>CONDITIONS TO THE COMPANY&rsquo;S OBLIGATION TO SELL.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(a)</TD><TD STYLE="text-align: justify">The obligation of the Company hereunder to issue and sell the Preferred Shares and the related Warrants
to the Buyer at the Closing is subject to the satisfaction, at or before the Closing Date, of each of the following conditions, provided
that these conditions are for the Company&rsquo;s sole benefit and may be waived by the Company at any time in its sole discretion by
providing the Buyer with prior written notice thereof:&nbsp;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Buyer shall have executed each of the other Transaction Documents to which it is a party and delivered the same to the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Buyer and each other Buyer shall have delivered to the Company the Purchase Price (less, in the case of the Buyer, the amounts withheld
pursuant to Section 4(g)) for the Preferred Shares and the related Warrants being purchased by the Buyer at the Closing by wire transfer
of immediately available funds.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
representations and warranties of the Buyer shall be true and correct in all material respects as of the date when made and as of the
Closing Date as though originally made at that time (except for representations and warranties that speak as of a specific date, which
shall be true and correct as of such specific date), and the Buyer shall have performed, satisfied and complied in all material respects
with the covenants, agreements and conditions required by this Agreement to be performed, satisfied or complied with by the Buyer at or
prior to the Closing Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><B>7.</B></TD><TD STYLE="text-align: justify"><B>CONDITIONS TO THE BUYER&rsquo;S OBLIGATION TO PURCHASE.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(a)</TD><TD STYLE="text-align: justify">The obligation of the Buyer hereunder to purchase its Preferred Shares and its related Warrants at the
Closing is subject to the satisfaction, at or before the Closing Date, of each of the following conditions, provided that these conditions
are for the Buyer&rsquo;s sole benefit and may be waived by the Buyer at any time in its sole discretion by providing the Company with
prior written notice thereof:&nbsp;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company shall have duly executed and delivered to the Buyer each of the Transaction Documents to which it is a party and the Company shall
have duly executed and delivered to the Buyer (A) such aggregate number of Preferred Shares as set forth on the signature page hereto,
and (B) Warrants initially exercisable for such aggregate number of Warrant Shares as is set forth on the signature page hereto, in each
case, as being purchased by the Buyer at the Closing pursuant to this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Buyer shall have received the opinion of Nason, Yeager, Gerson, Harris &amp; Fumero, P.A., the Company&rsquo;s counsel, dated as of the
Closing Date, in the form acceptable to the Buyer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Intentionally
omitted</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">(iv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Intentionally
omitted</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">(v)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[Intentionally
omitted]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">(vi)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company shall have delivered to the Buyer a certified copy of the Certificate of Designations as certified by the New York Secretary of
State within ten (10) days of the Closing Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">(vii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company shall have delivered to the Buyer a certificate, in the form acceptable to the Buyer, executed by the Secretary of the Company
and dated as of the Closing Date, as to (i) the resolutions consistent with Section&nbsp;3(b) as adopted by the Company&rsquo;s board
of directors in a form reasonably acceptable to the Buyer, (ii) the Certificate of Incorporation of the Company and (iii)&nbsp;the Bylaws
of the Company, each as in effect at the Closing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 28 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">(viii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each
and every representation and warranty of the Company shall be true and correct as of the date when made and as of the Closing Date as
though originally made at that time (except for representations and warranties that speak as of a specific date, which shall be true and
correct as of such specific date) and the Company shall have performed, satisfied and complied in all respects with the covenants, agreements
and conditions required to be performed, satisfied or complied with by the Company at or prior to the Closing Date. The Buyer shall have
received a certificate, duly executed by the Chief Executive Officer of the Company, dated as of the Closing Date, to the foregoing effect
and as to such other matters as may be reasonably requested by the Buyer in the form acceptable to the Buyer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">(ix)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Intentionally
omitted</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">(x)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Common Stock (A) shall be designated for quotation or listed (as applicable) on the Principal Market and (B) shall not have been suspended,
as of the Closing Date, by the SEC or the Principal Market from trading on the Principal Market nor shall suspension by the SEC or the
Principal Market have been threatened, as of the Closing Date, either (I) in writing by the SEC or the Principal Market or (II) by falling
below the minimum maintenance requirements of the Principal Market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">(xi)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company shall have obtained all governmental, regulatory or third party consents and approvals, if any, necessary for the sale of the
Securities, including without limitation, those required by the Principal Market, if any.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">(xii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No
statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered, promulgated or endorsed by
any court or Governmental Entity of competent jurisdiction that prohibits the consummation of any of the transactions contemplated by
the Transaction Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">(xiv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company shall have delivered notice to the Principal Market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">(xv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company and its Subsidiaries shall have delivered to the Buyer such other documents, instruments or certificates relating to the transactions
contemplated by this Agreement as the Buyer or its counsel may reasonably request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><B>8.</B></TD><TD STYLE="text-align: justify"><B>TERMINATION.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">In the event that the Closing
shall not have occurred with respect to a Buyer within five (5) days of the Execution Date, then the Buyer shall have the right to terminate
its obligations under this Agreement with respect to itself at any time on or after the close of business on such date without liability
of the Buyer to any other party; provided, however, (i) the right to terminate this Agreement under this Section 8 shall not be available
to the Buyer if the failure of the transactions contemplated by this Agreement to have been consummated by such date is the result of
the Buyer&rsquo;s breach of this Agreement and (ii) the abandonment of the sale and purchase of the Preferred Shares and the Warrants
shall be applicable only to the Buyer providing such written notice, provided further that no such termination shall affect any obligation
of the Company under this Agreement to reimburse the Buyer for the expenses described in Section 4(g) above. Nothing contained in this
Section 8 shall be deemed to release any party from any liability for any breach by such party of the terms and provisions of this Agreement
or the other Transaction Documents or to impair the right of any party to compel specific performance by any other party of its obligations
under this Agreement or the other Transaction Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 29 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><B>9.</B></TD><TD STYLE="text-align: justify"><B>MISCELLANEOUS.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(a)</TD><TD STYLE="text-align: justify"><U>Governing Law; Jurisdiction; Jury Trial</U>. This Agreement, and all claims or cause of action (whether
in contract, tort or statute) that may be based upon, arise out of or relate to this Agreement, or the negotiation, execution or performance
of this Agreement (including any claim or cause of action based upon, arising out of or related to any representation or warranty made
in or in connection with this Agreement or as an inducement to enter into this Agreement) shall be governed by and construed and enforced
in accordance with the internal laws of the State of Delaware without regard to conflict of law principles that would result in the application
of any law other than the law of the State of Delaware. The parties (a) hereby irrevocably and unconditionally submit to the jurisdiction
of the state courts of Delaware and to the jurisdiction of the United States District Court in the City and County of Wilmington, New
Castle County for the purpose of any suit, action or other proceeding arising out of or based upon this Agreement, (b) agree not to commence
any suit, action or other proceeding arising out of or based upon this Agreement except in the state courts of Delaware or the United
States District Court in the City and County of Wilmington, New Castle County, and (c) hereby waive, and agree not to assert, by way of
motion, as a defense, or otherwise, in any such suit, action or proceeding, any claim that it is not subject personally to the jurisdiction
of the above-named courts, that its property is exempt or immune from attachment or execution, that the suit, action or proceeding is
brought in an inconvenient forum, that the venue of the suit, action or proceeding is improper or that this Agreement or the subject matter
hereof may not be enforced in or by such court. EACH PARTY HEREBY WAIVES ITS RIGHTS TO A JURY TRIAL OF ANY CLAIM OR CAUSE OF ACTION BASED
UPON OR ARISING OUT OF THIS AGREEMENT, THE OTHER TRANSACTION DOCUMENTS, THE SECURITIES OR THE SUBJECT MATTER HEREOF OR THEREOF. THE SCOPE
OF THIS WAIVER IS INTENDED TO BE ALL-ENCOMPASSING OF ANY AND ALL DISPUTES THAT MAY BE FILED IN ANY COURT AND THAT RELATE TO THE SUBJECT
MATTER OF THIS TRANSACTION, INCLUDING, WITHOUT LIMITATION, CONTRACT CLAIMS, TORT CLAIMS (INCLUDING NEGLIGENCE), BREACH OF DUTY CLAIMS,
AND ALL OTHER COMMON LAW AND STATUTORY CLAIMS. THIS SECTION HAS BEEN FULLY DISCUSSED BY EACH OF THE PARTIES HERETO AND THESE PROVISIONS
WILL NOT BE SUBJECT TO ANY EXCEPTIONS. EACH PARTY HERETO HEREBY FURTHER WARRANTS AND REPRESENTS THAT SUCH PARTY HAS REVIEWED THIS WAIVER
WITH ITS LEGAL COUNSEL, AND THAT SUCH PARTY KNOWINGLY AND VOLUNTARILY WAIVES ITS JURY TRIAL RIGHTS FOLLOWING CONSULTATION WITH LEGAL COUNSEL.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(b)</TD><TD STYLE="text-align: justify"><U>Counterparts</U>. This Agreement may be executed in two or more identical counterparts, all of which
shall be considered one and the same agreement and shall become effective when counterparts have been signed by each party and delivered
to the other party. In the event that any signature is delivered by facsimile transmission or by an e-mail which contains a portable document
format (.pdf) file of an executed signature page, such signature page shall create a valid and binding obligation of the party executing
(or on whose behalf such signature is executed) with the same force and effect as if such signature page were an original thereof.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(c)</TD><TD STYLE="text-align: justify"><U>Headings; Gender</U>. The headings of this Agreement are for convenience of reference and shall not
form part of, or affect the interpretation of, this Agreement. Unless the context clearly indicates otherwise, each pronoun herein shall
be deemed to include the masculine, feminine, neuter, singular and plural forms thereof. The terms &ldquo;including,&rdquo; &ldquo;includes,&rdquo;
&ldquo;include&rdquo; and words of like import shall be construed broadly as if followed by the words &ldquo;without limitation.&rdquo;
The terms &ldquo;herein,&rdquo; &ldquo;hereunder,&rdquo; &ldquo;hereof&rdquo; and words of like import refer to this entire Agreement
instead of just the provision in which they are found.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 30 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(d)</TD><TD STYLE="text-align: justify"><U>Severability; Maximum Payment Amounts</U>. If any provision of this Agreement is prohibited by law
or otherwise determined to be invalid or unenforceable by a court of competent jurisdiction, the provision that would otherwise be prohibited,
invalid or unenforceable shall be deemed amended to apply to the broadest extent that it would be valid and enforceable, and the invalidity
or unenforceability of such provision shall not affect the validity of the remaining provisions of this Agreement so long as this Agreement
as so modified continues to express, without material change, the original intentions of the parties as to the subject matter hereof and
the prohibited nature, invalidity or unenforceability of the provision(s) in question does not substantially impair the respective expectations
or reciprocal obligations of the parties or the practical realization of the benefits that would otherwise be conferred upon the parties.
The parties will endeavor in good faith negotiations to replace the prohibited, invalid or unenforceable provision(s) with a valid provision(s),
the effect of which comes as close as possible to that of the prohibited, invalid or unenforceable provision(s). Notwithstanding anything
to the contrary contained in this Agreement or any other Transaction Document (and without implication that the following is required
or applicable), it is the intention of the parties that in no event shall amounts and value paid by the Company and/or any of its Subsidiaries
(as the case may be), or payable to or received by any of the Buyers, under the Transaction Documents (including without limitation, any
amounts that would be characterized as &ldquo;interest&rdquo; under applicable law) exceed amounts permitted under any applicable law.
Accordingly, if any obligation to pay, payment made to the Buyer, or collection by the Buyer pursuant the Transaction Documents is finally
judicially determined to be contrary to any such applicable law, such obligation to pay, payment or collection shall be deemed to have
been made by mutual mistake of the Buyer, the Company and its Subsidiaries and such amount shall be deemed to have been adjusted with
retroactive effect to the maximum amount or rate of interest, as the case may be, as would not be so prohibited by the applicable law.
Such adjustment shall be effected, to the extent necessary, by reducing or refunding, at the option of the Buyer, the amount of interest
or any other amounts which would constitute unlawful amounts required to be paid or actually paid to the Buyer under the Transaction Documents.
For greater certainty, to the extent that any interest, charges, fees, expenses or other amounts required to be paid to or received by
the Buyer under any of the Transaction Documents or related thereto are held to be within the meaning of &ldquo;interest&rdquo; or another
applicable term to otherwise be violative of applicable law, such amounts shall be pro-rated over the period of time to which they relate.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 31 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(e)</TD><TD STYLE="text-align: justify"><U>Entire Agreement; Amendments</U>. This Agreement, the other Transaction Documents and the schedules
and exhibits attached hereto and thereto and the instruments referenced herein and therein supersede all other prior oral or written agreements
between the Buyer, the Company, its Subsidiaries, their affiliates and Persons acting on their behalf, including, without limitation,
any transactions by the Buyer with respect to Common Stock or the Securities, and the other matters contained herein and therein, and
this Agreement, the other Transaction Documents, the schedules and exhibits attached hereto and thereto and the instruments referenced
herein and therein contain the entire understanding of the parties solely with respect to the matters covered herein and therein; provided,
however, nothing contained in this Agreement or any other Transaction Document shall (or shall be deemed to) (i) have any effect on any
agreements the Buyer has entered into with, or any instruments the Buyer has received from, the Company or any of its Subsidiaries prior
to the Execution Date with respect to any prior investment made by the Buyer in the Company or (ii) waive, alter, modify or amend in any
respect any obligations of the Company or any of its Subsidiaries, or any rights of or benefits to the Buyer or any other Person, in any
agreement entered into prior to the Execution Date between or among the Company and/or any of its Subsidiaries and the Buyer, or any instruments
the Buyer received from the Company and/or any of its Subsidiaries prior to the Execution Date, and all such agreements and instruments
shall continue in full force and effect. Except as specifically set forth herein or therein, neither the Company nor the Buyer makes any
representation, warranty, covenant or undertaking with respect to such matters. For clarification purposes, the Recitals are part of this
Agreement. No provision of this Agreement may be amended other than by an instrument in writing signed by the Company and the Buyer, and
any amendment to any provision of this Agreement made in conformity with the provisions of this Section&nbsp;9(e) shall be binding on
all Buyers and holders of Securities, as applicable; provided that no such amendment shall be effective to the extent that it (A) applies
to less than all of the holders of the Securities then outstanding or (B) imposes any obligation or liability on the Buyer without the
Buyer&rsquo;s prior written consent (which may be granted or withheld in the Buyer&rsquo;s sole discretion). No waiver shall be effective
unless it is in writing and signed by an authorized representative of the waiving party, provided that the Buyer may waive any provision
of this Agreement, and any waiver of any provision of this Agreement made in conformity with the provisions of this Section&nbsp;9(e)
shall be binding on all Buyers and holders of Securities, as applicable, provided that no such waiver shall be effective to the extent
that it (1) applies to less than all of the holders of the Securities then outstanding (unless a party gives a waiver as to itself only)
or (2) imposes any obligation or liability on the Buyer without the Buyer&rsquo;s prior written consent (which may be granted or withheld
in the Buyer&rsquo;s sole discretion). No consideration (other than reimbursement of legal fees) shall be offered or paid to any Person
to amend or consent to a waiver or modification of any provision of any of the Transaction Documents unless the same consideration also
is offered to all of the parties to the Transaction Documents, all holders of the Preferred Shares or all holders of the Warrants (as
the case may be). From the Execution Date and while any Preferred Shares or Warrants are outstanding, the Company shall not be permitted
to receive any consideration from a Buyer or a holder of Preferred Shares or Warrants that is not otherwise contemplated by the Transaction
Documents in order to, directly or indirectly, induce the Company or any Subsidiary (i) to treat the Buyer or holder of Preferred Shares
or Warrants in a manner that is more favorable than to other similarly situated Buyers or holders of Preferred Shares or Warrants, as
applicable, or (ii) to treat the Buyer(s) or holder(s) of Preferred Shares or Warrants in a manner that is less favorable than the Buyer
or holder of Preferred Shares or Warrants that is paying such consideration; provided, however, that the determination of whether a Buyer
has been treated more or less favorably than another Buyer shall disregard any securities of the Company purchased or sold by the Buyer.
The Company has not, directly or indirectly, made any agreements with the Buyers relating to the terms or conditions of the transactions
contemplated by the Transaction Documents except as set forth in the Transaction Documents. Without limiting the foregoing, the Company
confirms that, except as set forth in this Agreement, no Buyer has made any commitment or promise or has any other obligation to provide
any financing to the Company, any Subsidiary or otherwise. As a material inducement for the Buyer to enter into this Agreement, the Company
expressly acknowledges and agrees that (x) no due diligence or other investigation or inquiry conducted by a Buyer, any of its advisors
or any of its representatives shall affect the Buyer&rsquo;s right to rely on, or shall modify or qualify in any manner or be an exception
to any of, the Company&rsquo;s representations and warranties contained in this Agreement or any other Transaction Document and (y) unless
a provision of this Agreement or any other Transaction Document is expressly preceded by the phrase &ldquo;except as disclosed in the
SEC Documents,&rdquo; nothing contained in any of the SEC Documents shall affect the Buyer&rsquo;s right to rely on, or shall modify or
qualify in any manner or be an exception to any of, the Company&rsquo;s representations and warranties contained in this Agreement or
any other Transaction Document.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 32 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(f)</TD><TD STYLE="text-align: justify"><U>Notices</U>. Any notices, consents, waivers or other communications required or permitted to be given
under the terms of this Agreement must be in writing and will be deemed to have been delivered: (i) upon receipt, when delivered personally;
(ii) upon receipt, when sent by electronic mail (provided that such sent email is kept on file (whether electronically or otherwise) by
the sending party, the sending party receives a read receipt or other acknowledgment of receipt from the recipient, and the sending party
does not receive an automatically generated message from the recipient&rsquo;s email server that such e-mail could not be delivered to
such recipient); or (iii) one (1) Business Day after deposit with an overnight courier service with next day delivery specified, in each
case, properly addressed to the party to receive the same. The mailing addresses and e-mail addresses for such communications shall be:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 2in"><U>If to the Company</U>:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 2in">Forward Industries, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 2in">700 Veterans Memorial Hwy. Suite 100</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 2in">Hauppauge, New York 11788</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 2in">E-mail: __________.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 2in">Attention: CFO</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 2in; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 2in">With a copy to (which shall not constitute notice or service of
process):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">___________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">___________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">E-mail: _________________.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">Attention: _________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in"><U>If to the Investor</U>:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">___________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">___________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">E-mail: _________________.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">Attention: _________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in">With a copy to (which shall not constitute notice or service
of process):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">___________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">___________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">E-mail: _________________.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">Attention: _________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 2in"></P>

<!-- Field: Page; Sequence: 33 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 2in"><U>If to the Transfer Agent</U>:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 2in">Equinity Trust Company, LLC</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 2in">48 Wall Street, Floor 23</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 2in">New York, New York 10005</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 2in">Attention: Bryan Anderson</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 2in">E-mail: __________.com</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 2in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">or to such other mailing address and/or e-mail address
and/or to the attention of such other Person as the recipient party has specified by written notice given to each other party five (5)
days prior to the effectiveness of such change. Written confirmation of receipt (A) given by the recipient of such notice, consent, waiver
or other communication, (B) mechanically or electronically generated by the sender&rsquo;s e-mail containing the time, date and recipient&rsquo;s
e-mail or (C) provided by an overnight courier service shall be rebuttable evidence of personal service, receipt by e-mail or receipt
from an overnight courier service in accordance with clause (i), (ii) or (iii) above, respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(g)</TD><TD STYLE="text-align: justify"><U>Successors and Assigns</U>. This Agreement shall be binding upon and inure to the benefit of the parties
and their respective successors and assigns, including any purchasers of any of the Preferred Shares and Warrants. The Company shall not
assign this Agreement or any rights or obligations hereunder without the prior written consent of the Buyer, including, without limitation,
by way of a Fundamental Transaction (as defined in the Warrants) (unless the Company is in compliance with the applicable provisions governing
Fundamental Transactions set forth in the Warrants) or a Fundamental Transaction (as defined in the Certificate of Designations) (unless
the Company is in compliance with the applicable provisions governing Fundamental Transactions set forth in the Certificate of Designations).
A Buyer may assign some or all of its rights hereunder in connection with any transfer of any of its Securities without the consent of
the Company, in which event such assignee shall be deemed to be a Buyer hereunder with respect to such assigned rights.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(h)</TD><TD STYLE="text-align: justify"><U>No Third Party Beneficiaries</U>. This Agreement is intended for the benefit of the parties hereto
and their respective permitted successors and assigns, and is not for the benefit of, nor may any provision hereof be enforced by, any
other Person, other than the Indemnitees referred to in Section 9(k).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(i)</TD><TD STYLE="text-align: justify"><U>Survival</U>. The representations, warranties, agreements and covenants shall survive the Closing.
The Buyer shall be responsible only for its own representations, warranties, agreements and covenants hereunder.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(j)</TD><TD STYLE="text-align: justify"><U>Further Assurances</U>. Each party shall do and perform, or cause to be done and performed, all such
further acts and things, and shall execute and deliver all such other agreements, certificates, instruments and documents, as any other
party may reasonably request in order to carry out the intent and accomplish the purposes of this Agreement and the consummation of the
transactions contemplated hereby.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(k)</TD><TD STYLE="text-align: justify"><U>Indemnification</U>. In consideration of the Buyer&rsquo;s execution and delivery of the Transaction
Documents and acquiring the Securities thereunder and in addition to all of the Company&rsquo;s other obligations under the Transaction
Documents, the Company shall defend, protect, indemnify and hold harmless the Buyer and each holder of any Securities and all of their
stockholders, partners, members, officers, directors, employees and direct or indirect investors and any of the foregoing Persons&rsquo;
agents or other representatives (including, without limitation, those retained in connection with the transactions contemplated by this
Agreement) (collectively, the &ldquo;<B>Indemnitees</B>&rdquo;) from and against any and all actions, causes of action, suits, claims,
losses, costs, penalties, fees, liabilities and damages, and expenses in connection therewith (irrespective of whether any such Indemnitee
is a party to the action for which indemnification hereunder is sought), and including reasonable attorneys&rsquo; fees and disbursements
(the &ldquo;<B>Indemnified Liabilities</B>&rdquo;), incurred by any Indemnitee as a result of, or arising out of, or relating to (i) any
misrepresentation or breach of any representation or warranty made by the Company or any Subsidiary in any of the Transaction Documents,
(ii) any breach of any covenant, agreement or obligation of the Company or any Subsidiary contained in any of the Transaction Documents
or (iii) any cause of action, suit, proceeding or claim brought or made against such Indemnitee by a third party (including for these
purposes a derivative action brought on behalf of the Company or any Subsidiary) or which otherwise involves such Indemnitee that arises
out of or results from (A) the execution, delivery, performance or enforcement of any of the Transaction Documents, (B) any transaction
financed or to be financed in whole or in part, directly or indirectly, with the proceeds of the issuance of the Securities, (C) any disclosure
properly made by the Buyer pursuant to Section&nbsp;4(i), or (D) the status of the Buyer or holder of the Securities either as an investor
in the Company pursuant to the transactions contemplated by the Transaction Documents or as a party to this Agreement (including, without
limitation, as a party in interest or otherwise in any action or proceeding for injunctive or other equitable relief). To the extent that
the foregoing undertaking by the Company may be unenforceable for any reason, the Company shall make the maximum contribution to the payment
and satisfaction of each of the Indemnified Liabilities which is permissible under applicable law. Except as otherwise set forth herein,
the mechanics and procedures with respect to the rights and obligations under this Section&nbsp;9(k) shall be the same as those set forth
in Section&nbsp;6 of the Registration Rights Agreement.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 34 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(l)</TD><TD STYLE="text-align: justify"><U>Construction</U>. The language used in this Agreement will be deemed to be the language chosen by the
parties to express their mutual intent, and no rules of strict construction will be applied against any party. No specific representation
or warranty shall limit the generality or applicability of a more general representation or warranty, except to the extent of any direct
conflict between them, in which case the more specific provision shall control. Each and every reference to share prices, shares of Common
Stock and any other numbers in this Agreement that relate to the Common Stock shall be automatically adjusted for any stock splits, stock
dividends, stock combinations, recapitalizations or other similar transactions that occur with respect to the Common Stock after the date
of this Agreement. Notwithstanding anything in this Agreement to the contrary, for the avoidance of doubt, nothing contained herein shall
constitute a representation or warranty against, or a prohibition of, any actions with respect to the borrowing of, arrangement to borrow,
identification of the availability of, and/or securing of, securities of the Company in order for the Buyer (or its broker or other financial
representative) to effect short sales or similar transactions in the future.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(m)</TD><TD STYLE="text-align: justify"><U>Remedies</U>. The Buyer and in the event of assignment by Buyer of its rights and obligations hereunder,
each holder of Securities, shall have all rights and remedies set forth in the Transaction Documents and all rights and remedies which
such holders have been granted at any time under any other agreement or contract and all of the rights which such holders have under any
law. Any Person having any rights under any provision of this Agreement shall be entitled to enforce such rights specifically (without
posting a bond or other security), to recover damages by reason of any breach of any provision of this Agreement and to exercise all other
rights granted by law. Furthermore, the Company recognizes that in the event that it or any Subsidiary fails to perform, observe, or discharge
any or all of its or such Subsidiary&rsquo;s (as the case may be) obligations under the Transaction Documents, any remedy at law would
inadequate relief to the Buyers. The Company therefore agrees that the Buyers shall be entitled to specific performance and/or temporary,
preliminary and permanent injunctive or other equitable relief from any court of competent jurisdiction in any such case without the necessity
of proving actual damages and without posting a bond or other security. The remedies provided in this Agreement and the other Transaction
Documents shall be cumulative and in addition to all other remedies available under this Agreement and the other Transaction Documents,
at law or in equity (including a decree of specific performance and/or other injunctive relief).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(n)</TD><TD STYLE="text-align: justify"><U>Withdrawal Right</U>. Notwithstanding anything to the contrary contained in (and without limiting any
similar provisions of) the Transaction Documents, whenever the Buyer exercises a right, election, demand or option under a Transaction
Document and the Company or any Subsidiary does not timely perform its related obligations within the periods therein provided, then the
Buyer may rescind or withdraw, in its sole discretion from time to time upon written notice to the Company or such Subsidiary (as the
case may be), any relevant notice, demand or election in whole or in part without prejudice to its future actions and rights.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">[<I>signature pages follow</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<!-- Field: Page; Sequence: 35 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD COLSPAN="2"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: left"><U>THE COMPANY</U>:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: left"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: left"><B>FORWARD INDUSTRIES,
INC.</B></P>

</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 50%">&nbsp;</TD>
  <TD STYLE="width: 5%">&nbsp;</TD>
  <TD STYLE="width: 45%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
  <TD STYLE="padding-bottom: 1pt">By:</TD>
  <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD>Name:</TD>
  <TD>Michael Pruitt</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD>Title:</TD>
  <TD>Chief Executive Officer</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD COLSPAN="2"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: left"><U>BUYER</U>:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: left"><B>_________________________________</B></P>
</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
  <TD STYLE="padding-bottom: 1pt">By:</TD>
  <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD>Name:</TD>
  <TD>___________________________</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD>Title:</TD>
  <TD>Authorized
Signatory</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="text-transform: uppercase"><B><U>Subscription
amounts</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"># of Shares of Series B Preferred Stock: __________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"># of Warrant Shares: __________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Aggregate Purchase Price: $__________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 36; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.21
<SEQUENCE>5
<FILENAME>forward_ex1021.htm
<DESCRIPTION>REGISTRATION RIGHTS AGREEMENT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 10.21</B></P>

<P STYLE="margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>REGISTRATION RIGHTS AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>THIS REGISTRATION RIGHTS AGREEMENT</B>
(this &ldquo;<U>Agreement</U>&rdquo;), dated as of May 23, 2025 (the &ldquo;<U>Execution Date</U>&rdquo;), is entered into by and between
<FONT STYLE="text-transform: uppercase"><B>Forward Industries, Inc.</B></FONT>, a New York corporation (the &ldquo;<U>Company</U>&rdquo;),
and <B>_______________</B>, a Delaware limited partnership (together with its permitted assigns, the &ldquo;<U>Buyer</U>&rdquo;). Capitalized
terms used herein and not otherwise defined herein shall have the respective meanings set forth in the Preferred Stock Purchase Agreement
by and between the parties hereto, dated as of the Execution Date (as amended, restated, supplemented or otherwise modified from time
to time, the &ldquo;<U>Purchase Agreement</U>&rdquo;).</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>WHEREAS:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">A.</FONT>Upon
the terms and subject to the conditions of the Purchase Agreement, (i) the Company has agreed to issue to the Investor, and the Investor
has agreed to purchase, up to $1,000,000 of the Company&rsquo;s Series B Convertible Preferred Stock pursuant to the Purchase Agreement
(such shares, the &ldquo;<U>Purchase Shares</U>&rdquo;), that are convertible into shares of the Company&rsquo;s common stock, par value
$0.01 per share (the &ldquo;<U>Common Stock</U>&rdquo;), and (ii) the Company has agreed to issue to the Investor certain Common Stock
Purchase Warrants exercisable into such number of shares of Common Stock as set forth therein (the &ldquo;<U>Warrant Shares</U>&rdquo;);
and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">B.</FONT>To
induce the Buyer to enter into the Purchase Agreement, the Company has agreed to provide certain registration rights under the Securities
Act of 1933, as amended, and the rules and regulations thereunder, or any similar successor statute (collectively, the &ldquo;<U>Securities
Act</U>&rdquo;), and applicable state securities laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>NOW, THEREFORE,</B> in consideration
of the promises and the mutual covenants contained herein and other good and valuable consideration, the receipt and sufficiency of which
are hereby acknowledged, the Company and the Buyer hereby, intending to be legally bound, agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">1.</FONT><U>DEFINITIONS</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">As used in this Agreement, the following
terms shall have the following meanings:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">a.</FONT>&ldquo;<U>Investor</U>&rdquo;
means the Buyer, any transferee or assignee thereof to whom the Buyer assigns its rights under this Agreement in accordance with <U>Section
9</U> and who agrees to become bound by the provisions of this Agreement, and any transferee or assignee thereof to whom a transferee
or assignee assigns its rights under this Agreement in accordance with <U>Section 9</U> and who agrees to become bound by the provisions
of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">b.</FONT>&ldquo;<U>Conversion
Shares</U>&rdquo; means any and all shares of Common Stock issuable or issued pursuant to a conversion of the Purchase Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">c.</FONT>&ldquo;<U>Person</U>&rdquo;
means any individual or entity including but not limited to any corporation, a limited liability company, an association, a partnership,
an organization, a business, an individual, a governmental or political subdivision thereof or a governmental agency.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">d.</FONT>&ldquo;<U>Register</U>,&rdquo;
&ldquo;<U>registered</U>,&rdquo; and &ldquo;<U>registration</U>&rdquo; refer to a registration effected by preparing and filing one or
more Registration Statements of the Company in compliance with the Securities Act and pursuant to Rule 415 under the Securities Act or
any successor rule providing for offering securities on a continuous basis (&ldquo;<U>Rule 415</U>&rdquo;), and the declaration or ordering
of effectiveness of such Registration Statement(s) by the United States Securities and Exchange Commission (the &ldquo;<U>SEC</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">e.</FONT>&ldquo;<U>Registrable
Securities</U>&rdquo; means all of the Purchase Shares, the Warrant Shares and all of the Conversion Shares that may, from time to time,
be issued or become issuable to the Investor under the Purchase Agreement and its related Transaction Documents (as defined therein) (without
regard to any limitation or restriction on purchases), and any and all shares of capital stock issued or issuable with respect to the
Conversion Shares or the Warrant Shares as a result of any stock split, stock dividend, recapitalization, exchange or similar event or
otherwise, without regard to any limitation on purchases under the Purchase Agreement or the Transaction Documents (as defined therein).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">f.</FONT>&ldquo;<U>Registration
Statement</U>&rdquo; means one or more registration statements of the Company covering only the resale of the Registrable Securities,
including, for the avoidance of doubt, any New Registration Statement (as defined below).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">2.</FONT><U>REGISTRATION</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">a.</FONT><U>Mandatory
Registration.</U> The Company shall, within ninety (90) calendar days after the Execution Date, file with the SEC an initial Registration
Statement on Form S-1 covering the maximum number of Registrable Securities as shall be permitted to be included thereon in accordance
with applicable SEC rules, regulations and interpretations so as to permit the resale of such Registrable Securities by the Investor under
Rule 415 under the Securities Act at then-prevailing market prices (and not fixed prices), as mutually determined by both the Company
and the Investor in consultation with their respective legal counsel; provided, however, the Company may delay filing or suspend the use
of any Registration Statement if the Company determines upon advice of legal counsel, that in order for the registration statement to
not contain a material misstatement or omission, an amendment thereto would be needed, or if the Board of Directors, upon advice of legal
counsel, reasonably believes that such filing or use would require premature disclosure of information that could materially adversely
affect the Company; provided, however, that in the event the Investor owns Conversion Shares (or securities convertible into Conversion
Shares) at the time of any such suspension of use of the registration statement, the Company shall use reasonable best efforts to make
such registration statement available for the resale of such securities by the Investor as soon as practicable thereafter. The initial
Registration Statement shall register only Registrable Securities. The Investor and its counsel shall have a reasonable opportunity to
review and comment upon such Registration Statement and any amendment or supplement to such Registration Statement and any related prospectus
prior to its filing with the SEC, and the Company shall give due consideration to all such comments. The Investor acknowledges that it
will be identified in the initial Registration Statement (and in any New Registration Statement) as an underwriter within the meaning
of Section 2(a)(11) of the Securities Act, and the Investor shall furnish all information reasonably requested by the Company for inclusion
therein. The Company shall use its commercially reasonable efforts to have the Registration Statement and any amendment declared effective
by the SEC at the earliest practicable date. The Company shall use commercially reasonable efforts to keep the Registration Statement
effective pursuant to Rule 415 promulgated under the Securities Act and available for the resale by the Investor of all of the Registrable
Securities covered thereby at all times until the date on which the Investor shall have resold all the Registrable Securities covered
thereby and no shares of Common Stock remain issuable under the Purchase Agreement (the &ldquo;<U>Registration Period</U>&rdquo;). The
effective Registration Statement (including any amendments or supplements thereto and prospectuses contained therein) shall not contain
any untrue statement of a material fact or omit to state a material fact required to be stated therein, or necessary to make the statements
therein, in light of the circumstances in which they were made, not misleading. Any time-based requirements set forth in this Agreement
shall be extended to the next Business Day if the applicable time falls on a weekend or federal holiday.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">b.</FONT><U>Rule
424 Prospectus</U>. The Company shall, as required by applicable securities regulations, from time to time file with the SEC, pursuant
to Rule 424 promulgated under the Securities Act, the prospectus and prospectus supplements, if any, to be used in connection with sales
of the Registrable Securities under the Registration Statement. The Investor and its counsel shall have a reasonable opportunity to review
and comment upon such prospectus prior to its filing with the SEC, and the Company shall give due consideration to all such comments.
The Investor shall use its commercially reasonable efforts to comment upon such prospectus within one (1) Business Day from the date the
Investor receives the substantially final pre-filing version of such prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">c.</FONT><U>Sufficient
Number of Shares Registered</U>. In the event the number of shares of Common Stock available under the Registration Statement is insufficient
to cover all of the Registrable Securities, the Company shall, to the extent necessary and permissible, amend the Registration Statement
or file a new Registration Statement (a &ldquo;<U>New Registration Statement</U>&rdquo;), so as to cover all of such Registrable Securities
(subject to the limitations set forth in <U>Section 2(a)</U>) as soon as reasonably practicable, but in any event not later than fifteen
(15) Business Days after the necessity therefor arises, subject to any limits that may be imposed by the SEC pursuant to Rule 415 under
the Securities Act. The Company shall use its commercially reasonable efforts to cause such amendment and/or New Registration Statement
to become effective as soon as reasonably practicable following the filing thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">d.</FONT><U>Offering</U>.
If the staff of the SEC (the &ldquo;<U>Staff</U>&rdquo;) or the SEC seeks to characterize any offering pursuant to a Registration Statement
filed pursuant to this Agreement as constituting an offering of securities that does not permit such Registration Statement to become
effective and be used for resales by the Investor under Rule 415 at then-prevailing market prices (and not fixed prices), or if after
the filing of the initial Registration Statement with the SEC pursuant to <U>Section 2(a)</U>, the Company is otherwise required by the
Staff or the SEC to reduce the number of Registrable Securities included in such initial Registration Statement, then the Company shall
reduce the number of Registrable Securities to be included in such initial Registration Statement (after consulting with the Investor
and its legal counsel as to the specific Registrable Securities to be removed therefrom) until such time as the Staff and the SEC shall
so permit such Registration Statement to become effective and be used as aforesaid. In the event of any reduction in Registrable Securities
pursuant to this paragraph, the Company shall file one or more New Registration Statements in accordance with <U>Section 2(c)</U> until
such time as all Registrable Securities have been included in Registration Statements that have been declared effective and the prospectus
contained therein is available for use by the Investor. Notwithstanding any provision herein or in the Purchase Agreement to the contrary,
the Company&rsquo;s obligations to register the Registrable Securities (and any related conditions to the Investor&rsquo;s obligations)
shall be qualified as necessary to comport with any requirement of the SEC or the Staff as addressed in this <U>Section 2(d)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">3.</FONT><U>RELATED
OBLIGATIONS</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">With respect to the Registration
Statement and whenever any Registrable Securities are to be registered pursuant to <U>Section 2</U>, including on any New Registration
Statement, the Company shall use its commercially reasonable efforts to effect the registration of the Registrable Securities in accordance
with the intended method of disposition thereof and, pursuant thereto, the Company shall have the following obligations:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">a.</FONT>The
Company shall prepare and file with the SEC such amendments (including post-effective amendments) and supplements to any Registration
Statement and the prospectus used in connection with such Registration Statement, which prospectus is to be filed pursuant to Rule 424
promulgated under the Securities Act, as may be necessary to keep the Registration Statement or any New Registration Statement effective
at all times during the Registration Period, and, during such period, comply with the applicable provisions of the Securities Act with
respect to the disposition of all Registrable Securities of the Company covered by the Registration Statement or any New Registration
Statement until such time as all of such Registrable Securities shall have been disposed of in accordance with the intended methods of
disposition by the seller or sellers thereof as set forth in such Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">b.</FONT>The
Company shall permit the Investor to review and comment upon the Registration Statement or any New Registration Statement and all amendments
and supplements thereto at least two (2) Business Days prior to filing such Registration Statement or New Registration Statement with
the SEC, and not file any such document in a form to which the Investor reasonably objects in writing. The Investor shall use its reasonable
best efforts to comment upon the Registration Statement or any New Registration Statement and any amendments or supplements thereto within
one (1) Business Day from the date the Investor receives the substantially final version thereof. The Company shall furnish to the Investor,
without charge, any correspondence from the SEC or the Staff to the Company or its representatives relating to the Registration Statement
or any New Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">c.</FONT>Upon
request of the Investor, the Company shall furnish to the Investor, (i)&nbsp;promptly after the same is prepared and filed with the SEC,
at least one copy of any Registration Statement and any amendment(s) thereto, including financial statements and schedules, all documents
incorporated therein by reference and all exhibits, (ii) upon the effectiveness of any Registration Statement, a copy of the prospectus
included in such Registration Statement and all amendments and supplements thereto (or such other number of copies as the Investor may
reasonably request) and (iii) such other documents, including copies of any preliminary or final prospectus, as the Investor may reasonably
request from time to time in order to facilitate the disposition of the Registrable Securities owned by the Investor. For the avoidance
of doubt, any filing available to the Investor via the SEC&rsquo;s live EDGAR system shall be deemed &ldquo;furnished to the Investor&rdquo;
or &ldquo;delivered to the Investor&rdquo; hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">d.</FONT>The
Company shall use commercially reasonable efforts to (i) register and qualify the Registrable Securities covered by any Registration Statement
under such other securities or &ldquo;blue sky&rdquo; laws of such jurisdictions in the United States as the Investor reasonably requests,
(ii) prepare and file in those jurisdictions, such amendments (including post-effective amendments) and supplements to such registrations
and qualifications as may be necessary to maintain the effectiveness thereof during the Registration Period, (iii) take such other actions
as may be necessary to maintain such registrations and qualifications in effect at all times during the Registration Period, and (iv)
take all other actions reasonably necessary or advisable to qualify the Registrable Securities for sale in such jurisdictions; provided,
however, that the Company shall not be required in connection therewith or as a condition thereto to (x) qualify to do business in any
jurisdiction where it would not otherwise be required to qualify but for this <U>Section 3(d)</U>, (y) subject itself to taxation in any
such jurisdiction, or (z) file a general consent to service of process in any such jurisdiction. The Company shall promptly notify the
Investor who holds Registrable Securities of the receipt by the Company of any notification with respect to the suspension of the registration
or qualification of any of the Registrable Securities for sale under the securities or &ldquo;blue sky&rdquo; laws of any jurisdiction
in the United States or its receipt of written notice of the initiation or threatening of any proceeding for such purpose. Notwithstanding
anything in this Agreement to the contrary, the Company shall not be obligated to register or qualify the Registrable Securities under
&ldquo;blue sky&rdquo; laws in any state which applies merit review.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">e.</FONT>As
promptly as reasonably practicable after becoming aware of any event or fact, the result of which makes a material fact included in any
Registration Statement, as then in effect, or any prospectus included therein untrue or results in the omission of a material fact required
to be stated therein or necessary in order to make the statements then made therein (in the case of any prospectus, in light of the circumstances
under which they were made) not misleading, the Company shall notify the Investor in writing of the happening of such event or existence
of such facts and promptly prepare a supplement or amendment to such Registration Statement to correct such untrue statement or omission,
and deliver a copy of such supplement or amendment to the Investor. The Company shall also promptly notify the Investor in writing (i)
when a prospectus or any prospectus supplement or post-effective amendment has been filed, and when any Registration Statement or any
post-effective amendment has become effective (notification of such effectiveness shall be delivered to the Investor by email or facsimile
on the same day of such effectiveness or by overnight mail), (ii) of any request by the SEC for amendments or supplements to any Registration
Statement or related prospectus or related information, and (iii) of the Company&rsquo;s reasonable determination that a post-effective
amendment to any Registration Statement would be appropriate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">f.</FONT>The
Company shall use its commercially reasonable efforts to prevent the issuance of any stop order or other suspension of effectiveness of
any Registration Statement, or the suspension of the qualification of any Registrable Securities for sale in any jurisdiction and, if
such an order or suspension is issued, to obtain the withdrawal of such order or suspension at the earliest possible moment and to notify
the Investor of the issuance of such order and the resolution thereof or its receipt of actual notice of the initiation or threat of any
proceeding for such purpose.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">g.</FONT>The
Company shall (i) cause all the Registrable Securities to be listed on the Principal Market if the listing of such Registrable Securities
is then permitted under the rules of the Principal Market, or (ii) secure designation and quotation of all the Registrable Securities
on the Principal Market. The Company shall pay all fees and expenses in connection with satisfying its obligation under this <U>Section
3(g)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">h.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; color: #010101">The
</FONT>Company shall cooperate with the Investor to facilitate the timely issuance of the Registrable Securities to be offered pursuant
to any Registration Statement, it being agreed that such Registrable Securities shall be issued as DWAC Shares and in such denominations
or amounts as the Investor may reasonably request and registered in such names as the Investor may request. &ldquo;<U>DWAC Shares</U>&rdquo;
means shares of Common Stock that are (i) issued in electronic form, (ii) the resale of which is registered under an effective registration
statement and (iii) timely credited, once a DWAC notice is received, by the Company to the Investor&rsquo;s or its designee&rsquo;s specified
Deposit/Withdrawal at Custodian (DWAC) account with DTC under its Fast Automated Securities Transfer (FAST) Program, or any similar program
hereafter adopted by DTC performing substantially the same function.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">i.</FONT>The
Company shall at all times provide a transfer agent and registrar with respect to its Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">j.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; color: #010101">If
reasonably requested in writing by the Investor, the Company shall: (i) as soon as practicable after receipt of written notice from the
Investor, incorporate in a prospectus supplement or post-effective amendment such information as the Investor reasonably believes should
be included therein relating to the sale and distribution of Registrable Securities, including, without limitation, information with respect
to the number of Registrable Securities</FONT> being sold, the purchase price being paid therefor and any other terms of the offering
of the Registrable Securities; (ii) make all required filings of such prospectus supplement or post-effective amendment as soon as practicable
upon notification of the matters to be incorporated in such prospectus supplement or post-effective amendment; and (iii) supplement or
make amendments to any Registration Statement or New Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">k.</FONT>The
Company shall use its commercially reasonable efforts to cause the Registrable Securities covered by any Registration Statement to be
registered with or approved by such other governmental agencies or authorities in the United States as may be necessary to consummate
the disposition of such Registrable Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">l.</FONT>Within
one (1) Business Day after any Registration Statement which includes the Registrable Securities is declared effective by the SEC, the
Company shall deliver, and shall direct legal counsel for the Company to deliver, to the Transfer Agent (with copies to the Investor)
confirmation that such Registration Statement has been declared effective by the SEC in substantially the form attached hereto as <U>Exhibit
A</U>. Thereafter, if requested by the Investor at any time, the Company shall direct its counsel to deliver to the Investor a written
confirmation whether or not the effectiveness of such Registration Statement has lapsed at any time for any reason (including, without
limitation, the issuance of a stop order) and whether or not the Registration Statement is current and available to the Investor for sale
of all of the Registrable Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">m.</FONT>The
Company shall take such other reasonable actions necessary to expedite and facilitate disposition by the Investor of Registrable Securities
pursuant to any Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">4.</FONT><U>OBLIGATIONS
OF THE INVESTOR</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">a.</FONT>The
Company shall notify the Investor in writing of the information the Company reasonably requires from the Investor in connection with any
Registration Statement hereunder. The Investor shall promptly furnish to the Company such information regarding itself, the Registrable
Securities held by it and the intended method of disposition of the Registrable Securities held by it as shall be reasonably required
to effect the registration of such Registrable Securities and shall execute such documents in connection with such registration as the
Company may reasonably request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">b.</FONT>The
Investor agrees to cooperate with the Company as reasonably requested by the Company in connection with the preparation and filing of
any Registration Statement hereunder and any amendments and supplements thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">c.</FONT>The
Investor agrees that, upon receipt of any notice from the Company of the happening of any event or existence of facts of the kind described
in <U>Section 3(f)</U> or the first sentence of <U>3(e)</U>, the Investor will immediately discontinue disposition of Registrable Securities
pursuant to any Registration Statement(s) covering such Registrable Securities until the Investor&rsquo;s receipt of the copies of a notice
regarding the resolution or withdrawal of the stop order or suspension as contemplated by <U>Section 3(f)</U> or the supplemented or amended
prospectus as contemplated by the first sentence of Section 3(e<U>)</U>. Notwithstanding anything to the contrary, the Company shall direct
the Transfer Agent to promptly deliver shares of Common Stock without any restrictive legend in accordance with the terms of the Purchase
Agreement in connection with any sale of Registrable Securities with respect to which an Investor has entered into a contract for sale
prior to the Investor&rsquo;s receipt of a notice from the Company of the happening of any event of the kind described in <U>Section 3(f)</U>
or the first sentence of <U>Section 3(e)</U> and for which the Investor has not yet settled.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">5.</FONT><U>EXPENSES
OF REGISTRATION</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">All reasonable expenses of the Company,
other than sales or brokerage commissions, incurred in connection with registrations, filings or qualifications pursuant to <U>Sections
2</U> and <U>3</U>, including, without limitation, all registration, listing and qualifications fees, printers and accounting fees, and
fees and disbursements of counsel for the Company, shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">6.</FONT><U>INDEMNIFICATION</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">a.</FONT>To
the fullest extent permitted by law, the Company will, and hereby does, indemnify, hold harmless and defend the Investor, each Person,
if any, who controls the Investor, the members, the directors, officers, partners, employees, agents, representatives of the Investor
and each Person, if any, who controls the Investor within the meaning of Section 20 of the Securities Exchange Act of 1934, as amended
(the &ldquo;<U>Exchange Act</U>&rdquo;) (each, an &ldquo;<U>Indemnified Person</U>&rdquo;), against any losses, claims, damages, liabilities,
judgments, fines, penalties, charges, costs, reasonable attorneys&rsquo; fees, amounts paid in settlement (such settlement with the consent
of the Company, and such consent not to be unreasonably withheld) or reasonable expenses, joint or several, (collectively, &ldquo;<U>Claims</U>&rdquo;)
incurred in investigating, preparing or defending any action, claim, suit, inquiry, proceeding, investigation or appeal taken from the
foregoing by or before any court or governmental, administrative or other regulatory agency, body or the SEC, whether pending or threatened,
whether or not an indemnified party is or may be a party thereto (&ldquo;<U>Indemnified Damages</U>&rdquo;), to which any of them may
become subject insofar as such Claims (or actions or proceedings, whether commenced or threatened, in respect thereof) arise out of or
are based upon: (i) any untrue statement or alleged untrue statement of a material fact in the Registration Statement, any New Registration
Statement or any post-effective amendment thereto or in any filing made by the Company in connection with the qualification of the offering
under the securities or other &ldquo;blue sky&rdquo; laws of any jurisdiction in which Registrable Securities are offered (&ldquo;<U>Blue
Sky Filing</U>&rdquo;), or the omission or alleged omission to state a material fact required to be stated therein or necessary to make
the statements therein not misleading, (ii) any untrue statement or alleged untrue statement of a material fact contained in the final
prospectus (as amended or supplemented, if the Company files any amendment thereof or supplement thereto with the SEC) or the omission
or alleged omission to state therein any material fact necessary to make the statements made therein, in light of the circumstances under
which the statements therein were made, not misleading, (iii) any violation or alleged violation by the Company of the Securities Act,
the Exchange Act, any other law, including, without limitation, any state securities law, or any rule or regulation thereunder relating
to the offer or sale of the Registrable Securities pursuant to the Registration Statement or any New Registration Statement or (iv) any
material violation by the Company of this Agreement (the matters in the foregoing clauses (i) through (iv) being, collectively, &ldquo;<U>Violations</U>&rdquo;).
The Company shall reimburse each Indemnified Person promptly as such expenses are incurred and are due and payable, for any reasonable
and documented legal fees or other reasonable expenses incurred by them in connection with investigating or defending any such Claim.
Notwithstanding anything to the contrary contained herein, the indemnification agreement contained in this <U>Section 6(a)</U>: (i) shall
not apply to a Claim by an Indemnified Person arising out of or based upon a Violation which occurs in reliance upon and in conformity
with information about or relating to the Investor or its sale of Registrable Securities furnished in writing to the Company by such Indemnified
Person expressly for use in connection with the preparation of the Registration Statement, any New Registration Statement or any such
amendment thereof or supplement thereto or prospectus contained therein, if such Registration Statement, New Registration Statement or
amendment thereof or supplement thereof or prospectus contained therein was timely made available by the Company pursuant to <U>Section
3(c</U>) or <U>Section 3(e)</U>; (ii) with respect to any superseded prospectus, shall not inure to the benefit of any such Person from
whom the Person asserting any such Claim purchased the Registrable Securities that are the subject thereof (or to the benefit of any Person
controlling such Person) if the untrue statement or omission of material fact contained in the superseded prospectus was corrected in
the revised prospectus, as then amended or supplemented, if such revised prospectus was timely made available by the Company pursuant
to <U>Section 3(c)</U> or <U>Section 3(e)</U>, and the Indemnified Person was promptly advised in writing not to use the incorrect prospectus
prior to the use giving rise to a violation and such Indemnified Person, notwithstanding such advice, used it; (iii) shall not be available
to the extent such Claim is based on a failure of the Investor to deliver or to cause to be delivered the prospectus made available by
the Company, if such prospectus was timely made available by the Company pursuant to <U>Section 3(c)</U> or <U>Section 3(e)</U>; and (iv)
shall not apply to amounts paid in settlement of any Claim if such settlement is effected without the prior written consent of the Company,
which consent shall not be unreasonably withheld. Such indemnity shall remain in full force and effect regardless of any investigation
made by or on behalf of the Indemnified Person and shall survive the transfer of the Registrable Securities by the Investor pursuant to
<U>Section 9</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">b.</FONT>In
connection with the Registration Statement or any New Registration Statement or prospectus, the Investor agrees to indemnify, hold harmless
and defend, to the same extent and in the same manner as is set forth in <U>Section 6(a)</U>, the Company, each of its directors, each
of its officers who signs the Registration Statement or any New Registration Statement, each Person, if any, who controls the Company
within the meaning of Section 20 of the Exchange Act (collectively and together with an Indemnified Person, an &ldquo;<U>Indemnified Party</U>&rdquo;),
against any Claim or Indemnified Damages to which any of them may become subject, under the Securities Act, the Exchange Act or otherwise,
insofar as such Claim or Indemnified Damages arise out of or are based upon any Violation, in each case to the extent, and only to the
extent, that such Violation occurs in reliance upon and in conformity with written information about the Investor or its offer and sale
of Registrable Securities including the information set forth on <U>Exhibit B</U> attached hereto or updated from time to time in writing
by the Investor and furnished to the Company by the Investor expressly for use in connection with such Registration Statement or prospectus
or any New Registration Statement or from the failure of the Investor to deliver or cause to be delivered the prospectus made available
by the Company, if such prospectus was timely made available by the Company pursuant to <U>Section 3(c)</U> or <U>Section 3(e)</U>; and,
subject to <U>Section 6(d)</U>, the Investor will reimburse any legal or other expenses reasonably incurred (and documented) by such Indemnified
Party in connection with investigating or defending any such Claim; provided, however, that the indemnity agreement contained in this
<U>Section 6(b)</U> and the agreement with respect to contribution contained in <U>Section 7</U> shall not apply to amounts paid in settlement
of any Claim if such settlement is effected without the prior written consent of the Investor, which consent shall not be unreasonably
withheld; provided, further, however, that the Investor shall be liable under this <U>Section 6(b)</U> for only that amount of a Claim
or Indemnified Damages as does not exceed the net proceeds to the Investor as a result of the sale of Registrable Securities pursuant
to such Registration Statement. Such indemnity shall remain in full force and effect regardless of any investigation made by or on behalf
of such Indemnified Party and shall survive the transfer of the Registrable Securities by the Investor pursuant to <U>Section 9</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">c.</FONT>Promptly
after receipt by an Indemnified Person or Indemnified Party under this <U>Section 6</U> of notice of the commencement of any action or
proceeding (including any governmental action or proceeding) involving a Claim, such Indemnified Person or Indemnified Party shall, if
a Claim in respect thereof is to be made against any indemnifying party under this <U>Section 6</U>, deliver to the indemnifying party
a written notice of the commencement thereof, and the indemnifying party shall have the right to participate in, and, to the extent the
indemnifying party so desires, jointly with any other indemnifying party similarly noticed, to assume control of the defense thereof with
counsel mutually satisfactory to the indemnifying party and the Indemnified Person or the Indemnified Party, as the case may be; provided,
however, that an Indemnified Person or Indemnified Party shall have the right to retain its own separate counsel comprised of one attorney
or law firm with the reasonable and documented fees and expenses to be paid by the indemnifying party, if, in the reasonable opinion of
counsel retained by the indemnifying party, the representation by such counsel of the Indemnified Person or Indemnified Party and the
indemnifying party would be inappropriate due to actual or potential differing interests between such Indemnified Person or Indemnified
Party and any other party represented by such counsel in such proceeding. The Indemnified Party or Indemnified Person shall cooperate
fully with the indemnifying party in connection with any negotiation or defense of any such action or claim by the indemnifying party
and shall furnish to the indemnifying party all information reasonably available to the Indemnified Party or Indemnified Person which
relates to such action or claim. The indemnifying party shall keep the Indemnified Party or Indemnified Person fully apprised at all times
as to the status of the defense or any settlement negotiations with respect thereto. No indemnifying party shall be liable for any settlement
of any action, claim or proceeding effected without its written consent, provided, however, that the indemnifying party shall not unreasonably
withhold, delay or condition its consent. No indemnifying party shall, without the consent of the Indemnified Party or Indemnified Person,
consent to entry of any judgment or enter into any settlement or other compromise which does not include as an unconditional term thereof
the giving by the claimant or plaintiff to such Indemnified Party or Indemnified Person of a release from all liability in respect to
such claim or litigation. Following indemnification as provided for hereunder, the indemnifying party shall be subrogated to all rights
of the Indemnified Party or Indemnified Person with respect to all third parties, firms or corporations relating to the matter for which
indemnification has been made. The failure to deliver written notice to the indemnifying party within a reasonable time of the commencement
of any such action shall not relieve such indemnifying party of any liability to the Indemnified Person or Indemnified Party under this
<U>Section 6</U>, except to the extent that the indemnifying party is prejudiced in its ability to defend such action.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">d.</FONT>The
indemnification required by this <U>Section 6</U> shall be made by periodic payments of the amount thereof during the course of the investigation
or defense, as and when bills are received or Indemnified Damages are incurred. Any Person receiving a payment pursuant to this <U>Section
6</U> that is later determined (via definitive adjudication) not to be entitled to such payment shall return such payment to the person
making it.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">e.</FONT>The
indemnity agreements contained herein shall be in addition to (i) any cause of action or similar right of the Indemnified Party or Indemnified
Person against the indemnifying party or others, and (ii) any liabilities the indemnifying party may be subject to pursuant to applicable
law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">7.</FONT><U>CONTRIBUTION</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">To the extent any indemnification
by an indemnifying party is prohibited or limited by law, the indemnifying party agrees to make the maximum contribution with respect
to any amounts for which it would otherwise be liable under <U>Section 6</U> to the fullest extent permitted by law; provided, however,
that: (i) no seller of Registrable Securities guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities
Act) shall be entitled to contribution from any seller of Registrable Securities who was not guilty of fraudulent misrepresentation; and
(ii) contribution by any seller of Registrable Securities shall be limited in amount to the net amount of proceeds received by such seller
from the sale of such Registrable Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">8.</FONT><U>REPORTS
AND DISCLOSURE UNDER THE SECURITIES ACT</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">With a view to making available
to the Investor the benefits of Rule 144 promulgated under the Securities Act or any other similar rule or regulation of the SEC that
may at any time permit the Investor to sell securities of the Company to the public without registration (&ldquo;<U>Rule 144</U>&rdquo;),
the Company agrees, at the Company&rsquo;s sole expense, for as long as the Investor owns Registrable Securities, to use commercially
reasonable efforts to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">a.</FONT>make
and keep public information available, as those terms are understood and defined in Rule 144 (with the failure of the Company for any
reason to satisfy the requirements of Rule 144(c)(1), referred to as a &ldquo;<U>Current Public Information Failure</U>&rdquo;);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">b.</FONT>file
with the SEC all reports and other documents required of the Company under the Securities Act and the Exchange Act so long as the Company
remains subject to such requirements and the filing of such reports and other documents is required for the applicable provisions of Rule
144;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">c.</FONT>furnish
to the Investor so long as the Investor owns Registrable Securities, promptly upon request (i) a written statement by the Company that
it has complied with the reporting and or disclosure provisions of Rule 144(c) with a confirmation that no Current Public Information
Failure has occurred, the Securities Act and the Exchange Act, (ii) a copy of the most recent annual or quarterly report of the Company
and such other reports and documents so filed by the Company, and (iii) such other information as may be reasonably requested to permit
the Investor to sell such securities pursuant to Rule 144 without registration; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">d.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; color: #010101">take
such additional action as is reasonably requested by the Investor to enable the Investor to sell the Registrable Securities pursuant to
Rule 144, including, without limitation, delivering all such legal opinions, consents, certificates, resolutions and instructions to the
Transfer Agent as may be reasonably requested from time to time by the Investor and otherwise reasonably cooperate with the Investor and
the Investor&rsquo;s broker to effect such sale of securities pursuant to Rule 144; provided, however, the Investor shall provide such
documents as may be reasonably required by the Transfer Agent in connection therewith, including any written representations or certifications
of the Investor or its broker (which shall not include any opinion of the Investor&rsquo;s counsel) that may be required by the Transfer
Agent in connection therewith.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #010101">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">The Company agrees that damages
may be an inadequate remedy for any breach of the terms and provisions of this <U>Section 8</U> and that Investor shall, whether or not
it is pursuing any remedies at law, be entitled to seek equitable relief in the form of a preliminary or permanent injunctions, without
having to post any bond or other security, upon any breach or threatened breach of any such terms or provisions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">9.</TD><TD STYLE="text-align: justify"><U>ASSIGNMENT OF REGISTRATION RIGHTS</U>.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; color: #010101">The
Company shall not assign this Agreement or any rights or obligations hereunder without the prior written consent of the Investor; provided,
however, that any transaction, whether by merger, reorganization, restructuring, consolidation, financing or otherwise, whereby the Company
remains the surviving entity immediately after such transaction shall not be deemed an assignment. The Investor may not assign its rights
under this Agreement without the prior written consent of the Company, other than to an affiliate of the Investor, in which case the assignee
must agree in writing to be bound by the terms and conditions of this Agreement</FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">10.</FONT><U>AMENDMENT
OF REGISTRATION RIGHTS</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">No provision of this Agreement may
be amended or waived by the parties from and after the date that is one (1) Business Day immediately preceding the initial filing of the
Registration Statement with the SEC. Subject to the immediately preceding sentence, no provision of this Agreement may be (i) amended
other than by a written instrument signed by both parties hereto or (ii) waived other than in a written instrument signed by the party
against whom enforcement of such waiver is sought. Failure of any party to exercise any right or remedy under this Agreement or otherwise,
or delay by a party in exercising such right or remedy, shall not operate as a waiver thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">11.</FONT><U>MISCELLANEOUS</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">a.</FONT>A
Person is deemed to be a holder of Registrable Securities whenever such Person owns or is deemed to own of record such Registrable Securities.
If the Company receives conflicting instructions, notices or elections from two or more Persons with respect to the same Registrable Securities,
the Company shall act upon the basis of instructions, notice or election received from the registered owner of such Registrable Securities
as set forth on the books and records of the Transfer Agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">b.</FONT>Any
notices, consents or other communications required or permitted to be given under the terms of this Agreement must be in writing and will
be deemed to have been delivered: (i) upon receipt when delivered personally; (ii) upon receipt when sent by email (provided confirmation
of transmission is mechanically or electronically generated and kept on file by the sending party); or (iii) one Business Day after deposit
with a nationally recognized overnight delivery service, in each case properly addressed to the party to receive the same. The addresses
for such communications shall be:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">If to the Company:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">Forward Industries, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">700 Veterans Memorial Hwy. Suite
100</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">Hauppauge, New York 11788</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">E-mail: ______________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">Attention: Kathleen Weisberg</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">With a copy to (which shall not
constitute notice or service of process):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">___________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">___________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">___________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">E-mail: _________________.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">Attention: _________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">If to the Investor:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">___________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">___________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">E-mail: _________________.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">Attention: _________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">With a copy to (which shall not
constitute notice or service of process):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">___________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">___________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">E-mail: _________________.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">Attention: _________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">If to the Transfer Agent:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">___________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">___________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">E-mail: _________________.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">Attention: _________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in">or at such other address and/or
email address and/or to the attention of such other Person as the recipient party has specified by written notice given to each other
party three (3) Business Days prior to the effectiveness of such change. Written confirmation of receipt (A) given by the recipient of
such notice, consent or other communication, (B) mechanically or electronically generated by the sender&rsquo;s email account containing
the time, date, and recipient email address, as applicable or (C) provided by a nationally recognized overnight delivery service, shall
be rebuttable evidence of personal service, or receipt from a nationally recognized overnight delivery service in accordance with clause
(i), (ii) or (iii) above, respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">c.</FONT>This
Agreement, and all claims or cause of action (whether in contract, tort or statute) that may be based upon, arise out of or relate to
this Agreement, or the negotiation, execution or performance of this Agreement (including any claim or cause of action based upon, arising
out of or related to any representation or warranty made in or in connection with this Agreement or as an inducement to enter into this
Agreement) shall be governed by and construed and enforced in accordance with the internal laws of the State of Delaware without regard
to conflict of law principles that would result in the application of any law other than the law of the State of Delaware. The parties
(a) hereby irrevocably and unconditionally submit to the exclusive jurisdiction of (I) the state courts of Delaware and (II) the United
States District Court in the City and County of Wilmington, New Castle County for the purpose of any suit, action or other proceeding
arising out of or based upon this Agreement, (b) agree not to commence any suit, action or other proceeding arising out of or based upon
this Agreement except in the state courts of Delaware or the United States District Court in the City and County of Wilmington, New Castle
County, and (c) hereby waive, and agree not to assert, by way of motion, as a defense, or otherwise, in any such suit, action or proceeding,
any claim that it is not subject personally to the jurisdiction of the above-named courts, that its property is exempt or immune from
attachment or execution, that the suit, action or proceeding is brought in an inconvenient forum, that the venue of the suit, action or
proceeding is improper or that this Agreement or the subject matter hereof may not be enforced in or by such court. <B>EACH PARTY HEREBY
WAIVES ITS RIGHTS TO A JURY TRIAL OF ANY CLAIM OR CAUSE OF ACTION BASED UPON OR ARISING OUT OF THIS AGREEMENT, THE OTHER TRANSACTION DOCUMENTS,
THE SECURITIES OR THE SUBJECT MATTER HEREOF OR THEREOF. THE SCOPE OF THIS WAIVER IS INTENDED TO BE ALL-ENCOMPASSING OF ANY AND ALL DISPUTES
THAT MAY BE FILED IN ANY COURT AND THAT RELATE TO THE SUBJECT MATTER OF THIS TRANSACTION, INCLUDING, WITHOUT LIMITATION, CONTRACT CLAIMS,
TORT CLAIMS (INCLUDING NEGLIGENCE), BREACH OF DUTY CLAIMS, AND ALL OTHER COMMON LAW AND STATUTORY CLAIMS. THIS SECTION HAS BEEN FULLY
DISCUSSED BY EACH OF THE PARTIES HERETO AND THESE PROVISIONS WILL NOT BE SUBJECT TO ANY EXCEPTIONS. EACH PARTY HERETO HEREBY FURTHER WARRANTS
AND REPRESENTS THAT SUCH PARTY HAS REVIEWED THIS WAIVER WITH ITS LEGAL COUNSEL, AND THAT SUCH PARTY KNOWINGLY AND VOLUNTARILY WAIVES ITS
JURY TRIAL RIGHTS FOLLOWING CONSULTATION WITH LEGAL COUNSEL</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">d.</FONT>This
Agreement and the Purchase Agreement constitute the entire agreement among the parties hereto with respect to the subject matter hereof
and thereof. There are no restrictions, promises, warranties or undertakings among the parties hereto, other than those set forth or referred
to herein and therein. This Agreement and the Purchase Agreement supersede all prior agreements and understandings among the parties hereto
with respect to the subject matter hereof and thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">e.</FONT>This
Agreement is intended for the benefit of the parties hereto and, subject to the requirements of <U>Section 9</U>, their successors and
permitted assigns and, except as set forth in <U>Section 6</U> with respect to those Persons entitled to indemnity thereunder, is not
for the benefit of, nor may any provision hereof be enforced by, any other Person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">f.</FONT>The
headings in this Agreement are for convenience of reference only and shall not limit or otherwise affect the meaning hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">g.</FONT>This
Agreement may be executed in two or more identical counterparts, all of which shall be considered one and the same agreement and shall
become effective when counterparts have been signed by each party and delivered to the other party; provided that a facsimile signature
or signature delivered by e-mail in a &ldquo;.pdf&rdquo; format data file, including any electronic signature complying with the U.S.
federal ESIGN Act of 2000, e.g., www.docusign.com, www.echosign.adobe.com, etc., shall be considered due execution and shall be binding
upon the signatory thereto with the same force and effect as if the signature were an original signature.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">h.</FONT>Each
party shall do and perform, or cause to be done and performed, all such further acts and things, and shall execute and deliver all such
other agreements, certificates, instruments and documents, as the other party may reasonably request in order to carry out the intent
and accomplish the purposes of this Agreement and the consummation of the transactions contemplated hereby.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">i.</FONT>The
language used in this Agreement will be deemed to be the language chosen by the parties to express their mutual intent and no rules of
strict construction will be applied against any party. The term &ldquo;or&rdquo; shall not be exclusive.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>* * * * * *</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B></B></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B><BR STYLE="clear: both">
</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>IN WITNESS WHEREOF,</B> the
parties have caused this Registration Rights Agreement to be duly executed as of the Execution Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD COLSPAN="2"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: left"><B><U>THE COMPANY</U>:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: left"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: left"><B>FORWARD INDUSTRIES,
INC.</B></P>

</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 50%">&nbsp;</TD>
  <TD STYLE="width: 5%">&nbsp;</TD>
  <TD STYLE="width: 45%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
  <TD STYLE="padding-bottom: 1pt">By:</TD>
  <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD>Name:</TD>
  <TD>Michael Pruitt</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD>Title:</TD>
  <TD>Chief Executive Officer</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD COLSPAN="2"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: left"><B><U>INVESTOR</U></B>:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: left"><B>________________________________</B></P>
</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
  <TD STYLE="padding-bottom: 1pt">By:</TD>
  <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD>Name:</TD>
  <TD> __________________________</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD>Title:</TD>
  <TD>Authorized
Signatory</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 211.5pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 211.5pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 211.5pt; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 211.5pt; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 211.5pt; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 211.5pt; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 211.5pt; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 211.5pt; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 211.5pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 211.5pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 211.5pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 211.5pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 211.5pt; text-align: justify">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><B><U>EXHIBIT A</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B><U>TO REGISTRATION RIGHTS AGREEMENT</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>FORM OF NOTICE OF EFFECTIVENESS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>OF REGISTRATION STATEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><U>EXHIBIT B</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B><U>TO REGISTRATION RIGHTS AGREEMENT</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Information About The Investor Furnished To The
Company By The Investor </B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Expressly For Use In Connection With The Registration
Statement</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>Information With Respect to </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As of the date of the Purchase Agreement, ____________________, did not beneficially own any shares of our common stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 14; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.22
<SEQUENCE>6
<FILENAME>forward_ex1022.htm
<DESCRIPTION>FORM OF WARRANT DATED MAY 23, 2025
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 10.22</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH
THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE
IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &ldquo;SECURITIES ACT&rdquo;), AND,
ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO
AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE
WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS SECURITY MAY BE PLEDGED IN CONNECTION
WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">COMMON STOCK PURCHASE WARRANT<BR>
FORWARD INDUSTRIES, INC.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 50%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="display: inline-block; width: 1.5in; float: left; white-space: nowrap">Warrant Shares: _______</FONT></P>
</TD>
  <TD STYLE="text-align: right; width: 50%">Initial Exercise Date:
May 23, 2025</TD></TR>
</TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">THIS COMMON STOCK PURCHASE WARRANT
(the &ldquo;<U>Warrant</U>&rdquo;) certifies that, for value received, <B>_________________________</B> or its assigns (the &ldquo;<U>Holder</U>&rdquo;)
is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after
the date hereof (the &ldquo;<U>Initial Exercise Date</U>&rdquo;) and until the fifth (5<SUP>th</SUP>) anniversary of the Initial Exercise
Date (the &ldquo;<U>Termination Date</U>&rdquo;) but not thereafter, to subscribe for and purchase from <FONT STYLE="text-transform: uppercase"><B>Forward
Industries, Inc.</B></FONT>, a New York corporation (the &ldquo;<U>Company</U>&rdquo;), up to ____________________ shares (as subject
to adjustment hereunder, the &ldquo;<U>Warrant Shares</U>&rdquo;) of Common Stock. The purchase price of one share of Common Stock under
this Warrant shall be equal to the Exercise Price, as defined in <U>Section 2(b)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify"><FONT STYLE="font-size: 10pt; text-transform: none">Section&nbsp;1.
<U>Definitions</U>. In addition to the terms defined elsewhere in this Warrant, the following terms have the meanings indicated in this
<U>Section 1</U>:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<U>Affiliate</U>&rdquo;
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control
with a Person, as such terms are used in and construed under Rule 405 under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<U>Bid Price</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or
quoted on a Trading Market, the bid price of the Common Stock for the time in question (or the nearest preceding date) on the Trading
Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30 a.m. (New York
City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average price of the
Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then listed
or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on the Pink Open Market (or a similar organization
or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported, or (d)
in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good faith
by the Holders of a majority in interest of the Warrants then outstanding and reasonably acceptable to the Company, the fees and expenses
of which shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<U>Business Day</U>&rdquo;
means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized or required by
law to remain closed&#894; <U>provided</U>, <U>however</U>, for clarification, commercial banks shall not be deemed to be authorized or
required by law to remain closed due to &ldquo;stay at home&rdquo;, &ldquo;shelter-in-place&rdquo;, &ldquo;non-essential employee&rdquo;
or any other similar orders or restrictions or the closure of any physical branch locations at the direction of any governmental authority
so long as the electronic funds transfer systems (including for wire transfers) of commercial banks in The City of New York generally
are open for use by customers on such day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<U>Commission</U>&rdquo;
means the United States Securities and Exchange Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<U>Common Stock</U>&rdquo;
means the Common Stock of the Company, par value $0.01 per share, and any other class of securities into which such securities may hereafter
be reclassified or changed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<U>Common Stock Equivalents</U>&rdquo;
means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire at any time Common Stock, including,
without limitation, any debt, preferred stock, right, option, warrant or other instrument that is at any time convertible into or exercisable
or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<U>Exchange Act</U>&rdquo;
means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<U>Person</U>&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company,
joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<U>Securities Act</U>&rdquo;
means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<U>Subsidiary</U>&rdquo;
means any subsidiary of the Company and shall, where applicable, also include any direct or indirect subsidiary of the Company formed
or acquired after the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<U>Trading Day</U>&rdquo;
means a day on which the Common Stock is traded on a Trading Market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<U>Trading Market</U>&rdquo;
means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date in question: the
NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market or the New York Stock Exchange (or
any successors to any of the foregoing).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<U>Transfer Agent</U>&rdquo;
means Equiniti Trust Company, LLC, or such other Person who is then serving as the transfer agent for the Company in respect of the Common
Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<U>VWAP</U>&rdquo; means,
for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or quoted
on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date) on the
Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30 a.m.
(New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average price
of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then
listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on the Pink Open Market (or a similar
organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported,
or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good
faith by the holders of a majority in interest of the Warrants then outstanding and reasonably acceptable to the Company, the reasonable
and documented fees and expenses of which shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<U>Warrants</U>&rdquo;
means this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 1in; float: left; white-space:nowrap">Section&nbsp;2.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Exercise</U>. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(a)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT><U>Exercise of Warrant</U>. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any
time or times on or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed
PDF copy submitted by e-mail (or e-mail attachment) of the Notice of Exercise in the form annexed hereto (the &ldquo;<U>Notice of Exercise</U>&rdquo;).
Within the earlier of (i) two (2) Trading Days and (ii) the number of Trading Days comprising the Standard Settlement Period (as defined
in <U>Section 2(d)(i)</U> herein) following the date of exercise as aforesaid, the Holder shall deliver to the Company the aggregate Exercise
Price for the Warrant Shares specified in the applicable Notice of Exercise by wire transfer or cashier&rsquo;s check drawn on a United
States bank unless the cashless exercise procedure specified in <U>Section 2(c)</U> below is specified in the applicable Notice of Exercise.
No ink-original Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of
any Notice of Exercise be required. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender
this Warrant to the Company until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant has been exercised
in full, in which case, the Holder shall surrender this Warrant to the Company for cancellation within three (3) Trading Days of the date
on which the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in purchases of a portion
of the total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant Shares purchasable
hereunder in an amount equal to the applicable number of Warrant Shares purchased. The Holder and the Company shall maintain records showing
the number of Warrant Shares purchased and the date of such purchases. The Company shall deliver any objection to any Notice of Exercise
within one (1) Business Day of receipt of such notice. Notwithstanding the foregoing, with respect to any Notice(s) of Exercise delivered
on or prior to 4:00 p.m. (New York City time) on the business day prior to the Initial Exercise Date the Company agrees to deliver the
Warrant Shares subject to such notice(s) by 4:00 p.m. (New York City time) on the Initial Exercise Date and the Initial Exercise Date
shall be the Warrant Share Delivery Date for purposes hereunder, provided that payment of the aggregate Exercise Price (other than in
the case of a cashless exercise) is received by such Warrant Share Delivery Date. <B>The Holder and any assignee, by acceptance of this
Warrant, acknowledge and agree that, by reason of the provisions of this Section 2(a), following the purchase of a portion of the Warrant
Shares hereunder, the number of Warrant Shares available for purchase hereunder at any given time may be less than the amount stated on
the face hereof.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(b)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT><U>Exercise Price</U>. The exercise price per Warrant Share under this Warrant shall be $6.50, subject to adjustment hereunder
(the &ldquo;<U>Exercise Price</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(c)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT><U>Cashless Exercise</U>. If at the time of exercise hereof there is no effective registration statement registering, or the prospectus
contained therein is not available for the issuance of the Warrant Shares to the Holder, then this Warrant may also be exercised, in whole
or in part, at such time by means of a &ldquo;cashless exercise&rdquo; (a &ldquo;<U>Cashless Exercise</U>&rdquo;) in which the Holder
shall be entitled to receive a number of Warrant Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(A) = as applicable: (i) the
VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise if such Notice of Exercise is (1) both executed
and delivered pursuant to <U>Section 2(a)</U> hereof on a day that is not a Trading Day or (2) both executed and delivered pursuant to
<U>Section 2(a)</U> hereof on a Trading Day prior to the opening of &ldquo;regular trading hours&rdquo; (as defined in Rule 600(b) of
Regulation NMS promulgated under the federal securities laws) on such Trading Day, (ii) at the option of the Holder, either (y) the VWAP
on the Trading Day immediately preceding the date of the applicable Notice of Exercise or (z) the Bid Price of the Common Stock on the
principal Trading Market as reported by Bloomberg L.P. as of the time of the Holder&rsquo;s execution of the applicable Notice of Exercise
if such Notice of Exercise is executed during &ldquo;regular trading hours&rdquo; on a Trading Day and is delivered within two (2) hours
thereafter (including until two (2) hours after the close of &ldquo;regular trading hours&rdquo; on a Trading Day) pursuant to <U>Section
2(a)</U> hereof or (iii) the VWAP on the date of the applicable Notice of Exercise if the date of such Notice of Exercise is a Trading
Day and such Notice of Exercise is both executed and delivered pursuant to <U>Section 2(a)</U> hereof after the close of &ldquo;regular
trading hours&rdquo; on such Trading Day;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(B) = the Exercise Price of
this Warrant, as adjusted hereunder; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(X) = the number of Warrant
Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such exercise were by means
of a cash exercise rather than a cashless exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If Warrant Shares are issued in such a Cashless
Exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the Securities Act, the Warrant Shares shall take
on the registered characteristics of the Warrants being exercised. The Company agrees not to take any position contrary to this <U>Section
2(c)</U>. In the event that this Warrant has not be exercised by the Holder as of the Termination Date, the Warrant shall be automatically
exercised immediately prior to its termination pursuant to the calculation set forth in this Section 2(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(d)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT><U>Mechanics of Exercise</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(i)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT><U>Delivery of Warrant Shares Upon Exercise</U>. The Company shall cause the Warrant Shares purchased hereunder to be transmitted
by the Transfer Agent to the Holder by crediting the account of the Holder&rsquo;s or its designee&rsquo;s balance account with The Depository
Trust Company through its Deposit or Withdrawal at Custodian system if the Company&rsquo;s transfer agent is then a participant in such
system and either (A) there is an effective registration statement permitting the issuance of the Warrant Shares to or resale of the Warrant
Shares by Holder or (B) this Warrant is being exercised via cashless exercise, and otherwise by physical delivery of a certificate, registered
in the Company&rsquo;s share register in the name of the Holder or its designee, for the number of Warrant Shares to which the Holder
is entitled pursuant to such exercise to the address specified by the Holder in the Notice of Exercise by the date that is the earliest
of (i) two (2) Trading Days after the delivery to the Company of the Notice of Exercise, (ii) one (1) Trading Day after delivery of the
aggregate Exercise Price to the Company and (iii) the number of Trading Days comprising the Standard Settlement Period after the delivery
to the Company of the Notice of Exercise (such date, the &ldquo;<U>Warrant Share Delivery Date</U>&rdquo;). Upon delivery of the Notice
of Exercise, the Holder shall be deemed for all corporate purposes to have become the holder of record of the Warrant Shares with respect
to which this Warrant has been exercised, irrespective of the date of delivery of the Warrant Shares, provided that payment of the aggregate
Exercise Price (other than in the case of a cashless exercise) is received within the earlier of (i) two (2) Trading Days and (ii) the
number of Trading Days comprising the Standard Settlement Period following delivery of the Notice of Exercise. If the Company fails for
any reason to deliver to the Holder the Warrant Shares subject to a Notice of Exercise by the Warrant Share Delivery Date, the Company
shall pay to the Holder, in cash, as liquidated damages and not as a penalty, for each $1,000 of Warrant Shares subject to such exercise
(based on the VWAP of the Common Stock on the date of the applicable Notice of Exercise), $100 per Trading Day (increasing to $500 per
Trading Day on the third Trading Day after the Warrant Share Delivery Date) for each Trading Day after such Warrant Share Delivery Date
until such Warrant Shares are delivered or Holder rescinds such exercise. The Company agrees to maintain a transfer agent that is a participant
in the FAST program so long as this Warrant remains outstanding and exercisable. As used herein, &ldquo;<U>Standard Settlement Period</U>&rdquo;
means the standard settlement period, expressed in a number of Trading Days, on the Company&rsquo;s primary Trading Market with respect
to the Common Stock as in effect on the date of delivery of the Notice of Exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(ii)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT><U>Delivery of New Warrants Upon Exercise</U>. If this Warrant shall have been exercised in part, the Company shall, at the request
of a Holder and upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new
Warrant evidencing the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall
in all other respects be identical with this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(iii)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT><U>Rescission Rights</U>. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant
to <U>Section 2(d)(i)</U> by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise by delivering
written notice to the Company at any time prior to the delivery of such Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(iv)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT><U>Compensation for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</U>. In addition to any other rights available
to the Holder, if the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions
of <U>Section 2(d)(i)</U> above pursuant to an exercise on or before the Warrant Share Delivery Date (other than any such failure that
is solely due to any action or inaction by the Holder with respect to such exercise), and if after such date the Holder is required by
its broker to purchase (in an open market transaction or otherwise) or the Holder&rsquo;s brokerage firm otherwise purchases for the Holder
shares of Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving
upon such exercise (a &ldquo;<U>Buy-In</U>&rdquo;), then the Company shall (A) pay in cash to the Holder the amount, if any, by which
(x) the Holder&rsquo;s total purchase price (including brokerage commissions, if any) for the shares of Common Stock so purchased exceeds
(y) the amount obtained by multiplying (1) the number of Warrant Shares that the Company was required to deliver to the Holder in connection
with the exercise at issue times (2) the price at which the sell order giving rise to such purchase obligation was executed, and (B) at
the option of the Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise
was not honored (in which case such exercise shall be deemed rescinded) or deliver to the Holder the number of shares of Common Stock
that would have been issued had the Company timely complied with its exercise and delivery obligations hereunder. For example, if the
Holder purchases Common Stock having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise of shares
of Common Stock with an aggregate sale price giving rise to such purchase obligation of $10,000, under clause (A) of the immediately preceding
sentence the Company shall be required to pay the Holder $1,000. The Holder shall provide the Company written notice indicating the amounts
payable to the Holder in respect of the Buy-In and, upon request of the Company, evidence of the amount of such loss. Nothing herein shall
limit a Holder&rsquo;s right to pursue any other remedies available to it hereunder, at law or in equity including, without limitation,
a decree of specific performance and/or injunctive relief with respect to the Company&rsquo;s failure to timely deliver shares of Common
Stock upon exercise of the Warrant as required pursuant to the terms hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(v)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT><U>No Fractional Shares or Scrip</U>. No fractional shares or scrip representing fractional shares shall be issued upon the exercise
of this Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company
shall, at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied
by the Exercise Price or round up to the next whole share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(vi)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT><U>Charges, Taxes and Expenses</U>. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer
tax or other incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the
Company, and such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder&#894;
<U>provided</U>, <U>however</U>, that, in the event that Warrant Shares are to be issued in a name other than the name of the Holder,
this Warrant when surrendered for exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and
the Company may require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto.
The Company shall pay all Transfer Agent fees required for same-day processing of any Notice of Exercise and all fees to the Depository
Trust Company (or another established clearing corporation performing similar functions) required for same-day electronic delivery of
the Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(vii)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT><U>Closing of Books</U>. The Company will not close its stockholder books or records in any manner which prevents the timely exercise
of this Warrant, pursuant to the terms hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(e)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT><U>Holder&rsquo;s Exercise Limitations</U>. The Company shall not effect any exercise of this Warrant, and a Holder shall not have
the right to exercise any portion of this Warrant, pursuant to <U>Section 2</U> or otherwise, to the extent that after giving effect to
such issuance after exercise as set forth on the applicable Notice of Exercise, the Holder (together with the Holder&rsquo;s Affiliates,
and any other Persons acting as a group together with the Holder or any of the Holder&rsquo;s Affiliates (such Persons, &ldquo;<U>Attribution
Parties</U>&rdquo;)), would beneficially own in excess of the Beneficial Ownership Limitation (as defined below). For purposes of the
foregoing sentence, the number of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties shall
include the number of shares of Common Stock issuable upon exercise of this Warrant with respect to which such determination is being
made, but shall exclude the number of shares of Common Stock which would be issuable upon (i) exercise of the remaining, nonexercised
portion of this Warrant beneficially owned by the Holder or any of its Affiliates or Attribution Parties and (ii) exercise or conversion
of the unexercised or nonconverted portion of any other securities of the Company (including, without limitation, any other Common Stock
Equivalents) subject to a limitation on conversion or exercise analogous to the limitation contained herein beneficially owned by the
Holder or any of its Affiliates or Attribution Parties. Except as set forth in the preceding sentence, for purposes of this <U>Section
2(e)</U>, beneficial ownership shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations
promulgated thereunder, it being acknowledged by the Holder that the Company is not representing to the Holder that such calculation is
in compliance with Section 13(d) of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in accordance
therewith. To the extent that the limitation contained in this <U>Section 2(e)</U> applies, the determination of whether this Warrant
is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which
portion of this Warrant is exercisable shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise shall
be deemed to be the Holder&rsquo;s determination of whether this Warrant is exercisable (in relation to other securities owned by the
Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable, in each case subject
to the Beneficial Ownership Limitation, and the Company shall have no obligation to verify or confirm the accuracy of such determination
and shall have no liability for exercises of this Warrant that are not in compliance with the Beneficial Ownership Limitation, provided
this limitation of liability shall not apply if the Holder has detrimentally relied on outstanding share information provided by the Company
or the Transfer Agent. In addition, a determination as to any group status as contemplated above shall be determined in accordance with
Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder, and the Company shall have no obligation to verify
or confirm the accuracy of such determination and shall have no liability for exercises of the Warrant that are not in compliance with
the Beneficial Ownership Limitation, except to the extent the Holder relies on the number of outstanding shares of Common Stock that was
provided by the Company. For purposes of this <U>Section 2(e)</U>, in determining the number of outstanding shares of Common Stock, a
Holder may rely on the number of outstanding shares of Common Stock as reflected in (A) the Company&rsquo;s most recent periodic or annual
report filed with the Commission, as the case may be, (B) a more recent public announcement by the Company or (C)&nbsp;a more recent written
notice by the Company or the Transfer Agent setting forth the number of shares of Common Stock outstanding. Upon the written or oral request
of a Holder, the Company shall within two Trading Days confirm orally and in writing or by electronic mail to the Holder the number of
shares of Common Stock then outstanding. In any case, the number of outstanding shares of Common Stock shall be determined after giving
effect to the conversion or exercise of securities of the Company, including this Warrant, by the Holder or its Affiliates or Attribution
Parties since the date as of which such number of outstanding shares of Common Stock was reported. The &ldquo;<U>Beneficial Ownership
Limitation</U>&rdquo; shall be 4.99% of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance
of shares of Common Stock issuable upon exercise of this Warrant. The Holder, upon notice to the Company, may increase or decrease the
Beneficial Ownership Limitation provisions of this <U>Section 2(e)</U>, provided that the Beneficial Ownership Limitation in no event
exceeds 9.99% of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common
Stock upon exercise of this Warrant held by the Holder and the provisions of this <U>Section 2(e)</U> shall continue to apply. Any increase
in the Beneficial Ownership Limitation will not be effective until the 61st day after such notice is delivered to the Company. The provisions
of this <U>Section 2(e)</U> shall be construed and implemented in a manner otherwise than in strict conformity with the terms of this
<U>Section 2(e)</U> to correct this paragraph (or any portion hereof) which may be defective or inconsistent with the intended Beneficial
Ownership Limitation herein contained or to make changes or supplements necessary or desirable to properly give effect to such limitation.
The limitations contained in this paragraph shall apply to a successor holder of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(f)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT><U>Compliance with Rules of Nasdaq Capital Market</U>. Until Stockholder Approval (as defined in the Preferred Stock Purchase Agreement
between the Company and the Holder dated as of the Initial Exercise Date) is obtained, the Company shall not issue any shares of Common
Stock upon conversion of the Preferred Shares (as defined in the Preferred Stock Purchase Agreement) or exercise of the Warrants, to the
extent that after giving effect thereto, the aggregate number of shares of Common Stock that would be issued pursuant to the Preferred
Stock Purchase Agreement, the Transaction Documents (as defined in the Preferred Stock Purchase Agreement), and the transactions contemplated
hereby and thereby would exceed 19.99% of the number of shares of Common Stock issued and outstanding immediately prior to the execution
of the Preferred Stock Purchase Agreement, which number of shares shall be reduced, on a share-for-share basis, by the number of shares
of Common Stock issued or issuable pursuant to any transaction or series of transactions that may be aggregated with the transactions
contemplated by this Preferred Stock Purchase Agreement under applicable rules of the Nasdaq Capital Market (such maximum number of shares,
the &ldquo;<U>Exchange Cap</U>&rdquo;). As soon as practicable after the Closing Date, but in any event no later than sixty (60) days
thereafter (the &ldquo;<U>Stockholder Meeting Deadline</U>&rdquo;), the Company shall hold a meeting of its stockholders to seek approval
of a waiver of the Exchange Cap and, if needed, an increase in the authorized number of shares of Common Stock. In connection with such
meeting, the Company shall provide each stockholder of the Company with a proxy statement in compliance with applicable Commission rules
and regulations and shall use its best efforts to solicit the Stockholder Approval and to cause its board of directors to recommend to
the Company&rsquo;s stockholders that they approve such proposal(s). The Company shall be obligated to seek to obtain the Stockholder
Approval by the Stockholder Meeting Deadline. If, despite the Company&rsquo;s best efforts the Stockholder Approval is not obtained on
or prior to the Stockholder Meeting Deadline, the Company shall cause an additional stockholder meeting to be held as soon as possible.
If, despite the Company&rsquo;s reasonable best efforts the Stockholder Approval is not obtained after such subsequent stockholder meetings,
the Company shall cause an additional stockholder meeting to be held semi-annually thereafter until such Stockholder Approval is obtained.
For the avoidance of doubt, if the Company fails to obtain Stockholder Approval, the Exchange Cap shall be applicable for all purposes.
The Company shall not issue or sell any shares of Common Stock pursuant to the Preferred Stock Purchase Agreement or any of the Transaction
Documents if such issuance or sale would reasonably be expected to result in: (i) a violation of the Securities Act; or (ii) a breach
of the rules of the Nasdaq Capital Market. The provisions of this Section 2(f) shall be implemented in a manner otherwise than in strict
conformity with the terms of this Section 2(f) only if necessary to ensure compliance with the Securities Act and the applicable rules
of the Nasdaq Capital Market. The limitations contained in this Section 2(f) may not be waived by the Company or the Holder</FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 1in; float: left; white-space:nowrap">Section&nbsp;3.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Certain Adjustments</U>. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(a)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT><U>Stock Dividends and Splits</U>. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or
otherwise makes a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable
in shares of Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise
of this Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way
of reverse stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares
of the Common Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction
of which the numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before
such event and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the
number of shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this
Warrant shall remain unchanged. Any adjustment made pursuant to this <U>Section 3(a)</U> shall become effective immediately after the
record date for the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately
after the effective date in the case of a subdivision, combination or re-classification.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(b)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT><U>Subsequent Equity Sales</U>. If, at any time while this Warrant is outstanding, the Company sells or grants any option to purchase
or sells or grants any right to reprice, or otherwise disposes of or issues (or announces any sale, grant or any option to purchase or
other disposition), any Common Stock or Common Stock Equivalents entitling any Person to acquire shares of Common Stock at an effective
price per share that is lower than the then Exercise Price (such lower price, the &ldquo;<U>Base Exercise Price</U>&rdquo; and such issuances,
collectively, a &ldquo;<U>Dilutive Issuance</U>&rdquo;) (if the holder of the Common Stock or Common Stock Equivalents so issued shall
at any time, whether by operation of purchase price adjustments, reset provisions, floating conversion, exercise or exchange prices or
otherwise, or due to warrants, options or rights per share which are issued in connection with such issuance, be entitled to receive shares
of Common Stock at an effective price per share that is lower than the then Exercise Price, such issuance shall be deemed to have occurred
for less than the Exercise Price on such date of the Dilutive Issuance), then the Exercise Price shall be reduced to equal the Base Exercise
Price. Such adjustment shall be made whenever such Common Stock or Common Stock Equivalents are issued. Notwithstanding the foregoing,
no adjustment will be made under this <U>Section 3(b)</U> in respect of an Excluded Securities (as defined in that certain Preferred Stock
Purchase Agreement by and between the parties dated on the date hereof). The Company shall notify the Holder in writing, no later than
the Trading Day following the issuance of any Common Stock or Common Stock Equivalents subject to this <U>Section 3(b)</U>, indicating
therein the applicable issuance price, or applicable reset price, exchange price, exercise price, conversion price and other pricing terms
(such notice, the &ldquo;<U>Dilutive Issuance Notice</U>&rdquo;). For purposes of clarification, whether or not the Company provides a
Dilutive Issuance Notice pursuant to this <U>Section 3(b)</U>, upon the occurrence of any Dilutive Issuance, the Holder is entitled to
receive a number of Warrant Shares based upon the Base Exercise Price on or after the date of such Dilutive Issuance, regardless of whether
the Holder accurately refers to the Base Exercise Price in the Notice of Exercise. For the avoidance of doubt, an issuance of shares of
Common Stock from the conversion of the Company&rsquo;s Series B Preferred Stock shall not be deemed a Dilutive Issuance hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(c)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT><U>Subsequent Rights Offerings</U>. In addition to any adjustments pursuant to <U>Section 3(a)</U> above, if at any time the Company
grants, issues or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the
record holders of any class of shares of Common Stock (the &ldquo;<U>Purchase Rights</U>&rdquo;), then the Holder will be entitled to
acquire, upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the
Holder had held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations
on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date on which a record is
taken for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders
of shares of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights (provided, however, that, to the extent
that the Holder&rsquo;s right to participate in any such Purchase Right would result in the Holder exceeding the Beneficial Ownership
Limitation, then the Holder shall not be entitled to participate in such Purchase Right to such extent (or beneficial ownership of such
shares of Common Stock as a result of such Purchase Right to such extent) and such Purchase Right to such extent shall be held in abeyance
for the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(d)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT><U>Pro Rata Distributions</U>. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend
or other distribution of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital
or otherwise (including, without limitation, any distribution of cash, stock or other securities, property or options by way of a dividend,
spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (a &ldquo;<U>Distribution</U>&rdquo;),
at any time after the issuance of this Warrant, then, in each such case, upon the exercise of this Warrant, the Holder shall be entitled
to participate in such Distribution to the same extent that the Holder would have participated therein if the Holder had held the number
of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including
without limitation, the Beneficial Ownership Limitation) immediately before the date of which a record is taken for such Distribution,
or, if no such record is taken, the date as of which the record holders of shares of Common Stock are to be determined for the participation
in such Distribution (provided, however, that, to the extent that the Holder&rsquo;s right to participate in any such Distribution would
result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution
to such extent (or in the beneficial ownership of any shares of Common Stock as a result of such Distribution to such extent) and the
portion of such Distribution shall be held in abeyance for the benefit of the Holder until such time, if ever, as its right thereto would
not result in the Holder exceeding the Beneficial Ownership Limitation).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(e)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT><U>Fundamental Transaction</U>. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in
one or more related transactions effects any merger or consolidation of the Company with or into another Person, (ii) the Company (and
all of its Subsidiaries, taken as a whole), directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance
or other disposition of all or substantially all of its assets in one or a series of related transactions, (iii) any, direct or indirect,
purchase offer, tender offer or exchange offer (whether by the Company or another Person) is completed pursuant to which holders of Common
Stock are permitted to sell, tender or exchange their shares for other securities, cash or property and has been accepted by the holders
of 50% or more of the outstanding Common Stock, (iv) the Company, directly or indirectly, in one or more related transactions effects
any reclassification, reorganization or recapitalization of the Common Stock or any compulsory share exchange pursuant to which the Common
Stock is effectively converted into or exchanged for other securities, cash or property, or (v) the Company, directly or indirectly, in
one or more related transactions consummates a stock or share purchase agreement or other business combination (including, without limitation,
a reorganization, recapitalization, spin-off, merger or scheme of arrangement) with another Person or group of Persons whereby such other
Person or group acquires more than 50% of the outstanding shares of Common Stock (not including any shares of Common Stock held by the
other Person or other Persons making or party to, or associated or affiliated with the other Persons making or party to, such stock or
share purchase agreement or other business combination)(each a &ldquo;<U>Fundamental Transaction</U>&rdquo;), then, upon any subsequent
exercise of this Warrant, the Holder shall have the right to receive, for each Warrant Share that would have been issuable upon such exercise
immediately prior to the occurrence of such Fundamental Transaction, at the option of the Holder (without regard to any limitation in
<U>Section 2(e)</U> on the exercise of this Warrant), the number of shares of Common Stock of the successor or acquiring corporation or
of the Company, if it is the surviving corporation, and any additional consideration (the &ldquo;<U>Alternate Consideration</U>&rdquo;)
receivable as a result of such Fundamental Transaction by a holder of the number of shares of Common Stock for which this Warrant is exercisable
immediately prior to such Fundamental Transaction (without regard to any limitation in <U>Section 2(e)</U> on the exercise of this Warrant).
For purposes of any such exercise, the determination of the Exercise Price shall be appropriately adjusted to apply to such Alternate
Consideration based on the amount of Alternate Consideration issuable in respect of one share of Common Stock in such Fundamental Transaction,
and the Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable manner reflecting the relative value
of any different components of the Alternate Consideration. If holders of Common Stock are given any choice as to the securities, cash
or property to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate Consideration
it receives upon any exercise of this Warrant following such Fundamental Transaction. The Company shall cause any successor entity in
a Fundamental Transaction in which the Company is not the survivor (the &ldquo;<U>Successor Entity</U>&rdquo;) to assume in writing all
of the obligations of the Company under this Warrant in accordance with the provisions of this <U>Section 3(e)</U> pursuant to written
agreements in form and substance reasonably satisfactory to the Holder and approved by the Holder (without unreasonable delay) prior to
such Fundamental Transaction and shall, at the option of the Holder, deliver to the Holder in exchange for this Warrant a security of
the Successor Entity evidenced by a written instrument substantially similar in form and substance to this Warrant which is exercisable
for a corresponding number of shares of capital stock of such Successor Entity (or its parent entity) equivalent to the shares of Common
Stock acquirable and receivable upon exercise of this Warrant (without regard to any limitations on the exercise of this Warrant) prior
to such Fundamental Transaction, and with an exercise price which applies the exercise price hereunder to such shares of capital stock
(but taking into account the relative value of the shares of Common Stock pursuant to such Fundamental Transaction and the value of such
shares of capital stock, such number of shares of capital stock and such exercise price being for the purpose of protecting the economic
value of this Warrant immediately prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory in
form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall succeed to, and
be substituted for (so that from and after the date of such Fundamental Transaction, the provisions of this Warrant referring to the &ldquo;Company&rdquo;
shall refer instead to the Successor Entity), and may exercise every right and power of the Company and shall assume all of the obligations
of the Company under this Warrant with the same effect as if such Successor Entity had been named as the Company herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(f)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT><U>Calculations</U>. All calculations under this <U>Section 3</U> shall be made to the nearest cent or the nearest 1/100th of a
share, as the case may be. For purposes of this <U>Section 3</U>, the number of shares of Common Stock deemed to be issued and outstanding
as of a given date shall be the sum of the number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(g)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT><U>Notice to Holder</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(i)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT><U>Adjustment to Exercise Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision of this <U>Section 3</U>,
the Company shall promptly deliver to the Holder by email a notice setting forth the Exercise Price after such adjustment and any resulting
adjustment to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(ii)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>If (A) the Company shall declare a dividend (or any other distribution in whatever form) on the Common Stock, (B) the Company shall
declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the Company shall authorize the granting to all
holders of the Common Stock rights or warrants to subscribe for or purchase any shares of capital stock of any class or of any rights,
(D) the approval of any stockholders of the Company shall be required in connection with any reclassification of the Common Stock, any
consolidation or merger to which the Company is a party, any sale or transfer of all or substantially all of the assets of the Company,
or any compulsory share exchange whereby the Common Stock is converted into other securities, cash or property, or (E) the Company shall
authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs of the Company, then, in each case, the Company
shall cause to be delivered by email to the Holder at its last email address as it shall appear upon the Warrant Register of the Company,
at least 10 calendar days prior to the applicable record or effective date hereinafter specified, a notice stating (x) the date on which
a record is to be taken for the purpose of such dividend, distribution, redemption, rights or warrants, or if a record is not to be taken,
the date as of which the holders of the Common Stock of record to be entitled to such dividend, distributions, redemption, rights or warrants
are to be determined or (y) the date on which such reclassification, consolidation, merger, sale, transfer or share exchange is expected
to become effective or close, and the date as of which it is expected that holders of the Common Stock of record shall be entitled to
exchange their shares of the Common Stock for securities, cash or other property deliverable upon such reclassification, consolidation,
merger, sale, transfer or share exchange; provided that the failure to mail such notice or any defect therein or in the mailing thereof
shall not affect the validity of the corporate action required to be specified in such notice. To the extent that any notice required
by this Warrant constitutes, or contains, material, non-public information regarding the Company or any of the Subsidiaries, the Company
shall simultaneously file the material terms of such notice with the Commission pursuant to a Current Report on Form 8-K. The Holder shall
remain entitled to exercise this Warrant during the period commencing on the date of such notice to the effective date of the event triggering
such notice except as may otherwise be expressly set forth herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(iii)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>Notwithstanding the provisions of <U>Section 3(a)</U> through <U>3(g)</U> above, whenever any event requiring an adjustment to
the Exercise Price or the number of shares issuable upon exercise of this Warrant shall occur prior to the date on which the Exercise
Price or the number of shares issuable upon exercise of this Warrant shall be determined pursuant to the terms of this Warrant, such adjustment
shall be effected upon the determination of the Exercise Price or number of shares, as the case may be, and any notice thereof to the
Holder required by <U>Section 3(g)</U> shall thereafter be promptly provided to the Holder pursuant to <U>Section 3(g)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 1in; float: left; white-space:nowrap">Section&nbsp;4.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Transfer of Warrant</U>. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(a)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT><U>Transferability</U>. Subject to compliance with any applicable securities laws, and the conditions set forth in <U>Section 4(d)</U>
hereof, this Warrant and all rights hereunder are transferable, in whole or in part, upon surrender of this Warrant at the principal office
of the Company or its designated agent, together with a written assignment of this Warrant substantially in the form attached hereto duly
executed by the Holder or its agent or attorney and funds sufficient to pay any transfer taxes payable upon the making of such transfer.
Upon such surrender and, if required, such payment, the Company shall execute and deliver a new Warrant or Warrants in the name of the
assignee or assignees, as applicable, and in the denomination or denominations specified in such instrument of assignment and shall issue
to the assignor a new Warrant evidencing the portion of this Warrant not so assigned, and this Warrant shall promptly be cancelled. Notwithstanding
anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company unless the Holder
has assigned this Warrant in full, in which case, the Holder shall surrender this Warrant to the Company within three (3) Trading Days
of the date on which the Holder delivers an assignment form to the Company assigning this Warrant in full. The Warrant, if properly assigned
in accordance herewith, may be exercised by a new holder for the purchase of Warrant Shares without having a new Warrant issued.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(b)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT><U>New Warrants</U>. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office
of the Company, together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by
the Holder or its agent or attorney. Subject to compliance with <U>Section 4(a)</U>, as to any transfer which may be involved in such
division or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be
divided or combined in accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the initial issuance
date of this Warrant and shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(c)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT><U>Warrant Register</U>. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose
(the &ldquo;<U>Warrant Register</U>&rdquo;), in the name of the record Holder hereof from time to time. The Company may deem and treat
the registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder,
and for all other purposes, absent actual notice to the contrary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(d)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT><U>Transfer Restrictions</U>. If, at the time of the surrender of this Warrant in connection with any transfer of this Warrant,
the transfer of this Warrant shall not be either (i) registered pursuant to an effective registration statement under the Securities Act
and under applicable state securities or blue sky laws or (ii) eligible for resale without volume or manner-of-sale restrictions or current
public information requirements pursuant to Rule 144, the Company may require, as a condition of allowing such transfer, that the Holder
or transferee of this Warrant, as the case may be, make usual and customary representations as to investment intent to the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(e)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT><U>Representation by the Holder</U>. The Holder, by the acceptance hereof, represents and warrants that it is acquiring this Warrant
and, upon any exercise hereof, will acquire the Warrant Shares issuable upon such exercise, for its own account and not with a view to
or for distributing or reselling such Warrant Shares or any part thereof in violation of the Securities Act or any applicable state securities
law, except pursuant to sales registered or exempted under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 1in; float: left; white-space:nowrap">Section&nbsp;5.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Miscellaneous</U>. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(a)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT><U>No Rights as Stockholder Until Exercise; No Settlement in Cash</U>. This Warrant does not entitle the Holder to any voting rights,
dividends or other rights as a stockholder of the Company prior to the exercise hereof as set forth in <U>Section 2(d)(i)</U>, except
as expressly set forth in <U>Section 3</U>. Without limiting any rights of a Holder to receive Warrant Shares on a &ldquo;cashless exercise&rdquo;
pursuant to <U>Section 2(c)</U> or to receive cash payments pursuant to <U>Section 2(d)(i)</U>, <U>Section 2(d)(iv)</U> and <U>Section
2(d)(v)</U> herein, in no event shall the Company be required to net cash settle an exercise of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(b)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT><U>Loss, Theft, Destruction or Mutilation of Warrant</U>. The Company covenants that upon receipt by the Company of evidence reasonably
satisfactory to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares,
and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant,
shall not include the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the
Company will make and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant
or stock certificate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(c)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT><U>Saturdays, Sundays, Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right
required or granted herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding
Business Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(d)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT><U>Authorized Shares</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(i)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>The Company covenants that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common
Stock a sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this
Warrant. The Company further covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged
with the duty of issuing the necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take
all such reasonable action as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of
any applicable law or regulation, or of any requirements of the Trading Market upon which the Common Stock may be listed. The Company
covenants that all Warrant Shares which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon
exercise of the purchase rights represented by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized,
validly issued, fully paid and nonassessable and free from all taxes, liens and charges created by the Company in respect of the issue
thereof (other than taxes in respect of any transfer occurring contemporaneously with such issue).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(ii)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>Except and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation,
amending its certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue
or sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this
Warrant, but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may
be necessary or appropriate to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality
of the foregoing, the Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise
immediately prior to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company
may validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant, and (iii) use commercially
reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof,
as may be, necessary to enable the Company to perform its obligations under this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(iii)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>Before taking any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable
or in the Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary
from any public regulatory body or bodies having jurisdiction thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(e)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT><U>Jurisdiction</U>. This Warrant, and all claims or cause of action (whether in contract, tort or statute) that may be based upon,
arise out of or relate to this Warrant, or the negotiation, execution or performance of this Warrant (including any claim or cause of
action based upon, arising out of or related to any representation or warranty made in or in connection with this Warrant or as an inducement
to enter into this Warrant) shall be governed by and construed and enforced in accordance with the internal laws of the State of Delaware
without regard to conflict of law principles that would result in the application of any law other than the law of the State of Delaware.
The parties (a) hereby irrevocably and unconditionally submit to the jurisdiction of the state courts of Delaware and to the jurisdiction
of the United States District Court in the City and County of Wilmington, New Castle County for the purpose of any suit, action or other
proceeding arising out of or based upon this Warrant, (b) agree not to commence any suit, action or other proceeding arising out of or
based upon this Warrant except in the state courts of Delaware or the United States District Court in the City and County of Wilmington,
New Castle County, and (c) hereby waive, and agree not to assert, by way of motion, as a defense, or otherwise, in any such suit, action
or proceeding, any claim that it is not subject personally to the jurisdiction of the above-named courts, that its property is exempt
or immune from attachment or execution, that the suit, action or proceeding is brought in an inconvenient forum, that the venue of the
suit, action or proceeding is improper or that this Warrant or the subject matter hereof may not be enforced in or by such court. EACH
PARTY HEREBY WAIVES ITS RIGHTS TO A JURY TRIAL OF ANY CLAIM OR CAUSE OF ACTION BASED UPON OR ARISING OUT OF THIS WARRANT OR THE SUBJECT
MATTER HEREOF. THE SCOPE OF THIS WAIVER IS INTENDED TO BE ALL-ENCOMPASSING OF ANY AND ALL DISPUTES THAT MAY BE FILED IN ANY COURT AND
THAT RELATE TO THE SUBJECT MATTER OF THIS TRANSACTION, INCLUDING, WITHOUT LIMITATION, CONTRACT CLAIMS, TORT CLAIMS (INCLUDING NEGLIGENCE),
BREACH OF DUTY CLAIMS, AND ALL OTHER COMMON LAW AND STATUTORY CLAIMS. THIS SECTION HAS BEEN FULLY DISCUSSED BY EACH OF THE PARTIES HERETO
AND THESE PROVISIONS WILL NOT BE SUBJECT TO ANY EXCEPTIONS. EACH PARTY HERETO HEREBY FURTHER WARRANTS AND REPRESENTS THAT SUCH PARTY HAS
REVIEWED THIS WAIVER WITH ITS LEGAL COUNSEL, AND THAT SUCH PARTY KNOWINGLY AND VOLUNTARILY WAIVES ITS JURY TRIAL RIGHTS FOLLOWING CONSULTATION
WITH LEGAL COUNSEL.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(f)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT><U>Restrictions</U>. The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered
and if the Holder does not utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(g)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT><U>Nonwaiver and Expenses</U>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder
shall operate as a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers or remedies, notwithstanding the fact
that all rights hereunder terminate on the Termination Date. If the Company willfully and knowingly fails to comply with any provision
of this Warrant, which results in any material damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient
to cover any costs and expenses including, but not limited to, reasonable attorneys&rsquo; fees, including those of appellate proceedings,
incurred by the Holder in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(h)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT><U>Remedies</U>. The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages,
will be entitled to specific performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate
compensation for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to
assert the defense in any action for specific performance that a remedy at law would be adequate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(i)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT><U>Notices</U>. Any notice, request or other document required or permitted to be given or delivered to the either party to the
other shall be delivered in by recognized overnight courier, facsimile or email as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">If to the Holder:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">___________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">___________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">___________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">___________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">E-mail: _________________.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">Attention: _________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">With a copy to (which shall not constitute
notice or service of process):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">___________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">___________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">___________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">___________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">E-mail: _________________.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">Attention: _________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">If to the Company:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">Forward Industries, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; color: #333333">700 Veterans Memorial
Hwy. Suite 100</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; color: #333333"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; color: #333333">Hauppauge, New York
11788</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; color: #333333"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; color: #333333"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">E-mail:</FONT></FONT>
___________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; color: #333333"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; color: #333333">Attention: Chief
Financial Officer</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; color: #333333">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; color: #333333"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">With a copy to (which shall not constitute
notice or service of process):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">___________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">___________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">___________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">___________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">E-mail: _________________.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">Attention: _________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(j)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT><U>Limitation of Liability</U>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant
to purchase Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the
Holder for the purchase price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company
or by creditors of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(k)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT><U>Successors and Assigns</U>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby
shall inure to the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted
assigns of Holder. The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and
shall be enforceable by the Holder or holder of Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(l)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT><U>Amendment</U>. No provision of this Warrant may be waived, modified, supplemented or amended except in a written instrument
signed, in the case of an amendment, by the Company and the Holder. No waiver of any default with respect to any provision, condition
or requirement of this Warrant shall be deemed to be a continuing waiver in the future or a waiver of any subsequent default or a waiver
of any other provision, condition or requirement hereof, nor shall any delay or omission of any party to exercise any right hereunder
in any manner impair the exercise of any such right.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(m)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT><U>Severability</U>. Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and
valid under applicable law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision
shall be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining
provisions of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(n)</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>&nbsp;<U>Headings</U>. The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose,
be deemed a part of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(o)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT><U>Electronic Signatures</U>. Electronically scanned and transmitted signatures, including by email attachment, shall be deemed
originals for all purposes of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">********************</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>(Signature Page Follows)<BR STYLE="clear: both">
</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, the Company
has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above indicated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD COLSPAN="2"><B>FORWARD INDUSTRIES, INC.</B></TD></TR>
                                                                                                                                          <TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD></TR>
                                                                                                                                          <TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD></TR>
                                                                                                                                          <TR STYLE="vertical-align: top">
<TD STYLE="padding-bottom: 1pt; width: 50%"></TD><TD STYLE="padding-bottom: 1pt; width: 5%">By:</TD><TD STYLE="border-bottom: Black 1pt solid; width: 45%">&nbsp;</TD></TR><TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD>Name: Michael Pruitt</TD></TR>
                                        <TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD>Title: Chief Executive Officer</TD></TR>
                                        <TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD></TR>
                                        <TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD></TR>
                                        <TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD></TR>
                                        </TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><U>Acknowledged and accepted by the Holder:</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>_______________________</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">By: ________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Name:&nbsp;__________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Title:&nbsp;&nbsp;&nbsp;Authorized Signatory</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">NOTICE OF EXERCISE</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">TO: FORWARD INDUSTRIES, INC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(1)</FONT>The
undersigned hereby elects to purchase _________________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only
if exercised in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(2)</FONT>Payment
shall take the form of (check applicable box):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2.5in; text-align: justify"><FONT STYLE="font-family: Wingdings">&uml;</FONT>
in lawful money of the United States&#894; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2.5in; text-align: justify"><FONT STYLE="font-family: Wingdings">&uml;</FONT>
if permitted the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection
2(c), to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure
set forth in subsection 2(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(3)</FONT>(Optional) If the exercise
is being done cashlessly, the net number of shares to be received is __________________.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(4)</FONT>Please issue said Warrant Shares in the name of the undersigned
or in such other name as is specified: <U></U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(5)</FONT>The Warrant Shares shall be delivered to the undersigned&rsquo;s
account with the following transfer agent: <U></U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[SIGNATURE OF HOLDER]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="padding-bottom: 1pt; width: 25%">Name of Investing Entity:</TD>
  <TD STYLE="border-bottom: Black 1pt solid; width: 75%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="padding-bottom: 1pt"><P STYLE="margin-top: 0; margin-bottom: 0"><I>Signature of Authorized</I></P>
                                  <P STYLE="margin-top: 0; margin-bottom: 0"><I>Signatory of Investing Entity:</I></P></TD>
  <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="padding-bottom: 1pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><I></I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Name of Authorized Signatory:</P>

</TD>
  <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="padding-bottom: 1pt">Title of Authorized Signatory:</TD>
  <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="padding-bottom: 1pt">Date:</TD>
  <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">ASSIGNMENT FORM</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(<I>To assign the foregoing Warrant, execute this
form and supply required information. Do not use this form to purchase shares</I>.)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">FOR VALUE RECEIVED, the foregoing Warrant and
all rights evidenced thereby are hereby assigned to</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 52%"><FONT STYLE="font-size: 10pt">Name:&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="width: 48%; border-bottom: Black 1pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">(Please Print)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Address:&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">(Please Print)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Phone Number:&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Email Address:&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Dated:&nbsp;&nbsp;</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Holder&rsquo;s Signature:&nbsp;______________________________</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Holder&rsquo;s Address:&nbsp;&nbsp;______________________________</FONT></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 16; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21.1
<SEQUENCE>7
<FILENAME>forward_ex2101.htm
<DESCRIPTION>LIST OF SUBSIDIARIES
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><B>Exhibit 21.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Subsidiaries</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Intelligent Product Solutions, Inc., Incorporated in New York</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Kablooe, Inc., Incorporated in New York</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>8
<FILENAME>forward_ex2301.htm
<DESCRIPTION>CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Exhibit 23.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Consent of Independent Registered Public Accounting Firm</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We consent to the incorporation by reference in this Registration Statement
on Form S-1 and related Prospectus, of our report dated December 27, 2024, with respect to the consolidated financial statements of Forward
Industries, Inc. and Subsidiaries as of September 30, 2024 and 2023, and for the years then ended which report is included in the Annual
Report on Form 10-K of Forward Industries, Inc. and Subsidiaries for the year ended September 30, 2024, filed with the Securities and
Exchange Commission. Our audit report includes an explanatory paragraph relating to Forward Industries, Inc. and Subsidiaries ability
to continue as a going concern.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We also consent to the reference to our firm under the caption &ldquo;Experts.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">/s/ CohnReznick LLP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Holmdel, New Jersey</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">June 10, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>9
<FILENAME>forward_ex107.htm
<DESCRIPTION>FILING FEE TABLE
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 107</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Calculation of Filing Fee Tables</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Form S-1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Form Type)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Forward Industries, Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact Name of Registrant as Specified in its Charter)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>Table 1: Newly Registered and Carry Forward
Securities</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="vertical-align: top; width: 7%; border: black 1pt solid; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 7%; border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt"><B>Security<BR>
    Type</B></FONT></TD>
    <TD STYLE="width: 21%; border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt"><B>Security
    Class Title</B></FONT></TD>
    <TD STYLE="width: 10%; border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt"><B>Fee
    <BR>
    Calculation <BR>
    or Carry <BR>
    Forward <BR>
    Rule</B></FONT></TD>
    <TD STYLE="width: 8%; border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt"><B>Amount<BR>
    Registered (1) (2)</B></FONT></TD>
    <TD STYLE="width: 10%; border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt"><B>Proposed<BR>
    Maximum<BR>
    Offering<BR>
    Price Per</B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt"><B>Unit (3)</B></FONT></P></TD>
    <TD STYLE="width: 11%; border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt"><B>Maximum
    <BR>
    Aggregate <BR>
    Offering <BR>
    Price</B></FONT></TD>
    <TD STYLE="width: 9%; border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt"><B>Fee
    Rate</B></FONT></TD>
    <TD STYLE="width: 17%; border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt"><B>Amount
    of Registration Fee</B></FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Fees
    to Be <BR>
    Paid</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; border-right: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Equity</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Common
    Stock, par value $0.01 <BR>
per share</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">457(c)</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">273,000</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">$6.18</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">$1,687,140</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">0.00015310</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">$258.30</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="4" STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt"><B>Total
    Offering Amounts</B></FONT></TD>
    <TD STYLE="vertical-align: top; border-right: black 1pt solid; border-bottom: black 1pt solid"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">$1,
    687,140</FONT></TD>
    <TD STYLE="vertical-align: top; border-right: black 1pt solid; border-bottom: black 1pt solid"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="4" STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt"><B>Total
    Fees Previously Paid</B></FONT></TD>
    <TD STYLE="vertical-align: top; border-right: black 1pt solid; border-bottom: black 1pt solid"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; border-right: black 1pt solid; border-bottom: black 1pt solid"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; border-right: black 1pt solid; border-bottom: black 1pt solid"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">$0</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="4" STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt"><B>Total
    Fee Offsets</B></FONT></TD>
    <TD STYLE="vertical-align: top; border-right: black 1pt solid; border-bottom: black 1pt solid"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; border-right: black 1pt solid; border-bottom: black 1pt solid"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; border-right: black 1pt solid; border-bottom: black 1pt solid"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">$0</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="4" STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt"><B>Net
    Fee Due</B></FONT></TD>
    <TD STYLE="vertical-align: top; border-right: black 1pt solid; border-bottom: black 1pt solid"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; border-right: black 1pt solid; border-bottom: black 1pt solid"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; border-right: black 1pt solid; border-bottom: black 1pt solid"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">$258.30</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(1)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant
to Rule 416, the securities being registered hereunder also include such indeterminable number of additional securities as may be issued
to prevent dilution as a result of stock splits, stock dividends, or similar transactions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(2)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amount
Registered consists of up to 27,429 shares of common stock that may be issued to the Selling Stockholder pursuant to the Purchase Agreement
between Forward Industries, Inc. and the Selling Stockholder, of which 24,929 shares of common stock were issued on May 16, 2025 to the
Selling Stockholder, and up to 245,571 shares of common stock that Forward Industries, Inc. may sell to the Selling Stockholder pursuant
to such Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(3)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Estimated
solely for the purpose of calculating the registration fee, based on the average of the high and low prices of the common stock on The
Nasdaq Capital Market on June 5, 2025, in accordance with Rule 457(c) of the Securities Act of 1933, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>10
<FILENAME>ford-20250528.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.0c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +Kopo7xRiXgen8uEbXpMOamFCaPty552+YkxvmRwfRnKLyQkHHYFayk6Io6G0TsA -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:srt-types="http://fasb.org/srt-types/2025" xmlns:FORD="http://forwardindus.com/20250528" elementFormDefault="qualified" targetNamespace="http://forwardindus.com/20250528">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://forwardindus.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="ford-20250528_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="ford-20250528_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2025" schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd" />
    <import namespace="http://fasb.org/us-gaap/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd" />
    <import namespace="http://fasb.org/us-types/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2025" schemaLocation="https://xbrl.sec.gov/country/2025/country-2025.xsd" />
    <import namespace="http://fasb.org/srt/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd" />
    <import namespace="http://fasb.org/srt-types/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>11
<FILENAME>ford-20250528_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.0c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://forwardindus.com/role/Cover" xlink:href="ford-20250528.xsd#Cover" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://forwardindus.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressesLineItems" xlink:label="loc_deiEntityAddressesLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressesTable" xlink:label="loc_deiEntityAddressesTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressesTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressesAddressTypeAxis" xlink:label="loc_deiEntityAddressesAddressTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_deiEntityAddressesTable" xlink:to="loc_deiEntityAddressesAddressTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AddressTypeDomain" xlink:label="loc_deiAddressTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiEntityAddressesAddressTypeAxis" xlink:to="loc_deiAddressTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AddressTypeDomain" xlink:label="loc_deiAddressTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiEntityAddressesAddressTypeAxis" xlink:to="loc_deiAddressTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_BusinessContactMember" xlink:label="loc_deiBusinessContactMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiAddressTypeDomain" xlink:to="loc_deiBusinessContactMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentType_30" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAmendmentFlag_30" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAmendmentDescription_30" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentRegistrationStatement_30" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentAnnualReport_30" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentQuarterlyReport_30" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentTransitionReport_30" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentShellCompanyReport_30" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate_30" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentPeriodStartDate_30" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentPeriodEndDate_30" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus_30" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentFiscalYearFocus_30" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate_30" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityFileNumber_30" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityRegistrantName_30" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityCentralIndexKey_30" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityPrimarySicNumber_30" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber_30" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode_30" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressAddressLine1_30" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressAddressLine2_30" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressAddressLine3_30" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressCityOrTown_30" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressStateOrProvince_30" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressCountry_30" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressPostalZipCode_30" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiCountryRegion_30" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiCityAreaCode_30" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiLocalPhoneNumber_30" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Extension" xlink:label="loc_deiExtension_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiExtension_30" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiWrittenCommunications_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSolicitingMaterial_30" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiPreCommencementTenderOffer_30" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer_30" xlink:type="arc" order="34" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSecurity12bTitle_30" xlink:type="arc" order="35" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiNoTradingSymbolFlag_30" xlink:type="arc" order="36" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiTradingSymbol_30" xlink:type="arc" order="37" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSecurityExchangeName_30" xlink:type="arc" order="38" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSecurity12gTitle_30" xlink:type="arc" order="39" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSecurityReportingObligation_30" xlink:type="arc" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAnnualInformationForm_30" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements_30" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer_30" xlink:type="arc" order="43" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityVoluntaryFilers_30" xlink:type="arc" order="44" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityCurrentReportingStatus_30" xlink:type="arc" order="45" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent_30" xlink:type="arc" order="46" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityFilerCategory_30" xlink:type="arc" order="47" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntitySmallBusiness_30" xlink:type="arc" order="48" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany_30" xlink:type="arc" order="49" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityExTransitionPeriod_30" xlink:type="arc" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentAccountingStandard_30" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber_30" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityShellCompany_30" xlink:type="arc" order="53" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityPublicFloat_30" xlink:type="arc" order="54" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent_30" xlink:type="arc" order="55" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding_30" xlink:type="arc" order="56" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock_30" xlink:type="arc" order="57" />
    </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>12
<FILENAME>ford-20250528_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.0c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>13
<FILENAME>ford-20250528_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.0c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://forwardindus.com/role/Cover" xlink:href="ford-20250528.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://forwardindus.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !? *X# 2(  A$! Q$!_\0
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< !1110 4444 %%%% !1110 4444 %%%% '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>May 28, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">S-1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Forward
    Industries, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000038264<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">13-1950672<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">NY<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">700 Veterans Memorial Highway<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Hauppauge<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NY<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">11788<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(631)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">547-3055<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>16</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="forward_s1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://forwardindus.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>ford-20250528.xsd</File>
    <File>ford-20250528_lab.xml</File>
    <File>ford-20250528_pre.xml</File>
    <File doctype="S-1" isOnlyDei="true" isUsgaap="true" original="forward_s1.htm">forward_s1.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>image_001.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="16">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>22
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "forward_s1.htm": {
   "nsprefix": "FORD",
   "nsuri": "http://forwardindus.com/20250528",
   "dts": {
    "schema": {
     "local": [
      "ford-20250528.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd",
      "https://xbrl.sec.gov/country/2025/country-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "ford-20250528_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "ford-20250528_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "forward_s1.htm"
     ]
    }
   },
   "keyStandard": 16,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 59,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2025": 16
   },
   "report": {
    "R1": {
     "role": "http://forwardindus.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2025-05-28",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forward_s1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-05-28",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forward_s1.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://forwardindus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://forwardindus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://forwardindus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://forwardindus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://forwardindus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CountryRegion",
     "presentation": [
      "http://forwardindus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://forwardindus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://forwardindus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://forwardindus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://forwardindus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://forwardindus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://forwardindus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://forwardindus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://forwardindus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://forwardindus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://forwardindus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://forwardindus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://forwardindus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://forwardindus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://forwardindus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://forwardindus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://forwardindus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://forwardindus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://forwardindus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://forwardindus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://forwardindus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://forwardindus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://forwardindus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://forwardindus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://forwardindus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://forwardindus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://forwardindus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://forwardindus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://forwardindus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://forwardindus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://forwardindus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://forwardindus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://forwardindus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://forwardindus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://forwardindus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://forwardindus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://forwardindus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://forwardindus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://forwardindus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://forwardindus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Extension",
     "presentation": [
      "http://forwardindus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://forwardindus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://forwardindus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://forwardindus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://forwardindus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://forwardindus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://forwardindus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12gTitle",
     "presentation": [
      "http://forwardindus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://forwardindus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://forwardindus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://forwardindus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://forwardindus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://forwardindus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>23
<FILENAME>0001683168-25-004372-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001683168-25-004372-xbrl.zip
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MWD! *KE?1I8"LS11 U@O)&VI\],-P&SKU,/0!<4)8 X^):GT?DE9/!)*U>T
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MS8O.%)U<M*QA8EOHO3E^TWOGZO]]Q\BLYK9O:N:Z5BOJ[+0]5U1387*Y-_;
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M.YI3IX'39^A31)8#R\CJQGR?M^]-G9'L>@:?@;%R=!$^+YH9[,S_;+(:]_H
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MU=$BU7%28^.PPX; 8%1)[>TDY%$GKFK8)J)KP-L'V_ EK.E& (5>1>$B #;
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M%Y.MR0E.,S/<O\F6%L+8U[BCDZ.6QC82AEOFERBMJTW9Y,N85+<5I(6=HK8
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MX?J]<J]-#O 7P-Z^E#'W 61\=P_(^ B C._N 1E_MKMV!RK376I,F$BZMGX
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MZ$SRQ?!2X7Z[#_.C^FVL)-83EB(2H H@W<-U0DY;C9/#'ES1)<8NO/B<;XC
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MT8F3NH%J=#L-JX_<MG_05%#Q]1YC >5G9-@]2?"]F0[[6@3O0+.WU>=M+9I
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M(&FUJC6<%./I!D^J *0!OG0 3TKL9:T0D]>P'#X_M(JO,7ANX3<2V.;'/<=
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M[L\]V8=D?WFW'/S,)*B2]X>O BCXR"=55:TM HRLC>HZR;4U\/ZH]T:8GGB
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MLZW?O[;4NKT/G6$&)@4WLL9SEN_D9/=T^X&+Z@=T^T9503@A2_ N36$LDSA
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MGX''5G?Y=J*O5C*=65%IT )#EQZ5HXTN"HX@5O5YL0"55]*SR)-?HLMNW-,
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MJ!#TW[0OK\LS$/VL[)>B]@;,#*SBF!-+"N& V*IDTC+-C*\-;@2BU^('B1^
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M*VGATH4GSPT7WL\HV </[K=]QOX;=\7Q9\C!A!#+Q*3Q&2SD6IHQ]&LT[%*
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M$< .+;*X*ECF(M_?TYO<MOMQA]^?Q3X3R2WG)",M+3E-:M;S*6?NSNR*E%1
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M8%K TM$\1N?YC)4EAHO/3(WMZF--S;9$QCERTU%9>$N!A[9DM<MLM81R4$[
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M&U)2CC!&31+I6D&>B$E[(GR4W#,3/6LR1FV!6-O W EHMW/;=EJWL<IX;JC
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MUTO@NQT&7Q$8P9M&[%2$*7##;C5'>FK[PN*IOFJF.[C3=WFPC4 N3W<@E]L
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M[27J'\$]K9M=8/0V J,/MAH8O>DPY=^>O7WQVS_P/UY]>/WS/_XO4$L#!!0
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M)P,#6(&OV>?8T<2$GG"28ZJ.#%!WZ#?E>'1KO[-M(>PU(+;2[Y;)>'CJA\^
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M3!J[8&<DQ'&&GHA,4J;S2]\X9 9[ ZR1^M>C/?)!C4FO5?*L\)9CO& OPY.
M__TT&41(]+)L\.<:9V7;IH1AEHZ$)A!L6M\U5__WI+@Q]S:#G0\.ZR*5<]@E
MSUWF-B\3,F_8JR5@#SH]%VQST;MZ+=MB?R0%P@-@]BGWK2T"P1IA*X-.F\0N
M\<ZZ9L#*:]&Y@%W**H]5,XUXVR!FJ2LU(6=>Z6TZBA+_ 2,FB+"D_BT3G$^@
MR\ETTSZ80H*Z@$PT$$V#/QJ/%(!T,!0_I:%XN;>A^+^(>P-GXDETBM[R//5
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MOZOM@'1\8@ZV>:=8W&&Q+"G9KL KT>[*Y)X$S0"[X,M;6S2Q.5)DY<8CYA]
M- 0J2OCO(3/]A3]UGVSMXT.V]C-D:Q\?LK5?\G[[TF,W^Q,TO3!>I6V J=&:
MMM>YFS<;8ZLMSY)-(G),W?WVZ9;>[VLXI+^FTYBC.R9K"V.9X@=@'PC,%-0U
M&UH%G;&I]#LCSG"T#=8<>O:F,INK9%4W%[ W&.^6$O!MGB?9BC(/*9HU7(F
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M]W/$<Q!:P+L[?7J*'81%*GY%&'+7!_-O!SW; /Q6XZ%N'#8@9]P6?B&;=8N
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M1;/?3(.*S5IZ(#N\#(-\S#VE]8LG".(RX(5#G1*;L-Z/"Y?(/2 3" VC'*U
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MB6T=*WQ>,-*!#H9K;&TVVV0Y,YD2N[6<A%2BQ!J3_WT%(R/Z'R))2JNK1+Z
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MC@P?C2'VK%)!,5#ZO5NWMT./NIB6XRI*'<2:<@!KXN4E$[7;YUCN8#O-U)$
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MS0\?Q1'-(>E&XOL2E^%I7L[?XN2\MLVZX(_+;,:9A#<6G?1/5*.L+^"/RY(
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M/>!=2T;/2"I'J*>T$=+ZW<$8VO$X3:F$<=3&I@]XZ*(M*58APN^*W\&CI .
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M*_QH=13[<")&66-?5[Y!VV;RN+D<S'2Z>C?%DE*"";=V4/W90AV]IB_/^,N
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M6R+%&4$2&ZU1Z6Y0"^1<^!K1!&+<+X[98#2$S-UZC3%U!V"27.DA7F]6%*A
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M+)E&P(&+4$0)LU>&!1<,;XTF^PHI=[DS""1$WP:*1KYL+1'I+D?0EALCJT7
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M+..F'F =*#1I"CN3TH?-"FF_3KOGP5'?VL41-E"^)FUR$XNAO3(CS8:\,WD
M+!WB/S_@\^BAM[]5?/O)/K[])>+;3_;Q[0>R"T$KVD4M:F<<"UG%HDGHY.1
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MXWPOUY]3KJM=4&G%FH'0V*D%VD0)/<QJ.+1 [9^/MT3D"BA9@\($I3BV@6$
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M?6Y>!+-J%NKDR+Q70LOP';1Q=C9\<6S^/ACVS)3A"_M/S?@.<1T.^CVS+LG
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MBPIO31Y;L%[V5FRL=O-#VP>[QG(CZ'DJZK!Y#PI+*1[^;8$'/UU1] X7G83
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MWP@)W(K-*Y%6EF\RO&NB"@]LYF6&N)*C=W"VT4&N,E NJ_)]7H'3 '!;S=D
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MQ 023%828YS0<&UN?D.L-B9&D3@=75$XY^-5Q0[5$*"1W;7P9$PU;.(QO5>
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MAGN;C0S%N#HW!XH\R%H<DA'86Q!$,W1B"00G0#8VQ@OH!>3/\5#^@PQ%C "
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MV8[%AMRQ6>7(<9PS=#ZK\];600WK'N;U_M5;%:?G/_\Q_(VRQU?(QG*%B%[
M7/Z/OPU_^^]/V/(G']J^@7T#^P:V#!_]L \??8GPT0_[\-%?;Q_=E3AOWS,E
M^*3I[RKIL!Q&F+28\$?)X0ET^_A__\>W>G'OS'*)[KN+W\Y?FAD\>64:?GM'
MR N[]>"IG8JG=U#SOFO;ST].W_1/GR7#XV<79^>GP\&9L:F'QX>/O>[8S?PG
M5CPX/G[XQC_?6I[:YJ'O@Z?^;$\C+6[XZ*[F9@$>D_F57;4GB^6Z\4<??WK[
M2^S935?C)YX_O&^\3UX5HW=9/DU>5RMC!'ZRAL_!Z^>W?/@.O'-,:'6=)R>4
M%/X7E9U[T>(7.KN?7KP=G'Z)4_NNKOA=C^L(^%N(:B;']M<C7/O#]\X/W[42
M]/E.XKYE(^UVSM#W4U:W7UB,/HU'KZ&ZW\=7[W8:/803]Z_67#N:SS^>GQR?
M>U$5@M,H*].;U6*15^!2=_,,C]^+#IE;#VO=+^M153!#6S8K5_,EIG+0A??)
M>_NIG>[_\=O_P%P1FU4'OS)_/=5X/9!@IN'<OH(!,R .#_SK&5S_Z@JX/)=Y
M\IJ!F,Q"%N#@_)^?8X@/(G*T;_7^%X/\^&MR@H>VV=M'6;W<._>_A'/_Q\_J
MW+]GE1I_>WKR["UJ]B_/7QW]]O\!4$L#!!0    ( "UWREJ]!6O%@$   -J:
M 0 2    9F]R=V%R9%]E>#$P,C$N:'1M[7UI<]MFENYW5O$_X.9.=XFW:$6R
MG>Z.G785)=$V9V1))5)Q^],42( 28A!@ Z!DYM??L[T;%I**M;04=F82FR3P
M;N<]^WG.+Q]'GX[?M5N_?.SWCN"_'O[OE]%@=-Q_]\N/_%_X]D?Y^I>#TZ,O
MWG#TY;C_SQ^F:5*\\?;WYH4WBF9A[IV$-]YY.O.3+G_0]89A%DU_@ ?AT3/U
M7!%^*U[X<729O/&RZ/*J>.O-_.PR@K_N_?#NEX-W_6]7T3@JX-6[+_=_^?$
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ML&1<LY!AAODS3HW8$+R?.4O.7 ?TP) Y#OH<A*M>1[E1P%W"(M&T^4I\ZX?
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M*F?OTVSF#5_LF^M*(3C_6S1;S*RP?/UMI; \Q2- 8S<Y8!P)XWNL%+8T<9W
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MJO+B%FK R@6(*H1^Q!W0>!QNP"2DI!>%NO0L*'>7+:P0$SZ0G14\BVF4 %<
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ME84.V]*9/\(6O]Z-%YA=5]^;4\541VVLE.FGLTW0N7_-+[ R?:H-%"7/P%\
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MEE$V.4:(&2N^>F.[);&G*\RHW7GE9AGEGM,XD^N3\"72*X$C450>N>M]-AG
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MZ"-NU_'@TV#4XZ\)TQ-^R]M.^W)ZKOX&K%@][9WT/QP//L!J^J ;'IS3"<.
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M^]^2Y'J2G#H-<*Y"GYE#5 &60>XXY0Y[;$VS-Y-8&/\EB>U^SFCM$G2=XXU
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M>;( M@T2K-LQ(LPN0*MG\L637W_]2<U!T_94AZUIBSJ0N6;OD1,HIPW[3;X
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M-@#WQ1CV8NE0(B'1T)*Z@0EUF*'*:U?BONA]0>/E#/DCFUJGZ_BRQ_-!=31
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MY5JW36K?(IZ5<'Q2HW30'3 WCQU#$#%"7[D"PA(>\K<%&A*)I J@TM\T9 R
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M8VO@*'U 0?IJ4616%-QTA)R"ZQ!V^1WFHN:ELBU]-IR^T3?P6_'MF"Z%>E+
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MO-U4CE4^.XE4"3%7)%K8NW$H>Q\=T",*ZK[ !_K4'"7(V?7Q"#\3)"N!<"6
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M^BTL>&"*^]-J?_-/ ?\!4$L#!!0    ( "UWREH*N8Q0]@   +8#   2
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MW$^W-ITVPLH*4$W$N38?"VE8U-"S*!JMY;](_]7_N&/NYB".>?T"4$L#!!0
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ML .S0%1+T6%*H9CB@DFP!P(V!"<"&V:*?H]:Y(FD"-KO%1]$1IG/K2@$"\?
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M6CNSLR9FNH3%E6GGR*$=FMF[21XE(L_K:>?C?[M??^W]=T]\N2GIO.ZE:2Q
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M#0CB$*S2*(<Y,8O/#>=GH8_L@JRMG!2('.1_/@S9.I2&(9SO0$;G2 T1M:<
M;Z33I1UG4=UXOD'-9:!/\'A4HA8K%:@!DR*"X&C^,SAEBA8B$8DXO;:CUG6S
MHLF8-8?C<<SY8)*XA5)@LDDLE8EG$1V(1Q<JV.[NS3H/TGT*FJ1S(G0!F/9]
M0_LM5 ^["WN=2-N<="Z^8P,/?XSF.T\1^0G-IT0*> GH-@Z$5.14W+R!?U!Q
MB>"2$C3(X=T#$8-"ENF<L>JNWH8*M "?O365:"'>CH')8@)<V:0N:3+PRG>9
MSI:HZCH"PK]"%]% C$5"F?$I7QKX7[(.C"Q#0D$7I "U$BZ?<-Y=X1.LIS=3
MC==^ 7J3@B>%6BQ0NT 2A&?ELG)!N15 :?)JCS/1%S1MD!;A11:.+W.X8T!O
M.;(8]F E=LY9@SMM5NJ?_TR+-OMKPV87L#G,NXX.]0N(G\&4TUX1RL7!]<]2
MD("*MM6M<D_ V7T0(<1(S8;G=0XU^?9ZYN(1<_D.KLVO^LRMO6#."K<&+]7G
M,!^$?TK=\!-?@H\?#_4!\O>&"&"KD]075WQGIGB>+&5:V&C+7<H$T'<NV/T^
M2LGB VKN[&WL[?VHJ*)(B_I[[[XKG13DP"<M(%<_9N]Q$^L,U%5"H:]ITYM)
MFY8J<1L$J<XD8V%'SP+/#X%4F2.-T0U+&:3 .1K6+^59&_N!U^OZH%X*LZK(
M*[BB%?'Y'%[M@5(5D@H!DX#7A:P3P%G]L+N!QBFKI.Q2H"GK'^!40#/@LWMV
MP,N3=$=%?:B3'\9ICK,ZI=]&H&<,(A@CGEH,$+5X(QL;SY25AG?.-LX8KXXT
ME:0>HN,<V"E-81!.<WMVGC,[?X[9!:03A'%_0HI$$ZFH2RHG'C#)R>"#, H'
M?6Q;%6T7\3J=Q /II)J0,D]6*KTCCN#0T1$4RAC;E)+.55*7DI JEXNI;!:'
M]3&C3+[B;412G*D+5W[$:KJL\$PNWKZ(]M7KB=1!9(.B'(WG.&XS1LVZK1=S
M%K:1E;9+#^0FH9E?-.T?"XR[\335\^^[]&W=L91:<-S?!)$;N0SESI,OT,3
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M!03%6P[X]_9N-?98>>X_ZVX'>[KQYG/3EM.ICV\T4?-H-(F+,!' DD&=T,%
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M:N]P V+A;B%.#35)V3<\>N[]L"U]5BT]X&4']0X_6/\4MG'$'IUJ@77]RO7
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M&3;^#!:/F6 9M:;7"6-E_T+5FY-XK IM:%#+N68R!^Z1:I9C8E-41H[L!AF
MD)WQOJ-@$)9TB*\A(M[J>+WL2L^:YYP;'OH?HJ^P?WK3/S,[Y@TN49MK,.@\
MV[V='STK&Q M";"Z.7=344O8$)>6GBR[?UR+]FYILZ5I4P8CF14F93""WU^E
M\83"PPPX4#+:ZE)(;F)5E.?E.?-"\&)R!45]3I! %23*1S)5@C-7I3^6>K+%
MUSB<NCIT$CL_VF:=(GP\"_M>MB$_[3(#::MP,$!00^4NLHJ 'KT(J[])!^66
M;>:HO+S(,#<A$^VZ$SL<35(QV6;*Q6=3#>>JT3?C0AN'1I%N%'Q>L^ CK4V2
MF!Y+N>;DRXAL_ %HI&1.HG,H1XB#M-+I[=$?\M,98W;\N[.Y"H O/P"^NPJ
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MX-Q:JR=45RH8YN%LERG2).3HR)2IQ^$U,SU30;&ND">,:*28ZH-9#?.+OHA
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M!7<[4_)UV*#/_!^/6C4YT%S.LS.-[)PJ"W!>IOU4#?UA.(KBZ>OV=9NC(B_
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MS9*D;D0<!0+#P16<Q,"3Z !,V>,HL1@DN@5H%TOSIRB>/'W9!&D,>G>?4H1
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MT!ASO>D707'B-[WC0<E&CV0C[IS@BM]XE$IBF%)#:U$J?NM'+/D^]9L$972
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M=XKX:L+R^3PG.D,O/#]SR?X*QQE7[F3MH*$?76(LF>0NO(B\S**7ALRBC)H
MCH ?ARY6?H5=U]?B(D7^B2 UMV25R#>R+<0G#_166>D5$XQM$*2!Z$^LQ?3!
M4@"EML+_=/C)Y3_C7[!Q*,@&>A/TWV$.EI$594KME8401#]1J54H9"G:@[45
MVF*<3%_5=&?L.U$-JMHQ&\J%^^ !'XM'IHZ\]+G6FSB^^MO.AIVGMZOQ#ZG(
MP:@?-%LBA!JPAYO(YF]61;A%TDVKS4+IEI58AI!8/%-$=X057BWKKK,7)SU=
M4TP]TTD=(]"R9$+:PS*4/9K@NJ?&Q**ZH8"75?JB*(KG!\$R/7BY?.*#K8A2
M.ZF)S+EP5;JH# 'Y6JN43)"'%ZCA_X"(!>OAYQ8>!YG2\3W,4[&1*F)0H?6\
MHOI(-,M)$1V@F",-)=7%&4[O@&$G;<H=+MQ]*NMZ&!V1:THP&3;\CCV*'8K\
M(,Z4ZA;7]_HU;4=KRI/[\*GE,:L1#@"R.F3!2_5''6Z:)]0X/7,_&),O/$W'
MQ4.0+R\>OD(PXB(>(!N,^_#I>DJL.;0-Q+AR1!XV3-2$23K,G'71Y2819O=.
MJE(&WX'\JUYN7 /5-OAS9Y/J(>&GO4T]!F85[5HF8LO';-:.3/U2(GV6RR"#
MLO+'EP$*DK6I%,A;!__ E=QO9D^P4&$$C$FA JF%O\EO.JY\&7BX)[/K],RE
ML2^S M=)"L*)F^F*S5' G-#@R9@QZO+<(:'N!8^70"2CR))U^D:"I='CL?6T
MJ2U3P>25G"H[23M)MLW#T- K/]0N<O&9R$BQ!>I5*8$A4":ZR&23>J/4(VCM
MEDAIP!QE-!YX;AS1)KT%AJ[Q/,HQ,T$/FKQWJKJ76S2Z%][EV,+S5)O,,;5)
MB!'G_878E'=5YWU%?2H,,/K0D/75R=O(VNG",\N3%B4+3J_E\_(C.;CM=V,A
M A(KQ2"W$;WQ).-%;-"LUT>YD' 2#4I65!>V*.7G&\,3H],G9Q@X>,Q$H4J:
MYY!3D:^9S<NO?%OB66C\0]XKS,@6U,FNT9CX<G?6HZGOR>12M0FI*HSBURFC
MW4^[8'=T?5(3@\:3S4"XD+7ZP$2Y$N 7Z'_P8I 3W'%1X&.@BRW@[@4)DI[R
M*6Q8'@<V"_0Z@;$E@'3.181XS&*$B\/(KB%Q)#S1G_$$FUC=!<:2;>)$\5F$
M3;Q$#71WTRRNJ#!T-6*F%16X=^/)].'XL5(\:PA[#BMR4=U2]1459$G7NLO4
M_F:&49GSE@U?DRAYXXGWTSD3C7D4:\#W*Z:JUJA,4:YA/+-<H[!4(X6W.&6I
MAC&74HUTX>F4I1H%2WE*J49F[5Q5*2S;P$1$K6S#F'/9AIDJVYA4LX'. "=Z
M?LU&IF##?%3!QJMP8;VV>:=(FFF423-+3IIIEDDSZWKXM'9;)__YU#YJ7YOM
MLP\G_YE;B'QQ_;VTF;0YUJ#_TN0^(^JU8/V>OE A2 YT3L9GWC_8KV,.0PKA
M-+L!$S/_B6/"'N"GO_ZTDQ734C1T)C7%F(I&F!*?L68OI37+>7!!+SN[39ZZ
M+<<XUSZ>O.H<[?[\,*5%2<V[3E#E4Y_YVX\A<F;*^D-3/DSNQ[PP'A U]TYK
M^O<U/Y#/GBK?GL!3RWK?#+7WIWAAK*%:GPW-SEZ;X@T_@)18VS<\F.(%S^)!
M!V,2+YI-'0XEFPBBCS)_+/GH$UP"Z!+(DF(*\0JJ[&2-0"C/$]?9V*XO\_*9
M0AUX9YG]@/5^_:D?1<,WU>K=W=UVR+K;-_YM]3#H]IU;%E:9?6,%5=N*K&IS
MO[';JM9J-="YFHV#O?I^#?_9J;+[QE9]NQ_!C40EU[2N"Q'V,0]5UPN;KNC?
M+2^V@I%9W\?Z[OJ^N66V@05<6#<^=!'X!)=S)?II@,8'-_SV+^^JUNK?YOM;
MGY>H DXU9+U:WX=_5WV92SX^\]/=9B1<&B]6N.SN-^&_!OS8V-MO5'M^<&<%
M]M_[/[;8_<%!30B:PS!DT61!<QC?P+N;]3W"D:B!G/D,IJCOLU*BS':)U?I>
MM5%;]666$F72S,V7KZZ@LM*LU:H"8J+I<$ERR3N+V+2\25WQUD)>U&NK+S#J
MC2K(C)47&,T-9W/E]WN9$N/EZB!"8C3QYQV0&&%3&CB:@*#5@9 X5&4#(C8^
M28B %H(.;(S!FA?4#,X9\FS)"TK#(<0V-*+,M1 W:Z">M*J-W6J]N>K+7/(%
MO/+"9NH-7&=A Y;/C(7-[L\@;SQ,1#WV/=H:C,9E9$TI:F8SY%ZU64J:M9<T
MK762-.%3?"NM6JW5W$U\*^P>#*/9R9Q+QOL&<SWF:N@Z42EA9C/D;K51JS:F
MYM!2Q*RFB-EY%2)F]V!7%S&M&8H8:4-MU4N]9A%ZS?X:")U6*70F"IW=UR!T
M=@]:S7D)G38'Y9+USH=)X[)$')4B9U9^[&JKE#EK+W/VUD7FI$RAO3&1\9"X
MD"(E+3*H;+/^5HJ'H[40#N60RQIR:5M."77+$1!3)R(M6T \U:W;PA2YO8,J
MNV]N.2+D?-UW AYO)IF"D"/8S$,$HLVC$?;1J @L$^R%TN"Y<JVU$"!K$H(&
M#:.^\OI%$Q$<5W['EZ=A+%G_6D B7/V@!D8,"!#04-(6C5:6(-4/K?1YK!&5
M HAHF'D(%? 9HEZ6$F9V$J:Q5ZT?K/HZ2PMF,G56/<GE(O 1Q,(/1H@KSHJ3
M[#]R"P<;(L6(:(S8$8>A8VU=6-1M?9,GP&GFRP8V#-,4E$ H**M_(:V!@V.G
MV@ ),74@8'E^F.5F7JRX?-A9'_U#\W#L2!7B/($Z.;,04N4;LVY 5_B- ZQ\
MLH+ "<W_L0;#M[2,C_& !;YYL7VXO1:*0CEDZ<M8E"@ 2;DVLN"ISHR#&ADF
M,H6^M=7D<@14C#JM[=3W;K:N63! 3RAL%^(=7KB(WI#H$FLA.<#$^&/53V2C
M6F^MA851:A 3Q<:JFQC/#\S"CZU6<S\W,-NH-;CL./DG1KS.M.!8"V&Q!N8&
MNB.::U"E5[HC5MD:6XBP &5CMU774\?@DY;%I05"E$AOYPE!Y5)$-EO[2T$3
MWD"^;FZ9%U;LFE>8ENIX/HJ4_UUY)EL3'R?L4V/J$[M$)T9KPUI]M]52!<M:
MI;T_%:ZD#BR+\F1K1^"5Q(.!%8SR)$I 30KIYRWS6@!D?W5"]K]KH9.LB?QH
MU$$O6?EU+OETK+[P6*N$]J?"D<":TG D(%F$$9,(#I[6D<4\BMV162=UI$DX
M)%'?1?SHK\P).RRX60^1L@9FSFZU65L/@5*:.1/),[57:Q4$RI/,'! IS9U:
M(VWFR&1UWPMC-[*\[BA7GGRQ8 8A4!H@4'X'(F";!/.WP(^'YFEDKT=\9AV\
MK#M55%.F]M&5(F551<KTB#/K+%/V6WOUE$RI3RE3KM@P8@@>^C+DRLJK*L)Y
MLA:"I90L#TB6)7N7%B)<FK7:WE[C(..7%?;/?<2\4&:BBF9?FL31I,WZ2I4U
ML'_J=2S570?[IW2HK+#(79ZRTIC.GS*>WGKI@^H2F5\=EQ),S#+"\]J4E*6F
M4:R!1'GY:2:Y$J4YE409!XN^]@?FY\#Z@MT42GGR"N5)F;6VPO19GL4CW"E'
M\0C;"7-9PM#$P1*9JW@X=$=CTN7,O^6NE8:* 3U8CJ.7XJ $^F7EV;&TCTIG
M[N*DSVMPN;1 H6DT\F-$"HY$=[EPJ311(FUITJC66(^"W_60+/5U0$DK1<N#
MY%FK3+C9*38-"2O (11ID1=6-K^V6'.A/-M\W67E&6X]!,R:J"ZE(V:R?%FK
M9+D9H;]J>DNWZ\=":P'Q@MVA0P'BB@&DJ41-OJ2AT!+H.J5:,[LAUP/ZM51J
M'B3/:T1_G;'0*9 Y2>),*7AF>:37 @"VE#P/DF?5,6"O$M"TPEZB6$]8Y_6$
M.Q6SPUTK'1;=81;_<?6+>6P-G<AR:2E?+ 1>,S_&GETQ3R_HV7&APKN0@OPX
M.3T_7GD66@.)L3Z(2F7NRV2)L>J@L)>$K2@4@$M\J;"4&*7$F*/$6*K+8 TD
MQJJ7"YV??#&O \L++0[".DE:K/Q6ER>[M!X6AHVT-D4[NMNA44O02A!78 H3
M0^@!([/1Y&*@[!Y1#EDB+CXD'M8F33XE'NII\3"%/5&*AW+(4CP\6CRL3<Y[
M2CPTTN+AJX581"EHLZ8T%<HS7PZY>EN^M#,/-^L::@2-NHQ3GH(>0 9#W D=
MV['P:B\/>3GD*F[Y\@[YDMN+BT.><XZ;\AQ/G WKXAEO(]GV;#9$5'3XZV72
ML>DB[KA.UQ19"YC1_=$)!FI]U@IS13ED*0@6* A67<'7SOI#'5;T[BKF!GPQ
MLAP/A('CF1.;N)SP9@RT4.I'8[U?1ZC;<L@7+B:6&4=8]1RD7#^ :$,-XI4T
M ,;,:TQ<+.V!<LA5W/)B-: :(=^^-]X-]>^^,>NU861>.P,6FF?LSKST!]@I
MB#ZHD%^[]]8<6,&- TO 1VMOS=Q5=6 J_&_XWICU'(J:G&!_Y_XSWYE_X5/K
M_\?.\Z <F&&WS^S8Q0&M(=H13A=FLSS;$!V:0EX8"BJ&I>()?>N6F1U,0_('
M3A1Q#<,"4R.P+<0XOW.BOMF.V,#<K=5%>")V>7#B:NOSMGEH=OWA"']C>2,U
MB%P+3E_U U.LP+AS7!>F,WMQX#EA'Y_$DE1:B^6Z(UFZJL5(,?U)-:<]]@?8
MX!)G#R.KUS/C(?P8L']B%D;;B]CTN<PA+H4YLJZ:0;[%O.?19OBOK2TP69EK
MOS$O0-_%*!7L%W#7&[/9?&O^9;DQ_%@WM[:$W+&=6[FH#C B"[8Z?A3Y@S?F
MD6MU?YAUF#?T7<>62]D"S>"-N3N,U ?R"[MTH9+( 1'AND/+MN$"_?6GVD_T
M=Q!07?GW])1=WW6M80@KDS^]A=-@1WVD4>WGMZ8F\I!H.,TDS2673HF$%4,W
MFS\GG(9B<_R)UL_YDJ_=WM))+8G\UKP>#6&-AX'5<;IOP?(8,+X19SZ2O*5_
MJ2J_A;\I6D SLP"A=>FK1F$O)?V[*NQGSLX&S/JQU6&@Y,!ZAL08T^VFXEB-
M#_7CJ4^HOQN^,S'9NAXN[8Z[:O]V=GC]Y^7)U:)NN_G.<1$'88QQ+7$!H$AW
M KH70MFB/+D4C*1)>;,BGN=1<[K20M/&TK^N%8=PP]"-%^A1]2OL7$S7'\P&
MMU$(:X$'X3=X2798WW)[F*6+ U._=/X S12PV(-OX02&%4=]/P )0+<FH5QB
MTS)8V"<+KC4KOF$5/AF9_$"?;W[P ^?Y/?88T(X'[A9Y;R624)=\6<GXZ'6D
M!&.A /U)V'?3J:R:/%'/PTBH4O[Z4^.GR>INY_W'\\NOAY<?S/;9AS^OKB_;
M)U<5^/EXFY^7M,'Y^ GR%C?E\[GS3KHW!'%W=GY^8(=S%C-QP*+QCD9OQM7,
MJ8;G@EK-T*H539$R'N@)FW5%&=T;?NC T 6.J8;5=\[[+PXH@,PU+X(8%,QW
M5>=]@>M@XDX^>"L_A:+RE7/'R:Y[I1?;QMO%&9C'?8?U0.<&<4NM%\][/3 E
M G/C(G"\KC.TW/%?;B[$R)O]E323Z\B$Z\C0KJ/L?1.J^P;O)K*VQ)4C+ID>
M"$C_#AT[0W(%A_(^Z5HHI94=Y/-/,?<#'P$+#[- 7MW],9F[QUV$&2.BDS4B
MQ.R-K&*KZUOP@17% 5/71W82.<@3A/24Z]O)CJVM[]J)W&6NK5$O7ML'8-+)
MM^Z<;MKG/C\7$3S5().H]-".3#\A7*QPO9IYE^MS[Y+G$$09M _<1ZNQRI0J
M_S0%;UK588'O.CNM8A8TGO)DE/)C*?)CK(/=ZH@0+CH^.IX%BBOHK3FJ;/)+
MU+"T+)N49KOT-YF7F,G9O%+2S)"^J_!R*[681U)ZYM+JJF\%F&P3C+P?_IVY
M.K+J QB8W<@/5F,UCY,WN<M(4_I9-^KZW;*E+K(<781AP/IWO^^%B#9:GNTY
MG>T4G?,ML=?)T>6Y7\ZM;GDW3F3A[=XOC_W\KO04F4MV+@]]$976)@)4SK&>
M<TS**FN]-<^'&'H+WYBG5AB5J65+22W;661JV4(RO1*U8XP)KU@D*7!OW[\U
MVQ_HA[]K^T=_,]D1-Z15T=?8[_<?O]LGG^^^'WZY[!S<5.\_[)Z>^7]]/!M\
M_];R6Y??K';0^,_I\/2FWMZM[5[L#ZK1;[OM]N7Q%:O]$I\<G=_[G;^&/\Y_
M&WWVVJUO=EAO.%_^_'I\_OWT^J15BVOQS?7AZ>U1X'W]*ZP&'_;OAMVCFV]'
M_^_ZZ[?.7NO3W;=^_<_C[O>=Z]'.P+IIW5U'WZZ__^?'9>_BZJ_.X.Z?Z&S/
M/^I<A:TOWE]A[;?HE^^7!^>Q8Y_N?8W:Y\Z7O3_^M8[8\?#3+W_4/]_?^.<'
M9T<7K6'\X>+DX./9T8]_3OKQ@-W;W:^L>MG[X;5_&]Q_\(YNA[U:M_?O[<[G
M;S>__LHI4NWX]@C_[$<#]_W_!U!+ P04    "  M=\I:<#;204,(  ! "0
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M>0  04%_!OA70#Q@"!0&Y^7C%]AKJ-\/\(# 8!X(& J%0/:JE_?J  0)%5;
MF<%$;-WA&"H*?S6CD%?1O+9#]-3@O)+V^:!K?/QBXA*24LHJJFKJ!P@ZNGKZ
M!H861TB65M;DG^SL3Y]Q<'1RIGAX>GG[^%X(#@D-"X^(C(K[A1:?<#TQZ2;]
MUJ^9M^]D91<5EY26E=^KJ*S[C5G?T/BPJ;FSJ[NGM^_)TV>O66]^'V(/CXQ^
M&N=,3'Z>FOXRL["XM,Q=65U;W_CN @%@T+_S/UW(/1</! *&P+^[0#SAWQN0
M$*@"#B9L9@MWIXI@\%=Y4>89A;4=?(K:I^9%SP<-\HLI$3XI+WRG_2G[>[!K
M_Y?L/[#_ND8!!!BT=WA@)$ $5C?4BJ[P__"^I]S:$+?MW^W[A^-)R/(9ES8T
M:_R+(GEG_.ZL,XZ8)4QF,B;A\'ME+#/JLBT)_9?#S/&XFR:WF">A LE'Q?T;
MA7$F:8>%6#K"/J,V68OCEGT_UXEL^SUKI<HGE*PUP!,G<%\>CSS/A"8,9(ZM
M1G(9[/;T",/7?;8M\R7]FFV3XEBG,:@9^M)._VB5/;FJPE<L?3NO^$@\D1#)
M6'2#;AT+L%(*MI13=; 8O#4AM9B&B(@A)GIQNG=4,GV_GO-.?=;CH2%C72ZI
M_VU'TC@BK+Y$B#;:EE/M8V>337KW;.S<L!&-_GGZ>?X:?'%9OW"V0*YZ4<E-
M/-1E^2W5G"R3-3PS/,O\W#K 0>BNRL^G6(28-M)M^=0UF1 T;*I1\O,#KK2@
M0.<.=GXV0F7K:71P&.9A0_SL2X?K&7EO<\-W+E<XAAL7OSBVJ<?8\@Z(+/=J
MY8P;Y@EURTDO7'*CU3_<U!R4'8^=7W^,<SIW<('V]7&:^Z-:![KU_";&M2ZH
MI'^QD0V66$8/NC7-VDS_ @L]U0=6E2SULC>?ZSAM258%^)>B,UU%+WG4T23(
ME$+G[9+TH#('X/Z2W2X TO$;CR\,-J;=I84,Y-@.E2S.[]/M-CA_PBW*FT5P
MU I?[LM6>REWY%2T-LBEK^O#?N)U(PT!EYL'_Q@>?5=U^1.&2N=*$%W8"IQ9
MP8-V:U4%HW['$]U6\)'5B^MN;DWRNI8&/6("^8Q41DM&G-#)8.LEDB1H@J3Z
MVR'1B3;YA..OVC1&?6.$VZ)OX,<'WV^@[O:GXD$= T93@5.I7.\^0U)^RX)W
M5W9 H3397R<WYW?'"OWW5HKY!;9N33/6LY@Y2X2Q6;]AZ^T>$^2)A-'P+:4=
MT>;FAFBRR%>Q.IMSZL58&*_)1"SW1E3>C=<??%?8/KSD<2=[N8XKQ*$KJD5)
MZ@BUHB3@@$8DK1M#VBQ))_)8+=_C"J35#1_3"[5+NV_F&!7S.-";(MK2HX%'
M"./B!H8J2/4%.8>T0A(#VG1*^WMSEWQW@9$<FSJ+9LUU(X\4KY8G__#7'(\H
M:(A7^_ -ZX/2"Z#:GV=#=H&9ZH /;]%]2U6U+L=4M'V5*-L-KM,^OM=J/T>Y
MC+*[^!C,)J9?OX-99+;?T1SE]PNP'3'77< AING3JD#UUM&AD,D<ZZ;7K8<I
MAQYF,'I'M&1"0)<-T[J77CE4G,)UTJ?57;"1WWHT#W#.W.XZV4?1>0NV=65B
MJ9D\VE?"*06]D95Z[Z5-( L->0P?J://2UWNC]S7K!G'$R1W@<PD W0XT?PP
M.T;'XW2C+T5-)?G%NUS:"O&N,Y'IY8Y,>N?(E L&JQPRAJ.X8C17"1].MQSR
M#?,C?K'368MX(\9SV[1:'A:AI1&8$%AV@2K/O%";=5 OZ)G+19-*W%K<SV=G
M3*T42R)/-XBDY'H;<);+I:?$:]L'*XOO*8Q<?WO"O9?HC.TK[-W"SM</)!!J
M2%P(9B6Z+(7^7G^QTJIV_?H*AMX9)M[,3@U-$YT)HX^5Q$Y'A3@@;[E+S'R4
MLXQ=\6*T;)J'Q,^1T2D",29.?$_;3?+C,S5MG@+TYW:;W&2U=;O<H'T&LZ0[
M3/VUZL!+V@O.Y*_^JK>MV)077U&>F7SLM1Q9[9G8ULL'A,0B(OSNBH8H/V(I
MM;QNZ\&\[-7%Q2VE2R98Y#H$0S?[H[%RSK0;6<%T>EJ7? V9$L&^,#E("34J
M.SZY<0TJE?*1H"G':7^\GX&M(7SQ>!7J*80:/.+H_(1X]<X^\4:3XE<LHX#5
MC<#N&OC9QL%O7.GHLV1P336IR;\=P0$S_%@^I1=K)YW??4AL4SS;5S@6$?7-
MBJ64X3PWMSGI7S#%_VA]8UD6&D6K;PW+?#!V!">C5ENP#+C9,VTO[GVLZ9U)
M:@6\#,VBYN3G67IEP2FL\W7U<=NG6\ES**_RHN0KMB04<-+2#%ZX=^^O8C^:
M%E(D'+<>"!$/EG^QH1^K3T?[O$3J A)7&UEQ3ZKL[5IXF$-BK%_Q5GG%/AUH
MY#3U3;1=]DMXGI>G\IMK,$Y*:H*LMMT@J9U6H^"1Q>_I94"E/^TEEJJ.H W6
M#9\H*:I*)T3E)SGP-(^8THTJ);1O.@;J*W$Y^N5FOH*U%*G<!KQ3LLR^.)6R
MHKSVO:=HBK(E 3^Z8W='_@E02P$"% ,4    "  M=\I:Z"EI62H#  #N"P
M$0              @ $     9F]R9"TR,#(U,#4R."YX<V102P$"% ,4
M"  M=\I:\UN;6/T*  !_A@  %0              @ %9 P  9F]R9"TR,#(U
M,#4R.%]L86(N>&UL4$L! A0#%     @ +7?*6ABRMC-8!P  W%<  !4
M         ( !B0X  &9O<F0M,C R-3 U,CA?<')E+GAM;%!+ 0(4 Q0    (
M "UWREIW\U2L7><  #!3!0 2              "  106  !F;W)W87)D7V5X
M,#,P-RYH=&U02P$"% ,4    "  M=\I:FEKRX8T&  "@&0  $@
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M<F1?97@Q,#<N:'1M4$L! A0#%     @ +7?*6@JYC%#V    M@,  !(
M         ( !2&H" &9O<G=A<F1?97@R,3 Q+FAT;5!+ 0(4 Q0    ( "UW
MREK;#D+%:P(  .0'   2              "  6YK @!F;W)W87)D7V5X,C,P
M,2YH=&U02P$"% ,4    "  M=\I:1U4@_-&J  "V$04 #@
M@ $);@( 9F]R=V%R9%]S,2YH=&U02P$"% ,4    "  M=\I:<#;204,(  !
M"0  #0              @ $&&0, :6UA9V5?,# Q+FIP9U!+!08     #0 -
+ #L#  !T(0,    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>forward_s1_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="ford-20250528.xsd" xlink:type="simple"/>
    <context id="AsOf2025-05-28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000038264</identifier>
        </entity>
        <period>
            <startDate>2025-05-28</startDate>
            <endDate>2025-05-28</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:AmendmentFlag contextRef="AsOf2025-05-28" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="AsOf2025-05-28" id="Fact000004">0000038264</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="AsOf2025-05-28" id="Fact000009">S-1</dei:DocumentType>
    <dei:EntityRegistrantName contextRef="AsOf2025-05-28" id="Fact000010">Forward     Industries, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2025-05-28" id="Fact000011">NY</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2025-05-28" id="Fact000012">13-1950672</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2025-05-28" id="Fact000013">700 Veterans Memorial Highway</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="AsOf2025-05-28" id="Fact000014">Suite 100</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="AsOf2025-05-28" id="Fact000015">Hauppauge</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2025-05-28" id="Fact000016">NY</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2025-05-28" id="Fact000017">11788</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2025-05-28" id="Fact000018">(631)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2025-05-28" id="Fact000019">547-3055</dei:LocalPhoneNumber>
    <dei:EntityFilerCategory contextRef="AsOf2025-05-28" id="Fact000020">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="AsOf2025-05-28" id="Fact000021">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2025-05-28" id="Fact000022">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
